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ABSTRACT 
Stereophotogrammetry and dense surface modelling are novel techniques that have 
been used to study face shape in genetic and neurodevelopmental disorders. In people 
with epilepsy, it has been recognised that the condition may be associated with 
underlying structural variants or malformations of cortical development in some cases. 
Here I recruited 869 people with epilepsy or unaffected relatives and control subjects 
to study face shape. I sought to explore whether face shape and symmetry, using new 
metrics for each, could help to predict those people with epilepsy who may have 
potential underlying genetic or structural causes. 
My reproducibility studies found that stereophotogrammetry and dense surface 
modelling were susceptible to error from changes in head position or face expression, 
but not from camera calibration, image acquisition and image landmarking. The next 
study found that in people with epilepsy, a measurement of atypical face shape, Face 
Shape Difference (FSD), was significantly increased in those with pathogenic structural 
variants compared to those without pathogenic structural variants. The FSD value was 
used to predict the presence of pathogenic structural variants with a sensitivity of 66-
80% and specificity of 65-78%. Body mass index affects face shape in a partly 
predictable manner. The effect of body mass index differences was controlled for in a 
further analysis. I then analysed facial asymmetry and showed that it was increased in 
people with developmental lesions in the brain but not in people with pathogenic 
structural variants. A final study showed that stereophotogrammetry, dense surface 
modelling, FSD and reflected FSD could be used to study a single genetic disorder 
associated with epilepsy, to find previously unrecognised face shape changes. 
Stereophotogrammetry and dense surface modelling therefore appear to be promising 
tools to aid both in discovery of underlying causes for epilepsy and in understanding of 
such causes in terms of facial development. 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
1.1 THE STUDY OF FACE SHAPE 
The face is one of the most important visual stimuli in humans and is a prime 
determinant of perceptions of identity, age, sex, ethnicity, health, sexual attractiveness, 
mood, and attention (Leopold and Rhodes, 2010). Indeed, natural selection has played 
an important role in variation of human face shape (Guo et al., 2014). It is unsurprising 
that humans have analysed facial shape and appearance throughout history and now 
use advanced imaging for this purpose, as I will outline below. 
This introduction is divided into three sections. Firstly, I will discuss the study of face 
shape from physiognomy to dysmorphology. Secondly, I will review the methods used 
to measure face shape, including three dimensional (3D) stereophotogrammetry. 
Lastly, I will explore the relationship between epilepsy, genomics and face shape. 
1.1.1 ARISTOTLE AND PHYSIOGNOMY 
Aristotle was the first known person to document inferences about character and 
personality from facial appearance, in his treatise, Physiognomonica. For example, 
regarding the nose, he stated:  
A nose broad at the tip means laziness, as witness cattle: but if thick from the tip, it means 
dullness of sense, as in swine; if the tip is pointed, irascibility, as in dogs; whilst a round, 
blunt tip indicates pride, as in lions. Men with a nose thin at the tip have the 
characteristics of birds. When such a nose curves slightly right away from the forehead, it 
indicates impudence, as in ravens: but when it is strongly aquiline and demarcated from 
the forehead by a well-defined articulation, it indicates a proud soul, as in the eagle; and 
when it is hollow, with the part next the forehead rounded and the curve rising upwards, 
it signifies lasciviousness, as in cocks. (Aristotle, trans. 1913) 
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These findings developed into the field of physiognomy (previously termed 
‘physiognomony’) in the Middle Ages when Islamic and European students read 
Aristotle’s work and scholars expanded on his observations of face and body shape 
(Ziegler, 2007). Ibn Sina, a famous ninth century Persian physician, thought of 
physiognomy as a practical science alongside medicine, astrology and alchemy. Michael 
Scot, a 13th century Scottish scholar, thought of it as a natural science and suggested 
that changes in appearance of the face or body occur due to the body’s humours. 
Physiognomers attached special importance to face shape, with one historian stating 
that the face “being the window to all cerebral powers, was the most individual of all 
bodily organs. In the face appeared most clearly the differences between individuals of 
the same species, so that it was the best source of information for casting a 
physiognomic judgement” (Ziegler, 2007). 
Despite the contribution of Scot and other proponents, a glaring weakness of 
physiognomy was that nobody could scientifically explain the mechanism by which 
facial (or bodily) shape reflected a person’s character. Thus, it waned in popularity 
during the Renaissance. It was later resurrected by a Swiss priest, Johann Lavater, in 
the 18th century. Lavater thought “The natural and essential bony skull and its carefully 
measured proportions are the true indicators of the character of man” (Stemmler, 
1993).  
His publications on physiognomy included illustrations of silhouetted face contours 
taken in profile view. Without any known empirical evidence, Lavater speculates on the 
significance of certain features seen in silhouette form. For instance, the angle below 
the nose is associated with wisdom and the absence of straight lines is associated with 
a good nature (Stemmler, 1993). Lavater was not taken seriously in scientific circles, 
but his ideas popularised physiognomy in the following century, and in particular 
paved the way for phrenology. 
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1.1.2 GALL AND PHRENOLOGY 
Franz Joseph Gall, a German physician, was the founder of phrenology, an offshoot of 
physiognomy. Phrenology was the study of skull shape and its relationship with mental 
and psychological attributes. Gall believed a neuroanatomical hypothesis that the brain 
was divided into discrete areas, each responsible for a specific psychological quality. 
The size of these areas was correlated with the importance of their corresponding 
psychological quality. Gall then went further and stated that the size of each brain area 
could be calculated from measurements of the external surface of the skull. His first 
observation occurred as a schoolchild, when he apparently saw that students with 
excellent verbal memory tended to have prominent eyes (Simpson, 2005). Therefore, 
the faculty of memory was located in the inferior frontal part of the brain according to 
Gall (Eling et al., 2011). He measured plaster casts of live subjects’ heads or the skulls of 
deceased subjects. He studied hundreds of people including psychiatric patients, 
criminals, artists and others with particular psychological traits (Simpson, 2005). 
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Figure 1 A typical phrenology chart from 1883 showing discrete anatomical parts of the 
brain and the psychological qualities that they were thought to represent. Representation 
occurred bilaterally in both cerebral and cerebellar hemispheres (Taken from the public 
domain). 
Gall correctly surmised a few aspects of brain function localisation in his phrenological 
map of brain areas and their qualities. He predicted that unique human qualities, such 
as language, calculation and causality were located in the frontal lobes, which were 
larger than in other animals (Figure 1). Nevertheless, physiologists found that many of 
Gall’s brain areas either performed no apparent function or one completely different to 
Page | 23  
 
his theory. For example, physiological experiments showed that the cerebellum was 
responsible for motor co-ordination and not sexual function, which Gall had proposed. 
By the 1840s, physiologists also asserted that there was no evidence of a relationship 
between the external skull surface and the brain shape (Parssinen, 1974). 
Phrenology had already been widely disseminated with the aid of Gall’s assistant, 
Spurzheim. In the UK, phrenology societies and journals were set up. A national 
newspaper said phrenology was believed by “a very large proportion of the shrewdest 
and best-informed of the middle and labouring classes” and one phrenology publication 
was said to have the fourth highest all-time readership of any book in the UK 
(Parssinen, 1974). One of the major legacies of the discredited science of phrenology is 
its endurance in current popular consciousness. For example, the specialty of 
dysmorphology was linked unfavourably to phrenology in an international newspaper 
as recently as November 2015 (The Economist, 2015). 
1.1.3 LOMBROSO AND EPILEPSY 
Within neurology, the development of phrenology by Gall was refined by Cesare 
Lombroso, another man who was later discredited. Lombroso was an Italian 
neuropsychiatrist, who developed an interested in criminals and forensic anthropology. 
He made a link between criminals and people with epilepsy, describing it thus in 1906: 
“… the idea that the great criminality was a kind of equivalence of epilepsy came 
through my mind I began to rummage among epileptic skeletons and skulls and I found 
the same proportions in the median occipital dimple and in the facial asymmetry” 
(Monaco and Mula, 2011).  
In 1871, he had found a dimple in the region of the occipital crest in an autopsy of a 
bandit and described the presence of such a dimple as being a sign of epilepsy and 
criminal behaviour. He subsequently analysed the facial appearance of 410 people with 
epilepsy and stated that a quarter of them had facial features in common with 
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criminals32. Needless to say, there has been no corroboration of this but Lombroso’s 
work perpetuated the stigma of epilepsy. 
1.1.4 DYSMORPHOLOGY 
Clinical genetics is a small medical specialty, developing from the 1960s onwards, and 
currently there are 3.2 clinical genetics consultants per million population in the United 
Kingdom (Federation of the Royal Colleges of Physicians of the UK, 2011), and 3.5 
board-certified clinical geneticists per million population in the United States (Cooksey 
et al., 2006). Dysmorphology, a subspecialty of clinical genetics and paediatrics, is the 
study of people with congenital malformations and birth defects. The term was coined 
in 1966 by David Smith, one of the pioneers of the discipline (Smith, 1966). Notably, he 
was not only interested in craniofacial abnormalities but also in explanations of how 
they arose. For example, Smith describes cleft lip as a malformation due to defective 
fusion of the lateral and median nasal processes, occurring prior to 36 days’ gestation, 
and being associated with almost ten times greater concordance in monozygotic twins 
than in dizygotic twins (Smith, 1966). 
For approximately one-third of all clinical geneticists, their main patient group (defined 
as >40% of all patients seen) comprises those with birth defects or dysmorphology 
(Cooksey et al., 2006). Traditionally, abnormalities of face structure and shape are 
under the remit of the dysmorphologist. Genetics and facial shape are closely linked, 
with up to 40% of genetic disorders showing a craniofacial manifestation (Hart and 
Hart, 2009). Heritability for human face shape ranges from 0.51 to 1.0 in a review of 
studies of twins and populations using cephalometry and from 0.61 to 0.87 using 
anthropometry (Kohn, 1991). A more recent study used a digitizer probe to measure 
surface points on human skulls from a collection in which familial relationships 
between the deceased people were known. They found significant heritability for 72% 
of craniofacial distances measured between skulls (Martínez-Abadías et al., 2009). 
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These findings are also found in studies of individuals using skull radiographs (also 
termed ‘cephalograms’).  
Such studies have only assessed the skeletal shape, but others have investigated soft 
tissue face shape. One group found that the genetic contribution to four facial 
measurements was 62-71% from assessing 79 pairs of twins (Savoye et al., 1998). 
Another study looked at 16-year-old children and their parents, finding that average 
heritability was about 0.7-0.8 for facial measurements but much less for dental 
measurements (Johannsdottir et al., 2005). It is important to note that many facial 
similarities are not captured by linear or angular measurements of the face (as used in 
all of the above studies) but nonetheless are well-recognised from human observation 
of monozygotic twins, families and ethnicities.  
There are three aspects of dysmorphology that I will consider here. Firstly, 
dysmorphologists may sometimes use quantitative methods, such as anthropometry, 
but more often rely on recognising a facial ‘gestalt’ and the constellation of features of a 
given syndrome. Such recognition requires years of experience with highly specialised 
training, and it has been suggested that the necessary skills cannot be taught formally 
(Reardon and Donnai, 2007; Robin, 2011). 
Secondly, the terminology used to describe findings may be a hindrance. Descriptions 
and terms are important in communication of dysmorphic features, be it in clinical case 
reports or in databases of congenital syndromes. Clinical geneticists use these 
publications and databases to identify syndromes and the need for standardised 
nomenclature was stated even in the 1980s (Diliberti, 1988). 
Such nomenclature has been slow to develop. As stated by an international panel of 
senior dysmorphologists in 2009: “The terms that clinicians use to describe a body part 
have gradually evolved in a haphazard and uncoordinated manner, and have not been 
critically reviewed” (Allanson et al., 2009a). For example, a finding such as ‘low-set 
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ears’ may have different meanings to different physicians. There are at least three 
anatomical reasons and eighteen corresponding diseases for why ears may appear to 
be low-set but are not truly low-set (Robinow and Roche, 1973). Other examples are 
the inability to define intermediate forms of polydactyly in the existing classification, or 
the presence of three overlapping and imprecise terms for a small eye (Biesecker, 
2005). 
The aforementioned international expert panel went on to publish a list of standardised 
definitions of a number of terms used in dysmorphology in 2009 (Allanson et al., 
2009b; Biesecker et al., 2009; Carey et al., 2009; Hall et al., 2009; Hennekam et al., 
2009; Hunter et al., 2009), which I have summarised in Table 1. For each term, the 
expert authors classified its definition as ‘objective’ or ‘subjective’ or ‘both’ if both 
alternatives existed. As an example, ‘macrotia’ was defined objectively as “median 
longitudinal ear length greater than 2SD above the mean and median ear width greater 
than 2SD above the mean” and was also defined subjectively as “apparently (sic) 
increase in length and width of the pinna” (Hunter et al., 2009). Some of these objective 
definitions rely on available normative values, notably from tables of face shape 
measurements using direct anthropometry (Farkas, 1994; Feingold and Bossert, 1974; 
Hall et al., 2007; Merlob et al., 1984). Even in this up-to-date list of dysmorphological 
features, 62% (244 of 396) of all terms only have subjective definitions. Also, 358 
recognised synonyms exist for the standardised definitions adding to the complexity of 
the nomenclature. 
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Body area Nos of 
terms 
Type of definition used  Nos of 
synonyms 
Examples of 
subjective terms Objective Subjective Both 
Cranium 10 0 6 (60%) 4 7 Plagiocephaly 
Scalp hair 9 2 5 (56%) 2 5 Low posterior hairline 
Face 9 0 5 (56%) 4 3 Triangular face 
Forehead 12 0 9 (75%) 3 9 Frontal bossing 
Maxilla, 
midface 
12 0 12 (100%) 0 17 Midface retrusion 
Mandible 6 1 3 (50%) 2  Micrognathia 
Chin 8 0 8 (100%) 0 3 Chin dimple 
Neck 5 0 5 (100%) 0 4 Neck webbing 
Periorbital 39 4 26 (67%) 9 26 Epicanthus 
Ear 73 33 37 (51%) 3 70 2nd degree microtia 
Nose 41 9 27 (66%) 5 46 Bifid nose 
Philtrum 10 2 4 (40%) 4 6 Tented philtrum 
Lips 15 3 8 (53%) 4 17 Lip freckle 
Mouth 9 2 5 (56%) 2 14 Upturned corners 
Oral cavity 36 11 20 (56%) 5 24 Small tongue 
Hands, feet 83 23 48 (58%) 12 97 Pes cavus 
Creases 7 3 4 (57%) 0 3 Absent palmar crease 
Nails 12 0 12 (100%) 0 7 Small nail 
All areas 396 93 244 (62%) 59 358  
Table 1 Dysmorphological terms, the objectivity of their definitions, and their synonyms. All 
of the terms used in a list of standardised definitions of dysmorphic features are included 
according to body area. Each of the 396 terms was defined by the expert panel using what 
they called ‘Objective’ criteria, ‘Subjective’ criteria or ‘Both’ objective and subjective 
criteria. Examples of the subjectively defined terms are in the final column. As well as 244 
(62%) dysmorphological terms only being defined subjectively, there also exist 358 
synonyms, adding to the complexity of the nomenclature. The list of terms can be found in a 
series of six review articles (Allanson et al., 2009b; Biesecker et al., 2009; Carey et al., 2009; 
Hall et al., 2009; Hennekam et al., 2009; Hunter et al., 2009). 
Thirdly, other physicians, especially in adult medicine and general practice, receive 
little training in dysmorphology and clinical genetics, and are less familiar with these 
fields (Taylor et al., 2006; Watson et al., 1999). Data from a 2003 survey of UK general 
practice and specialty trainees revealed that 85% of trainee general practitioners and 
46% of specialty trainees had no postgraduate genetics training (Burke et al., 2006). Of 
note, 63% of neurology trainees nevertheless thought that genetics was an element of a 
case at least once a week. In a more recent 2012 survey of family physicians in the USA 
and Canada, 54% of respondents said that they were not knowledgeable about genetic 
testing (Mainous et al., 2013). Also in the USA, surveys have reported that 26% of 
medical students in clinical training have formal teaching in genetics (Wolyniak et al., 
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2015). Similarly, 22% of allied health professionals reported that they had at least 
‘satisfactory’ training in genetics (Christianson et al., 2005). About two-thirds of 
neurologists and psychiatrists in the USA do not feel confident about genetic testing 
and 49% of neurologists do not have access to a geneticist (Salm et al., 2014). 
On the other hand, only a minority of clinical geneticists specialise in adults – 7% 
according to one US study (Cooksey et al., 2006). There is concern that a large 
unidentified population of adults with dysmorphic features and genetic syndromes 
remain undiagnosed by their physicians, compounded by the fact that multiple 
physicians may be involved in treatment of the different manifestations of a patient’s 
syndrome (Taylor et al., 2006; Williams, 2007). In one study, the referral of adults to an 
adult clinical genetics service resulted in 50% of them having their overall diagnosis 
changed, often on the basis of clinical examination alone (Maves et al., 2007). 
In conclusion, dysmorphology is practised by only a few clinicians and it is not 
necessarily objective or consistent between such practitioners. Many adults with 
genetic syndromes or dysmorphism may not be identified in the course of their clinical 
care.  
By contrast, there have been significant advances in imaging-based analysis of facial 
shape, particularly using 3D stereophotogrammetry, and these techniques may be 
useful in clinical practice. 
1.2 THE STUDY OF FACE SHAPE MEASUREMENT 
1.2.1 DIRECT ANTHROPOMETRY 
Anthropometry is the study of measurement of humans. Measurements can be made 
directly on a subject or indirectly from images of the subject. Modern facial 
anthropometry developed as a method of identification of criminals in late nineteenth 
century Paris. Alphonse Bertillon devised a system to identify people based on ten 
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measurements. These included head length, facial width and ear length, but the scope 
for error in measurements led to its demise in forensics use in favour of fingerprinting 
(Maguire, 2009). 
Craniofacial anthropometry for clinical use was pioneered by Leslie Farkas, a 
Hungarian plastic surgeon in the late twentieth century. He advocated precise 
measurement of the human face by using sliding callipers, spreading callipers, angle 
meters and measuring tape. He also placed emphasis on soft tissue facial ‘landmarks’ 
that could be reliably identified in different subjects. 
Landmarks are specific anthropometric points on the face surface that are reproducible 
and precisely defined. Once identified, distances and angles may be calculated between 
them. Farkas described 47 landmarks on the head and face (Farkas, 1994) and many of 
these were originally identified by artists during and after the Renaissance (Farkas et 
al., 1985). As such, many of them can be identified visually either by colour (e.g. lip 
contour) or shape (e.g. eyelid contour). A remaining few landmarks are derived from 
cephalometric points and traditionally were identified using palpation, such as soft 
tissue gnathion: Gnathion is the midpoint of the lower border of the mandible and soft 
tissue gnathion is the point anterior to that on the skin surface. Others, such as 
opisthocranion are on the posterior aspect of the head and therefore not facial 
landmarks. 
Most importantly, Farkas used measurements between landmarks in large groups of 
subjects of different age, sex and ethnicity, to create tables of normative values (Farkas, 
1994). 
The normative data could be used for clinical measurements. For example, Farkas and 
colleagues used craniofacial anthropometry in people with Down syndrome to show 
that 37% of measurements were ‘subnormal’ or ‘supranormal’ – i.e. outside normal 
limits of two standard deviations from the same measurement in the mean age-
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matched, sex-matched control face. Subnormal measurements included head 
circumference in 71%, head length in 66%, midface depth in 63%, and ear length in 
72% of people with Down syndrome (Farkas et al., 2001). Farkas took this approach a 
step further. A list of those measurements that differ most from the normal value were 
compiled. Then the z-scores of deviation from the mean were plotted on a single axis 
for each of these measurements. The resulting graph displays the z-scores and the 
pattern was described as a ‘craniofacial pattern profile’ (Figure 2). Different subjects 
can be plotted on the same graph to assess similarity in facial appearance. This method 
was used for Down syndrome, in which craniofacial pattern profiling had a sensitivity 
of 97% (Allanson et al., 1993). 
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Figure 2 Craniofacial pattern profile for two patients with Sotos syndrome. Not shown as 
unable to confirm copyright clearance. 
Craniofacial anthropometry is not routinely used in clinical practice despite the above 
benefits. The use of such instruments is time-consuming and it may be difficult for 
subjects, such as children, to co-operate with the examination. Farkas describes the 
need for exact positioning of the subject, with some measurements best taken with the 
subject supine and others taken in the ‘standard’ head position (Farkas, 1994). He 
further notes that an assistant is sometimes needed to ensure the correct position. 
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Another disadvantage is that measurements can only be taken with the subject present. 
This may result in inadequately trained individuals taking the measurements, and no 
opportunity to rectify any errors afterwards (Allanson, 1997). One study found that in 
0.5% of measurements by experienced researchers, the value was recorded wrongly, 
introducing a further error into calculations (Jamison and Ward, 1993). 
At present, no study has used an automated form of direct anthropometry. In other 
industries, co-ordinate measuring machines are used for precise surface measurements 
in manufacturing but these are unacceptably slow for clinical use. For the human face, 
co-ordinate measuring machines have only been used for facial casts (Ayoub et al., 
2003; Khambay et al., 2008; Lincoln et al., 2015). One related technique, which has not 
been widely used, is to use a handheld digitiser to trace the contour of a surface or 
record specific points in 3D space. One centre has used the Microscribe digitiser 
(Solution Technologies Inc; Oella, MD, USA) to assess 50 soft tissue landmarks on the 
face (Ferrario et al., 2004). The subject’s head had to be fixed in a frame and collection 
of landmarks, which were already pre-marked on the skin, took approximately one 
minute by an operator. Accuracy was within 1.1mm of direct anthropometry for eight 
out of eight distances, with a mean error of 0.22mm (Ferrario et al., 1998). 
1.2.2 INDIRECT ANTHROPOMETRY (TWO DIMENSIONAL) 
Indirect anthropometry is the use of images to perform anthropometric measurements. 
Two-dimensional (2D) imaging of the face can be in the form of photographs 
(photogrammetry) or radiographs (cephalometry). 
The term ‘photogrammetry’ was coined in 1867 by Albrecht Meydenbauer, a German 
surveyor (Albertz, 2007). He described the use of a camera with crosshairs, at a known 
distance from the target, to provide measurements of the target just from the camera 
images. Since then, his technique has been successfully used in architecture and 
mapping. Photogrammetry of the face has been performed for research since 1940 
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(Beard and Burke, 1967) and unlike standard anthropometry, it allows for a permanent 
record of facial shape to be stored as two-dimensional images that can be reanalysed if 
needed. Usually at least two photographs are needed: the first is a frontal view, and the 
second is a lateral or profile view. An oblique view may also sometimes be taken. A 
number of shortcomings of photogrammetry have been described. 
Farkas found that there was a significant systematic error when using photogrammetry 
(Farkas, 1994). Three measurements were consistently longer: facial width by an 
average of 3.6mm, nasal width by 2.4mm, and lower facial width by 21.6mm. Eleven 
measurements were consistently shorter and another fifteen showed mixed 
differences. Farkas had two main explanations for this. Firstly, landmarks are not 
always visible or clear enough on a photograph, even when marked on the subject’s 
face beforehand. This may be due to obscuration by other parts of the subject’s face or 
hair. Secondly, photographic distortion occurs. Diliberti and Olson identified 12 sources 
of error when a three-dimensional (3D) object is photographed on to two-dimensional 
film (Diliberti and Olson, 1991). One is projection error due to the short distance 
between the camera and the subject. For instance, in frontal views, the distance 
between the tip of the nose and the base of the nose was 46% shorter on 
photogrammetry compared to direct anthropometry, whereas the distance from the 
root of the nose to the lips was much more concordant (Farkas, 1994). The 
measurement error is exaggerated in this case because it is perpendicular to the 
focusing plane. Poor lighting, poor focusing and poor head positioning also introduce 
errors. One study, of 14 children and adults with 22q11 microdeletion syndrome, found 
that 5 out of 14 different facial measurements differed by at least 10% between direct 
anthropometry and photogrammetry (Guyot et al., 2003). Four of these measurements 
were taken from frontal photographs in which different landmarks may be at different 
depths relative to the measurement plane. There is less variability in depth for profile 
photographs. 
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A software program has also been developed to analyse facial features from a single 
colour photograph of a subject and compare it to faces in a database of dysmorphology 
syndromes. Two case reports of its success in retrospectively detecting facial features 
of two genetic disorders have been published so far (Gripp et al., 2016). 
Cephalometry uses multiple radiographs of the skull and facial skeleton. Measurements 
of various bony landmarks are taken and compared to normative values. The technique 
involves exposing subjects to ionising radiation, and does not utilise any soft tissue 
landmarks, thereby disregarding much information about facial appearance (Allanson, 
1997). 
1.2.3 INDIRECT ANTHROPOMETRY (THREE-DIMENSIONAL) 
Over the last two decades, more advanced imaging methods have been developed that 
can capture and store the three-dimensional (3D) face surface. Three methods capture 
only the exterior face surface: moiré photography, laser scanning and 
stereophotogrammetry (see Section 1.2.5). Two methods also capture the underlying 
craniofacial skeleton: computed tomography (CT) and magnetic resonance imaging 
(MRI). 
Moiré photography of the face was first described in the 1970s. A camera is placed 
behind a grid and thus projects a moiré pattern of alternating light and dark fringes on 
the surface of the target object. The fringes are distorted by curvature of the object and 
resemble contour lines. The surface with the superimposed bands can be captured in a 
photograph. In one study of face shape, there was a 10% error in length calculations 
(Madden and Karlan, 1979). Also, to calculate fringe spacing, faces had to be 
maintained very close to the camera with the nose less than 1mm away. A study using 
facial soft tissue landmarks also found that accuracy and precision were poor (Douglas, 
1986). One group used moiré photography to measure lip morphology in infants and 
control adult faces (Kawai et al., 1990a, 1990b). However, a frame was used to fix the 
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head in position along with a long shutter speed of 250ms. Major disadvantages of the 
technique are limited field of view, poor accuracy and a cumbersome setup.  
More recently, a team have compared moiré photography, using a standard projector 
and personal computer, with stereophotogrammetry (Artopoulos et al., 2014). They 
found no significant differences between the two with a mean surface error of 0.14mm 
for moiré photography and 0.15mm for the Di3D stereophotogrammetry system 
(Dimensional Imaging, Glasgow, UK). However, the study is of limited relevance 
because the authors used polymer face models with a reflective coating and only 
analysed the middle third of the face. Moiré photography from one source could not 
capture the ears or jawline. Also both systems had slow shutter speeds (0.07s for moiré 
photography and 0.05s for the Di3D system) compared to other stereophotogrammetry 
devices. 
Laser scanning uses a laser and a sensor placed at a known angle and distance from the 
laser. A spot or stripe (also called ‘slit’) is projected on to the target surface and its 
scattered reflection is detected by the sensor. Triangulation is used to calculate the 3D 
co-ordinates of the surface point. Typically, the laser beam must move across the face 
in sequential horizontal or vertical stripes. Scanners may be portable. Accuracy has 
been reported to be 1.9±0.8mm for face shape measurements using a plaster model 
(Kau et al., 2007). The principal disadvantage is that scan acquisition times are at least 
0.3-7 seconds for the face (Kau et al., 2005), which means accuracy may be reduced due 
to movement in a living subject. One review describes subject discomfort during laser 
scanning (Riphagen et al., 2008) and the eyes must be closed with some lasers, thus 
limiting capture of periocular shape, including the palpebral fissure. As the laser beam 
originates from one static source, there may be limited coverage of sharply contoured 
face regions (such as the eyes, nose and lips) causing artefacts. Another disadvantage is 
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that there is no surface colour information, unlike in stereophotogrammetry, meaning 
that some facial landmarks may not be identified as accurately. 
1.2.4 COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING 
Clinical CT scanners use X-rays to construct face structure using stacked slices, usually 
5mm apart. An advantage is that detailed information about bony structures 
underlying the face surface is also known. This allows bony landmarks to be used, 
which should be less affected by movement or facial expression than soft tissue 
landmarks. Facial bone structure is also known to be affected in some conditions 
affecting face shape, such as fetal alcohol syndrome (Sant’Anna and Tosello, 2006). In 
one study comparing 3D CT to stereophotogrammetry in 70 people, CT could only 
identify half of all (14 of 28) facial landmarks used (Metzger et al., 2013). 
MRI scans of the head can also generate 3D images of the face and underlying 
structures. They have been used for assessing face shape in children in three studies by 
one group (Chakravarty et al., 2011; Liu et al., 2012; Marečková et al., 2015). MRI has 
the potential advantage of capturing detailed brain structure as well as craniofacial soft 
tissue and skeletal shape. In one study, face shape, particularly jaw length, was found to 
explain 8% of brain size variance in 12-18-year-old French Canadian girls (Marečková 
et al., 2015). Brain images were not analysed in the same 3D image as craniofacial 
landmarks. Instead the brain outline was extracted from the raw MRI images and then 
brain volume was calculated (Smith et al., 2002), so more sophisticated analysis of the 
relationship between brain and face shape was not possible. 
The main disadvantage of CT scans is that they expose a subject to ionizing radiation. 
MRI scanners use no ionizing radiation but generate a strong magnetic field and cannot 
be used in people with some electronic medical devices (e.g. vagal nerve stimulators, 
pacemakers) or metal implants. The presence of metal, such as dental crowns, may 
create artefacts on CT images. Both types of scan are relatively contraindicated in 
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pregnant women. Size and weight restrictions apply to subjects as they must be able to 
lie on a gantry within a tunnel-shaped scanner. As well as subjects transferring 
themselves on to a gantry, they must be able to lie still for at least 10 seconds for a CT 
scan and over a minute for an MRI scan.  
Lying supine introduces another error. Facial structures, including soft tissue and the 
mandible, are known to be distorted by the force of gravity in different postures (Kau et 
al., 2007). Facial landmarks moved by 1-4mm in the sagittal and in the frontal planes in 
all subjects lying supine in one study (O’Boyle et al., 1996). 
Scanners are very expensive, requiring dedicated staff, and are not portable. The 
resulting images do not capture any surface colour, which may be important for 
identifying certain facial landmarks. MRI images may not capture all of the facial 
surface: in one study, the authors inferred the location of missing facial landmarks 
using 2D photographs (Liu et al., 2012). 
1.2.5 STEREOPHOTOGRAMMETRY 
One powerful method for investigating facial shape is stereophotogrammetry, an 
extension of photogrammetry. Stereophotogrammetry is a specific form of 
photogrammetry that uses at least two or more photographs to determine 3D 
measurements and co-ordinates.  
In the 1930s, clinicians applied cartographic principles to create contour maps of the 
human face using multiple cameras and plotting machinery (Beard and Burke, 1967). 
The time, effort and cost needed to produce such contour maps prevented them being 
used clinically. In 1989, Thomas and colleagues described the use of three 35mm 
cameras to simultaneously acquire images of a subject’s face (Thomas et al., 1989). 
Landmarks were marked after the images were digitised and then computer software 
created a 3D map of the landmark co-ordinates. In the last twenty years, at least three 
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manufacturers have developed commercial stereophotogrammetry systems for the 
human face (Tzou et al., 2014). The technique has been used in orthodontics (Lane and 
Harrell, 2008), plastic surgery (Honrado and Larrabee, 2004), forensic science (Evison 
et al., 2010) and dysmorphology (Hammond et al., 2004). It has also been used to study 
facial attractiveness (Galantucci et al., 2014) and ethnic variation in face shape (Kau et 
al., 2010). 
Stereophotogrammetry uses at least two cameras to take images simultaneously with 
subsequent image processing by computer software. Accuracy is reported to be within 
0.5mm for all major commercial systems (Riphagen et al., 2008; Tzou et al., 2014). 
Image acquisition time is shorter than with other methods and often under 4 
milliseconds (Lane and Harrell, 2008). Cameras are portable, emit no laser or ionising 
radiation and collect surface texture and colour information. 
It is important to maintain a fixed, known spatial arrangement between cameras or else 
accuracy is compromised. In commercial systems, up to six cameras are usually housed 
in a casing to fix their positions. In addition, before each use, most camera systems 
must be calibrated to adjust for any small changes in the positions and angles of all 
cameras. 
A stereophotogrammetry device also has computing hardware to create a 3D image 
and the process has been described in detail (Lane and Harrell, 2008). The image is 
comprised of two parts: a set of 3D surface co-ordinates describing the geometry of the 
surface, and a colour photograph of the skin and texture. A computer program 
combines these to create the final 3D image. The set of 3D co-ordinates may be referred 
to as a ‘point cloud’ and comprises tens of thousands of points. Older devices may 
generate multiple sets of 3D surface co-ordinates and ‘stitch’ them together, whereas 
newer systems generate one 3D surface immediately, reducing errors. The colour 
photograph is then projected on to the 3D surface in an image viewer software 
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program to allow facial features and landmarks to be more easily identified. However, 
it should be noted that the colour photograph itself is not used in face shape analysis. 
Passive stereophotogrammetry uses natural facial features to identify common points 
between each camera’s image. The method depends on background lighting and may 
not work for uniform regions of colour and texture. Active stereophotogrammetry 
combines light projection with stereophotogrammetry. A random light pattern is 
‘actively’ projected on to the face at the exact time of image capture. Projecting light 
makes the camera less dependent on background lighting conditions and a random 
pattern is used to help detect facial contours, since uniform areas of colour and texture 
are the hardest to capture accurately. The projected light pattern is not present in the 
final generated 3D surface. Note that in practice, most commercial cameras, including 
the one used for my work, apply passive stereophotogrammetry but also use a 
photographic ‘flash’ at the time of image capture. Thus passive systems can also reduce 
the effect of background light variation on image quality. 
A related technique to active stereophotogrammetry is that of structured light 
projections. Here, a specific non-random light pattern is projected on to the face. The 
light pattern is deformed by the face contour and captured by one or more cameras. 
The deformed light pattern itself is used to identify the same point on a face surface in 
each camera. One widely used structured light system (Axis Three, Miami, FL, USA) was 
compared to three stereophotogrammetry devices and found to have a slower image 
capture time of 1-2s and an accuracy of 0.5mm compared to 0.1-0.3mm for 
stereophotogrammetry (Tzou et al., 2014). 
The accuracy of stereophotogrammetry for face images has been assessed in 13 
published studies (see Table 5 in Chapter 3), which are discussed in detail in Chapter 3. 
Accuracy was assessed in most studies by comparing the distance between two face 
surface landmarks using stereophotogrammetry with the ‘gold standard’ direct 
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anthropometric measurement. The mean error from eleven of the studies was 0.52mm 
and another two reported the error as being less than 1mm without providing exact 
values. Precision or reproducibility error in seven studies was approximately 0.8mm 
but varied from 0.06mm in automated repeat imaging of mannequin heads, to 2.8mm 
for distances on infant scalps between different operators. 
1.2.6 METHODS OF ANALYSING 3D FACE SHAPES 
1.2.6.1 SHAPE ANALYSIS USING DIRECT ANTHROPOMETRY 
Direct anthropometry and indirect anthropometry, including stereophotogrammetry, 
allow the creation of a 3D co-ordinate map of the face surface. In the instance of direct 
anthropometry, the 47 classical landmarks described by Farkas could be used as the 
point co-ordinates. These points were used to measure 103 linear and arc distances, 
and 29 angles (Farkas and Deutsch, 1996). A three-dimensional map could theoretically 
be constructed using trigonometry from such measurements. No such map has been 
created or used in clinical research but combinations of linear and arc measurements 
have been analysed together.  
Farkas had a database of normative distributions for each of the distances between 
facial landmarks and for each subject, he could create z-scores, which were the number 
of standard deviations of a measurement from the age-matched, sex-matched mean 
measurement (Farkas, 1994). As aforementioned, the distribution of z-scores for 
different facial measurements can be displayed graphically as a craniofacial pattern 
profile (Figure 2). Building upon this, Farkas and colleagues developed the ‘craniofacial 
variability index’, which measured the ‘degree of facial disharmony’ in subjects (Ward 
et al., 1998). The z-scores of 16 distances throughout the face are found and then the 
standard deviation of these z-scores is calculated to give the index. A high craniofacial 
variability index was found to correlate with subjective impression of dysmorphism in 
a range of syndromes. However, small numbers of patients with syndromes were 
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included – no more than four for any syndrome – and all of the syndromes, such as 
Crouzon syndrome, were chosen because they clearly affect craniofacial features. 
Landmarks have been used to derive volumes. An Italian study conducted crude 
estimates of lip and nose volume from 3D images of people with Down syndrome 
(Ferrario et al., 2004). This was done by assuming the lip or nose comprised tetrahedra 
defined by four landmarks each. For example, the nose consisted of one tetrahedron 
using both alar crests, pronasale and subnasale, and another tetrahedron using the 
same landmarks except with nasion instead of subnasale (Figure 3). 
 
Figure 3 Nasal volume can be calculated using five landmarks by approximating the nose to 
two tetrahedra. The nasal landmarks used are shown in an inferior view and profile view. 
The first tetrahedron has a base formed from both alar crests (Ac) and pronasale (Prn) 
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with the apex formed by nasion (N). The second tetrahedron has the same base but uses 
subnasale (Sn) as the apex. Figure used with permission from Ferrario et al, 2004. 
In a more mathematical approach, one group in Dublin used only five landmarks of the 
face (nasion, subnasale, gnathion, left and right tragions) and nine distances between 
the landmarks to compare face shape in patients with schizophrenia and people 
without (Hennessy et al., 2004). They used direct calliper measurements for all nine 
distances and used these to derive 3D point co-ordinates for all five landmarks, which 
they thought of as the face shape. The authors termed their next step ‘geometric 
morphometrics’ (Hennessy and Stringer, 2002). In this, they used generalised 
Procrustes analysis to align the 3D face shapes together. Then a set of eight principal 
components was used to describe the variations seen between patients and control 
subjects, with just three principal components being able to distinguish the two groups 
of subjects. These processes are also described later. The authors noted that their 3D 
analysis allowed them to identify subtle differences in face shape that were missed on 
an earlier analysis, by the same group, based solely on landmarks (Lane et al., 1997). 
One such difference was of a lengthened lower mid-face height in patients. Thus even a 
limited analysis using five surface points was more discriminating in some areas than 
using inter-landmark distances alone. 
1.2.6.2 SYMMETRY ANALYSIS USING EARLY STEREOPHOTOGRAMMETRY 
Stereophotogrammetry also allows for classical anthropometric measurements to be 
found with high reproducibility and for more complex analysis. Normative data on 
inter-landmark distances has been created for Italian children using 
stereophotogrammetry instead of direct anthropometry (Ferrario et al., 1999). High 
reproducibility has also been shown in studies of subjects with facial dysmorphism 
(Aldridge et al., 2005; Heike et al., 2009). The technique also has the potential to 
analyse facial structure in much more detail than direct anthropometry. Using the first 
stereophotogrammetry devices, researchers were able to construct precise lines 
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between landmarks and then reference planes on digital images. These annotations 
were used to quantify facial asymmetry and show it is significantly greater in those 
people with operated cleft palates (Ras et al., 1995). Another group studied facial 
asymmetry using distances and angles between landmarks, and compared a control 
population with people affected by one of eighteen syndromes (Shaner et al., 2000). 
They could find no significant difference in asymmetry and they note a number of 
limitations. The choice of particular landmarks means that only those landmarks are 
assessed for asymmetry and not other parts of the face. Also, asymmetry of one 
landmark may have been compensated for by asymmetry in the other chosen landmark 
too, as was the case for tragion and subnasale. 
1.2.6.3 SHAPE ANALYSIS USING LASER SCANNING 
The aforementioned group in Dublin applied geometric morphometrics to analyse 
sexual dimorphism using laser scanning, showing statistical differences between male 
and female face shape (Hennessy et al., 2002). Laser scanning, landmarking of 65 points 
and generalised Procrustes analysis was used by another group to study schizophrenia 
and they found that the face was vertically elongated in patients (Buckley et al., 2005). 
These findings should be applicable to stereophotogrammetry too. 
Laser scanning was also used by Paternoster and colleagues to collect face images in 
over 3800 subjects as part of the Avon Longitudinal Study of Parents and Children, for 
whom genetic data had already been collected (Paternoster et al., 2012). They then 
carried out a genome-wide association study for 54 landmark distances in the face. One 
distance between nasion and menton was significantly associated with a SNP in an 
intron of the PAX3 gene and this association was also successfully replicated. The 
authors found that 1.3% of the variation in nasion-menton distance was explained by 
this polymorphism. There are three factors complicating interpretation of this finding. 
Menton is not a face surface landmark but rather a derived point from calculations 
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using other landmarks. No other measurement using menton and no other 
measurement along the same axis as nasion-menton was found to be associated with 
any SNP. Thirdly, the PAX3 gene is implicated in Waardenburg syndrome, a syndrome 
characterised by telecanthus and a broad nose, but these features are not associated 
with variation in the nasion-menton distance. On the other hand, a similar genome-
wide association study using upper face landmarks from MRI imaging data as well as 
2D photography, also found an association between the PAX3 gene locus and distances 
between the endocanthion and nasion (Liu et al., 2012). 
1.2.6.4 MATRIX ANALYSIS USING STEREOPHOTOGRAMMETRY 
Another landmark-based method is the Euclidean distance matrix analysis (Lele and 
Richtsmeier, 1995). This method involves the creation of a matrix of all distances 
between all landmarks; for example, with 22 landmarks, there would be (22x21/2) = 
231 inter-landmark distances. The matrices between different subjects can be 
compared mathematically without the need to adjust for face size or orientation. This 
approach has been used in conjunction with standard inter-landmark distance 
comparisons in one study with conflicting results (Weinberg et al., 2008). Standard 
inter-landmark distances identified a different pattern of face shape differences from 
matrix analysis in two groups, controls and relatives of people with cleft lip/palate. 
Furthermore, the matrix analysis results only appeared to be significant at p<0.1, 
instead of p<0.05 used for inter-landmark distances. This would suggest matrix 
analysis offers little improvement over inter-landmark distance comparison. Others 
have also noted that the technique only assesses distances but not the underlying facial 
shape, and visualising specific differences in face shape is difficult (Hallgrimsson et al., 
2015). 
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1.2.6.5 CONCLUSION 
Even with all of these complex analyses, only a few facial landmarks were studied. This 
means that the data of the other thousands or tens of thousands of surface point co-
ordinates with 3D imaging is discarded. As one review states “Landmarks do not 
contain information on the spaces, curves, or surfaces between them” (Richtsmeier et 
al., 2002). 
Dense surface modelling is one method that overcomes many of the limitations of 
landmark-based anthropometry and is only possible with 3D imaging techniques. 
1.2.7 DENSE SURFACE MODELLING USING STEREOPHOTOGRAMMETRY 
Dense surface models (DSMs) of the face were developed by Tim Hutton and Peter 
Hammond (Hutton, 2004; Hutton et al., 2001). The method allows complex shape 
surfaces to be compared with each other in their entirety. The process begins with 
landmark-based anthropometry. A sparse set of landmarks is manually identified by an 
operator on a 3D face image. Each landmark is said to have correspondence between 
different images because it identifies the same anatomical point. The set of landmarks 
is then used to co-register face surfaces together. Once registered, a dense 
correspondence is created from the previous sparse (landmark-based) 
correspondence. The dense correspondence uses all of the surface point co-ordinates of 
the specified region, which may be the whole face or just one part of the face. Principal 
component analysis is used to reduce the dataset of approximately 20,000 surface 
points to 30-200 principal components, which describe almost all of the face shape 
variation. The process is described in more detail in Chapter 2. 
Dense surface modelling was first applied to images captured using 3dMD DSP400 and 
3dMD MU2 camera systems (Hammond et al., 2004). It has also been used with images 
captured by the Canfield Vectra CR-10 system (Cox-Brinkman et al., 2007; P. Hammond 
et al., 2008). It has been successfully used to discriminate face images of control 
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subjects from those with 22q11 deletion syndrome, Cornelia de Lange syndrome, Fabry 
disease, fetal alcohol syndrome, fibrodysplasia ossificans progressiva, fragile X 
syndrome, Noonan syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, 
Williams syndrome and Wolf-Hirschhorn syndrome (Bhuiyan et al., 2006; Cox-
Brinkman et al., 2007; de Souza et al., 2013; Hammond et al., 2012a, 2012b, 2005, 2004; 
Heulens et al., 2013; Suttie et al., 2013). DSM-based analysis identified an unrecognised 
facial phenotype in mild Wolf-Hirschhorn syndrome and Bardet-Biedl syndrome 
(Hammond et al., 2012a; Tobin et al., 2008). Another DSM-based analysis could predict 
the facial shape of people with genetic deletions based on the shape of the faces of 
people with corresponding duplications at the same locus (Hammond et al., 2014). 
The Dublin group, mentioned earlier in Section 1.2.6.1, later developed their technique 
to incorporate further surface points after manual landmarking, which they call 
‘pseudolandmarks’. Up to 1700 pseudolandmarks are incorporated into an image by 
using geometric morphometrics combined with dense correspondence creation, which 
is done using the method developed by Hutton. Using this they found an increased 
facial width and altered facial height in people with schizophrenia or bipolar disorder 
(Hennessy et al., 2010, 2007). 
Another more recent study also combined 3D stereophotogrammetry with dense 
surface modelling to assess the effect of candidate genes on facial shape in three 
populations of mixed ancestry (Claes et al., 2014). They developed markers of shape 
variation called response-based imputed predictors to quantify the variation in face 
shape due to sex and ethnicity, and found that 24 single nucleotide polymorphisms 
appeared to be associated with differences in these new variables. Limitations of the 
study are multiple testing of predictor variables and the lack of validation in terms of 
reproducibility: observers were used to rate the femininity and racial contribution to 
the facial shape of each individual as a comparison. 
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Studies using DSM and the principal components distinguished between affected and 
unaffected individuals using pattern recognition algorithms such as closest mean, 
linear discriminant analysis, support vector machines and response-based imputed 
predictors (Claes et al., 2014; Hammond et al., 2005). This involved the generation of 
random pairs of stratified training-validation subsets of affected-unaffected subjects, 
with the training set being used to build a dense surface model and the validation set 
for unseen classification. For example, in closest mean discrimination testing, the 
average faces of the affected and unaffected individuals in a training set model are 
generated and the Euclidean dense surface model-based distance between a validation 
set face and the two means is computed. The validation face is classified as affected or 
unaffected according to which mean is closest. These algorithms are useful for 
comparing one homogeneous group with another or with controls. However, they are 
not useful in detecting facial dysmorphism per se. Therefore, a new measurement of 
face shape was developed and used in the present study (Section 2.7.1). 
1.3 FACE SHAPE AND EPILEPSY 
1.3.1 BRAIN AND FACE DEVELOPMENT 
Brain development is closely associated with face development. The central nervous 
system originates from ectoderm through the process of neurulation in the third week 
of gestation (Figure 4). Neurulation creates the neural tube, precursor to the brain and 
spinal cord, and the neural crest cells. By the end of the seventh week of gestation, the 
cerebral hemispheres have formed. The facial prominences derive from neural crest 
cells and appear during the fourth week. They include the frontonasal prominence, two 
paired maxillary prominences and two mandibular prominences. The prominences fuse 
to form the external face surface by the seventh week. Major facial malformations, such 
as cleft palate, occur before the seventh week. The process of human face development 
is described by others in much greater detail (Som and Naidich, 2013). 
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Figure 4 An illustration of the origin and development of the human face. Neural crest cells 
formed after neurulation migrate to form facial prominences which then fuse and develop 
into the facial soft tissues and skeleton. The figure is reproduced here as permitted by the 
publisher (Adameyko and Fried, 2016). 
Signalling molecules and pathways are complex, with over 80% of all genes being 
expressed in the mammalian brain (Lein et al., 2007). Despite the complexity, three 
general principles have been suggested whereby brain development and face 
development influence each other (Marcucio et al., 2015; Sisodiya, 2008). Firstly, there 
is a shared origin of face and brain cells from the neural ectoderm. Neural crest cells 
give rise to the skull, facial skeleton, special sensory organs, and facial soft tissue. They 
are also subject to the same patterning genes, such as the Homeobox family in the 
neural tube, as is the developing brain, so that transplanting neural crest cells 
elsewhere still results in the same structure that it was programmed to form. 
Secondly, the brain is a structural scaffold for other tissues developing adjacent to it, 
including the face. For example, the skull develops in close apposition with the brain, 
seen in evolutionary and developmental studies. Tensile strain applied by the forebrain 
cells appears to cause expansion of the developing cranium (Richtsmeier and Flaherty, 
2013). In mice, increased brain growth leads to a flatter face whereas a smaller brain is 
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associated with a longer face and prognathism. This is thought to be from physical 
displacement of facial tissue sideways by the expanding brain (Marcucio et al., 2015). 
Thirdly, there are shared molecular signals between the face and brain. One aspect of 
face development that is better understood than other regions is the frontonasal 
ectodermal zone, which controls growth and development of the upper jaw. Blocking a 
molecule, SHH, from signalling within the brain causes loss of expression of the same 
gene, Shh, in the frontonasal ectodermal zone and thus failure of upper jaw growth in 
chick embryos (Marcucio et al., 2005). Signalling from the face is also important for 
brain development and has been recognised more recently. When the rostral neural 
crest, from which the facial skeleton is made, is surgically excised, there is not only 
absence of the facial bones, but also anencephaly. Brain development thus seems to be 
partly dependent on a signal (such as FGF8) from the neural crest (Le Douarin et al., 
2012). 
Developmental disorders have also suggested a relationship of the face and brain 
development. Three examples will be described. In craniosynostosis, the primary defect 
is thought to be premature closure of skull sutures. However, mutations in fibroblast 
growth factor genes are associated with the condition and these growth factors are 
known to stimulate neurogenesis and axon growth. In mice models, there appears to be 
evidence of primary changes in the brain not associated with the effects of suture 
closure (Richtsmeier and Flaherty, 2013). The first study of genetic polymorphisms and 
human craniofacial variation found that a fibroblast growth factor gene, FGFR1, is 
associated with the shape of the cranium in normal individuals in three different 
ethnicities (Coussens and van Daal, 2005). Cranium shape was taken as a simple ratio 
of width (biparietal diameter) to length (occipitofrontal diameter). The same gene is 
also implicated in dysembryoplastic neuroepithelial tumours (Rivera et al., 2016). 
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Another severe developmental disorder is holoprosencephaly. Here the brain and 
craniofacial structures are both affected by malformations in the midline. In the brain, 
this ranges from joined cerebral hemispheres with one ventricle to fusion of just the 
frontal lobe. In the face, cyclopia, the presence of only one eye and orbit, is the most 
severe malformation but milder anomalies include median cleft lip, flat nose and 
midface hypoplasia. The most severe brain malformation is strongly associated with 
the presence of the most severe facial malformation, cyclopia (Ming and Muenke, 
1998).  
In aniridia, it is well-recognised that there is absence of the iris in affected individuals 
due to mutations in the PAX6 gene, a transcription regulator expressed in the 
developing eye. Only more recently was it recognised that heterozygous PAX6 
mutations may be associated with a range of brain malformations such as 
polymicrogyria (Sisodiya, 2008) and that PAX6 is involved in cortical patterning and 
axon guidance (Georgala et al., 2011). 
Much remains to be elucidated but it is clear that the face may be affected in genetic or 
developmental disorders of the brain. 
1.3.2 EPILEPSY 
Epilepsy is conceptually defined by the International League Against Epilepsy as a 
“disorder of the brain characterised by an enduring predisposition to generate epileptic 
seizures and by the neurobiologic, cognitive, psychological, and social consequences of 
this condition” (Fisher et al., 2005). A later operational definition states that epilepsy is 
diagnosed in any one of three conditions: 1. Two or more unprovoked or reflex seizures 
occurring more than 24 hours apart; 2. One unprovoked or reflex seizure with a high 
probability of further seizures; 3. Diagnosis of any epilepsy syndrome (Fisher et al., 
2014). 
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Epilepsy may also be classified by aetiology as: Structural, genetic, infectious, 
metabolic, immune or unknown (Scheffer et al., 2017). Genetic epilepsy includes not 
just epilepsy due to a known genetic mutation, but also epilepsy thought to have a 
genetic basis from family history, prior clinical research or molecular genetics. 
It is one of the commonest neurological disorders with an annual global incidence of 
50.4 per 100,000 (Ngugi et al., 2011). Approximately 75 million people are thought to 
suffer from epilepsy worldwide, with a prevalence of 11 per 1000 (Ngugi et al., 2010). 
People with a diagnosis of epilepsy have a two-fold increased risk of premature 
mortality (Neligan et al., 2011), an increased risk of other psychiatric or somatic 
disorders (Gaitatzis et al., 2004), and an increased risk of accidents and traumatic 
injury (Wirrell, 2006).  The large psychosocial burden of epilepsy includes decreased 
intellectual functioning and decreased likelihood of employment or marriage (Sillanpää 
et al., 1998). 
There may be a number of factors affecting face shape in people with epilepsy. These 
include genetic syndromes, developmental disorders, trauma and anti-epileptic drugs. 
1.3.3 GENETIC OR DEVELOPMENTAL DISORDERS CAUSING EPILEPSY AND FACIAL 
DYSMORPHISM 
Facial dysmorphism and seizures have been known to co-exist as part of a syndrome 
for a long time. As outlined earlier, the stigma of epilepsy has been perpetuated by 
misleading work by Cesare Lombroso amongst others (Section 1.1.3). In the early 
1900s, William Aldren Turner, a neurologist at the National Hospital in Queen Square 
and the then Chalfont Colony for Epileptics, also noted facial similarities. In the 
population of patients at Chalfont, he thought that 45% had a “facies epileptica". The 
presence of this facial phenotype was thought to be correlated with the degree of 
intellectual disability (Eadie, 2006). The patients in institutions were recognised to 
have more severe epilepsy often associated with intellectual disability or other features 
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and Turner may have detected facial dysmorphism due to genetic syndromes causing 
epilepsy. Such syndromes were carefully described once the specialty of clinical 
genetics developed. 
One of the earliest dysmorphology reference books, Atlas of the Face in Genetic 
Disorders, lists all known or suspected genetic disorders with facial dysmorphism, 
excluding developmental and teratogenic conditions (Goodman, 1977). The book 
describes 190 syndromes, of which 28 have seizures as a characteristic. These may be 
subdivided into 8 out of 27 chromosomal disorders (30%), 3 out of 66 conditions with 
autosomal dominant inheritance (5%), 12 out of 79 conditions with autosomal 
recessive inheritance (15%) and 5 out of 18 conditions with X-linked inheritance 
(28%) as summarised in Figure 5. It is notable that chromosomal disorders had the 
highest frequency of epilepsy. Chromosomal disorders consisted of duplications and 
deletions of part of or a whole chromosome. 
 
Figure 5 Genetic syndromes associated with facial dysmorphism according to Atlas of the 
Face in Genetic Disorders, 1977. They are subdivided into mode of inheritance as given in 
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the book and the presence or absence of seizures. AD = autosomal dominant, AR = 
autosomal recessive. 
Each syndrome is described by a list of all known facial features. This allows for a crude 
analysis of the number of facial features. In all syndromes associated with seizures, the 
median number of facial features was 10, whereas it was 8 in the syndromes with no 
known associated seizures (Figure 6). Chromosomal disorders with seizures were 
associated with a median of 12 facial features, compared to 7 in autosomal dominant 
diseases, 8 in autosomal recessive diseases and 9 in X-linked diseases. It is important to 
note that we now know that the genetic categories are not mutually exclusive and that 
this may not have been an exhaustive list, but nevertheless it illustrates that (large) 
chromosomal deletions, duplications or rearrangements may have an association with 
seizures and facial dysmorphism. 
 
 
Figure 6 Genetic syndromes associated with facial dysmorphism according to Atlas of the 
Face in Genetic Disorders, 1977. The number of described facial features is greater in 
syndromes with seizures than in those without seizures (10 vs 8 median number of 
features). 
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Thirty years later, in one dysmorphology textbook, 26 syndromes are listed as causing 
facial dysmorphism and frequent seizures (Jones, 2006). These are shown in Table 2. 
Again, the majority of the syndromes here are due to structural variants (SVs), which 
comprise copy number variants (CNVs) as well as chromosomal inversions and 
translocations (Section 1.3.4). 
Syndrome Cause 
Acrocallosal syndrome Mutation 
Angelman syndrome Structural variant 
Autosomal recessive chondrodysplasia punctata Mutation 
Coffin-Siris syndrome Structural variant* 
Deletion 4p syndrome Structural variant 
Deletion 9p syndrome Structural variant 
Deletion 11q syndrome Structural variant 
DiGeorge syndrome Structural variant 
Duplication 3q syndrome Structural variant 
Encephalocraniocutaneous lipomatosis Unknown 
Fetal varicella syndrome Acquired 
FG syndrome Mutation 
Generalised gangliosidosis type 1 syndrome Mutation 
Hypomelanosis of Ito Structural variant 
Killian/Teschler-Nicola syndrome** Structural variant 
Linear sebaceous nevus sequence Mutation 
Menkes syndrome Mutation 
Miller-Dieker syndrome Structural variant 
Neurocutaneous melanosis sequence Unknown 
1p36 deletion syndrome Structural variant 
Schinzel-Giedion syndrome Mutation 
Sturge-Weber syndrome Unknown 
Trisomy 13 syndrome Structural variant 
Tuberous sclerosis Mutation 
X-ATR Structural variant* 
Zellweger syndrome Mutation 
Table 2 List of syndromes in Smith’s recognizable patterns of human malformation, 6th 
edition, 2006. Causes are listed afterwards as described in the book. X-ATR = X-linked 
alpha-thalassaemia/mental retardation. *Both structural variants and mutations are 
listed as causes. **Now called Pallister-Killian syndrome. 
Looking at the relationship from the field of epilepsy research, some of the same 
chromosomal syndromes were described in the mid-2000s (Bahi-Buisson et al., 2005; 
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Singh et al., 2002). A detailed review of 21 chromosomal abnormalities associated with 
seizures found that ten were associated with microcephaly and five were known to 
have facial dysmorphism: Angelman syndrome, deletion 2p syndrome, deletion 8q 
syndrome, Miller-Dieker syndrome, Wolf-Hirschhorn syndrome (deletion 4p 
syndrome) and fragile X syndrome (Singh et al., 2002). Smith-Magenis syndrome and 
deletion 9p syndrome were not thought to exhibit facial dysmorphism. It is noteworthy 
that there is incomplete overlap between syndromes described by neurologists and 
those by dysmorphologists. 
More recent research into epilepsy genetics is described below. 
1.3.4 GENETIC EPILEPSY 
Epilepsy itself has a genetic basis in at least some individuals, as highlighted by the 
revised terminology for epilepsy classification (Scheffer et al., 2017). Twin studies 
show that monozygotic twin concordance rates are 21% for focal epilepsy and 64% for 
generalised epilepsy, compared to 4% and 9% for dizygotic twins, respectively (Corey 
et al., 2011). Approximately 5% of people with epilepsy have a first-degree relative and 
genetic heritability has been estimated to be about 70% for some types (Helbig et al., 
2008). The genetic causes may be monogenic or polygenic. Monogenic causes are due 
to de novo or inherited single gene mutations. Polygenic causes may be due to either 
common variants conferring mildly increased risk of seizures or rarer variants 
conferring greater increased risk. Some genetic conditions may present as broader 
syndromes in which seizures are one of many characteristics and these were described 
in the previous section. 
Monogenic epilepsy disorders have been best described in family studies and many of 
the causative genes are in ion channel subunits. Mutations in such genes may cause 
different phenotypes in different individuals, with one example being SCN1A, the gene 
encoding sodium channel alpha subunit 1. The clinical phenotype of SCN1A mutations 
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ranges from asymptomatic to generalised epilepsy with febrile seizures plus or to 
Dravet syndrome (Brunklaus and Zuberi, 2014). This variable expressivity is even true 
of the same SCN1A mutation in the same family and is probably due to the influence of 
other genes. Another striking feature of mutations in SCN1A causing Dravet syndrome 
is that over 90% occur de novo in affected individuals. This can limit the usefulness of a 
family history and pedigree in making the diagnosis. A high prevalence of de novo 
mutations with reduced penetrance and/or variable expressivity has been documented 
in other monogenic forms of epilepsy too, both for generalised epilepsy (Pandolfo, 
2013) and in focal epilepsy, such as those thought to be due to KCNT1 gene mutations 
(Møller et al., 2015). 
In most people with a presumed genetic cause of epilepsy, the genes remain unknown. 
These ‘common epilepsies’ are those which are not part of a broader syndrome and are 
thought to show complex, polygenic inheritance (Sisodiya and Mefford, 2011). Six 
individual genome-wide association studies suggested that there were seven loci for 
genes associated with the common epilepsies (Leu et al., 2016). A meta-analysis of 
genome-wide association studies including over 8000 people with epilepsy has also 
implicated a locus at 4p15.1 (International League Against Epilepsy Consortium on 
Complex Epilepsies, 2014). Another genome-wide association study in children with 
febrile seizures either related to or unrelated to the measles-mumps-rubella vaccine 
also found six loci. Two were known, two were immunological genes and only 
associated with febrile seizures after vaccination, and two were novel loci for genes 
involved in magnesium transport and potassium channel regulation (Feenstra et al., 
2014). Together, the studies show that common variants may exist but require careful 
phenotyping and/or large sample sizes for detection. 
Rarer variants, with an allele frequency of under 1%, have also been studied. They may 
take the form of point variants or as structural variants (SVs). Structural variants 
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include unbalanced chromosomal abnormalities such as deletions and duplications, 
which are termed ‘copy number variants’ (CNVs). Structural variants also include 
balanced abnormalities such as inversions, ring chromosomes or translocations. 
Oligonucleotide array comparative genomic hybridization (aCGH) is a technique that 
can rapidly compare a subject’s DNA with a reference sample to look for CNVs. With the 
advent of aCGH, CNVs are the most frequent class of genetic cause of epilepsy. Three 
particular CNVs – 15q13.3 deletion, 15q11.2 deletion and 16p13.11 deletion – have 
been associated with genetic generalised epilepsy and the latter two are also associated 
with focal epilepsy (Sisodiya and Mefford, 2011). All three are also known to be 
associated with intellectual disability, autism and schizophrenia. Another group of 
CNVs was found to be causative for epileptic encephalopathies. Overall, CNVs are found 
in up to 5% of people with epilepsy in some cohorts, such as in children referred for 
aCGH at one centre (Olson et al., 2014). Copy number variants also demonstrate highly 
variable expressivity, including within families, such that diagnosis is not 
straightforward. Even people with epilepsy and structural abnormalities may have SVs 
contributing to their epilepsy (Helbig et al., 2014; Sisodiya and Mefford, 2011). The 
finding of seven different CNVs in people thought to have hippocampal sclerosis is a 
case in point (Catarino et al., 2011). Most other SVs that have been described are not 
recurrent but instead appear to be rare and such new SVs are continually being found 
(Mefford et al., 2010). For example, one SV leading to loss of the WWOX gene, was found 
to cause epilepsy and microcephaly (Ben-Salem et al., 2015). 
Supporting the theory that shared genes underlie epilepsy and other neuropsychiatric 
disorders, a genome-wide association study of SVs in genetic generalised epilepsy and 
controls found that deletions containing genes known to cause neurodevelopmental 
disorders or autism spectrum disorders were more likely to be found in the epilepsy 
group with an odds ratio greater than 4:1 (Lal et al., 2015). 
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Interestingly, further investigation of these SVs reveals additional phenotypic features. 
One report of 17 people with 15q13.3 deletion found that there was no significant 
dysmorphism, but that six (35%) had a bulbous nasal tip (van Bon et al., 2009). A 
subsequent review of 260 cases with 15q13.3 deletion again found no consistent 
dysmorphic features, but found that 10 of 55 children were reported to have 
microcephaly and 15 of 55 were reported to have macrocephaly (Lowther et al., 2015). 
In a European study, rare CNVs have been found in 71 out of 222 (32%) of children 
with ‘complex’ epilepsy associated with dysmorphism, brain abnormalities on MRI or 
intellectual disability (Helbig et al., 2014). The authors had clinical information on the 
presence or absence of dysmorphism for 207 subjects and the presence of 
dysmorphism was associated with a significantly increased chance of having a rare CNV 
(50% in those with dysmorphism vs 21% in those without). Unfortunately, the nature 
of dysmorphism is not clarified. 
Whole exome and whole genome sequencing, also called next generation or massively 
parallel sequencing, is a technology which automates DNA sequencing using large-scale 
high-throughput machines. It has been used successfully to identify new genetic 
syndromes with epilepsy. For example, EEF1A2 mutations have been found to be the 
cause of intellectual disability, epilepsy, autism and microcephaly in four people 
(Nakajima et al., 2015). Two of the four, both unrelated girls, had facial dysmorphism 
with deep set eyes, epicanthal folds, depressed nasal bridge, lower lip eversion and 
downturned corners of the mouth. A limited form of next generation sequencing can be 
used to explore only the commonest genes involved in a condition. Such targeted 
sequencing of 265 genes has been successfully used in a gene panel for epilepsy with a 
detection rate of nearly 50% (16) in 33 selected patients from across Germany and 
Switzerland (Lemke et al., 2012). It is not clear if facial dysmorphism was present but 
the authors note that clinical assessment of dysmorphism is not helpful except in 
specific cases. In the UK, gene panel testing for epilepsy syndromes is becoming 
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available (Dixit and Suri, 2016). Note that currently aCGH is still necessary for 
confirming the presence of SVs. 
To my knowledge, there is only one clinical overview of facial dysmorphism in epilepsy 
(Dixit and Suri, 2016). This educational article reviews nine recently recognised 
syndromes, specifically chosen because they are not detected by karyotyping. Three of 
the syndromes are due to structural variants and found using aCGH: 1p36 deletion, 
Koolen-deVries syndrome and Kleefstra syndrome. 
1.3.5 BENEFITS OF GENETIC DIAGNOSIS 
Given ongoing research, the cost and the delay involved in reaching a genetic diagnosis 
in epilepsy, it is pertinent to ask whether it is necessary to obtain such a diagnosis. In 
the case of CNVs in people with hippocampal sclerosis, for example, surgical resection 
was successful in all eight described (Catarino et al., 2011). It remains true that the 
complete phenotypes and significance of many structural variants are not fully known. 
Nevertheless, there are important reasons for pursuing a genetic diagnosis. Firstly and 
most importantly, it may improve clinical management. It may end the ‘diagnostic 
odyssey’ which in itself may be therapeutic for patients and may prevent unnecessary 
investigations. A diagnosis may also help for medicolegal and employment purposes, as 
well as allowing patients to seek further information or support. Lastly, a genetic 
diagnosis often aids prognosis and prenatal counselling (or preimplantation genetic 
diagnosis). In a consecutive series of 88 people attending an adult genetics clinic in the 
USA, 52 were referred to appropriate specialties for related diseases and 35 benefited 
from symptom management (Maves et al., 2007). Out of 53 patients with a provisional 
diagnosis, 27 had it changed in clinic with 11 changed from the history and physical 
examination alone. 
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In epilepsy, a genetic diagnosis can optimise treatment such as avoidance of 
carbamazepine and lamotrigine in SCN1A mutation-positive Dravet syndrome or the 
use of the ketogenic diet in GLUT1 deficiency syndrome (Brunklaus et al., 2012; Kass et 
al., 2016). A case series by Kasperavičiūtė and colleagues describes a patient with 
seizures, who was found to have 17q12 deletion (Kasperavičiūtė et al., 2011). The 
diagnosis allowed him to receive specific specialist care regarding known 
consequences of the deletion which included impaired glucose tolerance, renal cysts 
and hypomagnesemia. A genetic diagnosis of epilepsy in itself is beneficial to patients 
and families. In a written survey sent to parents by Caminiti and colleagues, 71% of 
parents still wished to have a genetic diagnosis for their affected child even when told it 
would have no effect on the child’s medical care (Caminiti et al., 2016). 
1.3.6 TRAUMA 
Trauma may affect the face in people with epilepsy and thereby affect analysis using 
face shape. Individuals with epilepsy have a 1.6 times greater risk of accident (absolute 
risk of 17% per year) than matched controls without epilepsy according to a 
prospective European study in which participants kept a daily diary of accidents (van 
den Broek and Beghi, 2004). There were significantly more wounds, abrasions and 
concussions in people with epilepsy and these were mostly related to seizure activity. It 
is not recorded how many of these affected the face but others report that about 80% of 
injuries are to cranial soft tissues (Lawn et al., 2004). Other reviews suggest that 5-10% 
of people with epilepsy may sustain dental or jaw injuries each year (Wirrell, 2006). 
The type and frequency of seizures are known to affect the frequency of injuries, with 
drop attacks and generalised tonic-clonic seizures being the most likely to lead to 
injury (Lawn et al., 2004; Tiamkao et al., 2009). Studies were often conducted in 
selected non-representative groups of people with epilepsy, such as those presenting to 
tertiary centres, those in nursing homes or those with intractable seizures. Previous 
facial morphometric studies have ignored facial injuries or excluded such cases on the 
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basis of patients’ recall of injuries (Evison et al., 2010; Hammond et al., 2005; Kau et al., 
2010). 
1.3.7 ANTI-EPILEPTIC DRUGS 
The so-called first generation anti-epileptic drugs are known to cause adverse effects 
that can alter face shape. These drugs include carbamazepine, phenobarbital, phenytoin 
and sodium valproate (Perucca, 2005). Facial dysmorphism may be especially severe 
for a fetus exposed to maternal phenytoin use with midface hypoplasia and other 
features in what some have called the “anticonvulsant face” (Orup et al., 2003). This 
may be of relevance given that some people with epilepsy may have suffered from in 
utero exposure to phenytoin, for example in familial epilepsy syndromes.  
In children and adults using first-generation anti-epileptic drugs, more subtle 
differences may occur. An analysis of patients with epilepsy followed up for 11 months 
showed that 50 out of 355 patients (14%) had skin and mucosal changes (Collaborative 
Group for Epidemiology of Epilepsy, 1988). Changes included gingival hyperplasia, acne 
and hirsutism. The study also showed that 136 patients (38%) experienced 
somnolence, vertigo, unsteadiness, ataxia or diplopia. These adverse effects may of 
course further increase the risk of facial injury in people with epilepsy, and are also 
noted in many newer anti-epileptic drugs. 
Phenytoin has been described to cause coarsening of facial features separate to the skin 
changes noted above. A case report of two twin pairs, with one of each pair using long-
term phenytoin, noted thickening of the lips and nose (Falconer and Davidson, 1973). 
Facial coarsening occurred in the majority of women using it according to one Brazilian 
report, but details are inconsistent (Trevisol-Bittencourt et al., 1999). There is limited 
information on the characteristics or, indeed, definition of such coarsening. 
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A more recent single centre study of cosmetic side effects due to anti-epileptic drugs in 
1900 patients found that 2.5% of people taking phenytoin experienced gingival 
hyperplasia but other skin changes were not significantly increased (Chen et al., 2015). 
Sodium valproate was associated with significantly increased risk of hair loss. Both 
sodium valproate and pregabalin were associated with weight gain.  The authors did 
not find any significant cosmetic effects from newer anti-epileptic drugs but note that 
larger scale studies are necessary. 
Weight gain indirectly affects face shape and has been well recognised in the case of 
sodium valproate. About 50% of people taking the drug show significant weight gain 
(>5kg) with risk factors being female sex and duration of therapy (Verrotti et al., 2011). 
Similarly, it would be expected that drugs known to cause weight loss, such as 
topiramate, may also affect face shape. 
Therefore, anti-epileptic drug use may affect face shape by different means and they 
should be considered as potential confounders in the study of face shape in people with 
epilepsy. 
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1.4 AIMS 
In summary, face and brain development are closely linked and this relationship is 
partly mediated by genetic factors. Therefore, disorders of brain development or 
function, such as epilepsy, may affect face shape too via a shared genetic mechanism. 
However, the clinical study of face shape is still primarily subjective and underused by 
the majority of physicians, including neurologists. There are powerful methods 
available to capture face shape information, such as stereophotogrammetry and 
sophisticated tools for analysis of these data, such as the use of dense surface modelling 
and principal component analysis. These methods may be useful in objectively 
detecting changes in face shape in people with epilepsy caused by particular genetic or 
developmental abnormalities.  
1.4.1 VALIDITY OF STEREOPHOTOGRAMMETRY AND DENSE SURFACE MODELLING 
I hypothesise that stereophotogrammetry and dense surface modelling are 
reproducible and robust techniques for face shape analysis in a population of subjects 
with epilepsy. 
Aims 
• To assess intra-operator and inter-operator reproducibility with these 
techniques. 
• To compare dense surface modelling to landmark-based analysis of facial shape 
and subjective assessments of dysmorphism. 
• To determine the effect of camera calibration, camera orientation and facial 
expression on the resulting image quality. 
• To explore the effect of body mass index on the analysis of face shape and 
attempt to correct for this. 
1.4.2 INVESTIGATION OF FACE SHAPE IN PEOPLE WITH EPILEPSY 
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I hypothesise that face and brain development are closely co-ordinated such that 
structural variants and developmental brain lesions that are associated with epilepsy 
are also associated with changes in facial shape or symmetry. 
Aims 
• To assess if facial shape change is related to the presence of established 
pathogenic structural variants and explore the function of genes contained in 
such variants. 
• To explore how facial shape change may be related to the presence of, the type 
of, or the size of a structural variant. 
• To determine if dense surface models may be useful in determining atypical 
face shape in people with a particular genetic syndrome. 
• To explore the relationship of facial symmetry and shape to the presence of 
developmental brain lesions. 
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1.5 EXPERIMENTAL APPROACH 
The first part of the study is to validate the techniques of stereophotogrammetry and 
dense surface modelling for face shape analysis. To do this, I propose to analyse each 
step in the process. Firstly, using a group of controls, I will explore reproducibility for 
identification of landmarks on the face, traditional measurements of face shape, and 
finally for two new metrics of face shape change. Then I will assess how robust the 
techniques are to environmental variables including head position, facial expression 
and camera re-calibration. 
People with epilepsy or specified genetic syndromes will then be recruited for the 
study over a period of 2-3 years. This will include adults with capacity to consent, 
children with the consent of parents or guardians, and adults without capacity to 
consent for whom the assent of a consultee has been obtained. Many of these people 
will already have been recruited as part of a related study of the genetics of epilepsy. 
Participants will undergo face image capture at an epilepsy treatment centre, height 
and weight measurement, and a blood test for genetic testing, if not already performed. 
Clinical details will include age, sex, handedness, history of facial trauma, previous anti-
epileptic drug use, genetic diagnoses, imaging findings and neuropsychometry findings. 
These will be recorded at the time of recruitment or from accessing the medical record. 
Some participants may be recruited for image capture only a second or third time to 
assess for the effects of age. 
After recruitment, I will perform dense surface modelling of the 3D face images to 
analyse face shapes using two new metrics – one for overall shape relative to controls 
and one for asymmetry. As they are new, I will explore the relationship of these metrics 
to the physiological variables of age and body mass index. I will also assess how well 
these metrics can differentiate between participants with underlying genetic disorders, 
as classified by the presence of structural variants, and participants without such 
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variants. I will then assess if the metrics can differentiate those people with epilepsy 
with a developmental brain lesion and those people with epilepsy without such a 
lesion. Finally, I hope to recruit a group of people with a known genetic syndrome to 
see if stereophotogrammetry and dense surface modelling can be used to detect shared 
facial features. 
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1.6 JUSTIFICATION OF RESEARCH 
The experimental approach described above fulfils the aims of this thesis. I believe that 
it is important to investigate face shape change in people with epilepsy. As I have 
described, face shape assessment is already commonly used in medicine, especially 
clinical genetics, to help diagnose genetic disorders. In some people with epilepsy, 
genetic causes are well-recognised and novel structural variants and genetic mutations 
have been recently discovered. Face shape analysis is part of the detailed phenotyping 
that will assist in understanding the effect of such conditions. The new method I 
propose involves digital image capture in two milliseconds and an objective, 
quantitative measurement using detailed 3D face shape images, which will be matched 
for age, sex and ethnicity to a reference cohort. The technique I investigate in my study 
is arguably less unpleasant and/or more objective than current techniques including 
direct anthropometry and inspection by a clinician. 
As noted above and in Section 3.1, there are few detailed studies of reproducibility and 
accuracy of stereophotogrammetry and landmark placements. There are no known 
studies of reproducibility and accuracy of dense surface modelling. Therefore, it is 
important for me to validate the technique I propose to use before recruitment of 
subjects. I will do this validation study (Chapter 3) only for adults with the capacity to 
consent. Some of these adults have epilepsy, which is important as they are the target 
population of my study. 
For all later studies, it is important to include participants who lack capacity to consent. 
I have described earlier (Section 1.3.4) that the presence of structural variants is 
associated with intellectual disability. I will not be able to assess the effect of a range of 
structural variants on facial shape thoroughly if participants who lack capacity to 
consent are not included. The same may apply to the presence of developmental brain 
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lesions, many of which are associated with developmental delay and intellectual 
disability (Guerrini and Dobyns, 2014). 
Similarly, many of those who are diagnosed to have genetic disorders are children and 
the study would be limited in power by excluding children. However, all children had 
already had genetic testing as part of their clinical care or other research studies and 
they will only undergo image capture as part of this study. Image capture will only be 
performed after informed consent from the parents in their local language and in 
accordance with local ethics committee or institutional review board approval. 
For all participants, after orientating and uncovering the face, image capture will use a 
single camera flash. The only invasive procedure in a minority of subjects will be a 
blood test for genetic analysis with their consent. Children will only be recruited if they 
have already had such a test performed for clinical reasons. In adults without capacity 
to consent, such a blood test was performed at the same time as their clinic visit and 
clinically indicated blood sampling. 
Face images and collected clinical or genetic data are kept on an encrypted drive in a 
locked room at all times. Face images are not used for any other purpose except for the 
following study. Storage of images is necessary for later analysis with other subjects 
and verification of findings.
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CHAPTER 2: METHODS 
 
2.1 LITERATURE REVIEW 
A literature review was conducted for each chapter. The principal search database used 
was MEDLINE via Pubmed, developed by the National Institutes of Health. The OVID 
database and was also consulted when appropriate, and occasionally, older articles 
were retrieved from the JSTOR collection. 
Multiple search terms and phrases were used for each chapter and section. As one 
example, for Section 1.1.4, the following terms were used: 
• Clinical genetics 
• Craniofacial 
• Dysmorphic 
• Dysmorphism 
• Dysmorphology 
• Facial gestalt 
• Malformations 
• Teratology 
2.2 RECRUITMENT OF SUBJECTS 
2.2.1 REFERENCE SUBJECTS 
Reference control subject images were used to provide a database of age-matched, sex-
matched, ethnicity-matched images for many of the subsequent analyses. Reference 
subjects were part of most study groups, but they were not compared to any study 
group except for Group 7. Individual reference subject images were only used in a 
study of inter-operator reproducibility (Sections 3.3.3 and 3.4.2) and not analysed 
further. However, composite average reference faces were created in a process 
Page | 70  
 
described later (Section 2.7.1) and these average images were used to assess facial 
shape change. In group 7, composite average reference faces were also compared to 
each of the probands (Chapter 8). All reference subject images were provided for use in 
the DSMs by Peter Hammond at the UCL Institute of Child Health, London. 
Reference subjects were all white European adults and children. They were previously 
recruited as volunteers, unaffected relatives of patients, or healthy infants attending a 
routine postnatal clinic, from the UCL Institute of Child Health. All reference subjects 
were healthy and had no known syndrome, previous craniofacial surgery or trauma. 
They have been previously used for comparison to children and adults with Williams 
syndrome, Smith-Magenis syndrome, 22q11 deletion syndrome, Noonan syndrome, 
Fabry disease, Wolf-Hirschhorn syndrome, fibrodysplasia ossificans progressiva and 
fetal alcohol syndrome (Cox-Brinkman et al., 2007; Hammond, 2007; Hammond et al., 
2012a, 2012b, 2005, 2004; Suttie et al., 2013). 
For reference subjects, images were captured using the DSP400 and MU2 commercial 
cameras (3dMD; Atlanta, GA, USA). There is no significant difference between face 
images captured on different stereophotogrammetric cameras (Weinberg et al., 2006). 
Multiple cameras have been used in previous studies (Hammond et al., 2005). 
2.2.2 RECRUITMENT OF CONTROL SUBJECTS 
Twenty control subjects were recruited to assess reproducibility of 
stereophotogrammetry and dense surface modelling under different conditions, 
including face position relative to the camera, face expression and camera calibration 
(Section 3.3.2). They were all adult volunteers, who were able to co-operate for 
repeated image acquisition. Eight of them were also people with epilepsy who had been 
recruited for the main study. Note that none of these 20 controls were compared to any 
other group and were used solely to assess reproducibility. No control subject had 
previous significant facial injury or surgery. 
Page | 71  
 
2.2.3 RECRUITMENT OF PEOPLE WITH EPILEPSY IN THE UNITED KINGDOM 
Principal recruitment of subjects was from routine attendance at adult epilepsy clinics 
in two locations within University College London Hospitals NHS Foundation Trust: the 
National Hospital for Neurology and Neurosurgery in Queen Square, London and at the 
Chalfont Centre for Epilepsy in Chalfont St Peter, Buckinghamshire. Subjects were also 
recruited from inpatient wards in these two locations, named the Sir Jules Thorn EEG 
Telemetry Unit and the Sir William Gowers Epilepsy Assessment Unit, respectively. 
The inclusion criteria consisted of participants who were: 
• Over the age of 18 years 
• Undergoing investigations for epilepsy, or have a known diagnosis of epilepsy 
• Able to provide informed consent 
• Willing to participate 
Recruitment of people with HNF1B mutations occurred at another site, the UCL 
Institute of Child Health. 
2.2.4 RECRUITMENT OF PEOPLE WITH EPILEPSY IN EUROPE 
Three other sites of recruitment for children and adults with epilepsy were also used:  
• Meyer Children’s Hospital (Ospedale Pediatrico Meyer), Florence, Italy 
• Erasmus Hospital (Hôpital Erasme), Brussels, Belgium 
• University Hospitals Leuven, Campus Gasthuisberg (Universitaire ziekenhuizen 
Leuven), Leuven, Belgium 
For each site, the study had been approved by the relevant ethics committees and/or 
institutional review boards. Written informed consent was obtained from study 
participants or informed assent was obtained from parents according to national 
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standards. Participants were either patients at the above institutions, or relatives of 
patients. 
2.2.5 GROUPS USED FOR ANALYSIS 
In total, 869 subjects were recruited for stereophotogrammetry and dense surface 
modelling. These subjects included control subjects, people with epilepsy and relatives 
of people with epilepsy. People with epilepsy comprised those with and without 
genotype data, those with and without brain imaging data, those with and without body 
mass index data, and those with and without age or ethnicity matched control subjects. 
Therefore, they were incorporated into a number of different groups, depending on the 
individual study. In some studies, facial shape change was quantified using a novel 
measurement called ‘Face Shape Difference’ (FSD). FSD required all recruited subjects 
to be compared to matched reference faces. Therefore, reference subjects were 
included in groups using FSD in subsequent analysis. If there were insufficient 
reference faces matched for age or ethnicity for a particular subject, then that subject 
was excluded. The study groups are described below and a summary is shown in Table 
3. 
Groups 1 2 3 4 5 6 7 
Centres All UK only 
Relatives No Yes No Yes No Yes 
Children Yes No Yes 
Genotyped Yes N/A 
BMI data N/A Yes N/A 
MRI data N/A Yes N/A 
FSD used Yes No Yes No Yes 
rFSD used No Yes 
 
Table 3 Summary of characteristics of the different groups used in studies. The purpose of 
this groups is described in the main text. ‘Centres’ refers to the sites of recruitment and was 
either from the UK only (‘UK’) or from the UK and other European sites (‘All’).  ‘Relatives’ is 
the inclusion of controls and unaffected relatives in analysis – they are separate from the 
reference subjects who were not used in any analysis but were part of all studies using a 
quantitative measure called ‘FSD’ (Section 2.7.1). ‘Children’ is the inclusion of people under 
16 years of age for analysis. ‘Genotyped’ means only people with genotype data were 
included in the group. ‘BMI data’ and ‘MRI data’ means that only people with BMI or MRI 
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imaging data, respectively, were included in the group. ‘FSD used’ refers to analysis of face 
shape using FSD within that group. ‘rFSD used’ refers to the use of reflected face images and 
the reflected FSD for all subjects to assess face asymmetry. 
Group 1 (Figure 7): This group was used as part of validation studies (Chapter 3). It 
was then used to study the relationship of facial shape change to the presence of 
pathogenic structural variants (Chapter 4). A positive result was seen and the group 
was then also incorporated as a training set within group 2, to see if the result could be 
validated in an additional sample.  
Inclusion criteria:  
1. Subjects who had undergone genotype analysis from two UK centres (Section 
2.2.3) and three European centres (Section 2.2.4) over one year of recruitment. 
2. Children with suspected epilepsy or a formal diagnosis of epilepsy made by a 
paediatric neurologist. Adults with a diagnosis of epilepsy made by a trained 
neurologist specialising in epilepsy.  
Exclusion criteria: 
1. People with known Mendelian inheritance of epilepsy or a syndrome associated 
with epilepsy.  
2. People with known imbalances of a whole chromosome were excluded. 
3. People who could not be compared to reference subjects for quantification of 
facial shape change (i.e. FSD) due to lack of matched controls. This could be due 
to age (insufficient matched controls existed over 52 years for men and over 54 
years for women) or ethnicity (sufficient matched controls only existed for 
white Europeans). 
4. Further exclusions were made ad hoc for sensitivity analyses, described in 
Chapter 4. 
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Figure 7 Study recruitment and groups used in exploring the relationship of face shape to 
structural variants in people with epilepsy. Initially, 118 people were analysed in group 1. 
An additional 63 people were then analysed separately within group 2 for validation. 
Reference subjects were only used to calculate FSD. SPG = Stereophotogrammetry 
Group 2 (Figure 7): This group comprised all subjects in group 1 and additional 
subjects recruited using the same inclusion and exclusion criteria over a further six 
months. The group 1 subjects formed a training set and the additional subjects formed 
a validation set. The results found using group 1 earlier were validated using only the 
new, additional subjects. Group 1 had to be included in group 2 to enable validation 
(described in Section 4.4.3), but the training set and validation set did not overlap. The 
whole of group 2 was then also used to assess the effect of three aspects of the size of 
pathogenic SVs on face shape: size of the SV in base pairs, size of the SV in number of 
genes, and size of the SV in number of genes expressed in the developing human 
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forebrain (Chapter 5). Within Chapter 5, a subsequent analysis was performed of only 
those people with complete information on all detected SVs, which is termed Group 2B 
(described separately in Chapter 5). 
Group 3 (Figure 8): This group was used in further validation studies involving facial 
expression, camera angle and camera calibration (Chapter 3). It was then used to 
explore the effect of body mass index (BMI) on face shape (Chapter 6).  
Inclusion criteria: 
1. People with height and weight measured at the time of stereophotogrammetry. 
Exclusion criteria: 
1. People under 18 years old 
2. People who were not white Europeans. There were insufficient subjects to 
explore how face shape changes with BMI in other ethnicities. 
3. People with craniofacial deformity, with previous craniofacial surgery, or with 
any known genetic syndrome/diagnosis were excluded. 
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Figure 8 Study recruitment and groups used in exploring the change in face shape to body 
mass index in different subjects. The first study used group 3 and found a predictable 
relationship between face shape and body mass index. The second study used group 4 to see 
if a quantitative measurement of face shape change, FSD, could be adjusted for BMI and if 
doing such an adjustment would affect the accuracy of previous findings in people with 
epilepsy and structural variants. SPG = Stereophotogrammetry 
Group 4 (Figure 8): The study using group 3 showed a predictable change in face shape 
with change in BMI. This new group was used to adjust the measure of face shape 
change (FSD) to account for BMI (Section 6.4.6). In particular, FSD was adjusted in 
people who had been genotyped to see if previous results in Chapters 4 and 5 were still 
true without BMI as a confounder. 
Inclusion criteria: 
1. People with height and weight measured at the time of stereophotogrammetry. 
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2. People with a diagnosis of epilepsy made by a trained neurologist specialising 
in epilepsy. 
Exclusion criteria: 
1. People who could not be compared to reference subjects for quantification of 
facial shape change (i.e. FSD) due to lack of matched controls. This could be due 
to age (insufficient matched controls existed over 52 years for men and over 54 
years for women) or ethnicity (sufficient matched controls only existed for 
white Europeans). 
Group 5 (Figure 9): This group was used in a longitudinal study explored the effect of 
age on face shape during the study recruitment period (Section 6.4.7), by assessing 
serial images of the same subject. 
Inclusion criteria: 
1. People with a diagnosis of epilepsy made by a trained neurologist specialising 
in epilepsy. 
2. People with more than one image taken in separate stereophotogrammetry 
sessions at least two weeks apart. 
Exclusion criteria: 
1. People who could not be compared to reference subjects for quantification of 
facial shape change (i.e. FSD) due to lack of matched controls. This could be due 
to age (insufficient matched controls existed over 52 years for men and over 54 
years for women) or ethnicity (sufficient matched controls only existed for 
white Europeans). 
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Figure 9 Study recruitment and groups used in two studies. The first is a longitudinal 
assessment of face shape change, using FSD with time, in group 5. The second study uses 
group 6 and assesses face shape asymmetry in people with epilepsy and brain lesions 
compared to people with epilepsy and without any brain lesions. SPG = 
Stereophotogrammetry 
Group 6 (Figure 9): This group was used in a study of the relationship between facial 
symmetry and the presence of unilateral or bilateral developmental brain lesions.  
Inclusion criteria: 
1. People with a diagnosis of epilepsy made by a trained neurologist specialising 
in epilepsy. 
2. People who had undergone magnetic resonance imaging of the brain for 
investigation of their epilepsy at the UK sites and had these scans reviewed by a 
neuroradiologist. 
Exclusion criteria: 
1. People with MRI imaging abnormalities including acquired intracranial lesions 
(such as stroke, trauma), undefined lesions or multiple lesions. 
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2. Exclusions were made ad hoc for sensitivity analyses, described in Chapter 7. 
Group 7: This group was used in a study of subjects with one particular genetic 
condition. It comprised only subjects with HNF1B mutations, including deletions, who 
were recruited during a support group event at the UCL Institute of Child Health. 
Inclusion criteria:  
1. People with a confirmed genetic diagnosis of HNF1B mutation or deletion.  
Exclusion criteria: 
1. People who could not be compared to reference subjects for quantification of 
facial shape change (i.e. FSD) due to lack of matched subjects. This could be due 
to age (insufficient matched reference subjects existed over 52 years for men 
and over 54 years for women) or ethnicity (sufficient matched reference 
subjects only existed for white Europeans). 
2.3 IMAGE CAPTURE 
Image capture was performed using the Mirror Vectra CR10 software program 
(Canfield Scientific, Fairfield, NJ, USA). The hardware used in all cases was a standard 
laptop or desktop personal computer, attached to the Canfield Vectra CR10 3D Face 
(Canfield Scientific, Fairfield, NJ, USA) camera system, shown in Figure 10. The 
manufacturer’s specification sheet states that the camera has a resolution of 10 
megapixels and resolves surfaces to 1.1mm. Capture time is two milliseconds. The 
camera was calibrated. Calibration involves placing a rigid patterned board in front of 
the camera at two angles and capturing two images of it. The camera uses this 
information to optimise creation of 3D images. Calibration was conducted at the start of 
each image capture session and after any movement of the camera, as per 
manufacturer’s recommendations. The camera lenses were not in the horizontal plane 
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and were angled upwards by 20 degrees (i.e. the camera system was rotated 20 
degrees anticlockwise around the long axis of the system). This has been well-
documented in other stereophotogrammetry studies and aids capture of the inferior 
aspect of the nose and chin (Ghoddousi et al., 2007; Heike et al., 2010). The angle is 
illustrated in Figure 11. 
 
Figure 10 The Canfield Vectra CR10 stereophotogrammetry camera system. The image 
shows two flash units above the main camera body. The camera body has two pods on each 
side with camera lenses facing along the axis of the camera. A mirror is used to allow the 
lenses in each pod to capture subjects in front of the camera. This arrangement allows the 
camera to be relatively flat and hence portable. Image is used with the written permission 
of Canfield Scientific. 
All participants were seated in a room with adequate indoor lighting. A height-
adjustable swivel chair was provided and participants sat facing the camera 
approximately one metre away. A typical position for image capture is shown in Figure 
11. Participants’ faces were then aligned within the two on-screen target areas (Figure 
12). If it was not possible to do this by adjustment of the chair, then the camera tripod 
height was adjusted too. Visual inspection was used to minimise lateral rotation of the 
face by rotating the swivel chair. 
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Figure 11 A typical position used for image capture of a subject’s face from another study 
using the same Canfield Vectra CR10 3D stereophotogrammetry camera model. Image is 
reprinted from Ghoddousi et al., 2007 with permission from Elsevier. 
 
Figure 12 Screenshot from the Mirror Vectra CR10 software program illustrating how 
subjects are aligned within the target field for each of the pairs of cameras to ensure 
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adequate coverage of the face surface in the 3D images (permission obtained from subject 
for use). 
Participants were then asked to remove any coverings on their head or garments that 
obstructed their face, including the chin and upper neck. Earrings and other piercings 
were removed if practical. They were also asked to adjust their hair to uncover their 
forehead and ears as much as possible. Hair bands and clips were provided for this 
purpose. 
All subjects were told to look at a target straight ahead in the vertical midline and 
slightly above their eye level. Height was adjusted so that the top of the camera was at 
eye level. Participants were told not to smile and to keep their lips together and their 
eyes open. If this was not possible, for example, in young children, multiple images 
were taken and the closest approximation to the neutral expression was used. An 
operator checked that all parts of the face were visible to the camera pairs using the 
software program (Figure 12) and then the image was taken. The procedure is in 
accordance with previous recommendations by one team from their experience of 
clinical stereophotogrammetry (Heike et al., 2010). 
Image capture is triggered from the personal computer and uses a synchronous flash 
from two on-board flash units. Images were assessed for eye opening, expression and 
adequate coverage of the face surface. Three-dimensional (3D) face surface images 
were automatically produced by the Mirror Vectra CR10 program approximately 30 
seconds after image capture (Figure 13). The fast image capture time allowed images to 
be obtained even when participants were unable to stay still. Images were exported as 
.obj 3D files, with corresponding .png texture files. There is no loss of image quality in 
these steps. Images could also be viewed in third party 3D image viewers (Figure 14). 
Image quality was reviewed again by the operator (Vamsi Chinthapalli) during the 
landmarking step. A final check of image quality was performed by another 
experienced operator (Peter Hammond or Mike Suttie) prior to creation of the dense 
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surface model. In these steps, emphasis was placed on ensuring adequate coverage of 
the face surface and detection of artefacts in face shape. Three subject images were 
excluded in total, out of 869, due to image quality during the studies. 
 
Figure 13 The Mirror Vectra CR10 software program automatically displays each face 
surface image after image capture. The image can be rotated and zoomed in or out to look 
for any artefacts or missing areas of the face surface. 
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Figure 14 Another view of the face surface image in a third-party image viewer, which 
allows the image to be freely rotated, moved or magnified. All of these functions are helpful 
in checking image quality. 
2.4 OTHER DATA COLLECTION 
Participants were asked directly for additional data after image capture: 
• Ethnicity of themselves and their parents 
• Handedness 
• Any history of facial trauma, including fractures, surgery, scars and dentition 
• Co-morbidities 
Date of birth was taken from medical records to calculate exact age at the time of image 
capture. Participants also had height and weight measurements performed using a 
portable freestanding stadiometer and weighing scales. This was done in all cases by a 
doctor or nurse after heavy clothing and footwear was removed. Height and weight 
measurements were always within one week of image capture and in most cases was 
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taken just prior to image capture. Body mass index was calculated using the standard 
formula:  
Body mass index (BMI) = weight (kg) / ((height (m) x height (m)) 
Standard definitions were used to categorise people who were underweight 
(BMI<18.5), of normal weight (BMI 18.5 – 24.9), overweight (BMI 25 – 29.9) or obese 
(BMI >29.9). These definitions are used by the World Health Organization and the 
National Institutes of Health in the USA (Flegal et al., 2013). 
Data were also obtained from the following sources: 
• Patient medical records 
• Nursing admission records (e.g. height and weight data) 
• Other research databases (e.g. genotype status) 
Other data for specific studies, such as MRI findings and anti-epileptic drug history, are 
described in the relevant sections. 
2.5 LANDMARKING 
One of the prerequisites for direct and indirect anthropometry is the identification of 
landmarks. In dense surface modelling, landmarks are used to co-register surface 
images for further comparison and analysis. 
For this study, 22 well-defined soft tissue landmarks were chosen (Figure 15). They 
were chosen for ease of identification from visual inspection alone, high 
reproducibility, and to allow comparison with other previously landmarked images. All 
of these have previously been reproducible using stereophotogrammetry (Gwilliam et 
al., 2006; Plooij et al., 2009; Toma et al., 2009). 
Landmarks are placed using the custom in-house Facemark software program (version 
2.0, ShapeFind; UCL Institute of Child Health, London, UK). Surface images can be freely 
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rotated, displaced and magnified to aid placement of landmarks. The software also 
allows for wireframe views of the face surface. Wireframe views make it easier to 
identify certain facial contours. 
One operator (Vamsi Chinthapalli) landmarked all images, for two reasons. Firstly, 
reproducibility of landmark placement on face surface images in 3D 
stereophotogrammetry is associated with the operator’s level of familiarity with the 
imaging software (Gwilliam et al., 2006). Secondly, intra-operator reproducibility error 
is consistently smaller than inter-operator reproducibility error (Gwilliam et al., 2006; 
Plooij et al., 2009; Schaaf et al., 2010). Nevertheless, reproducibility of landmark 
placement was assessed for the current studies. An assessment of inter-operator 
reproducibility was initially performed to ensure that there was no significant 
systematic error between the operator here (Vamsi Chinthapalli) and another 
experienced operator (Peter Hammond; see Chapter 3). Assessment of inter-operator 
reproducibility also gives an indication of whether the method of 
stereophotogrammetry with landmarking could be expanded in subsequent clinical or 
research applications to have multiple operators.  
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Each landmark is described in more detail below and is shown in Figure 15. 
 
Figure 15 A typical face surface image, showing 14 of the 22 landmarks applied to the face 
(circles with black outline). The other 8 are paired landmarks on the right side of the face 
and are shown if visible (solid black circles). The landmarks are: 1. Exocanthion (paired) 2. 
Endocanthion (paired) 3. Palpebrale superius (paired) 4. Palpebrale inferius (paired) 5. 
Nasion 6. Pronasale 7. Subnasale 8. Alare nasi (paired) 9. Labiale superius 10. Labiale 
inferius 11. Cristae philtri (paired) 12. Cheilion (paired) 13. Gnathion 14. Otobasion inferius 
(paired) 
 
2.5.1 EXOCANTHION (PAIRED: EXOL AND EXOR) 
Also termed the ‘lateral canthus’ or ‘lateral palpebral commissure’, this is the lateral 
junction of the upper and lower eyelid (Farkas, 1994; Hall et al., 2009). The angle here 
is usually more acute than for the endocanthion. It is readily identifiable on visual 
inspection due to different colour and contour between the skin and conjunctiva. This 
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landmark and the following three landmarks are difficult to measure using direct 
anthropometry due to patient discomfort on palpation. 
2.5.2 ENDOCANTHION (PAIRED: ENDOL AND ENDOR) 
Also termed the ‘medial canthus’ or the ‘medial palpebral commissure’, this is the 
medial junction of the upper and lower eyelid (Farkas, 1994; Hall et al., 2009). Often the 
junction here extends towards the nose to form the lacus lacrimalis, in which tears 
collect before being drained by the lacrimal duct. In those cases, the actual junction is 
used. This landmark is also easily identified in a similar manner to exocanthion. 
2.5.3 PALPEBRALE SUPERIUS (PAIRED: PSUPL AND PSUPR) 
This is the midpoint of the free margin of the upper eyelid. As the eyelid curves in three 
dimensions, it is difficult to use this definition in practice. Farkas uses the “highest 
point” of the free margin, but this requires the subject or image to be placed in the 
Frankfort horizontal plane, which may introduce further errors (Farkas, 1994). 
Therefore, the midpoint can also be defined as the point on the free margin of the upper 
eyelid, which intersects with a line perpendicular to and bisecting the bicanthal line, as 
judged by visual inspection. The bicanthal line is the line connecting exocanthion and 
endocanthion. The position is affected by eyelid opening so care was taken to ensure 
subjects had their eyes fully open in images. This definition and method of placement 
have been used in a previous study assessing ptosis (Cox-Brinkman et al., 2007). For 
accuracy, the bicanthal line should be viewed perpendicularly by rotating the face 
laterally or there may be a parallax error in landmark placement. 
2.5.4 PALPEBRALE INFERIUS (PAIRED: PINFL AND PINFR) 
This is defined in a similar fashion to palpebrale superius. It is the point on the free 
margin of the lower eyelid, which intersects with a line perpendicular to and bisecting 
the bicanthal line. 
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2.5.5 NASION (N) 
The bony nasion is the point of intersection of the nasal bones and the frontal bone, at 
the superior end of the nasofrontal suture. The soft tissue nasion has been defined as 
the midline point overlying this (Hennekam et al., 2009) and is always superior to the 
endocanthion (Farkas, 1994). From visual inspection, it is approximately horizontal to 
the first crease overlying the upper eyelids, known as the supratarsal fold. This means 
that it is dependent on the degree of forward or backward tilt of the head (Gwilliam et 
al., 2006). It is not the deepest point along the nasofrontal angle, which is the 
subnasion, occurring inferior to the level of the supratarsal folds. Subnasion may be 
easier to identify in some individuals, but is also absent in those who have no 
depression between the nose and forehead. Nasion is incorrectly thought to be palpable 
due to it being mistaken for subnasion. 
2.5.6 PRONASALE (PRN) 
This is the most anterior point on the nose in the midline. It is more difficult to place in 
flat or bifid noses (Farkas, 1994). It is best identified when inspecting the face in profile 
view and again in frontal view. 
2.5.7 SUBNASALE (SN) 
This means ‘below the nose’ and has been recently defined as the base of the nose 
(Hennekam et al., 2009). It is the midpoint of the angle at which the columella and the 
surface of the upper lip meet (Farkas, 1994). The columella is the tissue that is between 
the nostrils when the nose is viewed from below, and forms the inferior border of the 
nasal septum. Like pronasale, this is seen best when the face is in profile view and then 
in frontal view. However, landmark placement is not affected by head tilt. 
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2.5.8 ALARI NASI (PAIRED: ALAL AND ALAR) 
The alar curvature is the lateral wall of the nose and lateral border of the nostril. The 
alare (plural alari) is the most lateral point on the alar curvature. It is identified by 
viewing the face from inferiorly and from frontally. The lack of definite soft tissue 
features means there may be less reproducibility in its placement. The alari are used as 
they are the only non-midline landmarks of the nose, and therefore give information on 
nasal width and nostril shape. The alar crest is a related landmark that is the most 
lateral point of insertion of the alar curvature into the face. However, the alar crest does 
not give information on the anterior projection of the nostrils and so was not used. 
2.5.9 LABIALE SUPERIUS (LS) 
This is the centre of the upper vermilion border, judged on inspection to be equidistant 
from the cristae philtri and at the most inferior point on the curve of the vermilion 
border. The vermilion lip is the reddish part of the lips, due to thinner epidermis and 
visibility of underlying blood vessels. The vermilion border demarcates the vermilion 
lip from the adjacent keratinised skin of the upper lip (Carey et al., 2009). It is not 
necessarily in the midline of the face. 
2.5.10 LABIALE INFERIUS (LI) 
This is the centre of the lower vermilion border, which separates the lower vermilion 
lip from the keratinised skin of the rest of the lower lip. 
2.5.11 CRISTAE PHILTRI (PAIRED: CHPL AND CHPR) 
The shape of the upper lip has been described as ‘Cupid’s bow’ in which the lateral 
portion of the vermilion border curves medially and superiorly until reaching two 
peaks, from which it continues medially and inferiorly to meet in the midline. Two 
pillars continue superiorly from the peaks to form the lateral boundary of the philtrum 
(Carey et al., 2009). The crista philtrum (plural cristae philtri) is defined as the 
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intersection of the upper vermilion border with the base of the pillar of the philtrum. 
The shape of the vermilion line and the elevation of the philtrum pillars both help to 
identify this landmark. However, one or both of these may be inconspicuous in some 
subjects, requiring image magnification. 
2.5.12 CHEILION (PAIRED: CHL AND CHR) 
Also termed the ‘labial commissure’, this is the most lateral point of the oral cavity, or 
in common parlance, the corner of the mouth. It may be difficult to identify the edge of 
the oral cavity and the beginning of the skin crease of the angle of the mouth in some 
subjects and the vermilion border helps identification here. 
2.5.13 GNATHION (GN) 
The bony gnathion is the most inferior median point on the lower border of the 
mandible. It has been traditionally used to denote the lowest point of the face. The soft 
tissue gnathion, also termed ‘menton’, is usually identified by palpation as the closest 
point on the surface of the face that corresponds to the bony gnathion (Farkas, 1994). 
From inspection, this is a difficult landmark to place. It is the only landmark for which 
palpation is traditionally preferred, but has been included to give an approximate 
representation of the vertical dimension of the face. The shape of a subject’s chin is 
influenced by body weight and skin laxity. To help identification and reproducibility, 
gnathion is placed in the midline of the lower jaw at a point on the lower curve of the 
chin such that a tangent in the midsagittal plane would approximate 45 degrees to the 
horizontal. 
2.5.14 OTOBASION INFERIUS (PAIRED: OTOL AND OTOR) 
This is the point of attachment of the ear lobe to the cheek (Farkas, 1994). It is 
important in determining facial width during analysis of face shape. It is also the easiest 
ear landmark to capture with the Vectra CR10 camera system. The posterior parts and 
superior parts of the external ear are more likely to be missed or obscured (for 
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example, by hair). Even when the whole ear is included, one group found that 3D 
surface images showed poorer resolution for the ear compared to other parts of the 
face (Gwilliam et al., 2006). Otobasion inferius was chosen instead of tragion or 
subaurale (the most inferior point of the earlobe), due to greater objectivity in 
placement. For example, attached earlobes make it impossible to place subaurale 
accurately. 
2.6 DENSE SURFACE MODELLING 
 
At this stage, it should be emphasised that the 3D face surface comprises over 20,000 
point co-ordinates, of which 22 have been manually designated as landmarks in the 
‘landmarking’ step in the previous section. Figure 18 below shows a wireframe view of 
a face surface showing these point co-ordinates. The next steps involved the creation of 
a dense surface model (DSM). The steps can be broken down into the following: 
1. Procrustes analysis 
2. Thin plate spline 
3. Dense correspondence creation 
4. Reverse thin plate spline 
5. Principal component (PC) analysis 
6. Face Shape Difference (FSD) calculation 
Previous studies have used the methods described here for dense surface model 
creation (Bhuiyan et al., 2006; Cox-Brinkman et al., 2007; de Souza et al., 2013; 
Hammond, 2007; Hammond et al., 2012a; P. Hammond et al., 2008; Hammond et al., 
2005, 2004; Heulens et al., 2013; Suttie et al., 2013). An in-house software program 
called DSMExplorer was used (version 2.1, ShapeFind; UCL Institute of Child Health, 
London, UK; made available by Peter Hammond) as in previous studies. The input data 
required are the raw object files for every subject’s face image and the list of point co-
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ordinates of all 22 landmarks for each image. A number of steps are used to generate 
the model and these are also described mathematically elsewhere (Hutton et al., 2003, 
2001). The following steps of generalised Procrustes analysis, thin-plate spline 
warping, dense correspondence creation and principal component analysis are all 
performed using the software program.  
 
 
Figure 16 An example of Procrustes analysis with two trapeziums (outlined in grey and 
black). Partial Procrustes analysis uses rotation and translation to superimpose shapes on 
one another. Full Procrustes analysis also uses scaling, but in this study, face size could be 
an important factor so no scaling was employed. Procrustes analysis can be employed with 
any number of landmarks, not just four as in the example above. When Procrustes analysis 
is used with more than two objects, it is called generalised Procrustes analysis. 
First, the images have to be co-registered or aligned using generalised Procrustes 
analysis. It is named after Procrustes, a character in Greek mythology who tortured 
victims by stretching their bodies or amputating their legs to make them fit on his bed. 
The analysis is a mathematical procedure to superimpose shapes as closely as possible 
on to one another (Figure 16). The shapes in this case were whole face surfaces. 
Superimposition is by means of rotating and translating shapes. Scaling is employed in 
some forms of Procrustes analysis but was not used in this thesis because face size 
information would be lost when all face surfaces are scaled to the same size. Face size 
may be affected, as well as face shape, by structural variants, body mass index and 
developmental brain lesions. The closest fit for all face surfaces is done using the ‘least-
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squares’ method of alignment, in which the sum of the square distances between each 
landmark in a pair of face surfaces is minimised. After Procrustes analysis, the actual 
shapes of the face surfaces have not been altered.  
In the next step, the shapes are warped on to a base surface shape so that all surface 
points can be labelled and included in analysis (Figure 17). This base surface can be any 
of the face surfaces in the group of faces being analysed and the choice of base surface 
makes no difference to later analysis (Hutton et al., 2001). The warping is performed 
using another mathematical technique known as thin-plate spline. 
 
Figure 17 Panel A shows an example of a simplified cross-section of part of two face 
surfaces, a base surface and Subject X’s face surface. Two landmarks, cheilion and gnathion, 
are shown with two surface points in between them. In reality there are hundreds of surface 
points in between these landmarks. Panel B shows thin plate spline being applied to the 
Subject X face surface, which is a mathematical function to ensure maximum closeness of fit 
of each surface point with the minimum deformation required. Panel C shows that once the 
surfaces are closely apposed after thin plate spline, a ‘dense correspondence’ can be created 
with labelled surface points interpolated between the landmarks for the Subject X face 
surface. In this case, surface points B1 and B2 on the base surface are matched to 
Page | 95  
 
equivalent points on the Subject X face surface, which can be termed X1 and X2. Panel D 
shows the reversal of thin plate spline to recreate the original face surface for Subject X. 
However, now the surface points all correspond to individual surface points on the base 
surface. 
Thin-plate spline can alter shapes such that fixed points (in this case the landmarks) 
are perfectly aligned for every face surface and all of the other surface points are as 
‘smoothly’ transformed on to the base surface as possible. In mathematical terms, the 
smoothness is due to the use of a function to balance the closeness of fit of all surface 
points with the minimum deformation (measured as the displacement of each point) 
needed. Note that thin plate spline is only used so that every face surface point on every 
face can correspond to an equivalent point, just as the landmarks are. This ‘dense 
correspondence’ allows sophisticated analysis of face shape not possible with 
landmarks alone. For example, after landmarking, the surface point of gnathion in one 
subject corresponds to a surface point labelled gnathion in every other subject. Dense 
correspondence means, for example, that the point just superior to gnathion 
corresponds to the point just superior to gnathion in all face surfaces of subjects. This is 
also true of each and every one of the over 20,000 surface points. Without dense 
correspondence, only landmarks themselves would be compared in shape analysis and 
variations in face shape in areas outside landmarks would be ignored, such as on the 
cheeks or forehead. Areas between landmarks, such as the shape of the nasal bridge 
between nasion and pronasale, would be ignored too. Thin plate spline, in turn, is 
necessary for the software program to create an accurate dense correspondence. Once 
the dense correspondence has been made for every image, the images undergo a 
reverse thin-plate spline warp to return them to their original shape. Now the dense 
correspondence has created approximately 20,000 ‘landmarks’ that are common 
between the faces and can be used for comparison (Figure 18).  
Each face image may have surface points covering extraneous areas such as the neck, 
that may or may not be included in other images. These areas are removed by ignoring 
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all points that do not form a dense correspondence within a certain distance (20mm). 
Thus, after the thin-plate spline and dense correspondence steps, all face images cover 
the same regions of the face. 
 
Figure 18 A wireframe view of the mean face surface in one of the studies. This shows all of 
the dense correspondence points created after thin plate spline interpolation, connected to 
each other with straight lines. The right nostril has been magnified to show the points more 
clearly. Each correspondence point can be compared in all of the subjects within the dense 
surface model (DSM). 
To compare the different shapes, principal component (PC) analysis was used. There 
are three reasons for this. Firstly, PC analysis allows a manageable dataset to be 
created, which can be utilised on personal computers. Secondly, the principal 
components illustrate specific characteristics of changes in face shape and size. For 
example, variation in one PC was shown to help classify a set of face surfaces as having 
Noonan syndrome or not having the syndrome (Hammond et al., 2004). Thirdly, PC 
analysis can provide a single metric to assess how atypical the shape of a face is – 
described later. A PC is a particular scalable transformation. PC analysis describes the 
overall transformation needed to obtain one shape from another using the smallest 
number of PCs to describe the greatest amount of variation between shapes. The first 
PC is computed to have the largest possible variance and so it is always the one that 
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describes as much of the variation as possible in one transformation. The PC is scalable 
in that a numerical coefficient can describe the extent to which any shape is 
transformed along the ‘axis’ of the PC (Figure 19). The second PC is the transformation 
that adjusts for the greatest amount of the remaining variation and is orthogonal, that 
is non-overlapping, to the first PC. This is continued until 99.0% of all face shape 
variation was explained by a number of successive PCs. In other words, a weighted 
linear sum of all PCs with their coefficients can describe each face surface shape, 
instead of approximately 20,000 point co-ordinates (Figure 19). The figure of 99% is a 
compromise between creating a manageable dataset and minimising face shape data 
loss. It is greater than in the only studies of face shape using principal components by 
other groups, which have used thresholds of 75-87% (Hennessy et al., 2010, 2007, 
2002; Prasad et al., 2015). All of these studies investigated one particular phenotype so 
detection of all variation was less important. In the present study, it was important to 
identify and detect any unrecognised facial dysmorphism. 
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Figure 19 Each principal component can be thought of as one dimension of shape variation 
along which a face surface can be transformed. The units or coefficients of each principal 
component represent the degree of transformation from the mean face surface. Only the 
first two principal components (PC1 and PC2) are shown here in two dimensions, with PC1 
along the x-axis and PC2 along the y-axis. In this dense surface model (DSM), the base 
surface is shown at (0,0). Increasing the value of PC1 increases facial size, which can be 
seen in the row of five images from (-2,0) to (2,0). Increasing PC2 elongates and narrows 
the facial shape, seen between (0,-2) and (0,2). Every subject’s face can be described by a 
point in this space, such as (1.54,0.95) for the above subject. However, the two principal 
components only capture 84.5% of facial variation in this dense surface model, Face1, and 
53 principal components are needed to capture over 99% of variation. This increased detail 
for the face shape can be seen in the panel on the right. 
A number of different groups of subjects were studied in my work and they are 
described in detail in Section 2.2.5. For each group of subjects, a separate DSM was 
created. The DSM covered the whole face (Figure 20 panel A) and was called Face1 for 
Group 1 subjects, Face2 for Group 2 subjects, and so on. Another DSM for Group 1 
subjects, called FaceR, was created to study reproducibility (Chapter 3). In total, eight 
DSMs were created for face shape and called Face1-Face7 and FaceR.  
The same groups were also used to create DSMs of just particular parts of the face. 
These parts were ‘feature-rich’ areas with multiple landmarks and contour changes: the 
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periorbital region only (Figure 20 panel B), the perinasal region only (Figure 20 panel 
C) and the perioral region only (Figure 20 panel D). These DSMs of parts of the face 
were used to explore the extent of regional face shape change and to see if DSMs of a 
part of the face were as discriminating and useful as a DSM of the whole face. Initially, 
software limitations meant that only DSMs of the periorbital region (Eyes1-Eyes6, 
EyesR) and the perinasal region (Nose1-Nose6, NoseR) were made. After a software 
upgrade, I was able to create DSMs of the perioral region for later studies (Mouth2-7). 
The DSMs of parts of the face were created in the same way as the DSM of the whole 
face except that they were trimmed to the region of interest only (Figure 20).
 
Figure 20 This shows the four different DSMs used in analyses throughout this study. The 
primary DSM was for the whole face (A). Three further DSMs investigated the usefulness of 
using one part of the face: the periorbital region only (B), the perinasal region only (C) or 
the perioral region only (D). 
Usually the more surfaces that are included in a DSM, the more PCs are needed to 
describe 99.0% of the face shape. In my studies, different numbers of principal 
components were needed to explain at least 99.0% of the face shape variation. DSMs 
are created independently from each other and may have a different number of PCs. 
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The action of each PC will also be different between DSMs. This means that PCs cannot 
be directly compared across DSMs. Hence in two validation studies here (which use 
either Group 2 and Group 4), the training set was included in the group as well as the 
validation set – but of course the validation set was assessed separately with no 
overlapping subjects in both the training and validation set. A summary of the different 
DSMs for each group of subjects and the number of PCs used is shown in Table 4. 
Group Chapter Whole face Periorbital Perinasal Perioral 
R 3 FaceR 53 EyesR 98 NoseR 46 N/A 
1 3,4 Face1 53 Eyes1 98 Nose1 46 N/A 
2 4,5 Face2 81 Eyes2 172 Nose2 70 Mouth2 79 
3 3,6 Face3 103 Eyes3 172 Nose3 70 Mouth3 79 
4 6 Face4 96 Eyes4 229 Nose4 87 Mouth4 72 
5 6 Face5 96 Eyes5 229 Nose5 87 Mouth5 72 
6 7 Face6 97 Eyes6 239 Nose6 79 Mouth6 92 
7 8 Face7 85 N/A N/A N/A 
Table 4 Summary of the DSMs made for each group of subjects in the following studies here. 
Group R is the same as Group 1 except with some landmarks replaced in some subjects as 
part of a reproducibility study (Chapter 4). Groups 1 to 7 are the groups of subjects 
described in Section 2.2.5. Groups 1 and 2 were used in the study of pathogenic structural 
variants in Chapters 4 and 5. Groups 3-5 were used in the study of BMI and age in Chapter 6. 
Group 6 was used in the study of developmental brain lesions in Chapter 7. Group 7 was 
used in the study of people with HNF1B mutations in Chapter 8. For each group, one DSM 
was made of the whole face and in some cases, more DSMs of other parts of the face. For 
each of these DSMs, the number of principal components (PCs) used is shown next to them. 
2.7 STATISTICAL ANALYSIS 
2.7.1 FACE SHAPE DIFFERENCE (FSD) 
Principal components provide a measure of the degree of facial surface transformation 
needed to reproduce the subject’s surface relative to an average matched face in a 
particular DSM. Differences in a subset of principal components have been used 
previously to discriminate between controls and people with a particular condition 
graphically. As part of the thesis, I sought to explore face shape in people with different 
underlying structural variants. I was not seeking to compare one homogeneous group 
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to a control group. Therefore, I created a measurement of overall facial dysmorphism, 
which was checked for technical validity by Peter Hammond.  
Within each DSM, I compared each subject face to an average control face. This control 
face was created using the mean of each and every principal component coefficient in a 
set of the 30 closest age-matched sex-matched ethnicity-matched reference control 
faces.  
Then, the square root of the sum of the squared differences between every principal 
component coefficient in the subject and the mean of the control set was calculated to 
give a ‘Face Shape Difference’ (FSD). The FSD value is an indicator of the difference in 
PCs in a subject relative to the matched control face surfaces. The FSD for a subject can 
be expressed algebraically as follows: 
FSD(𝑥) = √(𝛴(𝑥𝑃𝐶1 − 𝑚𝑃𝐶1)
2 + (𝑥𝑃𝐶2 − 𝑚𝑃𝐶2)
2 + (𝑥𝑃𝐶3 − 𝑚𝑃𝐶3)
2 + ⋯ ) 
Or more concisely as: 
FSD(𝑥,𝑚) = √∑ (𝑥𝑖−𝑚𝑖)2
𝑛
𝑖=1    for 𝑥 ∈ 𝑀 
where i indexes the n principal components (PC1, PC2, PC3, etc.) capturing 99% shape 
variation in dense surface model M and x is an arbitrary subject’s face which is 
compared to m, its matched mean from the control set. 
The square root of the sum of the squared differences is a statistical tool that is used to 
combine the difference between unrelated variables, as is the case with PCs. 
During matching, if a subject was not of the same ethnicity, he or she was excluded 
from further analysis. There were sufficient controls to generate mean PCs between the 
ages of 2.6 to 50 years for men and 2.7 to 53 years for women. The maximum 
discrepancy in age between subjects and the matched control set mean age was kept at 
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9 months for children and 3 years for adults. The average discrepancy in age was 
0.44% for male subjects and 0.74% for female subjects. 
2.7.2 REFLECTED FACE SHAPE DIFFERENCE 
To test asymmetry, an additional face image was created for every subject using the 
mirror image of the original face surface with landmarks. The landmarks were 
relabelled from ‘left’ to ‘right’ and vice versa for all paired landmarks and no change 
was made to midline landmarks to avoid introducing any error from repeat 
landmarking. After the DSM was created including these mirror images for subjects, I 
calculated the distance between each face and its mirror image in terms of the square 
root of the sum of squared differences of every principal component. Algebraically, the 
formula is: 
FSD(𝑥,𝑟) = √∑ (𝑥𝑖−𝑟𝑖)2
𝑛
𝑖=1    for 𝑥 ∈ 𝑀 
where i indexes the n principal components (PC1, PC2, PC3, etc.) capturing 99% shape 
variation in dense surface model M and x is an arbitrary subject’s face which is 
compared to r, its reflected face surface image. 
This distance was termed the ‘reflected face shape difference’ (reflected FSD) and a 
similar measure has been used before to detect facial asymmetry in autism spectrum 
disorders (Hammond et al., 2008). Like FSD, reflected FSD only measures the extent of 
any difference in the face images. 
One can see that for reflected FSD, control subjects are not necessary as a subject’s face 
is compared only with its reflection. 
2.7.3 POWER CALCULATION 
The following power calculations were for two of my studies assessing FSD in people 
with pathogenic SVs and in people with unilateral developmental brain lesions. The 
Page | 103  
 
tests were to detect a two-sided difference between the means of two sample groups 
and calculated using a statistical website (http://powerandsamplesize.com) using the 
following formula, in which the two sample groups are designated A and B, with nA 
people in A, nB people in B, and the sample size ratio or matching ratio described as 
nA/nB: 
 
There has been no known previous use of FSD before and it was unclear, a priori, how 
different it would be in different samples of people with epilepsy. However, there have 
been studies looking at differences in the underlying PCs that make up FSD. A study of 
22q11 deletion syndrome shows a difference in three of the first four PCs and in one of 
these PCs, the mean difference is approximately 3 units with a standard deviation of 5.6 
units (derived from Figure 11A in Hammond et al., 2004). Assuming that the 22q11 
deletion syndrome is a more easily recognisable dysmorphic syndrome than most and 
that the mean difference in a group of all pathogenic SVs would be much less, I chose a 
conservative estimate of mean difference of 1 unit with the same standard deviation, 
expected to be found in three PCs. Therefore, the mean difference in FSD and the 
sample size can be worked out as: 
Assumed total number of PCs in the DSM = 50 (Hammond et al., 2004) 
Number of PCs with 1 unit difference between affected and control subjects= 3 
Page | 104  
 
Number of PCs with 0 units difference between affected and control subjects = 47 
Mean difference in FSD = √(1 × 3) + (0 × 47) = 1.7 
µa = 1.7  Mean FSD increase in affected subjects  
µb = 0.0  Mean FSD increase in control subjects  
σ = 5.6  Standard deviation of affected subjects  
α = 0.05 Type 1 error threshold 
1-β = 0.8 Type 2 error threshold 
κ = 0.2  Sampling ratio of 1 affected subject per 5 unaffected subjects used 
From the formula described at the start of this section, the minimum required sample 
size is calculated as: 102 unaffected subjects and 20 affected subjects. 
There is one study that quantifies differences in PCs due to asymmetry (Hammond et 
al., 2008). This study found that in comparing those with autism to controls, the 
difference in face shape using an “asymmetry index”, another statistical measure 
derived from DSMs and PCs, was approximately 0.67 (6.77 in autism and 6.10 in 
controls) with a variance of 2.84 (hence standard deviation of √2.84 = 1.69).  
Assuming that autism and developmental brain lesions may be associated with a 
similar degree of facial asymmetry, the required sample size can be calculated from: 
µa = 6.77 Mean asymmetry index in affected subjects  
µb = 6.10 Mean asymmetry index in unaffected subjects 
σ = 1.69 Standard deviation of affected subjects 
α = 0.05 Type 1 error threshold 
1-β = 0.8 Type 2 error threshold 
κ = 0.2  Sampling ratio of 1 affected subject per 5 unaffected subjects used 
From the formula described at the start of this section, the minimum required sample 
size is calculated as: 240 unaffected subjects and 60 affected subjects. 
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2.7.4 STATISTICAL TESTS USED WITH FSD 
Statistical tests used in each analysis are described in detail in subsequent chapters. An 
α value of 0.05 was used in all tests unless otherwise specified. In summary, normality 
of data was assessed with the Shapiro-Wilks test. For non-parametric data, the 
Wilcoxon Mann-Whitney test and Kruskal-Wallis tests were used with the null 
hypothesis that FSD was equal in both groups of subjects. For parametric data, the 
paired or unpaired t-test and the ANOVA tests were used. Spearman’s rank correlation 
coefficient or Pearson’s correlation coefficient were used to compare associations 
between data. Analysis was conducted using SPSS software (versions 19-23, SPSS Inc; 
Chicago, IL, USA). 
2.8 ETHICS APPROVAL 
This study was approved by the Joint Research Ethics Committee of the National 
Hospital for Neurology and Neurosurgery and the Institute of Neurology, University 
College London as part of ‘A Population Based Genetic Study of Epilepsy’ (Study 
Number 00/N081, Chief Investigator: Sanjay Sisodiya). The relevant amendment was 
approved on 26th March 2009. The study was sponsored by University College 
Hospitals National Health Service Foundation Trust and participants were recruited 
from two locations within the Trust: 
• National Hospital for Neurology and Neurosurgery, Queen Square, London 
• Chalfont Centre for Epilepsy, Chesham Lane, Chalfont St Peter 
Reference control subjects had been previously recruited by Peter Hammond after 
written, informed consent and approval by University College London Hospital 
Research Ethics Committee. 
Recruitment from European centres is described above. 
2.9 DATA PROTECTION 
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All image data was stored in coded form on an encrypted drive of a personal computer 
used with the stereophotogrammetric camera. The personal computer was stored in a 
room that was locked with a key and also had a combination door lock.  
A backup portable hard drive and desktop hard drive also contained coded image data. 
Both of these were also encrypted. They were stored in a room at a different physical 
site, which was accessed using a swipe card and a combination door lock. 
Access to the rooms was limited to researchers in the same department and passwords 
for the encrypted drive were known only to four research staff who were directly 
recruiting participants and performing image capture. Codes for participant data were 
stored in an encrypted spreadsheet, in a restricted folder on University College London 
Hospitals NHS Foundation Trust servers. 
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CHAPTER 3: VALIDATION OF STEREOPHOTOGRAMMETRY 
AND DENSE SURFACE MODELLING 
3.1 INTRODUCTION 
Stereophotogrammetry is a method of measurement and as such, it must be 
scientifically validated before being used in clinical research. Validation is even more 
important for stereophotogrammetry because it is a relatively novel technique and it 
contains a number of steps that can each introduce error.  
In 1996, Farkas, the leading researcher using direct anthropometry, stated that there 
was a need to prove the reliability of 3D surface scanning methods (Farkas and 
Deutsch, 1996). Some earlier research had noted high accuracy to within 0.3mm but 
not in living subjects or systematically (Beard and Burke, 1967; Thomas et al., 1989). 
The first study in which 3D indirect anthropometry was compared to direct 
anthropometry was performed using laser surface scanning of 30 young adults in 1995 
(Aung et al., 1995). The authors found that they could identify 37 out of 41 standard 
anthropometric facial landmarks from the scan whereas four needed to be marked on 
the face beforehand. In terms of accuracy, just over half of all linear measurements 
between landmarks (42 of 83) were deemed unreliable because they showed a mean 
difference of >2mm between the two methods – they also tended to be the longest 
measurements although the authors do not comment upon that. The least reliable 
measurements used landmarks at the periphery of the face such as the tragus, glabella 
and gnathion. The errors were partly due to the vertical scanning movement of the 
laser beam being less suited for horizontal plane accuracy, the 15 second image 
acquisition time and the difficulty of identifying landmarks on a laser scan, which lacks 
photographic information of the surface. Despite these limitations, for over a third of 
measurements (28 of 83), the mean error was less than 1.5mm. Since then, 
Page | 108  
 
stereophotogrammetry has entered widespread clinical practice and reproducibility 
has been assessed using this method of image capture. 
3.1.1 VALIDATION STUDIES OF CURRENT STEREOPHOTOGRAMMETRY CAMERAS 
Over the last 13 years, there have been many other studies of accuracy and 
reproducibility using different stereophotogrammetry systems and configurations 
(Table 5). Accuracy refers to how close a measurement is to the true value – and in the 
majority of these studies, the ‘gold standard’ for measurements of the true value were 
performed using direct anthropometry. Reproducibility or precision is the degree to 
which repeated measurements are the same, and were usually performed for the same 
operator (intra-operator) and between operators (inter-operator). I will look at these 
studies in more detail regarding the overall accuracy and reproducibility, and also for 
the following individual steps in the image analysis procedure: 
1. Image capture and registration 
2. Head position 
3. Face expression 
4. Face dysmorphism 
5. Landmarking 
6. Dense surface model creation 
Three current camera manufacturers are represented in the scientific literature and 
they are 3dMD (3dMD; London, UK), Canfield (Fairfield, NJ, USA: Canfield Scientific Inc) 
and Di3D (Dimensional Imaging; Glasgow, UK). Their models all use passive 
stereophotogrammetry but with a synchronised camera flash. According to the three 
manufacturers’ camera specifications, image capture speed is 1-3.5ms, accuracy is 
within 0.2mm, and all create a 3D mesh framework with a colour surface image (Tzou 
et al., 2014). Due to the similarities between the cameras, studies using all of them for 
face shape measurement were analysed (Table 5 and Table 6). 
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It should be noted that seven studies were of mannequin heads or casts of the face. This 
may underestimate error as there is no movement, no change in expression, and they 
lack soft tissue imaging characteristics. Loss of image detail due to soft tissue reflection 
is noted in one study (Ghoddousi et al., 2007). By contrast, direct measurements on 
human faces may not be a ‘gold standard’ in certain cases and mannequins/casts may 
be superior. Facial soft tissue may show slight deformation during direct 
anthropometry using callipers or measuring tape. For example, two studies noted the 
difficulty of accurately measuring the inner and outer canthus of the eye with callipers 
due to delicate and sensitive structures around them (Ghoddousi et al., 2007; Heike et 
al., 2009). Thus it is useful to include studies of both human faces and of casts or 
mannequins of the human face, because each type has its own limitations. 
3.1.2 STUDIES OF ACCURACY OF STEREOPHOTOGRAMMETRY 
Twelve studies compare the accuracy of 3D stereophotogrammetry to direct 
anthropometry as a gold standard (Chen et al., 2015; Dindaroğlu et al., 2015; Fourie et 
al., 2011; Ghoddousi et al., 2007; Heike et al., 2009; Kook et al., 2014; Lee et al., 2004; 
Lübbers et al., 2010; Schaaf et al., 2010; Weinberg et al., 2006; Winder et al., 2008; 
Wong et al., 2008). Two others compare it to specialised direct co-ordinate 
measurement machines and one compares it to CT scans (Ayoub et al., 2003; Khambay 
et al., 2008; Metzger et al., 2013). Another five studies look at reproducibility only 
(Aldridge et al., 2005; de Menezes et al., 2010; Gwilliam et al., 2006; Othman et al., 
2013; Plooij et al., 2009). They are all listed in Table 5 and Table 6. One other study 
comparing stereophotogrammetry to moiré photography was excluded because the 
authors looked at agreement between both methods but not accuracy or precision 
(Artopoulos et al., 2014).  
The studies all show that stereophotogrammetry using any of the cameras has an 
accuracy of within 1mm compared to direct anthropometry, although often worse than 
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that stated by the manufacturers. Therefore this would suggest that 
stereophotogrammetry is superior to 2D indirect anthropometry, laser scanning and 
moiré photography in terms of accuracy.  
3.1.3 STUDIES OF REPRODUCIBILITY OF STEREOPHOTOGRAMMETRY 
Nine studies assessed the absolute reproducibility error (Aldridge et al., 2005; Ayoub et 
al., 2003; de Menezes et al., 2010; Gwilliam et al., 2006; Plooij et al., 2009; Schaaf et al., 
2010; Weinberg et al., 2006; Winder et al., 2008; Wong et al., 2008) and two other 
studies only looked at intraclass correlation coefficients for reproducibility (Dindaroğlu 
et al., 2015; Othman et al., 2013).  
All studies showed that intra-operator and inter-operator reproducibility was within 
1mm with the exception of two studies. One of these studies was in an obsolete camera 
model known to have less surface point resolution than newer cameras even in 2004 
(Gwilliam et al., 2006; Hammond et al., 2004). The other study used only two 
landmarks, left and right frontotemporal, that were each used to measure two diagonal 
distances across the skull vault with no corresponding formal landmark on the 
opposite side of the skull (Schaaf et al., 2010). Instead the authors took the end point of 
their distances as the “contralateral occipital area close to the lambdoid suture”. Using 
only one clearly defined landmark to measure a linear distance (in this case, the oblique 
length of the cranium in infants) would appear to be a less accurate method than using 
a start and end landmark, but this has not been studied. Both landmarks are on the 
lateral forehead and not commonly used in anthropometric studies. The landmarks 
were also placed on images of infants’ heads covered by a tight-fitting cap, further 
reducing accuracy as the forehead itself was not visible. 
All studies that compared intra-operator reproducibility to inter-operator 
reproducibility found that intra-operator reproducibility was greater, except for one 
study (de Menezes et al., 2010). This study compared intra-operator reproducibility for 
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measurements from two different images of each subject’s face to inter-operator 
reproducibility for the same image of each subject’s face. Therefore, the intra-operator 
reproducibility error also includes the errors from a second image acquisition. 
Reproducibility error has been poorly studied in direct anthropometry. A number of 
studies comment on how errors can be introduced by poor landmark identification, 
poor instruments and poor measurement technique (Allanson et al., 1993; Hunter, 
1996; Jamison and Ward, 1993). One author comments on the need for further studies 
of these errors (Allanson, 1997). It is likely that reproducibility error is smaller for 
stereophotogrammetry than for direct anthropometry although the two methods have 
not been compared.
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Study Year Camera model Comparison Face Age Area of face Accuracy (mm) Reproducibility (mm) 
Ayoub et al 2003 Proprietary research system CM M I Whole face 0.42 0.20 
Lee et al 2004 Genex DA M A Whole face 1.11 
 Aldridge et al 2005 3dMD Nil H A, C Whole face 
 
0.83 
Weinberg et al 2006 3dMD, Genex Facecam 250 DA M A Whole face <1.00 <0.60 
Gwilliam et al 2006 DSP400 Nil H A, C Whole face 
 
50% <1.0 (IA), 8% <1.0 (IE) 
Ghoddousi et al 2007 (Canfield Vectra CR10) DA, 2DP H A Whole face 0.23 
 Khambay et al 2008 Di3D System CM M A Whole face 0.20 
 Winder et al 2008 Di3D System DA M A Whole face 0.62 0.06 
Wong et al 2008 3dMDface System DA H A Whole face 0.9 0.8 
Heike et al 2009 3dMDface System DA H A, C Whole face <1.00 
 Plooij et al 2009 3dMDface System Nil H A Whole face 
 
0.26 (IA), 0.32 (IE) 
Lubbers et al 2010 3dMD DA M A Whole face 0.41 
 Schaaf et al 2010 3dMD Cranial System DA H I Cranium 
 
1.1-1.3 (IA), 2.6-2.8 (IE) 
de Menezes et al 2010 Canfield Vectra CR10 Nil H A Whole face 
 
0.53 (IA), 0.29 (IE) 
Fourie et al 2011 Di3D System DA, LS, CT C A Whole face 0.86 
 Metzger et al 2013 3dMD CT H A Whole face 2/3 of landmarks show no sig difference 
Othman et al 2013 Canfield Vectra CR10 Nil H A Whole face 
 
ICC = 0.68-0.97 (IA) 
Kook et al 2014 Di3D System DA, CT, LS M A Whole face 0.32-0.85 
 Chen et al 2015 3dMD Cranial System DA H A Ear auricle 0.27 
 Dindaroglu et al 2015 3dMDflex System DA, 2DP H A Whole face 0.21 ICC = 0.94 (IA), 0.94 (IE) 
Table 5 Studies of accuracy and precision of stereophotogrammetry, where accuracy is in comparison to another measurement method in the Comparison 
column and reproducibility is for repeated measurements using stereophotogrammetry alone. If known, IA is used for intra-operator reproducibility and IE 
for inter-operator reproducibility. Measurements with ICC are only for the intraclass correlation coefficient and were not given as absolute errors in the 
studies. The Comparison column shows other methods of measurement used: 2DP = 2D photography, CM = Co-ordinate measuring machine, CT = Computed 
tomography, DA = Direct anthropometry, LS = Laser scanning. The face column shows the subjects used: C = Cadaver face, M = mannequin or cast of face, H = 
Live human subject. The Age column lists the age of subjects: I = Infants, C = Children, A = Adults. 
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Study Year Measurements* Least accurate landmarks Landmarked^ Notes 
Ayoub et al 2003 Co-ordinates Pronasale, alare nasi Yes Infants with cleft lip 
Lee et al 2004 Linear Zygoma Yes Assessed at 4 different angles 
Aldridge et al 2005 Linear Nasion, tragion No Children with Down syndrome/craniosynostosis 
Weinberg et al 2006 Linear Nasion, gnathion, exocanthion, alare nasi Yes 
 Gwilliam et al 2006 Co-ordinates Alar crest, nasion, gonion, menton No Measures landmarking precision 
Ghoddousi et al 2007 Linear Intercanthal width, alar length, upper lip Yes 
 Khambay et al 2008 Co-ordinates Nostrils No Measures landmarking accuracy 
Winder et al 2008 Linear Cheilion, glabella, gnathion Yes 
 Wong et al 2008 Linear Endocanthion, tragus, gnathion No 
 Heike et al 2009 Linear Columella width, upper face height, mouth width Yes 22q11.2 deletion syndrome 
Plooij et al 2009 Co-ordinates Alare, tragion No Measures landmarking precision 
Lubbers et al 2010 Linear Not assessed Yes 0.10mm operator & 0.11mm calibration error 
Schaaf et al 2010 Linear Not assessed No 
 de Menezes et al 2010 Linear Cheilion Yes 
 Fourie et al 2011 Linear Cheilion, alare, tragus, pronasale, subnasale Yes Stereophotogrammetry was worse than CT 
Metzger et al 2013 Linear Exocanthion, gonion, labiale superior & inferior No 
 Othman et al 2013 Linear Not known No 
 Kook et al 2014 Linear Exocanthion, cheilion Yes 
 Chen et al 2015 Linear Upper third of face Yes 
 Dindaroglu et al 2015 Linear, Angular Cheilion, subnasale, tragus No  ICC 0.85 to 0.99 for angular measurements 
 
Table 6 Studies of accuracy and precision of stereophotogrammetry with further details and notes 
*Error is measured for linear measurements between points, co-ordinates of points, or angles between three or more points 
^If yes, studies were conducted with landmarks marked on the faces directly for use in all methods of face shape measurement
Page | 114  
 
3.1.4 VALIDATION STUDIES OF CANFIELD VECTRA CR10 CAMERA 
The Canfield Vectra CR or Vectra CR10 stereophotogrammetry camera was used by me 
and this specific camera has been studied by a number of other groups for accuracy and 
reproducibility.  
One group, based at the University of Milan, had previous experience of researching 
accuracy of stereophotogrammetry using older cameras (de Menezes et al., 2009). 
Using a cubic object, they found a mean absolute error of 0.02mm (0.2%) and of 0.04 
degrees (0.04%) for linear and angular measurements respectively between the 
Canfield Vectra CR10 and direct measurement (de Menezes et al., 2010). They then 
assessed reproducibility in ten young adult human faces for 50 landmarks, including 15 
out of the 22 landmarks used in my study: exocanthion (2), endocanthion (2), nasion, 
pronasale, subnasale, alare (2), labiale superius, labiale inferius, cristae philtri (2), 
cheilion (2). They also use three further landmarks close to landmarks in my study: 
menton for gnathion and subaurale for lower auricular attachment (2). Mean 
reproducibility error was 0.29mm - 0.53mm. Cheilion-cheilion distance was the least 
reproducible in all analyses but the mean reproducibility error was always less than 
1.2mm. Note that the authors had marked all landmarks on the subjects’ faces before 
image capture, so landmark placement errors were not part of the reproducibility 
assessment. 
The same group later showed that the same camera could be used to assess the angle of 
the occlusal plane (the plane of intersection of the upper and lower teeth) using a 
subset of the same facial landmarks, with a mean interoperator error of 0.9-1.9 degrees 
(Rosati et al., 2012). The group then used 3D face surfaces and superimposed a 3D 
dental cast image from laser scanning. They found that the mean absolute error for 
distances between facial landmarks and dental landmarks was less than 1.7mm 
compared to in vivo measurements. They have also used the Canfield Vectra camera to 
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look at lip protrusion and facial aesthetics using facial landmarks but without any 
further assessment of accuracy or reproducibility (Rosati et al., 2014; Rossetti et al., 
2013).  
Another group compared the accuracy of stereophotogrammetry with direct 
anthropometry and 2D photographs. They do not specify the stereophotogrammetry 
camera model that they use but from the figures in their manuscript, it appears to be a 
Canfield Vectra CR10 system (Ghoddousi et al., 2007). They found a mean absolute 
error of 0.23mm for facial landmark distances using stereophotogrammetry compared 
to direct anthropometry. Others have used similar Canfield Vectra CR10 cameras to 
measure breast shape, except with three camera pods instead of two (Quan et al., 2011; 
Roostaeian and Adams, 2014). They did not perform an assessment of the camera’s 
accuracy. 
These studies show that accuracy and reproducibility in the Canfield Vectra system is 
unlikely to be significantly different to the other stereophotogrammetry cameras. 
Furthermore, they are reassuring given that one group used very similar facial 
landmarks to my own work. Even so, it is not clear exactly how their camera was set up. 
Background lighting, subject positioning and subject expression are likely to differ from 
my study. Landmarks were marked on the skin beforehand, which I did not do here. 
Also my subject population included a much broader age range and people with illness. 
Therefore, I have conducted a study of image reproducibility as part of this thesis to 
address these issues. 
3.1.5 IMAGE CAPTURE AND REGISTRATION ERROR 
Three studies specifically looked at the reproducibility of 3D image capture of the face 
at two or more prolonged time intervals. The first two studies used laser scanning and 
structured light systems and found accuracy within 1mm for time intervals between 3 
days and 3 weeks – although one study used plaster casts (Kau et al., 2005; Ma et al., 
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2009). The third study used 3D stereophotogrammetry at intervals of 1 minute and 3 
weeks in 15 adult subjects, without using landmarks. The authors found that the mean 
system error in image capture and registration was less than 1.1mm looking at over 
20,000 point co-ordinates on the face surface (Maal et al., 2010). They then found that 
in repeated images of one subject’s face over 6 weeks, the mean error between all point 
co-ordinates was 0.36mm (Maal et al., 2011).  
This suggests that repeated image capture in itself does not introduce significant 
errors, even at time intervals of up to three weeks. This is important for two reasons: in 
my work, I have used stereophotogrammetry to recruit subjects over two years and in 
one particular study I explore the change in face shape with age longitudinally. 
3.1.6 HEAD POSITION 
Another source of error during image capture is the change in a subject’s position. One 
published study of head position during clinical photography found that adult head 
position was reproducible even without a mirror (Chiu and Clark, 1991). With 
stereophotogrammetry, the 3D image can be manipulated on screen into a desired 
position so head position should be irrelevant. One caveat is that the subject should 
face the field of view of the cameras. Looking off centre may lead to areas of the face 
missing in the 3D image. Two studies of head position in stereophotogrammetry using 
a 2-camera system suggest that accuracy is not affected if horizontal rotation of the face 
is less than 15-30 degrees from the midline (Lee et al., 2004; Lübbers et al., 2010). 
However, both studies used mannequins and there has been no assessment of the effect 
of head position and orientation for human face images. Therefore, I have included 
head position in my own study of reproducibility. It is especially relevant to my subject 
population which includes children and people with intellectual disability, both of 
whom may not be able to maintain the ideal head position during image capture. 
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3.1.7 FACIAL EXPRESSIONS 
Five studies have assessed the effect of different facial expressions on 
stereophotogrammetry. Using facial landmarks, two studies showed that a neutral 
facial expression was the most reproducible with a mean error less than 0.74mm 
(Johnston et al., 2003; Sawyer et al., 2009). Both studies had compared a neutral 
expression to smiling, cheek puffing, lip pursing and eye closure, using 15 identical or 
very similar landmarks to my own study.  
Maal and colleagues used a different method to landmarking in which they analysed the 
root mean square difference for each of over 20,000 point co-ordinates in different 
facial expressions. They found that a laughing facial expression tripled the mean error 
in all point co-ordinates to 1.5mm compared to a neutral expression (Maal et al., 2010). 
In their subsequent study of one subject over 6 weeks, they looked to see if errors from 
facial expression variation could be reduced by asking the subject to wear a wax bite 
during both instances of image capture. The mean error did not vary with and without 
the wax bite (0.35mm vs 0.36mm) and error was maximal around the eyes and the 
mouth (Maal et al., 2011). The final study aimed to look at the effect of involuntary 
facial movements. In an unusual protocol, two of the study authors underwent repeated 
stereophotogrammetry to show the effect of ‘involuntary’ movements between photos 
on landmark positions (Lübbers et al., 2012). They conclude that involuntary 
movements increase error up to 3.3mm for some measurements compared to a 
mannequin. However, their conclusion seems unwarranted given that the subjects 
stated they adopted a neutral pose just before image capture. There are also likely to be 
other differences between a human face and a mannequin head aside from facial 
expressions.  
Taken together, the research suggests that there is good reproducibility of a neutral 
facial expression in stereophotogrammetry, and even maximal facial distortion from 
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laughing or cheek puffing causes small errors of approximately 1-2mm. The studies do 
not assess how much change there is in landmark positions due to facial expressions 
though. Therefore, I have also assessed the reproducibility of measurements using 
landmarks and using FSD with different facial expressions. 
3.1.8 SUBJECTS WITH FACIAL DYSMORPHISM 
Three of the validation studies used subjects with dysmorphic facial features, which can 
affect the accuracy of stereophotogrammetry. Facial shape may not be captured fully, 
such as in 3D images that omit low set ears. Distortion of facial features can make it 
more difficult to place landmarks, such as ptosis obscuring the view of the outer 
canthus and exocanthion. 
The three studies each used a specific population of people with dysmorphism: infants 
with cleft lip, children with Down syndrome or craniosynostosis, and children with 
22q11.2 deletion syndrome (Aldridge et al., 2005; Ayoub et al., 2003; Heike et al., 
2009). Two of the studies do not comment upon the effect of dysmorphism on accuracy 
and precision, but Heike and colleagues state that they found no difference between 
subjects with and without 22q11.2 deletion syndrome in terms of accuracy. However, 
their study included 20 subjects with 22q11.2 deletion with a mean age of 11 years and 
20 control subjects with a mean age of 25 years. Therefore, comparable control 
subjects had not been used and the sample was small overall. They point out that the 
syndrome causes subtle facial changes and that accuracy may be affected significantly 
in other conditions because of landmarking error (Heike et al., 2009). I study a 
population of people with epilepsy in whom some subjects were known to have facial 
dysmorphism. These previous studies suggest that dysmorphism itself should not affect 
the accuracy of landmark placement. 
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3.1.9 LANDMARKING ERROR 
Landmark placement or ‘landmarking’ is the major operator-dependent step in 
stereophotogrammetry and DSM creation in my studies. Thus it was very important to 
look at errors in this step.  
Twelve of the stereophotogrammetry studies described above relied on palpation and 
identification of landmarks on a subject’s face directly, much as in direct 
anthropometry. When using stereophotogrammetry, they did not have to find the 
position of landmarks on the 3D images as the faces were already marked. Therefore, 
they did not assess for errors due to landmarking. The remaining studies placed 
landmarks on the face images. Five of these studies measured linear distances between 
these landmarks. Unfortunately, this means one cannot estimate the error in the 
placement of each landmark itself. For example, if two landmarks have been placed 
5mm superiorly to their true locations, the distance between them would be the same 
as if they had been placed accurately. Three studies assessed point co-ordinates and 
specifically explored landmarking errors.  
One study compared landmark placement on facial casts between a direct co-ordinate 
measuring machine and stereophotogrammetry (Khambay et al., 2008). Co-ordinate 
measuring machines (CMMs) use a moving probe to specifically measure co-ordinates 
in space, in this case with a manufacturer’s reported accuracy of 0.0005mm, but they 
are impractical to use on a human face. The authors found that the CMM reproducibility 
was 0.1mm and using the CMM as the gold standard, the mean accuracy of 
stereophotogrammetry landmarking was 0.19-0.23mm. Intra-operator reproducibility 
error when placing landmarks was 0.06-0.07mm. Another study has found that 75-92% 
of facial landmarks (11 of 24 were also used in my study) have an intra-operator error 
of <1mm, which falls to 25-46% of landmarks for inter-operator error of <1mm 
(Gwilliam et al., 2006). A third group found intra-operator and inter-operator 
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reproducibility to be similar at 0.65-1.00mm and, of their 49 landmarks, fifteen are also 
used in my study (Plooij et al., 2009). 
Landmark placement appears to be accurate for a subset of the landmarks used in this 
study, using different cameras. However, the traditional descriptions of landmark 
locations do not allow accurate placement because they are designed for direct 
anthropometry. Hence it is possible that the same landmark has been placed in slightly 
different locations in different studies depending on the features used. Such variation 
and interpretation is another reason to conduct my own study of reproducibility. I have 
fully described the features used to place landmarks in my study in Chapter 2. 
One other study to note is of landmark reproducibility in 3D face images obtained from 
laser scanning (Toma et al., 2009). The authors assessed landmark reproducibility for 
19 of the 22 landmarks used within this study. They found that intra-operator 
reproducibility was <1mm for 89% of co-ordinates and inter-operator reproducibility 
was <1mm for 83% of co-ordinates. They used their findings to rank all co-ordinates in 
order of reproducibility and the worst five were exocanthion (left and right), 
palpebrale superius (left and right), glabella, nasion and pogonion. Of these, glabella 
and pogonion were not used here, but gnathion is in a similar location to pogonion 
(Figure 21). 
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Figure 21 A cross-section of the face showing bony and soft tissue landmarks. The relevant 
landmarks here are: Gn = bony gnathion, gn = soft tissue gnathion (used in my work), Pg = 
bony pogonion, pg = soft tissue pogonion. Soft tissue pogonion and soft tissue gnathion are 
both landmarks of the chin in the midline, and gnathion is likely to show similar 
reproducibility in placement to pogonion. Image used with written permission from 
Springer (Bartzela et al., 2012) 
Nasion and exocanthion have been found to be the least accurate or precise in some 
stereophotogrammetry studies too (Table 6). Given these findings, extra care has been 
taken to use clear definitions for these landmarks and also to optimally view images 
(on a large monitor with magnification and rotation used as needed) before landmark 
placement. I also reassessed landmark reproducibility and particularly the effect of 
landmarking error in dense surface models and especially FSD, which has never been 
studied before to my knowledge. 
3.1.10 DENSE SURFACE MODELLING ERROR 
Dense surface models (DSMs) have been used in face shape analysis for over a decade 
(Hammond et al., 2004). However, no stereophotogrammetry study has assessed the 
effect of errors in head position, image capture or facial expression on the generation of 
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DSMs. One study has looked at the effect of landmarking error on dense surface 
modelling but used different landmarks to my studies (Fagertun et al., 2014). In this 
study, the authors selected 36 adult face images taken using a Canfield Vectra M3 
system, which uses three camera pods. The 3D face images were initially converted to 
2D images for automatic detection and annotation of surface landmarks by specialised 
software. They were then transformed back to 3D images and experienced operators 
manually checked and adjusted landmarks. Another difference to the current study is 
that the authors used 73 landmarks, only 24 of which are classical landmarks and 49 
were termed “pseudo-landmarks”. Overall, there was a mean intra-operator 
reproducibility error of 1.5mm. Next, they chose different subsets of the 73 landmarks 
and created dense surface models. They analysed which of the DSMs predicted the 
location of the remaining landmarks better than the operators. Intriguingly, the mean 
error variance for every point on the DSM was reduced to 0.54mm when the model was 
made from only 14 particular landmarks instead of the 73-landmark DSM. Also, the 14-
landmark DSM could then predict the position of 16 other landmarks more precisely 
than the operators. There are three caveats to these findings though. The authors do 
not mention, although it is evident in their data, that their 14-landmark DSM also 
predicts over 50 landmarks with less precision than the 73-landmark DSM. Secondly, 
much of the benefit of their 14-landmark DSM was for increasing the accuracy of the 
‘pseudo-landmarks’ on the jaw, which are not used in most other studies, including this 
current one. Thirdly, a reduced landmark set may not be appropriate for study 
populations including people with facial dysmorphism or children. 
3.1.11 SUMMARY 
Therefore, given the different errors that are possible with stereophotogrammetry, 
which have not been fully described for my patient population, my camera system and 
my landmarks, I have conducted a study of intra-operator reproducibility. Although all 
analyses were performed by me, I also assessed inter-operator reproducibility between 
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me and another operator (Peter Hammond). The purpose of inter-operator 
reproducibility was to consider future applications of this technology in which multiple 
operators may be landmarking images. 
I then assessed particular sources of error in more detail. Firstly, I looked at image 
capture and registration error. Then I explored the effect of head position 
systematically in three dimensions. Lastly, I investigated the effect of facial expressions. 
For these detailed assessments, the effect on dense surface models was also 
investigated. 
3.2 HYPOTHESES 
I hypothesise that landmark reproducibility using the camera and associated software 
is similar to that seen in previous studies. Furthermore, I hypothesise that FSD, the 
primary endpoint in the following studies, is robust to variables in image capture, such 
as calibration, orientation and facial expression. 
3.3 METHODS 
3.3.1 SUBJECTS AND DENSE SURFACE MODELS 
For this study, three different sets of subjects were used and two different DSMs were 
created. An overview of the groups is shown later in Figure 26. Set 1 was of control 
subjects before I started any data collection from patients (Figure 22). Their images 
had been captured during a previous study (Hammond et al., 2005). Twenty images 
were chosen randomly, using an online random number generator (available at 
http://www.random.org), and used to assess inter-operator reproducibility of 
landmark placement for two operators (Peter Hammond and Vamsi Chinthapalli). The 
purpose of this analysis was to identify any significant errors in reproducibility before 
data collection proceeded. 
Page | 124  
 
 
Figure 22 Inter-operator reproducibility was assessed in the group of reference subjects 
between two operators. A random selection of 20 face surface images, called Set 1, from the 
total of 388 images was chosen with landmark placements compared. 
Set 2 comprised twenty adults with epilepsy recruited in my study (Figure 23). They 
were selected randomly from Group 1 using the aforementioned online random 
number generator (available at http://www.random.org), the first group recruited for 
my study, which comprised 163 people with epilepsy. As noted earlier, few studies 
have looked at reproducibility of landmarks in people with facial dysmorphism and 
none have looked at reproducibility of DSMs. For this set, I assessed intra-operator 
reproducibility of landmark placement. 
 
Figure 23 Intra-operator reproducibility was assessed by looking at a random selection of 
20 people with epilepsy, Set 2, within the total sample of 163 people with epilepsy in Group 
1. The same operator placed landmarks twice with an interval of six months to minimise 
recall bias. 
Using the same set of adults who had repeat landmarks applied, I explored the effect of 
landmark placement on FSD. For each region of the face, two DSMs were created using 
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the full study cohort at the time. Three regions of the face were assessed and the 
original DSMs with the original landmark placements were called Face1, Eyes1 and 
Nose1 (Figure 24). The repeat DSMs with the revised landmark placements were called 
FaceR, EyesR and NoseR – ‘R’ signifying ‘Reproducibility’ DSM. The only difference 
between Face1 and FaceR was the location of landmarks in the face images of the 
chosen twenty subjects; as was the case for Eyes1 and EyesR, and Nose1 and NoseR 
(Figure 25). Therefore, any effect on FSD in FaceR will be due to variation in landmark 
placements; likewise for EyesR and NoseR. 
 
Figure 24 Three DSMs (Face1 for whole face, Eyes1 for periorbital region, Nose1 for 
perinasal region) created using 163 people with epilepsy (Group 1) and 388 reference 
subjects. Within this group, 20 people with epilepsy, Set 2, had been randomly chosen to be 
part the intra-operator reproducibility error study, but not the remaining 143 people with 
epilepsy. 
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Figure 25 In the FSD reproducibility study, the previous set (Set 2) of 20 adults with epilepsy 
and repeat landmark placements were now included in new DSMs of the same regions – 
FaceR, EyesR and NoseR. The only difference between Face1 DSM and FaceR DSM is that 20 
people had their landmarks replaced in FaceR. Everything else was kept constant, so this 
study only looks at how landmark reproducibility affects DSM creation and subsequent 
calculation of FSD. 
 
Figure 26 Overview of reproducibility studies looking at landmark placement and intra-
operator error, inter-operator error and arguably most importantly, the DSM 
reproducibility study. 
A third set, Set 3, of twenty adult subjects was then used to investigate the effect of 
calibration, head positioning and facial expressions. Eight of these people were also 
people with epilepsy who had been recruited into my later studies. The third set was 
incorporated into a separate set of DSMs (Face3, Eyes3, Nose3, Mouth3) along with the 
Group 3 study cohort of people with and without epilepsy. The effect on FSD was 
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assessed due to repeat calibration, variation in head position and variation in facial 
expressions. 
3.3.2 IMAGE CAPTURE AND LANDMARKING 
In the first set of control subject images, three different stereophotogrammetry systems 
had been used for image capture including 3dMD DSP400, Genex Facecam and Canfield 
Vectra CR10. In the second and third sets, subjects were prospectively acquired and 
images were all taken using one Canfield Vectra CR10 system. For the second set, only 
one image was taken per subject using the methods described in Chapter 2.  
For the third set only, image acquisition comprised eleven images per subject (Table 7). 
All eleven images were taken in the same photography session over approximately 30 
minutes. As far as possible, lighting and position was kept as similar as possible 
between images. Image 1 was in a neutral position and neutral facial expression. 
Images 2-7 were taken at six different angles, two per axis of rotation. For these, the 
camera system was rotated because this was more practical and measurable than 
attempting to alter the subject’s head position itself. The camera was mounted on a 
tripod using a Manfrotto 410 adjustable junior gear head with spirit level and angle 
markings in one degree increments (Cassola, Italy: Lino Manfrotto + Co. Spa). This 
tripod mount could be rotated in three dimensions and the axes of rotation are shown 
in Figure 27. The horizontal x-axis runs between both camera pods and the vertical y-
axis runs between individual cameras within a pod. The z-axis is perpendicular to the 
other two axes.  
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Figure 27 Axes of rotation of the camera used to assess head position relative to the camera 
using aviation terminology. Yaw is rotation around a vertical column, in this case the 
centre of the tripod base. Pitch is rotation around a horizontal line between the two pods. 
Roll is rotation in a plane perpendicular to both of the other rotations described and is 
around an imaginary line between the subject and the centre of the camera. 
 
Rotation can be described using aviation terminology as pitch (along x-axis), yaw 
(along y-axis) and roll (along z-axis). I chose an angle of 5.0 degrees clockwise and 5.0 
degrees anticlockwise for each axis as the size of rotation. This angle was measurable 
using our tripod and corresponded to visually noticeable rotation of the face. For pitch, 
the camera was orientated to have a baseline pitch of -20 degrees clockwise, which is 
well-recognised to aid coverage of the subnasal region of the face (Ghoddousi et al., 
2007; Heike et al., 2010). All changes in pitch described below are in relation to this 
baseline. 
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After these images, Image 8 was taken back in the neutral position after re-calibration 
of the camera system. Images 9-11 were taken with different facial expressions. These 
were taken to see the maximal effect that expressions could have on face shape. 
Therefore, subjects were asked to open their mouth fully (Image 11), similar to the 
laughing posture previously found to cause the largest error in registration (Maal et al., 
2010). Smiling fully with lips open (Image 9) was chosen as a reproducible and natural 
facial expression, which has also been studied before (Johnston et al., 2003; Sawyer et 
al., 2009). Finally lip puckering was chosen as a different and extreme example of facial 
expression (Image 10). These images were compared to Image 8, of the face in a neutral 
expression. Image 1 was not used as the comparison because re-calibration (performed 
prior to Image 8) could affect the results. 
The sequence for these images is shown in Table 7 and the images themselves are 
shown for one participant (Vamsi Chinthapalli) in Figure 28. 
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Image Pitch (°) Roll (°) Yaw (°) Expression Calibration 
1 0 0 0 Neutral Yes 
2 0 0 -5 Neutral No 
 
3 0 0 5 Neutral No 
 
4 0 -5 0 Neutral No 
 
5 0 5 0 Neutral No 
 
6 -5 0 0 Neutral No 
 
7 5 0 0 Neutral No 
 
8 0 0 0 Neutral Yes 
9 0 0 0 Smile No 
 
10 0 0 0 Pucker No 
 
11 0 0 0 Open mouth No 
 
 
Table 7 Sequences of images taken per participant for the third set. Head position was 
assessed relative to the camera in terms of camera pitch, roll and yaw in degrees clockwise. 
Then images were taken after re-calibration in different facial expressions: neutral, smile 
with lips open, lips puckering and mouth open. 
Page | 131  
 
 
Figure 28 Raw 3D face images for one participant in the third set to illustrate the sequence 
described in the methods. Images 2-7 show the effect of camera rotation. Image 8 is the 
same as image 1 but with re-calibration. Images 9-11 show different facial expressions: 
smiling with lips open, lip puckering and mouth open. 
A final detailed assessment of head position was performed in one subject (Vamsi 
Chinthapalli). For this, the subject underwent capture of 125 3D face images in one 
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photography sitting over six hours. This consisted of images taken at degree intervals 
of -10, -5, 0, 5, 10 for each of the three axes x, y and z (pitch, yaw, roll) in every 
combination. To aid accuracy, the subject maintained the same face position relative to 
the camera by resting one point on his chin on a second tripod mount, which was fixed. 
This location did not interfere with any landmark placements. In addition, the tripod 
was automatically excluded from the face models used in DSM creation because it was 
outside the lower boundary of the face used in DSM creation, which is typically close to 
gnathion. These images were also included with the twenty control subjects in four 
DSMs (Face3, Eyes3, Nose3, Mouth3) to look for differences in FSD. 
Landmarking was performed using all 22 landmarks previously described. All DSMs 
were created using the methods described in Chapter 2. Landmark abbreviations are 
used as in Chapter 2: exocanthion (exo L/R), endocanthion (endo L/R), palpebrale 
superius (psup L/R), palpebrale inferius (pinf L/R), nasion (n), pronasale (prn), 
subnasale (sn), alari nasi (ala L/R), labiale superius (ls), labiale inferius (li), cristae 
philtri (chp L/R), cheilion (ch L/R), gnathion (gn) and otobasion inferius (oto L/R). 
3.3.3 INTER-OPERATOR REPRODUCIBILITY ERROR 
Inter-operator reproducibility was assessed by calculating the Euclidean distance 
between the two placements of for each landmark. When landmarking in Facemark, 
Cartesian co-ordinates are automatically created in three dimensions and the 
Pythagorean formula may be used: 
 𝑑 = √(𝑥1 − 𝑥2)2 + (𝑦1 − 𝑦2)2 + (𝑧1 − 𝑧2)2 
 d = Euclidean distance between first and second placement of landmark 
 (x1,y1,z1) = first operator placement of landmark 
 (x2,y2,z2) = second operator placement of landmark 
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For each landmark, this distance was measured for every face image and then the mean 
and standard deviation were calculated. 
In addition, 12 inter-landmark distances were measured using the same formula above 
between pairs of landmarks. The distances used are in Table 8 and are also seen in 
Figure 29, Figure 30 and Figure 31. All have been used in previous studies except for 
palpebral fissure height and face width (de Menezes et al., 2010; Ghoddousi et al., 2007; 
Heike et al., 2009; Kook et al., 2014; Metzger et al., 2013; Weinberg et al., 2006; Wong et 
al., 2008). Palpebral fissure height uses two landmarks, palpebrale superius and 
palpebrale inferius, not used in other stereophotogrammetry studies of reproducibility, 
but used in other studies of facial dysmorphism (Hammond et al., 2005; Tassabehji et 
al., 2005). Otobasion inferius is also not used in other reproducibility studies but many 
use a nearby landmark, either tragion or subaurale, to measure face width. The reason 
for using otobasion inferius in this study is explained in Chapter 2. The distances use 
every landmark at least once. For inter-landmark distances, the 2-way mixed models 
intraclass correlation coefficient (ICC) was calculated. 
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Inter-landmark distances Name 
R exocanthion – L exocanthion Biocular width 
R endocanthion – L endocanthion Intercanthal width 
R palpebrale superius – palpebrale inferius R palpebral fissure height 
L palpebrale superius – palpebrale inferius L palpebral fissure height 
R alare nasi – L alare nasi Nostrils width 
R crista philtrum – L crista philtrum Philtrum width 
R cheilion – L cheilion Labial fissure width 
Labiale superius – labiale inferius Lip height 
R otobasion inferius – L otobasion inferius Face width 
Nasion – gnathion Face height 
Subnasale – pronasale Nose protrusion 
Subnasale – gnathion Lower face height 
Table 8 Inter-landmark distances measured for reproducibility error 
 
Figure 29 Four inter-landmark distances around the eyes are shown here. Each line is 
labelled and the start and end landmarks for each line are: 1 = psupR to pinfR, 2 = exoR to 
exoL, 3 = endoR to endoL, 4 = psupL to pinfL 
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Figure 30 Five further inter-landmark distances of the nose and mouth regions. Each line is 
labelled and the start and end landmarks for each line are: 5 = alaR to alaL, 6 = prn to sn, 7 
= chpR to chpL, 8 = chR to chL, 9 = ls to li 
Page | 136  
 
 
Figure 31 Three more inter-landmark distances of facial dimensions used in the 
reproducibility study. Distances are: 10 = otoR to otoL, 11 = n to gn, 12 = sn to gn. 
3.3.4 INTRA-OPERATOR REPRODUCIBILITY ERROR 
This was assessed in a second set of subjects, all with epilepsy. One operator (Vamsi 
Chinthapalli) placed landmarks on the face images a second time, six months after the 
first placement. Reproducibility was then compared in the same way as for inter-
operator reproducibility in the previous section, including using inter-landmark 
distances. For FSD values, the Shapiro-Wilks test of normality was performed to see if 
data were normally distributed. FSD values were not normally distributed in any of the 
six DSMs. Paired FSD values for each subject from the original and repeat DSMs were 
then tested to see if they were significantly different using a related samples Wilcoxon 
signed rank test for non-parametric data. In the three pairs of DSMs (Face1, FaceR, 
Eyes1, EyesR, Nose1, NoseR), the FSD values were also compared using 2-way 
Spearman’s rank correlation coefficient (ρ). This coefficient was chosen because the 
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data were not necessarily expected to have a linear relationship between the original 
and repeat DSMs. 
In a separate analysis of FSD reproducibility, I compared FSD values between Image 1 
and Image 8 in all of the subjects in Set 3. These images were part of the same DSMs, 
unlike the analysis in the paragraph above. This means the FSD values here should 
theoretically be identical for the same person. Hence, the differences in these FSD 
values for each subject show the reproducibility error in FSD due not just to 
landmarking, but to all the errors from repeat image acquisition. Therefore, it will 
include errors from changes in head position, face expression, camera calibration, 
image capture and registration, and repeat landmarking. Statistically, the median 
absolute difference (MAD) was used to describe this difference, where MAD is the 
median of the absolute difference between all FSD values and the median FSD value of 
the whole cohort. The FSD values between image 1 and image 8 were then also 
compared using a test of normality and then either a paired samples t-test or related 
samples Wilcoxon signed rank test. 
3.3.5 CALIBRATION ERROR 
Images in the third set of subjects were compared to assess if there was any additional 
error due to camera re-calibration. These are image 1 and image 8 in Table 7, which 
were of the same subject and taken in the same photography session. Two separate 
images are now being compared unlike in the first and second sets, in which the same 
image had different landmark placements by the same or a different operator. Using 
two images means that error in a landmark’s absolute co-ordinates cannot be assessed 
because each image has a separate frame of reference and therefore different co-
ordinates for the same point in space. Thus to compare the reproducibility, I only used 
inter-landmark distances.  
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3.3.6 HEAD POSITIONING 
Errors due to head positioning were measured in the same way as for calibration error 
using inter-landmark distances. The four DSMs were then assessed (Face3, Eyes3, 
Nose3, Mouth3) and FSD values were not distributed normally. There are six face 
images per subject at different angles of rotation, two in each plane. All six were 
compared with each other and with the neutral position to assess for any significant 
difference in FSD using the related samples Friedman’s two-way analysis of variance by 
ranks. This test is the non-parametric equivalent of the analysis of a two-way analysis 
of variance (ANOVA). 
For the detailed analysis of one subject’s images for five angles in each of the three axes, 
the independent samples Kruskal-Wallis test was used to assess if FSD varied 
significantly with camera rotation. 
3.3.7 FACIAL EXPRESSIONS 
Differences in inter-landmark distances due to facial expressions were calculated as for 
calibration error and compared to the distances when in a neutral expression. After a 
test for normality, an ANOVA test and post-hoc Tukey test were used to explore the 
relationship in any errors. The difference in FSD was assessed for each facial 
expression and for each of the four DSMs. A related samples Friedman’s two-way 
analysis of variance by ranks was used for this. 
3.4 RESULTS 
3.4.1 SUBJECT CHARACTERISTICS 
Each set had twenty subjects and age and sex characteristics are provided in Table 9. 
There were nine male subjects in set 1 and ten in each of sets 2 and 3. The age range 
was widest for set 1 (0.5 – 81.2 years) whereas in sets 2 and 3, all participants were 
adults except for one. 
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 Set 1 Set 2 Set 3 
Subject Age Sex Age Sex Age Sex 
1 0.5 F 3.3 M 25.4 F 
2 2.0 M 21.6 F 28.5 F 
3 8.3 M 23.0 F 30.8 F 
4 10.7 F 24.2 F 31.0 F 
5 12.4 F 31.7 F 31.0 M 
6 14.2 M 31.9 F 31.2 F 
7 24.1 M 33.2 F 32.4 F 
8 24.9 F 35.9 M 33.3 M 
9 28.7 M 36.0 M 33.7 F 
10 29.5 F 38.9 F 35.1 M 
11 33.4 F 39.2 M 37.2 F 
12 34.8 F 39.7 F 37.6 M 
13 35.0 F 39.9 F 38.8 M 
14 35.8 F 41.4 M 45.2 M 
15 40.5 F 42.1 M 48.9 F 
16 41.0 M 42.2 M 51.0 M 
17 42.2 M 47.4 M 53.0 M 
18 47.0 M 47.9 M 56.1 M 
19 53.6 M 48.8 F 56.1 M 
20 81.2 F 49.3 M 66.9 F 
Table 9 Age and sex characteristics of the twenty subjects analysed in each set 
3.4.2 INTER-OPERATOR AND INTRA-OPERATOR REPRODUCIBILITY FOR LANDMARK 
POSITIONS 
For inter-operator reproducibility in 20 control subject images from Set 1, seven 
landmarks were reproducible to within 1mm and twenty were reproducible to within 
2mm (Table 10). For intra-operator reproducibility in 20 subject images from Set 2, I 
found that fourteen of the 22 landmarks were reproducible to within 1mm, and all 
were reproducible to within 2mm. Inter-operator landmarking showed a greater mean 
distance between landmark placements than for intra-operator landmarking for all 
except six landmarks: cheilion (left and right), otobasion inferius (left and right), nasion 
and gnathion. The alari nasi positions were particularly prone to variation in inter-
operator comparisons. 
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 Intra-operator Inter-operator 
Rank Landmark Mean (mm) SD (mm) Landmark Mean (mm) SD (mm) 
1 ls 0.30 0.20 ls 0.58 0.32 
2 chpL 0.49 0.40 chpL 0.63 0.29 
3 exoL 0.55 0.38 endoL 0.83 0.50 
4 sn 0.56 0.31 exoL 0.84 0.60 
5 prn 0.62 0.41 otoR 0.86 0.51 
6 pinfR 0.67 0.34 chL 0.96 0.85 
7 psupR 0.69 0.72 exoR 0.99 1.18 
8 endoR 0.71 0.49 pinfL 1.01 0.69 
9 exoR 0.72 0.68 endoR 1.03 0.74 
10 endoL 0.74 0.60 chpR 1.03 0.75 
11 chpR 0.76 0.46 chR 1.03 0.80 
12 li 0.76 0.56 pinfR 1.05 0.48 
13 pinfL 0.80 0.54 otoL 1.09 0.71 
14 psupL 0.97 0.55 prn 1.20 0.40 
15 chL 1.05 1.18 li 1.06 0.60 
16 chR 1.12 1.32 psupR 1.45 0.70 
17 otoR 1.17 0.92 psupL 1.65 1.33 
18 alaR 1.29 0.64 n 1.66 0.92 
19 alaL 1.41 0.80 sn 1.67 1.15 
20 otoL 1.72 1.51 gn 1.69 1.18 
21 gn 1.77 2.00 alaR 2.86 1.04 
22 n 1.84 2.92 alaL 3.57 1.12 
 All landmarks 0.94 0.82 All landmarks 1.31 0.77 
Table 10 Intra-operator and inter-operator reproducibility in placement of the 22 soft 
tissue facial landmarks. The mean and standard deviation are shown for the discrepancy, 
in terms of Euclidean distance (mm), between the landmarks. 
For inter-landmark distances, the overall mean inter-operator reproducibility error 
was 0.71mm and the overall mean intra-operator reproducibility error was 0.34mm. 
The inter-operator reproducibility error was less than 1.5mm for any distance and was 
>1mm for three distances. Intra-operator reproducibility was within 1mm for all but 
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one of the distances. There was a high intraclass correlation coefficient for all 
measurements, with the lowest being for the philtrum width (distance between cristae 
philtri) at 0.94 (Table 11). The nose width measurement (right alare to left alare) had 
an intraclass correlation coefficient of 0.99-1.00. These results show good 
reproducibility of landmark placement, comparable to previous stereophotogrammetry 
studies. 
 Intra-operator Inter-operator 
Distance Mean 
(mm) 
SD (mm) ICC Mean 
(mm) 
SD (mm) ICC 
exoR - exoL 0.31 0.97 0.99 0.37 1.00 1.00 
endoR - endoL 0.06 1.19 0.97 1.20 1.24 0.98 
psupR - pinfR 0.16 0.38 0.99 0.42 0.72 0.96 
psupL - pinfL 0.16 0.41 0.99 0.60 0.66 0.97 
alaR - alaL 0.22 0.31 1.00 0.62 0.79 0.99 
chpR - chpL 0.37 1.19 0.94 0.86 1.22 0.94 
chR - chL 0.94 2.28 0.95 0.13 1.87 0.99 
ls - li 0.01 0.59 1.00 0.60 0.86 1.00 
otoR - otoL 0.16 0.99 1.00 0.24 0.47 1.00 
n - gn 0.54 3.12 0.99 1.00 1.50 1.00 
sn - prn 0.02 0.74 0.99 1.44 1.47 0.97 
sn - gn 1.18 1.87 0.99 1.04 1.78 0.98 
Table 11 Intra-operator and inter-operator reproducibility of inter-landmark distances 
with mean and standard deviation of the difference between both measurements and the 
intraclass correlation coefficient. 
3.4.3 INTRA-OPERATOR REPRODUCIBILITY IN FSD ACROSS TWO DSMS IN PEOPLE 
WITH EPILEPSY 
I also assessed the effect of landmark placement on the subsequent dense surface 
model creation and FSD. Three pairs of DSMs were assessed for FSD reproducibility 
due to repeat landmarking using Set 2 subjects (Face1 to FaceR, Eyes1 to EyesR, Nose1 
to NoseR). Landmarking is used in thin plate spline deformation of face surfaces for a 
dense correspondence creation. Therefore, it may affect the dense correspondence and 
subsequent principal component analysis. Different landmark placements in some 
subjects in a cohort would thus be expected to alter any given DSM and affect FSD for 
all images within the group. This is what was found as FSD values were not the same in 
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each pair of DSMs with the original and repeat landmark placements. Despite different 
absolute values, FSDs for each subject were not significantly different between DSMs of 
the face (Face1 vs FaceR; p=0.678), the periorbital region (Eyes1 vs EyesR; p=0.496) of 
the perinasal region (Nose1 vs NoseR; p=0.369). There was also strong correlation 
between the FSD values in all three DSM comparisons (Table 12). In the DSMs of the 
whole face, the twenty images that had repeat landmark placements showed strong 
correlation between the old and new FSD values (Face1 vs FaceR, ρ=0.94; p=1.48 x e-9). 
Correlation was similar for DSMs of the periorbital region (Eyes1 vs EyesR, ρ=0.94; 
p=1.21 x e-9) and weaker for DSMs of the perinasal region (Nose1 vs NoseR, ρ=0.90; 
p=1.02 x e-7). This suggests that FSD does not vary significantly when landmarks are 
repositioned and use different DSMs. 
 Redo landmark cases 
(n = 20) 
Significance All subjects 
(n = 117) 
Significance 
Face1 & 
FaceR 
0.94 1.48 x e-9 0.99 7.13 x e-114 
Nose1 & 
NoseR 
0.90 1.02 x e-7 0.99 6.74 x e-91 
Eyes1 & 
EyesR 
0.94 1.21 x e-9 0.99 1.04 x e-113 
Table 12 Spearman’s rank correlation coefficients for correlation between FSD values in 
three different DSMs of the face, perinasal region and periorbital region. Correlation is 
shown for just the 20 face images that had repeat placement of landmarks in the revised 
DSMs and then for all subjects in the DSM. 
3.4.4 OVERALL REPEAT IMAGE REPRODUCIBILITY OF FSD IN THE SAME DSM 
Because two different DSMs are used for each face region in the previous section, the 
absolute FSD values could not be directly compared themselves. However, I was able to 
use another group of people to assess how much FSD varies in the same DSM due to 
errors in both repeat image acquisition and repeat landmarking of a subject. 
For Set 3, I obtained 11 images for each of 20 control subjects that were all used in the 
same DSMs – i.e. Face3, Eyes3, Nose3 and Mouth3. In Set 3, image 1 and image 8 are 
taken of the same person in the same sitting at two different time intervals with camera 
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re-calibration in between. The only noticeable differences between the images should 
be changes in patient position, patient expression, camera re-calibration and 
landmarking. Comparing changes in FSD between image 1 and image 8 for all twenty 
subjects allows me to estimate the overall reproducibility error in FSD from repeated 
image acquisition of a subject. These twenty subjects had all of their images included in 
four DSMs: Face3, Eyes3, Nose3 and Mouth3. Within the four DSMs, data were not 
normally distributed for the FSD values of the 20 control subjects in the original images 
and/or the recalibrated images. 
The median difference in FSD between repeat images for these subjects was: 0.10 
within Face3, 0.02 for Eyes3, 0.06 for Nose3 and 0.10 for Mouth3. Because these values 
are meaningless without knowing the distribution of FSD in the whole model, this has 
also been calculated (Table 13). Table 13 shows that compared to the overall 
distribution of FSD in each of the four DSMs, the median reproducibility error from 
repeat image acquisition is up to 0.10 of FSD.  
The FSD values were not significantly different between image 1 and image 8 in DSMs 
of the whole face (related samples Wilcoxon signed rank test, p=0.46), periorbital 
region (related samples Wilcoxon signed rank test, p=0.68), perinasal region (related 
samples Wilcoxon signed rank test, p=0.39) and perioral region (related samples 
Wilcoxon signed rank test, p=0.94). Therefore there is no significant reproducibility 
error in FSD between two separate images taken for each of twenty subjects. 
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 DSM 
Face3 Eyes3 Nose3 Mouth3 
Median 9.26 13.12 8.78 6.86 
Minimum 6.22 8.04 5.84 4.10 
1st quartile 8.35 11.50 7.79 5.97 
3rd quartile 10.51 15.08 10.04 8.04 
Maximum 31.33 42.72 38.53 21.72 
MAD 1.02 1.80 1.07 0.97 
Median FSD error for 
repeat Set 3 images 
0.10 0.02 0.06 0.10 
Table 13 Median FSD reproducibility error in four DSMs is shown in the bottom row for 
repeat image acquisition and landmarking in 20 control subjects (Set 3). This error is 
contrasted with the overall distribution of FSD in the four DSMs for all people with epilepsy 
and relatives. The median FSD reproducibility error is approximately 1-10% of the overall 
median absolute difference (MAD) seen in FSD in different subjects. The DSMs are for the 
whole face (Face3), the periorbital region (Eyes3), the perinasal region (Nose3) and the 
perioral region (Mouth3). 
3.4.5 CAMERA CALIBRATION 
Inter-landmark distances had a mean reproducibility error of between 0.05mm and 
0.31mm before and after re-calibration of the camera system (Table 14). The errors are 
less than the mean intra-operator reproducibility for inter-landmark distances that was 
already assessed (Table 11).  
Distance Mean (mm) SD (mm) ICC 
exoR - exoL 0.11 0.47 1.00 
endoR - endoL 0.23 0.70 0.99 
psupR - pinfR 0.25 0.63 0.88 
psupL - pinfL 0.31 0.76 0.88 
alaR - alaL 0.21 0.59 0.99 
chpR - chpL 0.15 0.82 0.98 
chR - chL 0.11 1.73 0.97 
ls - li 0.05 1.32 0.98 
otoR - otoL 0.31 1.35 1.00 
n - gn 0.17 1.70 0.99 
sn - prn 0.09 0.42 0.99 
sn - gn 0.16 1.82 0.98 
Table 14 Reproducibility error of inter-landmark distances with mean and standard 
deviation of the difference between measurements taken before and after camera re-
calibration 
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3.4.6 HEAD POSITIONING ERROR 
Head positioning may affect landmark or FSD reproducibility and has previously only 
been studied in mannequins. All twenty subjects in Set 3 were included in the study of 
head position relative to the camera. For each of the six different camera angles relative 
to head position, the overall mean reproducibility error in inter-landmark distance 
measurement was between 0.74mm and 0.85mm when compared to the distances 
measured in a neutral position (Table 15). Greater reproducibility error was seen in the 
longest distances: sn – gn, n – gn and otoR – otoL. No individual inter-landmark 
distance had a mean error greater than 2mm in any position. The least reproducible 
distance appeared to be palpebral fissure height. Intraclass correlation coefficients 
were calculated for each inter-landmark distance between the different camera angles 
and showed strong agreement throughout (ICC 0.96-1.00).  
In all four DSMs, FSD values were not significantly different due to head position 
relative to the camera. Median FSD values are shown in Table 16. It would appear that 
whole face FSD is most affected by changes in camera roll and yaw, but not pitch. Also, 
the perinasal FSD seems to be least affected by any changes in head position, which is 
probably due to its central position allowing for detailed image capture at different 
camera angles. 
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 Pitch -5° Pitch 5° Roll -5° Roll 5° Yaw -5° Yaw 5°  
Distance Mean 
(mm) 
SD 
(mm) 
Mean 
(mm) 
SD 
(mm) 
Mean 
(mm) 
SD 
(mm) 
Mean 
(mm) 
SD 
(mm) 
Mean 
(mm) 
SD 
(mm) 
Mean 
(mm) 
SD 
(mm) 
ICC 
exoR - exoL 0.37 0.48 0.46 0.57 0.40 0.50 0.57 0.69 0.29 0.37 0.50 0.68 1.00 
endoR - endoL 0.64 0.81 0.63 0.87 0.52 0.79 0.51 0.75 0.42 0.50 0.59 0.74 1.00 
psupR - pinfR 0.55 0.67 0.58 0.78 0.65 0.71 0.71 0.80 0.55 0.60 0.49 0.60 0.96 
psupL - pinfL 0.59 0.80 0.61 0.71 0.69 0.77 0.74 0.87 0.67 0.76 0.67 0.74 0.96 
alaR - alaL 0.41 0.53 0.52 0.60 0.54 0.64 0.57 0.76 0.53 0.60 0.55 0.67 1.00 
chpR - chpL 0.62 0.79 1.12 1.31 0.83 1.15 0.82 1.06 0.99 1.19 0.86 1.06 0.99 
chR - chL 0.94 1.23 1.41 1.63 0.99 1.30 1.32 1.49 1.17 1.48 1.08 1.34 0.99 
otoR - otoL 1.11 1.39 1.15 1.54 0.89 1.16 0.94 1.37 1.22 1.79 0.94 1.29 1.00 
n - gn 1.27 1.85 1.28 1.63 1.05 1.52 1.18 1.59 1.61 2.18 1.19 1.69 1.00 
ls - li 0.94 1.14 0.86 1.12 0.89 1.08 0.94 1.14 0.89 1.13 0.68 0.93 1.00 
sn - prn 0.36 0.44 0.45 0.55 0.47 0.56 0.40 0.49 0.40 0.50 0.33 0.43 1.00 
sn - gn 1.25 1.77 1.19 1.63 1.12 1.46 1.42 1.62 1.35 1.80 1.30 1.52 1.00 
Overall 0.75 1.01 0.85 1.12 0.75 1.01 0.84 1.08 0.84 1.10 0.76 0.98  
Table 15 The reproducibility error of inter-landmark distances in 20 control subject face images according to the angle in degrees clockwise of the camera 
with respect to the subject’s face. The overall mean reproducibility error in each position is 0.85mm or less in all angles tested. The intraclass correlation 
coefficient (ICC) is above 0.95 for each inter-landmark distance between the different camera angles.   
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 DSM 
Position Face3 Eyes3 Nose3 Mouth3 
Neutral 8.44 11.75 8.54 5.97 
Yaw -5 8.81 11.71 8.35 6.3 
Yaw 5 8.76 11.84 8.44 6.15 
Roll -5 8.75 11.54 8.38 5.98 
Roll 5 8.71 11.72 8.65 6.46 
Pitch -5 8.44 11.72 8.51 6.12 
Pitch 5 8.48 11.79 8.63 6.35 
Significance p=0.73 p=0.39 p=0.77 p=0.33 
Table 16 Median FSD values of twenty control subjects, in seven different camera angles 
relative to the subject’s face. The final row shows that there is no significant difference in 
FSD values in any camera angle for any of the DSMs as calculated by Friedman’s two-way 
analysis of variance by ranks. 
In the analysis of one subject in greater detail, 125 images were obtained and Figure 32 
shows 25 of the images over a range of five angles for both pitch and yaw, with roll kept 
unchanged from the neutral position. Reproducibility of inter-landmark distances 
appeared to be worse at angles greater than five degrees in any of the three axes. FSD 
also increased with angles over five degrees anticlockwise or clockwise. This is shown 
in one subset in Table 17, in which FSD for the whole face and the overall mean inter-
landmark distance error are displayed for the 25 images shown in Figure 32.  
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Figure 32 Untextured raw images captured for one control subject with different angles, in 
degrees clockwise, of pitch and yaw for the camera system. Roll angle was kept at zero from 
neutral. The images are not to scale but show that different parts of the face are visible at 
different angles. In particular, the underside of the chin is better captured with a lower 
pitch angle and a yaw angle close to zero is best for capturing both ears. The tripod mount 
used to maintain the same face position is also seen in some images but this was outside the 
face region used for landmarking or dense surface model creation. 
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0.45 
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8.5 
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4.8 
0.72 
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5.0 
0.08 
5.6 
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5.5 
5.2 
0.32 
7.6 
9.3 
7.3 
4.6 
1.24 
10 
12.4 
8.5 
5.6 
4.4 
0.60 
8.7 
8.0 
5.1 
4.8 
0.06 
6.6 
7.9 
5.2 
5.0 
0.09 
7.1 
7.8 
5.2 
4.3 
0.21 
10.2 
10.7 
6.0 
4.4 
0.47 
Table 17 Grid of reproducibility errors for 25 face images of one subject taken with 
different angles of camera pitch and yaw. FSD values for the whole face, periorbital region, 
perinasal region and perioral region are shown in the top four rows respectively with 
overall mean inter-landmark distance errors on the lowest row. The values correspond to 
the images in Figure 32. FSD values over 8 for the whole face are shaded in light grey and 
values over 10 are shaded in medium grey. FSD appears to increase with greater angles 
(clockwise or anticlockwise) in yaw. Inter-landmark distance errors also appear to increase 
with yaw. 
 
The relationship of FSD with each axis was found to be significantly different for 
differences in pitch (median FSD 6.28 vs 6.34 vs 7.31 at 0, 5, 10 degrees; p=0.002; 
n=125) or yaw (median FSD 6.10 vs 6.34 vs 8.47 at 0, 5, 10 degrees; p<0.001; n=125) 
but not for roll (median FSD 6.89 vs 6.57 vs 6.69 at 0, 5, 10 degrees; p=0.669; n=125). 
The relationship between angle of rotation and FSD does not appear to be linear. There 
is little difference between 0 and 5 degrees but a larger increase in FSD between 5 and 
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10 degrees (Figure 36). A similar increase was found with FSDs of the periorbital 
(Eyes3), perinasal (Nose3) and perioral (Mouth3) DSMs. 
In face images with the highest FSD values, visual inspection showed that the camera 
angles were large enough to prevent complete capture of the face. Figure 33 shows 
three examples of face images illustrating the loss of detail in various parts of the face 
that would normally be captured in a neutral position. 
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Figure 33 Three examples of face images A, B and C, which had high FSD values. The 
original image position is shown on the left and the same image is rotated on the right to 
show missing regions of the face. Image A was taken at pitch=-10, roll=-10, yaw=-10 
degrees and misses parts of the right side of the face including the ear. There are also 
missing areas over the nose surface, the right eyebrow and the right lower lip. Image B was 
Page | 152  
 
taken at pitch=10, roll=-5, yaw=-10 degrees and also misses areas of the right side of the 
face. Image C was taken at pitch=10, roll=5, yaw=10 degrees and shows the left periorbital 
region and the underside of the nose have missing areas. 
In the three face images, A, B and C, FSD for the whole face was 18.9, 13.8 and 8.82 
respectively, significantly higher than the median FSD of 6.52. They were taken at pitch, 
roll and yaw angles of (-10,-10,-10) degrees for A, (10,-5,-10) degrees for B and 
(10,5,10) degrees for C. At these angles it appears that there are significantly larger 
areas of the face that are missing. In face images A and B, the right side of the face is 
poorly captured. There are areas of the face that are completely missing or in which 
one can see ‘holes’ in the face. These ‘holes’ are large triangular polygons between 
vertices that represent surface point co-ordinates. If point co-ordinates were not 
captured in one part of the face, then the resulting triangular polygons are large and 
visible. For example, in image A, there is missing detail over the right eyebrow, the right 
lower lip and the right side of the nose. Looking at the original image position, these 
areas appear to be obscured due to the angle. In image B, the same occurs but to a 
lesser extent. Image C shows that the underside of the nose and the region under the 
eyebrows is poorly captured if the camera is not pitched up higher (anticlockwise). 
This confirms the need to position subjects carefully to capture all areas of the face. In 
later studies, a check of face coverage was done by immediate visual inspection of each 
captured 3D face image including rotation of the wireframe image on screen. 
3.4.7 IMAGE FILE SIZE AND FSD 
Since there are large areas that are missing, it is possible that the images with high 
FSDs have fewer surface points stored in total and so a smaller image file size. For each 
face image, all of these surface points are stored in a Wavefront object (.obj) file with 
tens of thousands of point co-ordinates. The file contains these co-ordinates prefixed by 
‘v’, which are then followed by surface face definitions prefixed by ‘f’ and comprising 
references to three or more vertices. All texture and colour information is stored in 
other files. The overall number of characters and therefore file size of an .obj file is 
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therefore proportional to the number of vertices contained within the file. It was found 
that there is no relationship of the file size with whole face FSD (ρ=0.00; p=0.98; Figure 
34). This suggests that missing point co-ordinates or lower resolution alone do not 
explain the greater FSD values seen. A limitation of this exercise is that in images with 
missing parts of the face, there may be increased inclusion of other extraneous parts in 
the image. For example, in Figure 33, part of the subject’s neck and shirt collar had been 
included in some images, which may mean the overall number of surface point co-
ordinates in the image remained the same as an image in neutral head position. 
 
Figure 34 Scatter plot of file size of a face image’s object file size in kilobytes (kB) and that 
face image’s FSD for the whole face, in a set of 125 images of the same subject taken at 
different angles. There is no correlation between file size and FSD (ρ=0.00; p=0.98). 
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3.4.8 INTER-LANDMARK DISTANCES AND FSD 
For inter-landmark distance error, there was no significant difference due to change in 
pitch angle (mean error 0.50 vs 0.53 vs 0.50 at 0, 5, 10 degrees; p=0.951) or roll angle 
(mean error 0.43 vs 0.53 vs 0.54 at 0, 5, 10 degrees; p=0.551). However, there was a 
significant difference in error with change in the angle of yaw (mean error 0.21 vs 0.46 
vs 0.71 at 0, 5, 10 degrees; p<0.001). Given that landmarking errors appeared to 
increase with change in camera yaw angle, I considered that the landmarking errors 
alone could explain the changes seen in FSD at different camera angles. Correlation 
between FSD and inter-landmark distance errors in all 125 images was weak though 
positive and significant (ρ=0.46; p=6.45 x e-8; Figure 35). Therefore, landmarking error 
alone does not seem to explain the reduced reproducibility of FSD with different 
camera angles. Other possible errors are those to do with repeat image capture: 
calibration, facial expression and facial position. 
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Figure 35 Relationship between FSD of the whole face and the mean inter-landmark 
distance reproducibility error for 125 faces of the same control subject. Correlation was 
weakly positive (Spearman’s rank correlation coefficient ρ=0.46; p=6.45 x e-8) 
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Figure 36 Graphs of the distribution of FSD for the whole face for different camera angles from the neutral position. There is no significant difference in FSD 
for camera roll angles up to 10 degrees (median FSD 6.89 vs 6.57 vs 6.69 at 0, 5, 10 degrees; p=0.669; n=125) but there is a significant difference in FSD for 
changes in camera pitch angle (median FSD 6.28 vs 6.34 vs 7.31 at 0, 5, 10 degrees; p=0.002; n=125) and camera yaw angle (median FSD 6.10 vs 6.34 vs 8.47 
at 0, 5, 10 degrees; p<0.001; n=125). For angles, only the magnitude is considered so clockwise and anticlockwise angles are treated the same. 
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3.4.9 DETERMINATION OF HEAD POSITION USING INTER-LANDMARK DISTANCES 
Given that FSD may be affected by camera angles, I sought to see if the angle of the face 
image could be reliably determined in any of the three axes from the raw landmark co-
ordinates. Absolute landmark co-ordinates will vary as people will sit in different 
postures, different heights and different lengths relative to the camera for each image. 
On the other hand, inter-landmark comparisons in specific axes may be able to provide 
a reference. 
Within each object file, the manufacturer states that the Canfield Vectra CR10 system 
stores points in a 3D frame where the x-axis is from left to right, the y-axis is from 
down to up and the z-axis is the distance away from the camera (Figure 37). I chose 
three inter-landmark distances to check the 3D frame and see how they varied with 
camera rotation. Biocular width, the distance between the exocanthions, has been used 
before as the most reliable horizontal line on face surfaces, with little displacement in 
the y-axis and z-axis (Maal et al., 2010; Plooij et al., 2009; Ras et al., 1996). Facial width, 
the distance between the otobasions, was used as a second potential horizontal line. 
The facial height, as judged from nasion to gnathion, runs through the midline of the 
face and was a third distance chosen for the least displacement in the x-axis. Midline 
face landmarks have also been used previously to determine the vertical plane (Toma 
et al., 2009). Note that the above studies have also used a straight line from 
exocanthion to the most superior point of the ear to define the horizontal plane. This 
assumes that ears are set at a normal height and in dysmorphology, it is well-known 
that low-set ears are a feature of many disorders. I found no dysmorphological 
conditions that cause a difference in the vertical position of one eye or ear compared to 
the other, although there may be natural variation.  
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Next the displacement of each of the three lines in each of the x, y and z axes was 
calculated for the different camera angles. For camera pitch, the greatest change was in 
the z-axis of the nasion to gnathion line. For camera roll and yaw, the greatest changes 
were in the y-axis and z-axis respectively, of both of the chosen horizontal lines. The 
biocular width line was chosen instead of facial width as this has been used before in 
studies due to its reproducibility. The mean displacement and its standard deviation 
are shown in Table 18. For the study of one subject at five angles per axis of rotation, 
there was a strong relationship between axis displacement and camera angle. Simple 
linear regression was used to show that 92% of the variation in the z-axis of face height 
was explained by camera pitch (r2=0.92; p= 1.12 x e-69, n=125). Similarly, 94% and 95% 
of the variation in y-axis and z-axis of biocular width was explained by camera roll 
(r2=0.94; p= 5.61 x e-78, n=125) and yaw (r2=0.95; p= 3.21 x e-80, n=125). 
 
Figure 37 Viewing from the Canfield Vectra CR10 camera, the z-axis is the optic axis of the 
camera, equivalent to the direction perpendicular to the plane of the four camera lenses. 
The x-axis and y-axis are horizontal and vertical, relative to the camera, in a plane parallel 
to the plane of the camera lenses. I chose three of the longest inter-landmark distances to 
assess if they could help determine facial angle relative to the camera reliably. These 
distances were right exocanthion to left exocanthion (exoR – exoL, biocular width), nasion 
to gnathion (n – gn, facial height) and right otobasion inferius to left otobasion inferius 
(otoR – otoL, facial width). 
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    Within one subject Within 20 subjects 
Rotation Angle Distance Axis Mean (mm) SD (mm) Mean (mm) SD (mm) 
Pitch -10 n-gn z -60.3 3.1 - - 
Pitch -5 n-gn z -48.0 3.8 9.2 6.8 
Pitch 0 n-gn z -38.2 4.4 15.0 10.1 
Pitch 5 n-gn z -31.3 5.2 17.7 9.2 
Pitch 10 n-gn z -14.3 5.5 - - 
Roll -10 exoR-exoL y -16.6 2.0 - - 
Roll -5 exoR-exoL y -9.0 2.9 -1.5 4.5 
Roll 0 exoR-exoL y -1.7 3.2 -1.5 4.8 
Roll 5 exoR-exoL y 6.1 3.5 -0.4 5.8 
Roll 10 exoR-exoL y 12.7 3.9 - - 
Yaw -10 exoR-exoL z -16.6 1.7 - - 
Yaw -5 exoR-exoL z -10.1 1.9 -1.7 3.7 
Yaw 0 exoR-exoL z -2.4 2.4 1.6 3.2 
Yaw 5 exoR-exoL z 3.9 2.4 5.3 4.4 
Yaw 10 exoR-exoL z 12.2 2.6 - - 
Table 18 Displacement in one selected axis of an inter-landmark distance showing the 
relationship with camera rotation. For the study of one subject and the study of 20 subjects, 
mean displacement in the selected axis increased with an increase in the camera angle. 
There was greater standard deviation between subjects than in the same subject. This 
suggests that though displacement between landmarks can be used to estimate the camera 
angle relative to the face, it is only helpful for repeated images of the same face. 
Using the same measures of displacement in the set of 20 control subjects, the change 
in axis for all three distances is much less predictable. Simple linear regression shows 
that only part of the displacement could be predicted by camera angle. This was true 
for camera pitch (r2=0.10; p= 0.004, n=80), camera roll (r2=0.01; p= 0.46, n=80) and 
camera yaw (r2=0.32; p= 5.22 x e-8, n=80). Therefore, change in displacement between 
suitable face landmarks is not a useful measurement to quantify the angle of the camera 
relative to the face. Controls were not assessed as fully as for one individual subject so 
it is not known if including camera angles 10 degrees from neutral would have 
increased the accuracy. 
In summary, although detailed analysis in repeated face images of one subject 
suggested that head position and angle could be inferred, using multiple subjects it was 
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not possible to reliably assess head position from a 3D face image. Thus, if head 
position is to be controlled for, then it has to be done at the time of image capture and 
cannot be checked retrospectively from captured images. However, there is no method 
of accurately fixing head position during image capture without interfering with image 
acquisition. I used an adjustable swivel chair and rotated the chair so that the head 
approximately faced the vertical midline of the camera (approximating yaw=0°) on 
visual inspection. I also used a visual target above the camera and adjusted the height 
of the chair so that eye level approximated the top of the camera, again on visual 
inspection from the side of the subject (approximating pitch=0°). Roll could not be 
reliably assessed prior to image capture, but has been noted to make no significant 
difference to FSD for variations from -10° to 10°. Further studies are needed to look at 
ways of fixing head position for accurate stereophotogrammetry. 
3.4.10 FACIAL EXPRESSIONS 
Facial expressions are likely to affect face shape, including landmark positions, and thus 
FSD. Three facial expressions were assessed in the twenty control subjects. Inter-
landmark distances as measured on these face images were compared to the distances 
on the face image with a neutral expression and the mean error for each distance in all 
subjects is shown in Table 19. The same twelve inter-landmark distances used for 
inter-operator reproducibility are used here and can be seen in Figure 29, Figure 30 
and Figure 31. 
The repeat images taken in a neutral expression after re-calibration are shown on the 
right-hand column as a comparison. Data were normally distributed and a one-way 
ANOVA was used to assess if there was any significant difference in any distance with 
four different facial expressions. Distances between the exocanthions, endocanthions 
and otobasions were not affected significantly by any facial expression. All other 
distances were significantly altered. 
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 Pucker Smile Mouth open Calibration Significance 
 Mean 
(mm) 
SD 
(mm) 
Mean 
(mm) 
SD 
(mm) 
Mean 
(mm) 
SD 
(mm) 
Mean 
(mm) 
SD 
(mm) 
One-way 
ANOVA 
exoR - exoL 0.15 0.81 0.19 1.71 0.06 1.31 0.11 0.47 p=1.00 
endoR - endoL 0.14 0.92 0.65 1.95 0.09 1.12 0.23 0.70 p=0.88 
psupR - pinfR 0.94 1.03 2.84 1.79 0.62 1.53 0.25 0.63 p=5.5 x e-8 
psupL - pinfL 1.01 1.17 3.07 1.84 0.86 1.65 0.31 0.76 p=1.5 x e-7 
alaR - alaL 1.42 1.64 4.00 1.72 1.17 1.77 0.21 0.59 p=0.0003 
chpR - chpL 3.42 2.23 3.05 2.53 0.79 2.29 0.15 0.82 p=0.000001 
chR - chL 12.2 7.14 14.3 4.95 0.80 5.98 0.11 1.73 p=4.1 x e-19 
ls - li 0.40 1.62 2.62 2.23 0.42 4.10 0.05 1.32 p=6.6 x e-36 
otoR - otoL 2.12 5.72 2.20 3.47 38.1 6.34 0.31 1.35 p=0.88 
n - gn 8.60 5.61 7.45 5.42 45.2 7.47 0.17 1.70 p=1.9 x e-22 
sn - prn 1.97 2.17 0.66 1.18 0.22 0.86 0.09 0.42 p=0.002 
sn - gn 2.34 5.80 3.72 3.25 41.1 6.27 0.16 1.82 p=1.1 x e-29 
Table 19 The inter-landmark distance reproducibility error in 20 control subject face 
images according to facial expressions. Expressions included lip puckering (Pucker), 
smiling with lips open (Smile) and opening the mouth wide (Mouth open). The errors are 
compared to the error found during re-calibration in a neutral expression. Analysis of 
variance (ANOVA) testing shows that there was a significant difference in error for all 
distances except those using exocanthion, endocanthion and otobasion. 
Tukey’s method was used as a post-hoc test to explore which face expressions affected 
each distance. Distances are shown in Table 20 along with face expression(s) that 
significantly alter their length. This shows that smiling, puckering lips or opening the 
mouth all increase the distance between the lips in the midline. In addition, the 
different facial expressions affect all of the other expressions in different ways. Smiling 
increases the width of the lips, philtrum and the nostrils but reduces the height of the 
palpebral fissure. Lip puckering reduces the width of the lips and philtrum. Lip 
puckering is the only expression that also reduces nasal protrusion. Opening the mouth 
affects all distances measured across the lips including lip height, face height and lower 
face height. Mouth opening also increases philtrum width but not lip width. 
 
Page | 162  
 
Distance Expressions reducing distance Expressions increasing distance 
exoR - exoL Nil Nil 
endoR - endoL Nil Nil 
psupR - pinfR Smile Nil 
psupL - pinfL Smile Nil 
alaR - alaL Nil Smile 
chpR - chpL Pucker Mouth open, Smile 
chR - chL Pucker Smile 
ls - li Nil Mouth open, Pucker, Smile 
otoR - otoL Nil Nil 
n - gn Nil Mouth open 
sn - prn Pucker Nil 
sn - gn Nil Mouth open 
Table 20 Summary of which facial expressions significantly reduce or lengthen each inter-
landmark distance using the post-hoc Tukey’s test. 
FSD values for the twenty control subjects in all four DSMs were significantly different 
between the four facial expressions (Table 21). 
 Facial expression 
DSM Neutral Smile Pucker Mouth open Significance 
Face3 8.38 10.8 11.3 13.8 p<0.001 
Eyes3 11.7 14.1 12.8 18.2 p<0.001 
Nose3 8.57 10 10.6 9.62 p<0.001 
Mouth3 5.9 11.1 11.2 22.6 p<0.001 
Table 21 The effect of different facial expression on the mean FSD in the twenty subjects. 
Significance was calculated using a related samples Friedman’s two-way analysis of 
variance. 
FSDs were highest with the mouth open for the whole face, periorbital and perioral 
DSMs. For the perinasal DSM, lip puckering and smiling caused the biggest increase in 
FSD. The distribution of FSD is shown in more detail for each of the four DSMs in Figure 
38. It can be observed that the periorbital DSM showed the highest FSDs with the 
mouth open even though no distance involving periorbital landmarks was significantly 
altered by mouth opening. Therefore, facial expressions that are not neutral may 
significantly alter FSD and need to be controlled for. In later studies, this was done by 
repeat instructions to maintain a neutral expression, as noted in Chapter 2, and visual 
inspection of the face itself and the 3D face image immediately after capture. 
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Figure 38 Box plots of the distribution of FSD with four facial expressions: Neutral, smiling 
with lips open, lips puckered and mouth wide open. FSD is shown for DSMs of the whole face 
(Face3), periorbital region (Eyes3), perinasal region (Nose3) and perioral region (Mouth3). 
FSD varied significantly with facial expression in all four DSMs. 
 
Page | 165  
 
 
 
3.5 DISCUSSION 
In this chapter, I have shown that reproducibility of stereophotogrammetry using the 
Canfield Vectra CR10 camera is comparable to previous studies. For inter-landmark 
distances (which are typically in the range 10-120mm), overall inter-operator 
reproducibility error was 0.71mm in controls. Overall intra-operator reproducibility 
error was 0.34mm in people with epilepsy. The reproducibility error is comparable to 
other studies of living subjects, which show mean errors of 0.26mm to 1.3mm for intra-
operator error and 0.29mm to 2.8mm for inter-operator error (Table 5). Intraclass 
correlation coefficients were between 0.94 and 1.00 for these measurements. The 
intraclass correlation coefficients are better than those previously obtained 
(Dindaroğlu et al., 2015; Othman et al., 2013).  
For point co-ordinates of landmarks themselves, the mean reproducibility error was 
0.94mm (intra-operator) and 1.31mm (inter-operator). This error is comparable to 
that seen in one study of point co-ordinate reproducibility in living subjects (Gwilliam 
et al., 2006), but greater than in another (Plooij et al., 2009). One other study also 
showed greater reproducibility but the authors used mannequin faces (Ayoub et al., 
2003). This also illustrates one of the drawbacks of only using inter-landmark distances 
for reproducibility error. Absolute errors in the position of two landmarks may be 
cancelled out in inter-landmark distances (e.g. if gnathion was 5mm superior and 
nasion was 5mm superior, then the inter-landmark distance from nasion to gnathion 
would still appear to be the same). 
To my knowledge, this is the first study that investigated the effect of camera 
calibration or head positioning on landmark placement reproducibility on living 
subjects. Two studies have looked at head position for mannequin faces previously and 
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only one of these looked at head positions in three dimensions (Lee et al., 2004; 
Lübbers et al., 2010). For images taken before and after calibration, the mean intra-
operator reproducibility error between inter-landmark distances was 0.18mm. This 
error is a combination of calibration itself, image acquisition error and landmarking 
error, since each image was acquired and landmarked separately (by Vamsi 
Chinthapalli). In fact, reproducibility error was less than the reproducibility error for 
patients’ images that were landmarked twice on the same image (0.18mm vs 0.34mm). 
This suggests that landmarking error is greater for patients with epilepsy or that 
landmarking precision improved with experience. The operator had landmarked an 
additional 1000 images between the first landmarking reproducibility study and this 
second study of calibration and landmarking reproducibility.  
Head positioning changes worsened landmark placement reproducibility. When 
analysing inter-landmark distances, there was a greater overall intra-operator 
reproducibility error of 0.75-0.84mm, compared to 0.34mm in the neutral position. The 
reason for this may be due to poorer image quality in regions with landmarks of 
interest. With camera yaw, I have shown that there are missing areas of the face on 
images and this would affect landmarks closest to the periphery of the face. These 
landmarks include otobasions and gnathion and distances using these landmarks were 
the ones showing the greatest error. 
Facial expression, as expected, significantly affected landmark placement. Similar to 
previous studies, opening the mouth causes the greatest change overall in inter-
landmark distances. There is variation in the extent of change seen in these distances. 
Distances between the eyes and the ears were not affected by facial expressions. The 
distances using lip landmarks were most affected and those involving the nose were 
also affected to a lesser degree.  
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The reproducibility of individual landmarks is comparable to previous findings, in 
which the majority of landmarks show a mean discrepancy of under 1mm. The least 
reproducible landmarks (>1mm error) comprised those with no clear surface features 
or boundaries to guide placement in all subjects, and comprised cheilion, nasion, 
gnathion, alari nasi, and otobasion inferius. Cheilion is at the corner of the mouth, but 
with the lips closed, a crease is often present here and it is difficult to judge exactly 
where the vermilion lip border is. Nasion, gnathion and alare nasi are all placed on the 
face surface where there are no discrete changes in shape contour or skin colour. 
Otobasion inferius, at the junction of the earlobe and the cheek, can be straightforward 
to place in some subjects but there are subjects who have attached earlobes, again with 
no obvious change in contour. Also, accurate image detail for otobasion is lacking when 
subjects are laterally rotated, which may also reduce reproducibility. All of these 
landmarks have been found to be poorly reproducible in multiple earlier studies too, 
except for otobasion inferius (Table 6), which was only used in one previous study 
(Gwilliam et al., 2006).  
For FSD, the overall reproducibility error appears to be low. For example, using the 
whole face DSM (Face3), FSD for all 163 subjects varied from 6.2 to 31.3 with a median 
absolute difference of 1.0 unit (Chapter 4). Compared to this, the median change in FSD 
in 20 control subjects who had undergone repeat camera calibration, repeat image 
acquisition and repeat landmarking, was 0.1 units. In different DSMs created 
specifically to check for landmark reproducibility, FSDs would be different because the 
principal components created in each DSM are unique. However, there was a strong 
positive correlation between the original DSM FSD and the repeat DSM FSD for the 
whole face, the periorbital region or the perinasal region (ρ=0.90-0.94; ρ2=0.81-0.88). 
FSD appears to be more sensitive to changes in head positioning and facial expressions 
though. Camera pitch and yaw (but not roll) between 5 and 10 degrees in either 
Page | 168  
 
direction significantly affected FSD in all DSMs. Yaw is equivalent to a subject laterally 
rotating his or her head left or right and pitch is equivalent to a subject flexing and 
extending their head forwards and backwards. Changing head position affects the 
coverage of the face surface with missing areas seen at extreme angles (10 degrees in 
any direction). However, the image file size analysis suggests the change in FSD is not 
simply due to missing point co-ordinate data alone. A limitation of the head positioning 
analysis is that the camera was changing position not the subject, when in practice the 
camera would actually be fixed in position. Unfortunately, it was not practical to have 
subjects turning their head to specified degree intervals in three axes and this may be 
why no other studies have attempted to assess head position in living subjects. Using 
camera rotation means that I may be missing changes to landmark position that occur 
when subjects have a different head position. One hypothetical example is if a subject 
extends her neck so that her head is angled backwards, then her eyes will be looking 
‘downwards’ towards the camera and this may give the appearance of ptosis. Another 
part of the head positioning study involved attempting to deduce the angle of head 
position from a 3D face surface image in the set of 20 control subjects. With repeated 
images in different positions for one subject, it was possible to estimate the angle using 
various inter-landmark distances, but unfortunately it could not be extrapolated to 
different subjects. Therefore, currently the only way of assessing head position was by 
visual assessment of the subject at the time of image capture. This is not ideal and other 
methods to assess head position are needed, given its potential impact on 
reproducibility error. This impact is not just specific to FSD but also to landmark 
placement. On the other hand, in repeated images of control subjects in the neutral 
position, as judged by visual inspection, there was good reproducibility. This suggests 
visual assessment of head position may be adequate at present. 
As with head positioning, FSD is affected significantly by facial expressions in all DSMs. 
Even DSMs of parts of the face have to be used with caution in the presence of certain 
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expressions that may not be expected to affect those parts. For example, opening the 
mouth appears to increase FSD of the periorbital region despite little change in 
landmarks in that region. This finding also suggests that changes in face expression are 
not always captured by landmark-based anthropometry despite dense surface 
modelling detecting a difference. For example, lip puckering or opening the mouth both 
increased FSD for the periorbital region (Eyes3) DSM. However, lip puckering and 
opening the mouth did not significantly alter inter-landmark distances using 
endocanthion, exocanthion, palpebrale superius and palpebrale inferius. The increased 
sensitivity of FSD compared to landmarks may be expected given that FSD takes into 
account the whole shape of the periorbital region, and not just a number of distance 
measurements between eight landmarks around the eye. In later chapters, it is shown 
that there are some subjects in whom the lips were apart. Based on this reproducibility 
data, such patients were excluded in sensitivity analyses to avoid confounding. No 
subject smiled or puckered their lips in later chapters. In these chapters, if a high FSD 
was obtained then the image was visually inspected first for altered head position or 
face expression. This principle may be necessary for future studies too. 
The use of landmarks is debatable too, as landmarking is the major operator-dependent 
step in the creation of DSMs and calculation of FSD. As mentioned earlier, landmark 
reproducibility has long been known to be dependent on definitions used and anatomy 
training, even in older studies using direct anthropometry. The use of DSMs means that 
the whole face surface is analysed without reliance only on landmarks. However, 
landmarks are needed for the thin plate spline warping and dense correspondence 
creation steps. Manually annotated landmarks allow computers to interpolate all other 
corresponding points. Any landmarks can be used for this but they need to try to 
encompass the face. If, say, all landmarks were those on the nose and lips alone, then a 
small error in landmark placement here would affect thin plate spline and dense 
correspondence more in the periphery of the face. 
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Advances in computation mean that new techniques are possible to improve the 
reproducibility of landmarks. There are now algorithms that can identify landmarks on 
a face surface using a maximum curvature function or by determining intersections of 
curves (Katina et al., 2016). Already, one technique for automated placement of 
landmarks is robust enough to work on incomplete face surface images (Sukno et al., 
2015). Incomplete face surface images occurred in the above studies, particularly in 
certain orientations, and previously the inability to automate landmark placement in 
incomplete images had been a major hindrance.  With automation, it may be possible to 
increase precision and accuracy in FSD further. 
One limitation of this study is that stereophotogrammetry was not compared to 
another method of landmark placement. This means one cannot determine the 
accuracy of absolute landmark positions from the current analysis. However, this 
should not affect the assessment of reproducibility. Reproducibility is of more 
importance as landmarks need to correspond as closely as possible for dense surface 
modelling and FSD calculation. It means that absolute comparisons of landmark 
positions or inter-landmark distances should be performed cautiously until accuracy is 
known. Another limitation is that camera position was changed during the analysis, not 
subject position or orientation. It could be argued that the effect of gravity on the face 
has been missed because of this. However, I do not believe this is a significant source of 
error.  It was more important to accurately measure the angle between the camera 
system and the face to quantify errors and there was no easy method to adjust and 
maintain a subject’s head at a set angle without compromising the 3D image or 
introducing further errors. 
3.6 CONCLUSION 
Landmark placement using the Canfield Vectra CR10 stereophotogrammetry camera 
system and in-house software gives comparable intra-operator and inter-operator 
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reproducibility to previous studies. FSD is reproducible in control human subjects and 
those with epilepsy in repeated images in the neutral position, with or without camera 
calibration. Head positioning and facial expressions are found to decrease 
reproducibility of landmark placement and FSD. These factors need to be considered 
during image capture. As noted above, this was performed largely using careful 
instructions and visual cues, adjusting the position of the face indirectly using the 
subject’s chair, and visual inspection of the face and 3D face image after capture. 
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CHAPTER 4: PATHOGENIC STRUCTURAL VARIANTS AND 
FACE SHAPE 
4.1 INTRODUCTION 
The association between chromosomal disorders, facial dysmorphism and epilepsy is 
well described (Goodman, 1977; Jones, 2006; Singh et al., 2002). Such chromosomal 
disorders comprise deletions, duplications, inversions and translocations of parts of a 
chromosome. These may be termed structural variants (SVs) and of these, deletions 
and duplications are now more commonly grouped together as copy number variants 
(CNVs) as discussed in Chapter 1. Given that brain development and face development 
are known to influence each other, it is perhaps not surprising that there is such an 
association between disorders of face shape and epilepsy, a disorder of the brain. 
Large structural variants, which are those that could be detected using karyotyping 
(approximately >5 megabases of DNA), were previously thought to be only responsible 
for rare epilepsy syndromes associated with intellectual disability and dysmorphism, 
such as Wolf-Hirschhorn syndrome (Singh et al., 2002).  
Through the use of array comparative genomic hybridization (aCGH) and single 
nucleotide polymorphism (SNP) microarrays, smaller structural variants (<5 
megabases of DNA) are now recognised as an important cause of neuropsychiatric 
disorders, including epilepsy. These technologies are able to detect structural variants 
over 25 kilobases in size reliably (Alkan et al., 2011). Indeed, SVs are collectively the 
commonest genetic abnormality in epilepsy, occurring in up to 10% of people with 
epilepsy in selected populations. Both recurrent SVs and rare SVs in epilepsy appear to 
be associated with the presence of facial dysmorphism (Helbig et al., 2014; van Bon et 
al., 2009). 
Stereophotogrammetry and dense surface modelling are reproducible and able to 
discriminate differences between different types of facial dysmorphism as well as 
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identifying facial features not recognised on visual inspection alone (Hammond et al., 
2012a, 2005). They have already been used in syndromes associated with epilepsy 
including Smith-Magenis syndrome and Wolf-Hirschhorn syndrome. 
Facial shape analysis may therefore be able to help identify patients with underlying 
recurrent or rare pathogenic SVs, particularly in those with epilepsy. 
4.2 HYPOTHESES 
In a group of people with epilepsy, I hypothesise that stereophotogrammetry and dense 
surface models can distinguish between those who do and those who do not have 
pathogenic SVs. I also hypothesise that this remains true after excluding the effect of 
several potential confounders: individual outliers, age differences, facial injury, face 
expression, anti-epileptic drug use and presence of intellectual disability. 
4.3 METHODS 
4.3.1 RECRUITMENT, IMAGE CAPTURE AND FACE SHAPE ANALYSIS 
Patients with epilepsy were recruited as described in Chapter 2. Two groups were 
analysed in turn – a training set (Group 1) and then a validation set (Group 2). Patients 
with known structural variants were invited to participate from three European 
institutions for this study to increase the number of people with epilepsy and SVs. 
Image capture, landmarking, dense surface model creation and calculation of Face 
Shape Difference (FSD) was performed as described in Chapter 2. Additional data 
collection is described below. 
4.3.2 CLASSIFICATION OF BRAIN IMAGING, INTELLECTUAL DISABILITY AND DRUG 
HISTORY 
Brain MRI scan findings were collected from imaging reports in the clinical record or on 
a clinical imaging database. Imaging reports were produced by experienced 
neuroradiologists. They were classified into three categories: normal, normal with 
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incidental findings and abnormal. ‘Normal with incidental findings’ was used to 
describe abnormalities that do not contribute to epilepsy, but nonetheless may be 
associated with underlying SVs. They comprised mild cortical atrophy, non-specific 
white matter lesions, and in one case a frontal lobe arachnoid cyst. 
Intellectual disability was determined from neuropsychology reports, full-scale or 
verbal intelligence quotient (IQ) scores, and clinical documentation of level of 
functioning in daily activities (Salvador-Carulla et al., 2011). Because of the difficulty of 
accurate retrospective assessment of intellectual disability and the particular difficulty 
in identifying borderline intellectual functioning (Wieland et al., 2014), especially in 
cases without formal neuropsychometry, only three categories were used – 
Normal/Mild, Moderate, or Severe/Profound – applying the same definitions as in the 
International Classification of Diseases, 10th Revision, by the World Health 
Organization. For adults, the earliest available neuropsychometric and clinical records 
were used to minimise confounding from potential effects on intellectual performance 
of chronic epilepsy, medical and surgical treatments, and neurodegeneration. 
Anti-epileptic drug use history was obtained from clinical records. All available records 
were inspected to check for the use of anti-epileptic drugs, recorded as ‘Yes’ or ‘No’. 
This approach was limited by the availability of clinical records. 
4.3.3 CLASSIFICATION OF DYSMORPHISM, FACIAL INJURIES AND EXPRESSION 
For all patients in group 1, four physicians specialising in adult neurology (Isabel 
Parees, Jasper Morrow, Jan Novy, Tabish Saifee) were asked to inspect each 3D face 
image. They were blinded to all clinical details except age and sex. They were asked to 
decide if there was facial dysmorphism, and were allowed to freely rotate the 3D image 
to view it from different angles. All images were classified by them as ‘Dysmorphic’ or 
‘Not dysmorphic’. All physicians had no specific dysmorphology training beyond their 
standard medical training and had been training specifically in neurology for at least 
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three years. Any faces known to the physician were excluded from analysis. Their 
clinical judgement of dysmorphism was compared to FSD values in the detection of SVs.  
One physician (Jan Novy) also reviewed all unprocessed 3D face images in group 2, 
blinded to all clinical details. He judged if there was any detectable acquired facial 
deformity that could be seen and where each was located. At the same time, he also 
assessed if the lips were apart and if there was sufficient coverage of the face for the 
DSMs, after relevant training. Patients deemed to have acquired facial deformity were 
then excluded from the relevant DSMs with reference to the regions covered by each 
one (Figure 20). The regions affected were decided by the evaluating physician for each 
image. For example, a patient with a suspected previous nasal fracture would typically 
be excluded from the Face2 and Nose2 DSMs but not from Eyes2. 
4.3.4 MOLECULAR ANALYSIS 
Patients were only included if they had undergone aCGH as part of research or clinical 
workup, or had had genome-wide SNP genotyping as part of earlier research studies. 
Oligonucleotide aCGH was performed using the Nimblegen 135K Microarray v3.1 
(Nimblegen, Madison, WI, USA) or the Agilent 44 K/60 K/75 K/105 K microarrays 
(Agilent Technologies) in an accredited clinical laboratory in accordance with 
manufacturer’s instructions. Pathogenicity of SVs, using internal and external 
databases, and confirmatory testing, such as fluorescence in situ hybridization and/or 
karyotyping, were determined by the laboratory. 
Genome-wide genotyping of SNPs was performed using the Illumina Human 610-Quad 
array (Illumina, San Diego, CA, USA) at the Institute for Genome Sciences and Policy 
Genotyping Facility, Duke University, USA with quality control measures across all 
batches. Further analysis for pathogenic SVs was performed using the PennCNV 
algorithm version 2008 June 26 as described previously (Heinzen et al., 2010). 
Page | 176  
 
Standard PennCNV software quality checks were followed with CNV calls excluded 
based on: log R ratio standard deviation of >0.28, B allele frequency >0.55, B allele 
frequency <0.45, B allele frequency drift >0.002, PennCNV confidence score <10, CNV 
based on <10 probes or CNV crossing the centromere. All deletions in known epilepsy 
hotspots or greater than 1Mb were visually inspected by a geneticist. 
If parents had also undergone testing, the laboratory criteria were used to determine if 
a SV was inherited or arose de novo. 
4.3.5 STATISTICS 
For the primary endpoint of a significant difference in FSD, the data were assessed for 
normality and then compared using the Mann-Whitney test. For categorical data on 
ethnicity and intellectual disability, the Kruskal–Wallis test was used. Fisher’s exact test 
was performed for differences in other categorical data. A receiver operating 
characteristic curve was calculated to assess sensitivity and specificity of the models. 
Bonferroni correction was applied for multiple comparisons. Analysis was conducted 
using SPSS (versions 19-23, SPSS Inc; Chicago, IL, USA). 
4.4 RESULTS 
4.4.1 SUBJECT POPULATION 
In group 1, 163 patients with epilepsy were recruited in total, of whom 30 were 
excluded due to lack of age-matched or ethnically matched controls and 15 due to lack 
of genotype data (Table 22). Pathogenic SVs were present in 38 patients and this subset 
was first compared to the remaining 80 patients without any SVs. The patients with SVs 
were younger, but the use of age-matching with controls accounts for this in all 
analyses. 
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 Patients  
with 
pathogenic 
SVs 
Patients  
without 
pathogenic 
SVs 
Control  
subjects 
Group 1 163 total N/A 
Excluded due to no genotyping; n (%) 15 (9.2%) - 
Excluded due to age; n (%) 
Excluded due to ethnicity; n (%) 
Number included; n (%) 
2 (1.2%) 
2 (1.2%) 
38 (23.3%) 
22 (13.5%) 
4 (2.4%) 
80 (49.1%) 
- 
- 
- 
Additional patients for Group 2  81 total N/A 
Excluded due to age; n (%) 
Excluded due to ethnicity; n (%) 
Number included; n (%) 
0 
1 (16.7%) 
5 (83.3%) 
11 (14.7%) 
6 (8.0%) 
58 (77.3%) 
- 
- 
- 
Total number included 43 138 388 
Age; mean age years (range) 25.8 
(3.3 - 53.9) 
38.8 
(2.8 - 56.3) 
21.3  
(2.4 - 53.2) 
Adults >18 years; n (%) 29 (67%) 135 (98%) 207 (53%) 
Males; n (%) 23 (53%) 054 (39%) 196 (51%) 
MRI findings; n (%) 
 Normal 
 Incidental findings 
 Abnormal 
 Not performed/unavailable 
 
16 (37%) 
02 0(5%) 
19 (44%) 
06 (14%) 
 
051 (37%) 
008 0(6%) 
075 (54%) 
004 0(3%) 
 
Intellectual disability; n (%) 
 Normal/mild 
 Moderate 
 Severe/profound 
 Unknown 
 
22 (51%) 
07 (16%) 
12 (28%) 
02 0(5%) 
 
131 (95%) 
004 0(3%) 
003 0(2%) 
000 0(0%) 
 
Detection method; n (%) 
 aCGH 
 SNP array 
 FISH/karyotyping 
 
31 (72%) 
08 (19%) 
04 0(9%) 
 
021 (15%) 
117 (85%) 
000 0(0%) 
 
- 
- 
Centre; n (%) 
 London 
 Brussels/Leuven 
 Florence 
 
19 (44%) 
06 (14%) 
18 (42%) 
 
135 (98%) 
- 
003 0(2%) 
 
388 (100%) 
- 
- 
Table 22 Summary of all subjects who were recruited for 3D stereophotogrammetry, the 
number of subjects excluded and the number of subjects analysed in dense surface models. 
Group 1 was used to create the first set of DSMs for training. The validation set, Group 2, 
included all 163 Group 1 patients and 81 additional patients in the DSM model. Only the 
additional untested patients were used for validation and therefore their characteristics 
are shown above. In the group with pathogenic structural variants, children were included, 
there were more male subjects, and subjects were recruited from three different centres. All 
patients were matched to control subjects based on age and sex for further analyses. MRI 
findings, intellectual disability and detection methods were obtained from clinical records 
and investigation reports 
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In group 2, there were 244 patients in total, which includes 163 from group 1 and 81 
additional patients. Only these additional 81 untested patients comprised the 
validation set in the comparisons below. Of the 81, 18 were excluded due to lack of 
matched controls. The remaining 63 patients had all undergone genotyping and 
comprised 5 patients with known pathogenic SVs and 58 without them. 
All of the patients with pathogenic SVs are detailed in Table 23. The variants range in 
size from 0.13Mb to 48.1Mb. They comprised 28 deletions, 15 duplications, 2 
translocations, 2 inversions and 1 triplication. 
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 Sex Age 
(yrs) 
SV type Size 
(Mb) 
Origin Method 
used 
Total 
genes 
in SV 
FB 
genes 
Face 
FSD 
01 Male 3.3 20pterp13 dup 1.2 de novo aCGH 25 2 8.2 
02 Male 5.8 14q24qter dup 29.5 de novo aCGH 132 16 9.8 
03 Male 7.7 2q22q23 del 10.1 de novo aCGH 15 6 17.7 
04 Male 10.7 11p15q13 inv N/A de novo FISH/karyo N/A N/A 11.9 
05 Male 10.7 17q21 del 
13q14 dup 
0.50 
0.14 
de novo aCGH 7 1 13.6 
06 Male 12.6 20p12 dup 4.9 de novo aCGH 14 4 8.2 
07 Male 19.4 16p13 del 0.81 unknown SNP array 7 1 12.0 
08 Male 22.6 4pterp13 dup 
4q35qter del 
41.8 
6.7 
de novo aCGH 226 33 24.8 
09 Male 23.3 2p13 del 0.51 de novo aCGH 1 0 11.4 
10 Male 24.1 15p;19p trans N/A unknown FISH/karyo N/A N/A 9.3 
11 Male 24.1 15p;19p trans N/A unknown FISH/karyo N/A N/A 12.4 
12 Male 24.6 2p16 del 0.17 unknown aCGH 0 0 11.0 
13 Male 25.6 16p13 del 0.26 unknown SNP array 14 1 10.2 
14 Male 27.5 15q13 del 1.5 unknown SNP array 9 0 8.1 
15 Male 27.5 14q35 del 3.6 unknown aCGH 8 1 10.6 
16 Male 29.2 17q12 del 2.1 unknown aCGH 23 0 11.9 
17 Male 31.8 1p36 del 2.3 de novo aCGH 49 3 11.4 
18 Male 33.2 1p21 del 5.6 unknown SNP array 23 2 8.6 
19 Male 36.0 15 dup inv N/A de novo FISH/karyo N/A N/A 9.8 
20 Male 37.3 15q dup 5.6 de novo aCGH 15 5 11.1 
21 Male 42.4 16p12 del 1.1 unknown SNP array 3 0 10.5 
22 Male 44.8 15q11 del 
16p13 del 
1.2 
0.83 
unknown SNP array 14 1 8.9 
23 Male 45.8 15q11 del 0.99 unknown SNP array 5 0 7.7 
24 Female 2.1 1q21q23 dup 11.3 de novo aCGH 71 11 12.4 
25 Female 3.5 8p23 dup 
17q12 dup 
0.35 
1.4 
inherited aCGH 18 1 11.1 
26 Female 6.9 3p36 dup 
17p11 dup 
0.83 
3.4 
unknown aCGH 51 3 9.2 
27 Female 13.6 22q13 dup 6.9 de novo aCGH 75 8 11.4 
28 Female 16.5 21q22 dup 0.13 inherited aCGH 2 0 20.6 
29 Female 17.0 22q11 del 2.5 de novo aCGH 54 1 11.0 
30 Female 17.1 9q22 del 4.4 de novo aCGH 38 3 10.5 
31 Female 17.4 1q44 del 2.6 de novo aCGH 14 2 14.1 
32 Female 18.0 15q26 del 2.23 de novo aCGH 15 4 7.3 
33 Female 22.9 7q22.1 trip 0.13 inherited aCGH 1 0 10.9 
34 Female 24.2 16p13 del 0.74 unknown aCGH 7 1 10.9 
35 Female 24.3 4p dup 48.6 de novo aCGH 111 12 12.1 
36 Female 24.3 3q11 del 4.3 unknown aCGH 13 0 8.2 
37 Female 35.0 11p13p14 del 0.63 unknown aCGH 5 0 9.2 
38 Female 40.9 22q13 del 3.5 de novo aCGH 42 1 10.6 
39 Female 41.0 15q11q13 dup 12.1 unknown aCGH 49 7 11.9 
40 Female 43.8 12p13 del 1.57 unknown aCGH 13 1 8.1 
41 Female 48.5 15q11q13 del 5.4 de novo aCGH 14 6 13.2 
42 Female 49.1 16p13 del 1.5 unknown SNP array 1 0 9.4 
43 Female 53.9 6q22 del 4.1 unknown aCGH 17 5 12.1 
Table 23 Detailed characteristics of all patients with pathogenic structural variants 
included in the study. Details of demographics, the type of SV, size in megabases of DNA 
(Mb), the inheritance or origin of the SV, the number of genes contained in the SV interval, 
and the whole face FSD value in the Face2 model. The method of detection refers to aCGH, 
FISH/karyotyping (‘FISH/karyo’) or genome-wide SNP array (‘SNP array’). ‘FB genes’ refers 
to the number of genes within the pathogenic SV interval that are known to be highly 
expressed in the fetal forebrain, according to the Human Brain Transcriptome public 
database (http://hbatlas.org/). All patients were in group 1 (training set), except for the 
following cases which were only present in group 2 and used for validation: 32, 33, 39, 41 
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and 43. Individuals 8 and 28 were outliers, but FSD was still significant in models for all 
three face regions after excluding both from analysis. 
 
4.4.2 FACE SHAPE DIFFERENCE IN PATIENTS WITH AND WITHOUT PATHOGENIC 
SVS IN THE TRAINING SET 
I looked to see if FSD could detect a difference between those with pathogenic SVs and 
those without. For each of the three DSMs of group 1 (Face1 for the whole face, Eyes1 
for the periorbital region, Nose1 for the perinasal region), I calculated FSD for every 
patient. Those with pathogenic SVs were then compared to those without pathogenic 
SVs. The median FSD was significantly greater in those with pathogenic SVs than those 
without, for all DSMs (Figure 39; whole face: 8.86 vs 7.65; p=0.001, periorbital region: 
10.6 vs 9.60; p=0.013, perinasal region: 7.62 vs 7.01; p=0.031, for pathogenic SV vs no 
pathogenic SV respectively). 
 
Figure 39 Box plots of the median, interquartile range and range of Face Shape Difference 
(FSD) for the three different models using the training cohort (n=118). FSD is significantly 
greater for the whole face model (Face1; 8.86 vs 7.65, p=0.001), the periorbital model 
(Eyes1; 10.6 vs 9.60, p=0.013), and the perinasal model (Nose1; 7.62 vs 7.01, p=0.031) in 
patients with pathogenic SVs. Outliers over 1.5 or 3 times the interquartile range from the 
upper quartile are shown in circles or asterisks, respectively. Excluding all outliers does not 
alter significance. 
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The distribution of FSD values shows outliers for all models, in groups with and 
without pathogenic SVs. After exclusion of all outliers, FSD was still significantly greater 
in those with pathogenic SVs (whole face: p=0.001, periorbital region: p=0.018, 
perinasal region: p=0.018). Another sensitivity analysis excluding outliers in the 
combined training and validation set (group 2) is discussed in Section 4.4.6. 
FSD of the whole face showed a strong positive correlation with the periorbital region 
(ρ=0.78; p<0.001). The perinasal region is less strongly correlated with FSD in other 
facial regions (ρ=0.50; p<0.001 with whole face, ρ=0.60; p<0.001 with periorbital 
region). This suggests that FSD of the whole face, periorbital region or perinasal region 
is significantly greater in people with epilepsy and pathogenic SVs, than in people with 
epilepsy without such variants. 
4.4.3 FACE SHAPE DIFFERENCE IN PATIENTS WITH AND WITHOUT PATHOGENIC 
SVS IN THE VALIDATION SET 
Next, I determined an optimum FSD cut-off value for detection of SVs using the training 
set from group 1 and judged accuracy of FSD for a new validation set. From the 
individual FSD values for those with and without pathogenic SVs, receiver operating 
characteristic (ROC) curves were created to see how accurate FSD is for differentiating 
those with SVs (Figure 40). The area under the curve was 0.69 (95% CI 0.60-0.80; 
p<0.001) for the Face1 model. An FSD value of 8.47 was found to be the optimal cut-off 
value with equal sensitivity and specificity (65.8%) for determining if an individual face 
image is from a patient with a pathogenic SV. FSD cut-off values were found for the 
Eyes1 and Nose1 models using the same method ( 
Table 24). As stated earlier, FSD values are specific to individual DSMs due to differing 
principal components (PCs) between DSMs. Therefore, I had to identify the equivalent 
FSD for the group 2 DSMs before validation could be tested in this group. 
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Figure 40 Receiver operating characteristic (ROC) curves of face FSD, periorbital FSD, and 
perinasal FSD used for detecting pathogenic SVs in the training cohort. The areas under the 
curve are 0.69, 0.64, and 0.61 respectively. The filled circles mark the optimal FSD cut-off 
values for equal sensitivity and specificity. These cut-off values were used for prediction in 
the validation set within group 2 (Face2, Eyes2, Nose2 DSMs) 
For the 118 patients who were each in group 1 and in group 2, FSD values in the 
original and second set of models showed very strong positive correlation as expected 
(Figure 41; Face1 vs Face2: ρ=0.96; p<0.001, Eyes1 vs Eyes2: ρ=0.96; p<0.001, Nose1 
vs Nose2: ρ=0.93; p<0.001; n=118 for all). The relationship between FSD values 
showed a strong positive correlation, suggesting that these values are highly 
reproducible. This is in agreement with a reproducibility study of FSD in different DSMs 
in Section 3.4.3. 
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Figure 41 For the 118 patients common to group 1 and group 2, there was very strongly 
positive correlation for FSD values between the Face1 and Face2 models (ρ=0.96; p<0.001). 
This was also true for the periorbital and perinasal region (Eyes1 vs Eyes2: ρ=0.96; 
p<0.001, Nose1 vs Nose2: ρ=0.93; p<0.001). Best-fit linear regression lines (shown) were 
used to convert the optimal FSD cut-off values from the group 1 DSMs to the corresponding 
group 2 DSMs so that it could be used to predict the presence of pathogenic SVs in the 
validation cohort. For example, the formula for the line in the first graph is: Face2 FSD = 
(1.30 x Face1 FSD) – 0.99. 
In the validation set, comprising only the 63 additional untested group 2 patients, the 
adjusted whole face FSD cut-off value (FSD=9.99) correctly showed that 4 of 63 
patients had pathogenic SVs. One additional patient with a pathogenic SV was not 
detected (i.e. 4/5, 80% sensitivity). Whole face FSD correctly classified 45 patients who 
were deemed to have no pathogenic SVs (45/58, 78% specificity). Using periorbital and 
perinasal FSD resulted in reduced sensitivity (3/5, 60% for both) but similar specificity 
(40/58, 69% and 45/58, 78%, respectively). Results are shown in Table 24.  
The validation set shows that FSD can discriminate between people with epilepsy with 
and without SVs with a sensitivity of 60-80% and specificity of 69-78%, depending on 
the region of the face analysed. 
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Face region Whole face Periorbital 
region 
Perinasal 
region 
Group 1 DSMs Face1 Eyes1 Nose1 
Number in training set 118 118 118 
Area under the curve 0.69 0.64 0.61 
Cut-off value 8.47 10.22 7.39 
Predicted sensitivity 66% 
(25/38) 
61% 
(23/38) 
63% 
(24/38) 
Predicted specificity 65% 
(52/80) 
61% 
(49/80) 
63% 
(50/80) 
Group 2 DSMs Face2 Eyes2 Nose2 
Number analysed in 
validation set 
63 63 63 
Equivalent cut-off value 9.99 12.96 8.66 
Actual sensitivity 80%  
(4/5) 
60%  
(3/5) 
60%  
(3/5) 
Actual specificity 78%  
(45/58) 
69% 
(40/58) 
78% 
(45/58) 
Positive predictive 
value 
26%  
(4/17) 
14% 
(3/21) 
19%  
(3/16) 
Negative predictive 
value 
98%  
(45/46) 
95%  
(40/42) 
96%  
(45/47) 
 
Table 24 The table shows all 6 DSMs of the 3 different facial regions. The top half is for 
DSMs of group 1, the training set, which were used to calculate a FSD cut-off value with 
equal sensitivity and specificity. This FSD cut-off value was translated into an equivalent 
FSD value in the group 2 DSMs using the 118 patients present in both groups. This 
translation is necessary because FSD values are only specific for the DSM they are 
calculated from, due to unique principal components for each DSM. This is further explained 
in Chapter 3. Then this adjusted FSD cut-off for group 2 DSMs was used to predict the 
presence or absence of pathogenic SVs in the 63 additional untested patients. Prediction 
was most accurate using the whole face DSM (Face2) with sensitivity of 80% and specificity 
of 78%. The periorbital and perinasal regions are both less sensitive and less specific. 
Group 2 DSMs were reassessed using all 181 patients: 43 with pathogenic SVs and 138 
without – to see if FSD was still significantly different in those with SVs as it was in 
group 1. On this occasion, due to developments in the DSMExplorer software program, 
it was possible to use a new DSM of only the perioral region. FSD was significantly 
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greater in patients with pathogenic SVs than in those without for all four DSMs of the 
face (whole face: 10.9 vs 8.91; p<0.001, periorbital region: 13.4 vs 11.6; p<0.001, 
perinasal region: 8.99 vs 7.93; p<0.001, perioral region: 9.70 vs 8.00; p<0.001, for 
pathogenic SV vs no pathogenic SV respectively). This is shown in Figure 42. 
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Figure 42 Box plots of FSD values in all patients in group 2 according to the presence of 
pathogenic SVs, in four DSMs of the whole face (Face2), periorbital region (Eyes2), 
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perinasal region (Nose2) and perioral region (Mouth2). FSD was significantly greater in 
those with pathogenic SVs for all four DSMs. 
 
4.4.4 FACE SHAPE CHARACTERISTICS IN PEOPLE WITH PATHOGENIC STRUCTURAL 
VARIANTS 
Given that FSD was increased, I analysed whether any of the people with pathogenic 
SVs had any common face shape characteristics. Of the 43 people recruited with 
pathogenic structural variants and epilepsy, 31 had pathogenic SVs unique to them 
within this group. Previous studies of people with epilepsy have also found that many 
people with epilepsy have individual or unique structural variants within the sample 
(Helbig et al., 2014). No shared facial features were expected given the diversity of SVs. 
Nevertheless, DSMs may identify subtle facial features common to all those with SVs. 
Therefore, each DSM had each PC (81 in Face2, 172 in Eyes2, 70 in Nose2) tested for 
any significant difference between patients with pathogenic SVs and those without. 
Bonferroni correction was applied for multiple testing. No individual PC was 
significantly different in those with pathogenic SVs and those without, in any of the 
models.  
The most common recurring pathogenic SV in the group was for 16p13.11 deletion in 
five cases. For only these five cases, there was no significant difference in FSD of the 
whole face compared to patients with no pathogenic SVs (10.2 vs 8.91; Mann-Whitney 
U test; p=0.09; n=143). There was also no significant association with any individual PC 
for the five patients. 
A composite average face can be created for a group of people by using the mean of 
every principal component (PC) for face images in that group. The average face can 
then be viewed in the DSMExplorer software. Upon inspection of the average face of 
patients with pathogenic SVs, there was no obvious facial dysmorphism. This was 
further analysed by colour-coding the average face for the difference in distance of each 
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surface point from the average face of people without pathogenic SVs. Therefore, there 
was no evidence for shared facial features in patients with pathogenic SVs. 
4.4.5 COMPARISON OF FSD WITH INSPECTION OF FACES BY NEUROLOGISTS 
Four physicians assessed all patients in group 1, except for one physician (Jan Novy) 
who was unable to assess the images of five patients because they were known to him. 
Their results are shown in Table 25. Sensitivity and specificity of their labelling of face 
images as ‘Dysmorphic’ were 47-74% and 74-94%, respectively. 
 
Judgement Physician 
1 
Physician 
2 
Physician 
3 
Physician 
4 
Patients 
with 
SVs 
Dysmorphic 28 25 21 17 
Not 
dysmorphic 
10 13 17 19 
Patients 
without 
SVs 
Dysmorphic 21 19 18 5 
Not 
dysmorphic 
59 61 62 72 
 Sensitivity 74% 66% 55% 47% 
 Specificity 74% 76% 78% 94% 
 
Positive 
predictive 
value 
57% 57% 54% 77% 
 
Negative 
predictive 
value 
86% 82% 78% 79% 
Table 25 Results from categorisation of all patients in group 1 as either ‘Dysmorphic’ or 
‘Not dysmorphic’ by four adult neurologists in training. Sensitivity ranges from 0.46 to 0.73 
and specificity ranges from 0.74 to 0.94. Neurologists were blinded to all clinical details and 
assessed 3D face images only. They were also told that there was at least one person with 
known facial dysmorphism in the group. 
 
4.4.6 EXCLUSION OF ALL FSD VALUES THAT ARE OUTLIERS 
For patients in group 2, a number of different factors were assessed in sensitivity 
analyses. Firstly, there are extreme outliers in all of the 4 DSMs that can be seen on the 
box plots (Figure 42). These outliers are defined using standard criteria as those values 
which lie more than 1.5 times the interquartile range above the upper quartile or 1.5 
times the interquartile range below the lower quartile. Outliers with and without 
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pathogenic SVs may bias the results and increase the chances of a type 1 or type 2 
error, and so a repeat analysis was done excluding all outliers. Upon exclusion of all 
outliers for each DSM, FSD was still significantly increased in patients with pathogenic 
SVs (Table 28). 
4.4.7 EXCLUSION OF IMAGES FROM CHILDREN AND EUROPEAN SITES 
Next I controlled for possible bias from ethnic differences or the higher number of 
children in the group with pathogenic SVs. excluded all face images from people 
recruited outside the UK. This comprised 21 subjects from Italy and 6 from Belgium. 
Only the European sites had recruited children into the study. Therefore, by excluding 
these sites, the sensitivity analysis was restricted to white British adults only. FSD was 
significantly increased for all four DSMs (Table 26). Thus, ethnicity differences at the 
different recruitment sites did not appear to be a confounder for the results for FSD. 
 FSD in UK adults 
with pSVs (n) 
FSD in UK adults 
without pSVs (n) 
Model Significance 
Whole face  11.0 
(19) 
8.87 
(135) 
Face2  
p =0.001* 
Periorbital 
region 
 13.4 
(19) 
11.7 
(135) 
Eyes2  
p =0.007* 
Perinasal 
region 
 9.29 
(19) 
7.92 
(135) 
Nose2 p =0.002* 
Perioral 
region 
 9.70 
(19) 
7.99 
(135) 
Mouth
2 
p =0.004* 
Table 26 FSD values in white British adults with and without pathogenic SVs (pSVs) for all 
four DSM models of the face. FSD was significantly increased in all DSMs in patients with 
pathogenic SVs. 
4.4.8 EXCLUSION OF IMAGES WITH FACIAL INJURY 
Overall 37 images were excluded on the basis of visual inspection by a physician and 
these comprised 46 acquired deformities, with 7 images thought to have two categories 
of deformities and 1 image thought to have three categories, shown below (Table 27). 
No images were found to have inadequate face coverage or excessive facial hair. All 
DSMs containing the injury in question were then excluded. For example, in a patient 
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with a scar over their eyebrows, the whole face DSM and periorbital DSM were 
excluded but not the perinasal and perioral DSMs, which would not be expected to have 
altered. Analysis of FSD in the remaining images still showed a significant difference 
between patients with pathogenic SVs and those without (Table 28). Facial injury did 
not appear to be a confounder in this study. 
Acquired deformities Number Notes 
Periorbital scar 14 1 pierced eyebrow; rest on eyebrow or eyelid 
Upper face scar 10 Usually forehead 
Nose fracture 7  
Lower face scar 4 Usually cheek or chin scars 
Nasal scar 3  
Perioral scar 3  
Face asymmetry 2 1 facial palsy, 1 with right temporalis wasting 
Skin lesions 2 Both raised lesions 
Contusion 1 On forehead 
Table 27 Categories of acquired facial deformities seen in all patients in group 2. 
4.4.9 EXCLUSION OF IMAGES WITH MOUTH OPEN 
Nineteen patients had their mouth open during image capture. In the previous chapter, 
it was seen that facial expression could influence landmark placement and also FSD. 
After excluding all of these patients, FSD remained significantly different between the 
patients with pathogenic SVs and those without in all DSMs (whole face: p=0.002, 
periorbital region: p=0.011, perinasal region: p=0.001, perioral region: p=0.004).  
Another analysis of only those who had their mouth closed and had no acquired facial 
deformity was conducted. In this analysis, anyone with any acquired deformity was 
excluded from all DSMs, not just the ones thought to be affected. This was because my 
earlier reproducibility study in Chapter 3 had suggested that FSD of regions of the face 
could be affected by facial expressions elsewhere – such as the periorbital FSD by 
mouth opening, despite unchanged periorbital landmark distances. This analysis also 
showed that FSD remains significantly increased in the presence of pathogenic SVs, in 
people with epilepsy (Table 28). 
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4.4.10 EXCLUSION OF IMAGES IN PATIENTS WITH MODERATE-SEVERE 
INTELLECTUAL DISABILITY 
Intellectual disability may also be a confounder in this study. People with moderate or 
severe intellectual disability may be less likely to be able to adopt a neutral head 
position, to be able to keep a neutral facial expression, or to understand instructions for 
image capture, such as to keep their eyes open. Whilst these factors were all taken into 
consideration at the time of image capture, people may have had less noticeable 
changes in head position or posture or face expression.  Head position was found to 
affect FSD in Chapter 3. Only those with an objective change in facial expression (i.e. 
with lips apart) were excluded in the previous section, and people who may be smiling, 
smirking, pouting or any other non-neutral expression with their lips together may not 
have been excluded.  
Data on intellectual function was available for 179 out of 181 subjects. For 127, this 
was derived from formal neuropsychometry assessment and for another 52, it was 
from clinical records alone.  Twelve people with moderate or severe/profound 
intellectual disability were in the group with pathogenic SVs whereas only three people 
had moderate to profound intellectual disability without a pathogenic SV. Exclusion of 
those with greater than mild intellectual disability did not change the significance of 
FSD findings for any DSM (whole face: p=0.007, periorbital region: p=0.047, perinasal 
region: p=0.004, perioral region: p=0.041). The sensitivity analysis is shown in Table 
28. 
Intellectual disability was classified in my study population on the basis of formal 
neuropsychometry assessment in 127 subjects, and clinical records alone in 52 further 
individuals. Two patients could not be categorised. FSD in the Face2 DSM for the whole 
face was significantly different for the three categories of intellectual disability (8.96 vs 
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11.1 vs 11.3; independent samples Kruskal-Wallis test; p<0.001, for normal/mild ID, 
moderate ID, severe/profound ID, respectively). FSD also differed significantly for the 
periorbital, perinasal and perioral regions alone. FSD appears to only increase with the 
severity of intellectual disability in the group of people with pathogenic SVs, but this is 
not true of those without (Figure 43). 
 
Figure 43 Box plots showing the association between FSD and intellectual disability. 
For those who underwent formal neuropsychometric estimation of IQ, there was also a 
significant but weakly negative correlation between IQ score and FSD (ρ=-0.31; 
p=0.001; n=122; shown in Figure 44).  
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Figure 44 Scatter plot of verbal IQ as measured on formal neuropsychometry testing with 
Face2 FSD in 127 patients for whom data was available. There is a weak negative 
correlation between IQ score and FSD (ρ=-0.31). 
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 FSD in patients 
with pSVs (n) 
FSD in patients 
without pSVs (n) 
Model Significance 
Exclusion of outliers 
Whole face 10.7 
(40) 
8.82 
(136) 
Face2 p<0.001 
Periorbital 
region 
13.1 
(38) 
11.4 
(134) 
Eyes2 p=0.002 
Perinasal 
region 
8.91 
(40) 
7.87 
(130) 
Nose2 p<0.001 
Perioral 
region 
9.64 
(40) 
7.98 
(134) 
Mouth2 p<0.001 
Physician review for deformity 
No face insult 11.0 
(37) 
8.64 
(107) 
 
Face2 
 
p <0.001* 
No periorbital 
insult 
13.2 
(40) 
11.2 
(126) 
 
Eyes2 
 
p <0.001* 
No perinasal 
insult 
8.99 
(43) 
7.87 
(128) 
 
Nose2 
 
p <0.001* 
No perioral 
deformity 
9.94 
(41) 
8.00 
(135) 
Mouth2 p <0.001* 
No face deformity and lips closed 
Whole face 10.6 
(25) 
8.63 
(102) 
 
Face2 
 
p =0.001* 
Periorbital 
region 
13.1 
(25) 
11.0 
(102) 
Eyes2 p =0.012* 
Perinasal 
region 
8.94 
(25) 
7.87 
(102) 
Nose2 p =0.002* 
Perioral 
region 
9.31 
(25) 
7.68 
(102) 
Mouth2 p =0.003* 
Only normal-mild intellectual disability 
Whole face  10.3 
(24) 
8.69 
(131) 
Face2  
p =0.007* 
Periorbital 
region 
 12.8 
(24) 
11.4 
(131) 
Eyes2  
p =0.047* 
Perinasal 
region 
 8.86 
(24) 
7.92 
(131) 
Nose2 p =0.004* 
Perioral 
region 
 8.94 
(24) 
 7.95 
(131) 
Mouth2 p =0.041* 
Table 28 Summary of sensitivity analyses looking at FSD values between patients with 
pathogenic SVs (pSVs) and those without, after exclusion of various potential confounders. 
FSD remains significantly increased in patients with pathogenic SVs in all subgroups. 
4.4.11 ANTI-EPILEPTIC DRUG HISTORY 
Anti-epileptic drug use may have contributed to part of the difference seen in FSD. 
Previous drug history was available for 170 of 181 patients and 158 were adults. Only 
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adults were compared to avoid bias from children, for whom different drugs may have 
been prescribed and there may be fewer previous drugs used. There was no significant 
difference in the total number of anti-epileptic drugs used between those with 
pathogenic SVs and those without (median 6 vs 6; n=158; Mann-Whitney U test; 
p=0.12). There was also no significant difference in the proportion of both groups who 
had used any individual anti-epileptic drug (Table 29). 
 Adults 
with 
pathogenic 
SVs 
Adults 
without 
pathogenic 
SVs 
Significance 
before 
correction 
Number in group 2 29 135 - 
Number with known drug 
history 27 131 
- 
Mean age (years) 32.7 40.1 - 
Mean no of drugs tried 5.5 6.8 - 
Median no of drugs tried 6 6 p=0.12 
Acetazolamide 4% 24% p=0.02 
Carbamazepine 67% 82% p=0.07 
Clobazam 52% 58% p=0.67 
Clonazepam 22% 18% p=0.59 
Gabapentin 11% 29% p=0.06 
Lamotrigine 59% 76% p=0.10 
Levetiracetam 59% 81% p=0.02 
Oxcarbazepine 15% 34% p=0.07 
Phenobarbital 37% 30% p=0.50 
Pregabalin 7% 22% p=0.11 
Phenytoin 37% 51% p=0.21 
Primidone 4% 12% p=0.31 
Tiagabine 7% 11% p=0.74 
Topiramate 44% 62% p=0.13 
Vigabatrin 7% 31% p=0.01 
Valproate 81% 73% p=0.47 
Zonisamide 15% 16% p=1.00 
Table 29 Comparison of previous or current anti-epileptic drug use between adults in group 
2 who had pathogenic SVs and those who did not. Anti-epileptic drug use was not 
significantly different for the total number of drugs used or for any individual anti-epileptic 
drug (after correcting for multiple testing). Note that rates of use for phenytoin and sodium 
valproate in particular are similar in both groups. 
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4.4.12 BODY MASS INDEX (BMI) 
Information on height and weight was available for 110 out of 181 patients, of whom 
15 had pathogenic SVs. There was a weakly positive correlation between FSD in the 
whole face and BMI (Face2: ρ=0.21; p=0.027; n=110; Figure 45). This was also true for 
perioral DSM FSD and BMI (Mouth2: ρ=0.24; p=0.011; n=110), but there was no 
correlation with BMI for FSD in the periorbital and perinasal DSMs. 
 
Figure 45 Scatter plot of FSD for the whole face DSM and BMI in 110 patients in group 2 for 
whom height and weight data was available. There is a weakly positive correlation of FSD 
with BMI shown by the regression line above (ρ=0.21; p=0.027). 
The mean BMI did not vary significantly between subjects with pathogenic SVs and 
subjects without (28.4 vs 27.2; independent samples t-test; p=0.06; n=110). As an 
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additional check, 64 patients who were outside of the normal BMI range (18.5-24.9) 
were excluded in a sensitivity analysis (Table 30). FSD was still significantly increased 
in patients with pathogenic SVs for analysis using the whole face, periorbital region or 
perioral region. FSD of the perinasal region was not significantly different between 
those with and without pathogenic SVs. 
Patients with normal BMI only 
 FSD in patients 
with pSVs (n) 
FSD in patients 
without pSVs (n) 
Model Significance 
Whole face  10.3 
(4) 
8.32 
(42) 
Face2  
p =0.021* 
Periorbital 
region 
 14.1 
(4) 
10.7 
(42) 
Eyes2  
p =0.023* 
Perinasal 
region 
 9.11 
(4) 
7.67 
(42) 
Nose2 p =0.051 
Perioral 
region 
 10.1 
(4) 
7.44 
(42) 
Mouth2 p =0.042* 
Table 30 Sensitivity analysis of all patients in Group 2 with available BMI data who were 
within the normal BMI range and categorised according to the presence or absence of a 
pathogenic SV (pSV). There was a significantly increased FSD in all DSMs except the 
perinasal region in those with pSVs. 
4.5 DISCUSSION 
The primary hypothesis that DSMs, and FSD specifically is able to discriminate between 
people with epilepsy and pathogenic SVs compared to people with epilepsy without 
pathogenic SVs, was true in this sample for the two groups overall. From my literature 
review, this appears to be the first time a computer-based analysis of face images has 
been able to discriminate people with a group of different genetic disorders in 
conjunction with epilepsy: the group of 43 people with pathogenic SVs had 31 unique 
and non-overlapping SVs amongst them. FSD was not able to correctly identify all 
individuals though, with a maximum sensitivity of 80% and maximum specificity of 
78%. 
Not surprisingly, using the whole face to calculate FSD proved to be the most accurate 
method with sensitivity of 66-80% and specificity of 65-78%. Regional DSMs using only 
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parts of the face performed worse with sensitivity of 60-63% and specificity of 61-78% 
for the periorbital and perinasal DSMs. The decreased sensitivity of the periorbital and 
perinasal DSMs is in keeping with a previous study comparing them to the whole face 
DSM using the same software (Hammond et al., 2005). Using the perioral region also 
seems to be able to differentiate those with SVs. The low positive predictive values (14-
26%) and high negative predictive values (95-98%) in all DSMs may suggest the 
technique is best used to screen for those who may have pathogenic SVs rather than as 
a diagnostic test.  
Previously, DSM was able to distinguish two particular genetic microdeletion 
syndromes associated with seizures, Smith-Magenis syndrome and Wolf-Hirschhorn 
syndrome, from controls (Hammond et al., 2012a, 2005). The current findings suggest 
that DSM may be useful in identifying a much wider range of pathogenic SVs. The most 
frequent recurring SV was 16p13.11 deletion in five cases and no evidence of atypical 
facial features was found for just this group in isolation, although there may be a trend 
towards a higher FSD. Given that 16p13.11 deletion is also a recurrent and relatively 
common microdeletion in people with epilepsy, and another such microdeletion at 
15q13.3 appears to have mild facial dysmorphism, it would be useful to study this 
deletion in a larger sample (Sisodiya and Mefford, 2011). 
FSD is a quantitative objective measurement that could identify novel patterns of 
abnormality of facial anatomy. DSM and PC analysis, upon which FSD is based, has 
already been shown to do this (Tobin et al., 2008). This may be because an increase in 
FSD does not directly translate to clinically observable dysmorphism. FSD is strictly 
based on face shape analysis. Clinical dysmorphism is based on subjective identification 
of individual features or a facial ‘gestalt’ (Hennekam et al., 2010). Recognition of faces 
by humans appears to be dependent on colour, pigmentation, motion as well as 
contour, and humans find it difficult to identify faces based on contour alone (Sinha et 
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al., 2006).  In keeping with this, some study participants with high FSD values were not 
thought to be dysmorphic when evaluated subjectively by their regular physician. I also 
found no evidence for shared facial features in people with epilepsy associated with 
diverse underlying genomic abnormalities, which was supported by visual inspection 
of the average face. 
Compared to FSD, four physicians training in neurology could identify patients with 
pathogenic SVs with a sensitivity of 47-74% and specificity of 74-94%. This is broadly 
similar to FSD, which may have slightly higher sensitivity and slightly lower specificity. 
Physicians were told that there were patients with dysmorphism in the group and were 
specifically primed to look for facial dysmorphism. The freely rotatable 3D face image 
offers advantages and disadvantages to assessing a real patient, but overall the lack of 
expression and motion may make it more difficult for physicians. 
Evaluation for dysmorphism should be part of the clinical examination in epilepsy. 
Indeed, one of the indications for aCGH in people with epilepsy is the presence of 
dysmorphic features (Kharbanda et al., 2015). However, dysmorphism may be missed 
by untrained clinicians and even clinical geneticists may take years to learn to 
recognise some patterns of facial dysmorphism (Reardon and Donnai, 2007). Outside of 
clinical genetics and especially in adult medicine, there is lack of confidence regarding 
genetic testing and a lack of awareness of dysmorphic features and genomic causes 
(Burke et al., 2006; Mainous et al., 2013; Maves et al., 2007; Salm et al., 2014; Williams, 
2007; Wolyniak et al., 2015). Another factor is that many syndromes have only been 
recently described and so there may be many adult patients with undiagnosed genomic 
disorders, including pathogenic SVs, presenting to adult medicine clinics. This has been 
noted for adult epilepsy (Dixit and Suri, 2016). 
A number of potential confounders were also assessed. Evidence of acquired facial 
deformity was present in 37 patients. All but five of these were scars, contusions or 
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abnormal nose shape, due to suspected trauma and injury. The remainder included a 
piercing, skin lesions, and facial asymmetry from suspected Bell’s palsy or surgery. The 
frequency is consistent with the higher prevalence of trauma in people with epilepsy 
(van den Broek and Beghi, 2004; Wirrell, 2006), although there are two differences. 
This sample was selected from tertiary epilepsy centres and may have an increased 
frequency of seizures compared to the general population of people with epilepsy. 
Secondly, only visual evidence of deformity was assessed by a physician blinded to 
clinical details, unlike previous studies which looked at clinical history. 
Facial expression was associated with differences in FSD in the earlier study of 
reproducibility. This was most marked for mouth opening. In this study, no patient was 
smiling or puckering their lips, but a number had their mouths open. This was 
especially apparent in children and those with intellectual disability, and both of these 
groups were more frequent in the group with pathogenic SVs. Thus, it was important to 
ensure that the increase in FSD was not just due to underlying differences in facial 
expression. 
Moderate or severe intellectual disability was present in 19 subjects with pathogenic 
SVs and 7 without pathogenic SVs. This is in keeping with the known association of SVs 
with intellectual disability (Helbig et al., 2014). Intellectual disability may affect FSD at 
the image capture stage. There may be less understanding of instructions given and 
more chance of images captured with the face in a different orientation or different 
expression. Nine out of 15 subjects with moderate to profound intellectual disability 
had their mouth open, for example. 
Anti-epileptic drug history, according to number of drugs tried, was not significantly 
different between the two groups with and without pathogenic SVs after children were 
excluded. However, the same number of drugs had been used in those pathogenic SVs 
despite their mean age being eight years younger, suggesting that refractory epilepsy 
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may be more prevalent in people with pathogenic SVs. At the same time, the difference 
in age could mean that there is shorter duration of drug use in the younger group. 
However, there were no data on age of onset of epilepsy. The two drugs implicated in 
altering facial shape, sodium valproate and phenytoin, showed similar rates of use in 
both groups too. However, this is a limited analysis because there was no information 
available on duration or cumulative dosage of these drugs.  
To some extent, the sensitivity analysis exploring weight may have corrected for the 
effect of sodium valproate and drugs such as pregabalin. On the other hand, it is 
difficult to justify excluding weight completely. It is well-known that some syndromes 
associated with epilepsy are also associated with obesity, such as Prader-Willi 
syndrome (Vendrame et al., 2010). Hence it is possible that some pathogenic SVs 
associated with epilepsy may also have an association with obesity. In this study, BMI 
was shown not to be a potential confounder. The role of BMI is explored further in 
Chapter 6 including a method of correcting FSD for BMI in this group of people with 
and without pathogenic SVs. 
A major limitation of the study is the small sample size. In particular, only five patients 
with pathogenic structural variants were recruited for the validation set. Since I am 
investigating a group of conditions which are heterogeneous in terms of their effect on 
face shape, a larger sample of people with different SVs is necessary to show if FSD is as 
sensitive and specific as this study suggests. As noted earlier, the current sample was 
also not representative of the wider population with epilepsy. Thirty-five of those with 
pathogenic SVs had been selected for genetic testing based on clinical information 
which may have included a subjective impression of dysmorphism; the remaining 8 of 
the 43 with pathogenic SVs had been recruited and genotyped as part of a genome-
wide association study. 
Page | 203  
 
Further research is needed to explore the usefulness of stereophotogrammetry and 
dense surface modelling, with larger patient samples, patients with other conditions, 
and other age groups and ethnicities. Other regions of the face, such as the ear, may also 
be informative in detecting dysmorphism. Finally, the role of potential confounding 
factors needs to be elucidated further. These include facial trauma, facial surgery, drug 
history and body mass index. 
4.6 CONCLUSION 
This study shows that patients with pathogenic structural variants have a more atypical 
face.  Structural variants are being discovered to be a more common cause of epilepsy 
and other clinical conditions than previously suspected, but it is not known which 
patients should be referred for clinical genetics testing, especially in adult medicine. I 
have shown that 3D stereophotogrammetry and dense surface modelling offers a 
promising avenue for detection of people who are likely to have clinically relevant 
structural variants. With further automation and refinement of stereophotogrammetry 
and dense surface modelling, it may help prioritise patients for genetic analysis for 
clinicians who are not experienced in dysmorphology or clinical genetics. 
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CHAPTER 5: STRUCTURAL VARIANTS ANALYSIS 
5.1 INTRODUCTION 
Before the use of chromosome microarrays, SVs in people with a disease were 
considered to be rare. Karyotyping, under light microscopy, was the commonest clinical 
investigation for genome-wide detection of SVs, but is limited to a resolution of 
approximately 5 megabases (Sharp et al., 2006). An observational study of 24,901 
amniocenteses performed for advanced maternal age found that 1.79% had 
chromosomal abnormalities on karyotyping (Caron et al., 1999). Population screening 
of newborns in Europe and Japan found prevalence rates of 0.85% and 0.63% 
respectively (Maeda et al., 1991; Nielsen and Wohlert, 1991). The majority of these 
were due to the following chromosomal disorders: trisomy 13, trisomy 18, trisomy 21, 
45X, 47XXX, 47XYY, 47XXY and ring Y chromosome (Maeda et al., 1991). 
SVs detected using karyotyping were always thought to be pathogenic, in that they 
were thought to be the cause of the disease (Shaffer and Lupski, 2000). Aneuploidies, 
such as Down syndrome, presented clinically with up to 100% penetrance, albeit with 
variable expressivity (Antonarakis et al., 2004), and even balanced translocations were 
associated with congenital malformations (Warburton, 1991). The identification of 
syndromes due to particular microdeletions (Shapira, 1998) and microduplications 
(Buckland, 2003; Lupski et al., 1991) using fluorescent in-situ hybridization (FISH), also 
suggested that submicroscopic SVs usually led to abnormal phenotypes. 
It is now known that there is much greater copy number variation than previously 
recognised in the genomes of apparently healthy humans across different populations 
(Iafrate et al., 2004; Redon et al., 2006; Sebat et al., 2004). Therefore, SVs cannot be 
assumed to be pathogenic and care is needed in interpreting results of chromosome 
microarray investigations. 
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Certain characteristics of SVs appear to predispose to pathogenicity (Girirajan et al., 
2012). The overall number of SVs is correlated with pathogenicity. Deletions are more 
likely to be pathogenic than duplications. SVs that are de novo, instead of being 
inherited, and SVs that are larger or that contain more genes in the interval are more 
likely to be pathogenic.  
In people with epilepsy, SVs are present in 5-30% depending on the study population, 
being more prevalent in the presence of features such as dysmorphism or intellectual 
disability (Helbig et al., 2014; Mullen et al., 2013; Striano et al., 2012). The SVs appear 
to be larger and contain more genes than in controls, especially for genes involved in 
ion channels and neurodevelopment (Lal et al., 2015; Striano et al., 2012). For example, 
SVs (especially deletions) that contain the genes for SCN1A, KCNQ2 and CHRNA4, are 
associated with epilepsy (Kurahashi et al., 2009; Wang et al., 2008). Therefore, the 
functions of genes contained in an SV interval are also important in determining 
pathogenicity of an SV.  
For many genes, the functions are not yet known or additional functions are recognised 
years after initial discovery. For example, the LGI1 gene was initially classified as a 
tumour suppressor gene associated with glial tumours and it was only later that it was 
found to be the cause of autosomal dominant partial epilepsy with auditory features 
(Kalachikov et al., 2002). For facial dysmorphism particularly, one alternative approach 
could be to look at gene expression in the relevant anatomical areas during the critical 
stages of facial development. Facial development is heavily dependent on embryonic 
forebrain genes (see Section 1.3.1). A transcriptome ‘atlas’ of embryonic and fetal gene 
expression in different parts of the human brain (Kang et al., 2011) enables a study of 
gene expression in people with atypical faces.  
Databases are also used to help characterise the nature of a given SV. These can include 
internal databases for a laboratory. There are also external databases of normal 
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variants, such as Database of Genomic Variants, and of affected individuals, such as 
DECIPHER. It is thought more likely that a variant seen in supposedly ‘normal’ 
individuals will not be pathogenic, or that variants that appear in conjunction with 
certain disease phenotypes are more likely to be pathogenic. Sophisticated protocols 
for classifying SVs have been developed, incorporating SV characteristics and databases 
(Galizia et al., 2012) and more recently using genome-wide studies of cases and 
controls with SVs (Lal et al., 2015). 
However, for many SVs, especially novel or rare SVs, it is not clear if they are indeed 
‘pathogenic’ and such SVs may still be misclassified. In Chapter 4, it was assumed that 
SVs were pathogenic based on laboratory classification. As explained above, the basis 
for such classification is evolving and there is no universal agreement on the 
pathogenicity of all detected SVs. One study has suggested that 1 in 5 of purported 
causative SVs less than 500kb in size may not be pathogenic in some 
neurodevelopmental disorders, for example (Vermeesch et al., 2011). Others have 
suggested a two-hit hypothesis for developmental delay associated with SVs, stating 
that some SVs alone are not pathogenic but may be so in combination (Girirajan et al., 
2010).  
On the other hand, SVs may not be detected at all, or they may be misclassified as being 
normal variants when they are actually pathogenic. Methods of detecting SVs are varied 
and include older techniques, such as bacterial artificial chromosome clone-based 
assays and fluorescence in-situ hybridisation. Oligonucleotide arrays have also been 
developed, as well as algorithms to detect SVs using genotype data collected from 
single nucleotide polymorphism (SNP) arrays. Exome and whole genome sequencing 
have been used to detect SVs in people with epilepsy but have been thought to be less 
reliable for SV detection than oligonucleotide arrays (Leu et al., 2016). 
Page | 207  
 
Subjects in Chapter 4 had been genotyped using two methods, SNP arrays or aCGH. 
Also, aCGH was performed in two different clinical laboratories, which may have used 
different criteria. Therefore, pathogenicity of SVs had not been defined using uniform 
criteria. 
In this study, I first look in more detail at the effect of SVs classified as ‘pathogenic’ in 
Chapter 4. This includes the use of a transcriptome ‘atlas’ to look for associations 
between gene expression and FSD. Then, I attempt to see if FSD can detect SVs that 
have not been classified as ‘pathogenic’. 
5.2 HYPOTHESES 
I hypothesise that FSD is positively correlated with: a) the size of pathogenic SVs b) the 
presence of deletions instead of duplications and c) the number of genes expressed in 
the human embryonic forebrain. I also hypothesise that FSD will still be able to 
discriminate between people with pathogenic SVs and people without pathogenic SVs 
in a sensitivity analysis using method of SV detection (aCGH vs SNP array). Finally, I 
hypothesise that FSD will be increased in people with any detected SV greater than 500 
kilobases, regardless of prior classification of pathogenicity. 
5.3 METHODS 
Throughout this chapter, SVs are deemed to be pathogenic if classified as such by the 
laboratory reporting the SV. In my final hypothesis, I explore whether FSD can detect 
SVs that may not have been classified as pathogenic. 
5.3.1 RECRUITMENT, IMAGE CAPTURE AND FACE SHAPE ANALYSIS 
All participants in Group 2 were included in the studies of pathogenic SV size, gene 
content and forebrain gene expression. These subjects comprised children and adults 
who had been genotyped and had been diagnosed with epilepsy (Figure 46). Exclusion 
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criteria were those with monogenic epilepsies, those with known imbalances of a 
whole chromosome and those who could not be matched for FSD. 
 
Figure 46 Recruitment of subjects for Group 2, which comprised 181 genotyped children 
and adults with epilepsy. Of these, 43 had pathogenic SVs detected by aCGH or SNP array 
and 138 had no such SVs. Reference subjects were only used to calculate FSD. SPG = 
Stereophotogrammetry 
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Figure 47 Recruitment of subjects into group 2B. This group comprised only people with 
epilepsy who had the complete genotype data available to allow assessment of all detected 
SVs, not just those that were pathogenic. 198 subjects were included after excluding those 
with no genotype data and those who could not be matched to reference subjects (due to 
age or ethnicity) for FSD calculation. SPG = stereophotogrammetry 
For analysis of all SVs above a certain size, patients with epilepsy were recruited from a 
new group, Group 2B (Figure 47). In group 2B, only people with the complete raw 
genotype information available were included. This meant the exclusion of some 
subjects for whom the laboratory report provided information on all pathogenic SVs 
but no information was available for all other detected SVs. Group 2B included some 
people who had raw genotype information available but with no classification of 
pathogenicity; these people had undergone SNP array genotyping for a prior genome-
wide association study. Other exclusion criteria comprised lack of age-matched 
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controls and lack of ethnicity-matched controls. Face images were collected as 
described previously in Chapter 3. 
5.3.2 DATA COLLECTION 
Genotype information was initially collected from different sources depending on the 
method used and is described in Chapter 5. More detailed SNP array data was collected 
from Dalia Kasperavičiūtė and Erin Heinzen, part of the EPIGEN research group which 
had initially performed the genotyping. The presence of SVs was assessed 
independently of a previous study using this data (Heinzen et al., 2010). Two people 
(Jan Novy and Vamsi Chinthapalli) used QuantiSNP (v2; Available from 
https://sites.google.com/site/quantisnp/), a Bayes hidden Markov model algorithm for 
detecting SVs from SNP array data, which has been previously shown to detect SVs 
from SNP array data (Colella et al., 2007). Default parameters were used to analyse data 
contained in Illumina GenomeStudio files. A threshold of at least 30 for the maximum 
log Bayes factor was used. During detection of SVs, copy number neutral loss of 
heterozygosity was ignored. 
For aCGH, the full report was accessed from the relevant laboratories to obtain the 
details of all SVs. For UK patients, it was also possible to obtain the data regarding all 
other SVs, including those that were considered benign or of unknown significance. For 
those patients who had both aCGH and SNP array data available, only the aCGH data 
were used. Array CGH is more sensitive and specific than older SNP arrays (Greshock et 
al., 2007). 
For the final hypothesis, tested in Section 5.4.4, all SVs greater than 500 kilobases were 
included in the analysis. This threshold was chosen based on previous reports, which 
suggest significant enrichment of SVs greater than this size in people with 
neurodevelopmental disorders (Vermeesch et al., 2011). In addition, the smallest 
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known recurrent microdeletion syndromes are approximately 500kb or larger in size 
(Girirajan et al., 2012; Miller et al., 2010). 
5.3.3 BIOINFORMATICS ANALYSIS 
The gene content of SVs was determined using the University of California, Santa Cruz 
(UCSC) Genome Browser (http://genome.ucsc.edu, hg version 18). The genome 
browser was accessed through the Genetic Diseases/Gene Discovery interface (GEDI; 
http://gedi.ci.uchicago.edu/) to obtain lists of genes contained within the affected 
interval. Genes adjacent to the SV interval were not included. Data on the breakpoints 
for all SVs were obtained from the original laboratories. Gene expression levels in the 
late human embryonic forebrain were acquired from the Human Brain Transcriptome 
database (http://hbatlas.org/). The Human Brain Transcriptome project collected 
transcriptome data in 27 regions of the brain from 57 post-mortem brain tissue 
samples in individuals with no known genetic disorders (Kang et al., 2011). They 
included developing brains with the earliest being at 5.7 weeks after conception, and 
there were two brain specimens used to establish gene expression under 56 days post-
conception. Gene expression in tissue samples was found using the Affymetrix 
GeneChip Human Exon 1.0 ST Array and is displayed for each gene on a graph of log2 
signal intensity with time (Figure 48). 
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Figure 48 Gene expression figure for a selected gene, AATF, from the Human Brain 
Transcriptome database. Signal intensity is plotted on a log base 2 scale. For this study, 
only genes expressed at a signal intensity >10 in the embryonic period were deemed to be 
expressed significantly (period 1, before 56 days post-conception). Therefore this gene was 
considered to be not expressed in the neocortex. NCX = neocortex, HIP = hippocampus, AMY 
= amygdala, STR = striatum, MD = mediodorsal nucleus of thalamus, CBC = cerebellar 
cortex. 
I noted only the earliest level of signal intensity in the neocortex, which was at or 
before 56 days’ post-conception. This age was chosen as facial development in humans 
occurs mostly before seven weeks of age (Som and Naidich, 2013). Also, molecular 
signals from the brain are thought to exert the greatest influence on facial development 
in the early embryonic period, before 56 days’ post-conception (Marcucio et al., 2015). 
Gene expression in the neocortex was categorised as present if signal intensity was 
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greater than 10 using a log2 scale or else as absent. This signal intensity threshold was 
used because genes known to be associated with cortical malformations, such as DCX, 
were expressed at a level greater than this (Kang et al., 2011). 
5.3.4 STATISTICAL ANALYSIS 
Spearman’s rank correlation coefficient was calculated to assess the strength of 
correlation. For SV size and gene content, the variables were parametric and an 
independent samples t-test was used to compare differences. For FSD, non-parametric 
tests were used. For FSD in any DSM, the Mann-Whitney U test was used to compare 
differences in groups with and without SVs. The Kruskal-Wallis test was used to look 
for differences between more than two groups of people. 
5.4 RESULTS 
5.4.1 PATHOGENIC SV SIZE AND GENE CONTENT 
Three models incorporating both the training and validation cohort (Face2, Eyes2, 
Nose2) were used to explore the genomic and clinical data.  
Exact breakpoints of the pathogenic SVs were known for 39 patients. Four others with 
pathogenic SVs had translocations or inversions detected by FISH or karyotyping, and 
so full data on pathogenic SV size were not available. They are not part of any 
subsequent analysis here. There was no correlation between whole face FSD and the 
size of the pathogenic SV in terms of total number of base pairs in the interval (ρ=0.20; 
p=0.22) or number of genes contained (ρ=0.19; p=0.25;Figure 49). Periorbital FSD 
showed positive correlation with the number of genes contained (ρ=0.38; p=0.018; 
significant after Bonferroni correction for 2 comparisons) but not the number of bases 
(ρ=0.25; p=0.13; not significant after Bonferroni correction for 2 comparisons). 
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Figure 49 Scatter plot showing the relationship between the number of genes affected in all 
pathogenic SVs for each patient compared to their face surface FSD for the whole face. No 
significant correlation was seen (p=0.25). 
5.4.2 GENE EXPRESSION IN THE EMBRYONIC FOREBRAIN FOR GENES CONTAINED 
IN PATHOGENIC SVS AND THE RELATIONSHIP TO FSD 
Within each pathogenic SV, I assessed the number of genes that were highly expressed 
in the human fetal forebrain (at 40-60 days of age) and this was performed only in 
participants with data on pathogenic SV interval breakpoints available. There was a 
significant positive correlation between the number of genes highly expressed in the 
embryonic forebrain and whole face FSD (ρ=0.34; p=0.036; n=39; Figure 50).  
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Figure 50 Scatter plot of the relationship between the total number of genes highly 
expressed in the embryonic human forebrain and within the breakpoints of a pathogenic SV 
for each patient, and FSD of the whole face. There was a significant positive correlation seen 
(ρ=0.34; p=0.036; n=39). The correlation appeared to be stronger for patients with 
deletions than those with duplications. 
In a secondary analysis, I looked at participants with deletions and duplications 
separately, and excluded two patients with both types of pathogenic SVs. Stronger 
positive correlation appeared to be present in patients with deletions (ρ=0.36; p=0.07; 
n=26) than in those with duplications (ρ=0.15; p=0.67; n=11). Mean pathogenic SV size 
and gene content were larger in patients with duplications than with deletions (11.5Mb 
vs 2.48Mb; p=0.009, 49 genes vs 13.5 genes; p=0.002) but FSD was not significantly 
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different for any of the three DSMs between those with deletions and those with 
duplications. 
 
5.4.3 SENSITIVITY ANALYSIS PERFORMED BY METHOD OF SV DETECTION 
Two genotyping methods for detecting pathogenic SVs were used: SNP arrays and 
aCGH. Thirty-one out of 43 patients (72%) with pathogenic SVs underwent aCGH, in 
contrast with only 15% of patients without pathogenic SVs. To exclude the possibility 
that method of SV detection is a confounder, I analysed only the people who underwent 
aCGH (n=56) and still found a significantly greater median FSD in those with 
pathogenic SVs using the whole face DSM (11.1 vs 9.26; p=0.005), or the periorbital 
DSM (13.7 vs 12.0; p=0.03), but not the perinasal DSM (9.11 vs 8.21; p=0.27). 
A similar analysis could be performed for SNP array data. Overall, 125 people 
underwent SNP array only, of whom 8 had pathogenic SVs. Median FSD was not 
different in the whole face DSM (9.11 vs 8.63; p=0.38), the periorbital DSM (12.9 vs 
11.4; p=0.38) or the perioral DSM (8.41 vs 7.82; p=0.22). The perinasal DSM showed 
significantly greater FSD in people with pathogenic SVs (8.81 vs 7.86; p=0.035). 
Therefore, FSD, in subjects who underwent genotyping using SNP array, was greater in 
those with pathogenic SVs than in those without pathogenic SVs. 
5.4.4 FSD IN PATIENTS WITH ANY SV OVER 500KB 
The final hypothesis was that FSD is increased in people with any SV, regardless of 
whether it has been classified as pathogenic or not. For this, a new dataset was used 
and analysis was performed in a new DSM. In total, 249 genotyped patients, with the 
full raw genotype, were recruited into group 2B (Figure 47). Of these, 46 were excluded 
due to being too old (>52years for men; >54years for women) for sufficient age-
matched controls. Five people were excluded due to lack of ethnicity-matched controls 
and only white British adults were therefore included. Ninety-nine patients had at least 
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one SV >500kb, the cut-off value used, and in these subjects, the mean SV size was 
1780kb (Table 31). There was no significant difference in FSD for any of the four DSMs 
between people with SVs and people without SVs. 
 Patients with 
SV>500kb 
Patients with 
no SV >500kb 
Significance 
 
Number 99 99  
Age 36.8 37.2  
Males 30 48  
aCGH 17 58  
SNP array 82 41  
Mean size (kb) 1780 N/A  
Face2B FSD 9.54 9.35 p=0.11 
Eyes2B FSD 13.6 12.8 p=0.82 
Nose2B FSD 8.9 8.84 p=0.73 
Mouth2B FSD 6.91 7.21 p=0.26 
Table 31 Characteristics of patients with and without SVs >500kb and the median FSD for 
the whole face DSM (Face5), periorbital DSM (Eyes5), perinasal DSM (Nose5) and perioral 
DSM (Mouth5). 
Looking at the types of SVs, 67 subjects had duplications over 500kb and 18 subjects 
had deletions over 500kb. Another 14 subjects had at least one duplication and one 
deletion over 500kb.  
Though FSD was unable to detect a difference in the group of people with any SV over 
500kb, it may be able to detect differences in people with deletions only. Deletions are 
more likely to be harmful than duplications (Girirajan et al., 2012) and phenotypic 
effects could include altered facial morphology. Therefore, FSD was compared between 
participants with any deletions over 500kb and genotyped participants without any 
known deletions over 500kb. 
FSD appeared to be greater for the face images of those 32 people who had any 
deletions over 500kb compared to those people without known deletions. This was 
only significant for the perinasal region (Nose5: 9.48 vs 8.73; p=0.020; significant after 
Bonferroni correction for 2 comparisons) and not significant for the whole face (Face5: 
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10.5 vs 9.36; p=0.042; not significant after Bonferroni correction for 2 comparisons), 
the periorbital region (Eyes5: 14.7 vs 13.0; p=0.029; not significant after Bonferroni 
correction for 2 comparisons) or the perioral region (Mouth5: 7.76 vs 7.04; p=0.14; not 
significant after Bonferroni correction for 2 comparisons). The results are shown in 
Figure 53. Hence, stereophotogrammetry and FSD may have a role in detecting 
deletions over 500kb. However, this is a small sample size and the results would need 
replication first. 
In the previous chapter, I have shown that subjects with deletions and duplications 
labelled as pathogenic have an increased FSD. Some people in this group of 32 subjects 
with deletions also had deletions already determined to be pathogenic. So I looked to 
see if the increase in FSD was only because of those people who had deletions 
previously classified as pathogenic. In the 32 patients with any deletion over 500kb, 26 
had undergone aCGH in a clinical laboratory: 11 of these were classified by the 
laboratory as having pathogenic deletions, 3 as deletions of unknown significance and 
12 as having ‘benign’ deletions. Subjects with ‘benign’ deletions were compared to 
subjects with deletions classified as unknown or likely pathogenic significance and 
there was no significant difference in FSD for any DSM, although Face5 FSD was greater 
in the latter group (10.4 vs 11.4; p=0.46). Therefore, the increase in FSD seen in people 
with any deletion over 500kb, might also be due to ‘benign’ deletions as well as 
pathogenic deletions in this small sample. 
Fourteen of the 32 subjects had more than one deletion over 500kb. Rather than using 
just a binary classification for presence of deletions, I explored if the number of 
deletions over 500kb in an individual was associated with FSD. FSD appeared to show a 
positive trend in relation to the number of deletions for each individual (Figure 51). 
However, no significant difference was found in the whole face DSM (9.36 vs 9.51 vs 
11.16 vs 10.14 vs 12.28; p=0.051; n=32; Kruskal-Wallis test). 
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Figure 51 The relationship between the number of deletions over 500 kilobases per person 
and the Face5 FSD. There was no significant difference in Face5 FSD between any of the 
groups (9.36 vs 9.51 vs 11.16 vs 10.14 vs 12.28; p=0.051; n=198; Kruskal-Wallis test) 
I also looked to see if FSD was correlated with the cumulative length of all deletions 
over 500kb in subjects. There appeared to be weakly positive correlation but this was 
not significant (Figure 52; ρ =0.13; p=0.48; n=32).  
Overall, in all 32 people with deletions, there were 49 deletions. Twenty-one of these 
were ‘benign’ deletions that overlapped with at least one other ‘benign’ deletion. For 
example, there were overlapping deletions seen in chromosome 8p23.1 (chr8: 
7,228,100-7,821,150, NCBI build 36.1, hg18), part of the beta-defensin gene cluster, 
which is known to show extensive copy number variation in humans (Machado and 
Ottolini, 2015). Excluding all overlapping ‘benign’ deletions, there were 28 deletions 
seen in 14 different chromosomes in 18 different subjects. Looking at just these 18 
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subjects, FSD of the whole face was still larger in the group with deletions but this was 
not significant (10.6 vs 9.36; p=0.11; n= 184). 
 
 
Figure 52 Scatter plot of FSD and the cumulative length of all deletions over 500kb found in 
an individual. There was no significant correlation between the two variables (ρ=0.13; 
p=0.48; n=32). 
 
In people with duplications only, there was no significant difference in FSD for any of 
the DSMs compared to people without duplications. 
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Figure 53 Box plots showing the distribution of FSD in 4 DSMs in patients with deletions 
>500kb and patients without such deletions. The median FSD is greater for the perinasal 
region (Nose5: 9.48 vs 8.73; p=0.040), but not for the whole face (Face5: 10.5 vs 9.36; 
p=0.084), the periorbital region (Eyes5: 14.7 vs 13.0; p=0.058) or the perioral region 
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(Mouth5: 7.76 vs 7.04; p=0.28). Bonferroni correction had been applied for multiple 
comparisons. 
5.5 DISCUSSION 
FSD was previously shown to differentiate between people with pathogenic SVs and 
people without pathogenic SVs. In this chapter, I further explored the relationship of 
FSD and SVs, both pathogenic SVs and non-pathogenic SVs. Initially, I looked at the size 
of pathogenic SVs and relationship to FSD. Only periorbital FSD was significantly 
correlated to the number of genes in an SV interval but this positive correlation was not 
strong (ρ=0.38) and was not associated with the number of bases in an SV interval. 
Whole face FSD was not associated with overall SV interval size in terms of number of 
genes or base pairs. SVs vary significantly in terms of gene content and the function of 
affected genes in an SV interval would be expected to be more relevant to the effect on 
face shape and FSD than size of SV alone. It may still be expected that overall SV burden 
is associated with both epilepsy and face shape, given that numerous genes and SVs 
have been associated with both phenotypes. A larger sample of people with SVs would 
be needed to look for such an effect. 
To explore the function and importance of affected genes, a transcriptome ‘atlas’ of the 
human brain was used to find gene expression levels in the embryonic forebrain. For 
those genes that are contained within a pathogenic SV, there was weak positive 
correlation between the number of genes highly expressed in the forebrain at the 
embryonic stage and FSD. This analysis combined the use SV interval size with a 
‘functional’ assessment of SV gene content, in which high gene expression in the 
embryonic forebrain was taken to mean a potential effect on facial embryology. Thus it 
is possible that genes in many of these SV intervals may be involved in regulating face 
and/or brain development. Some genes expressed in the human embryonic forebrain 
are already known to affect face development (Marcucio et al., 2015, 2011). One 
anthropometric study suggested that the PAX3 gene is associated with the position of 
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the nasal root (Paternoster et al., 2012). Although there are methodological limitations 
explained in Chapter 1, the result is intriguing as PAX3 is expressed in the embryonic 
murine midbrain and hindbrain, as well as being linked to a human condition, 
Waardenburg syndrome, with facial dysmorphism (Goulding et al., 1991). I found that 
PAX3 was not highly expressed in the human forebrain when looking in the human 
transcriptome atlas. Genes thought to be potential causes of epilepsy syndromes, such 
as CHRNA4 and SCN1A, were not necessarily expressed highly in the neocortex in the 
embryonic period, although genes implicated in epilepsy may exert their effects 
through later or more localised expression. The transcriptome atlas and relevance to 
genes involved in facial development is therefore not yet clearly understood. Reviewing 
all of the actual individual genes contained in an SV interval and their functions or 
clinical significance may be necessary in future studies. 
Also, I showed that FSD is still able to differentiate people with pathogenic SVs from 
people without these SVs, when excluding SNP array cases altogether and only 
assessing aCGH cases. This is important because there is debate over the method of 
detection used for SVs, with SNP array potentially having a worse signal-to-noise ratio 
than aCGH (Alkan et al., 2011). 
Apart from the platform used, a second difficulty in SV detection is in determining the 
pathogenicity of SVs. It is clear that this requires multiple steps and even then 
interpretation must be cautious (Fry et al., 2016; Galizia et al., 2012; Lal et al., 2015; 
Miller et al., 2010; Mullen et al., 2013; Olson et al., 2014; Striano et al., 2012). Methods 
used currently to determine pathogenicity of SVs in epilepsy can make more use of 
databases of known SVs, SVs containing known epilepsy genes and SVs in known 
epilepsy hotspots. Even so, some SVs are classified as likely pathogenic on the basis of 
size, inheritance and location.  
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In the final hypothesis of this chapter, previous interpretations of pathogenicity were 
ignored to see if FSD was useful in detecting people with SVs that may not have been 
deemed ‘pathogenic’. All detected SVs greater than 500kb were considered to be 
relevant for analysis. This showed that for SVs overall, there was no change in FSD. 
However, for deletions over 500kb there was a significant increase in FSD in one out of 
four DSMs, which was the perinasal DSM. The other three DSMs suggested a trend to 
greater FSD in people with any deletion over 500kb, but this was not significant. 
Increased FSD was seen in some people with deletions over 500kb for deletions that 
had not been characterised as ‘pathogenic’ previously. If confirmed in further studies, 
this would suggest that FSD may able to detect SVs that are thought to be benign, and 
thus these SVs may exert subtle effects on face shape that have been hitherto 
unrecognised. The implications of this may be broad, given that 5-10% of the general 
population are considered to have a SV greater than 500kb (Itsara et al., 2009). 
Inspecting these ‘benign’ deletions, some were in areas of known copy number 
variation, such as those in the beta-defensin gene cluster and these were excluded. 
After exclusion, the number of people with deletions was only 18 and there was no 
significant increase in FSD. However, even these areas of known copy number variation 
have been found to be linked to clinical phenotypes, with, for example, copy number 
variation in the beta-defensin gene cluster being linked to Crohn’s disease, psoriasis 
and HIV susceptibility (Machado and Ottolini, 2015). Hence, the implications of greater 
FSD in people with any deletion over 500kb are not clear. There may be confounding 
from deletions with no clinical significance or there may be as yet unknown effects on 
facial development and morphology from such deletions. 
A limitation of the study is the small sample size, especially in sensitivity analyses and 
in comparison to other studies of SVs in people with epilepsy (Helbig et al., 2014; 
Mefford et al., 2010; Mullen et al., 2013; Striano et al., 2012). Also, the techniques used 
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here including the imputation of SVs from SNP array data and determination of 
significant SVs using size only are useful for an exploratory analysis only. 
The bioinformatics analysis of the genes contained in an SV interval is also limited both 
in the genes considered and the extent of gene function. Genes adjacent to the SV 
interval were ignored. However, it could be argued that such genes may be affected by 
changes in copy number in neighbouring DNA through a number of mechanisms (de 
Smith et al., 2008). A gene that overlaps the SV breakpoint could also have reduced 
expression or may form a new fusion gene. Certain SVs are known to affect the 
expression of flanking genes (both upstream and downstream) through disruption of 
regulatory elements necessary for those genes. There may also be position effects in 
which a regulatory or promoter element may be closer to or further from its target 
gene due to an SV, which could then lead to increased or decreased gene expression, 
respectively. Structurally, an SV may cause some neighbouring genes to be located 
closer to a heterochromatin region of DNA, which is more tightly packed and so 
potentially more difficult for gene expression to occur within it.  
On the other hand, it is not always the case that genes within an SV interval are affected 
uniformly (de Smith et al., 2008). Some SVs may occur in chromosomal loci that exhibit 
imprinting: In this case, the effect of the SV in terms of gene expression would depend 
upon whether it occurs in the paternal or maternal copy. Some genes, such as those for 
α-defensins, show no effect of copy number variation on mRNA levels. 
In terms of the genes studied for the bioinformatics analysis, I avoided any assumptions 
about the gene function and used a transcriptome atlas to look at the expression levels 
in the developing human brain. However, different time points or sites of expression 
could have been chosen. Another approach for studying the genes is pathway analysis 
using raw genotype data. This has the advantage of potentially detecting changes due to 
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an SV in a known molecular pathway and thus inferring a possible mechanism by which 
facial dysmorphism occurs. 
Another limitation was that FSD-based analysis was limited by the lack of age-matched 
controls above the ages of 52-54 years. This meant that about 40% of the genotyped 
patient cohort could not be analysed. Incorporating more controls would help increase 
sample size in future studies using FSD and DSMs. 
5.6 CONCLUSION 
FSD is significantly increased in people with SVs, particularly deletions, after correcting 
for the potentially confounding effects of method of SV detection or laboratory-
determined pathogenicity. FSD is not associated with overall size of SVs though. FSD 
also appears to be associated with genes expressed in the human forebrain and appears 
to be able to detect deletions of no apparent clinical significance. These initial findings 
need to be addressed in larger studies. 
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CHAPTER 6: FACE SHAPE AND THE EFFECT OF BODY MASS 
INDEX AND AGEING 
6.1 INTRODUCTION 
Individual human body shape changes with body weight. The widely-used Body Mass 
Index (BMI) adjusts weight (kg) to the square of height (m2), and was considered a 
good predictor of skinfold thickness and body ‘build’ (Keys et al., 1972). BMI shows a 
significant correlation with the circumference of the head, chest, waist, hip, arm, thigh 
and knee (Wells et al., 2007), and with the profile area of the chest, waist, and hip (Lin 
et al., 2002). BMI correlates strongly with total fat mass, abdominal subcutaneous fat 
mass, and abdominal visceral fat mass measured by MRI (Janssen et al., 2002). 
Clinically, increased BMI has been used as a measure of obesity, and predicts increased 
risk of cardiovascular disease, cerebrovascular disease, cancer and mortality across 
different ethnicities (Whitlock et al., 2009; Zheng et al., 2011). 
The effect of BMI and body weight on craniofacial shape remains unclear. Research has 
focussed on the predisposition to obstructive sleep apnea (OSA). BMI is associated with 
increased neck circumference, thyromental angle, and thyromental distance in patients 
with OSA (Lam et al., 2005), but it is suggested that craniofacial characteristics 
contribute to OSA largely independently of BMI (Lee et al., 2010). Only one group has 
looked at facial soft tissue changes in OSA, and reported that Malay patients with OSA 
had increased BMI and increased buccal and submandibular fat deposition (Banabilh et 
al., 2009).  
Knowledge of the facial changes that occur with a changing BMI could help better refine 
the technique of DSM and FSD. This is important because in Chapter 4, I found that 
there is a weak positive correlation of FSD with BMI. A number of genetic syndromes, 
such as Bardet-Biedl syndrome, Prader-Willi syndrome and Smith-Magenis syndrome, 
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are also associated with obesity (Cassidy et al., 2012; Elsea and Girirajan, 2008; 
Mykytyn et al., 2002). Notably all three of these disorders have been analysed using 
dense surface modelling (de Souza et al., 2013; Hammond et al., 2005; Tobin et al., 
2008). Epilepsy is also associated with some obesity syndromes, including Prader-Willi 
syndrome and Smith-Magenis syndrome, and obesity may therefore be linked to some 
genetic causes of epilepsy.  
In addition, it may also predict those susceptible to conditions such as OSA or nocturnal 
asthma (Calhoun, 2003). Facial fat distribution may also be a useful marker of 
cardiovascular risk and mortality, similarly to anthropometric abdominal fat 
measurements (Ashwell et al., 2012). This could negate the need to use whole-body 
imaging methods, as have been proposed (Wells et al., 2007). Therefore, the first part of 
this chapter explores the effect of BMI on FSD in a larger sample of people with epilepsy 
than in Chapter 4. I also investigate whether the effect of BMI on FSD can be controlled 
for. 
A second part of this chapter was to assess the effect of ageing on FSD in particular and 
face shape in general. Much of the research into the effects of ageing on the face are 
from the field of orthopaedics. Since the 1920s, it has been known that there is a 
gradual increase in the size of the craniofacial skeleton throughout life, with, for 
example, a 5% increase in the size of the skull between adolescence and old age (Israel, 
1973). Longitudinal cephalometric studies over the last 40 years have confirmed 
skeletal growth in adulthood and have also shown that there is an increase in facial 
height and chin protrusion with age (Akgül and Toygar, 2002; Forsberg, 1979; Pecora 
et al., 2008; West and McNamara, 1999). Lateral cephalograms also delineate the soft 
tissue profile of the face and these studies noted face surface changes. For example, 
Pecora and colleagues have drawn the face in profile at three different time points over 
40 years for male and female subjects (Pecora et al., 2008). They found that there was 
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an increase in lip length but a decrease in upper lip thickness. Soft tissue thickness 
increased in the chin and the nose grew forwards and downwards throughout the time 
period up to at least a mean age of 57-58 years. 
Farkas and colleagues used direct anthropometry in the largest study of age-related 
changes to the face in 600 adults, although this was a cross-sectional study (Farkas et 
al., 2004). They showed that facial width (zygoma – zygoma) was relatively unchanged 
between different age groups in adults. By contrast, jaw widths and facial height 
increased by approximately 1-5mm into middle adulthood, defined as 50-60 years, 
with a subsequent decrease by the age of 80 years, possibly due to muscle atrophy. 
Direct anthropometry using handheld digitizer probes has been used to measure 
specific nose or lip distances in two other cross-sectional studies which confirm earlier 
cephalometric findings (Sforza et al., 2011, 2010). These studies again highlight a 
limitation of anthropometry because they were unable to comment on shape changes 
in regions without landmarks and detected shape changes are described in terms of an 
increase or decrease in inter-landmark distances. More recently, 
stereophotogrammetry has been used in plastic surgery to assess facial skin sagging 
due to gravity (See et al., 2008). A recent review summarises what is known about 
facial ageing in different regions for each layer from skin to bone (Gerth, 2015).  
With dense surface models (DSMs), age has been described as an ‘unavoidable’ 
confounder in studies and the effect of age on facial features in certain syndromes has 
been explored (Hammond et al., 2005, 2004). In all DSMs using a wide age range of 
subjects, the first PC seems to represent overall facial size in terms of both height and 
width. However, these findings from DSMs have mostly been from studies including 
children and adults, and have all been cross-sectional. There has been no longitudinal 
study using dense surface modelling to assess the effect of facial changes with age on 
face shape analysis. This is important because if FSD is to be used as a clinically useful 
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marker, it should not be unduly affected by age. Also, facial dysmorphism is known to 
vary in some syndromes with age and can become more obvious or less obvious with 
age. For example, 22q11 deletion syndrome is found to become less obvious with age, 
in a study using dense surface modelling (Hammond et al., 2005). Age-matching should 
account for variation due to age, but this has not been proven in any study. 
Here I use stereophotogrammetry and dense surface modelling to explore changes in 
face shape with weight, height, BMI and ageing in a group of people attending an 
epilepsy unit.  
6.2 HYPOTHESES 
Firstly, I hypothesise that stereophotogrammetry and dense surface models can 
identify variation in face shape due to differences in body mass index. Secondly, I also 
hypothesise that this is predictable and thus the effect of body mass index on FSD may 
be reduced. Thirdly, during follow up of patients undergoing repeat 
stereophotogrammetry, I hypothesise that in a time interval of up to two years, there is 
no significant difference in face shape analysis, including FSD. 
6.3 METHODS 
6.3.1 RECRUITMENT, IMAGE CAPTURE AND FACE SHAPE ANALYSIS 
Patients with epilepsy and relatives at two UK centres were recruited as described for 
groups 3, 4 and 5 in Chapter 2. In short, group 3 comprised adults with height and 
weight measurement, excluding potential confounders. Such confounders included 
known genetic syndromes (including those with SVs) and facial trauma. This group was 
chosen to establish and describe the relationship of BMI to face shape in DSMs. The 
exclusion criteria were chosen to minimise confounding by other factors. 
Group 4 was used to test the second hypothesis that the effect of weight could be 
minimised for FSD. FSD itself could not be tested in group 3 because that group 
Page | 231  
 
contained no reference subjects, included people without epilepsy and also had people 
who would not have sufficient matched reference subjects to enable FSD calculation. 
Group 4 comprised only adults with epilepsy who had height and weight 
measurements. Additionally, people were only included if they could be matched for 
age, sex and ethnicity to sufficient reference subjects to allow FSD to be calculated. The 
recruitment of groups 3 and 4 is shown in Figure 54. Group 5 comprised people with 
epilepsy, who underwent repeat imaging of the face after recruitment during 
subsequent visits to the UK site for clinic appointments (Figure 55). 
 
Figure 54 This is a duplicate of Figure 8. It summarises the characteristics of those 
recruited for Group 3 and Group 4. Group 3 was for an initial exploratory study of whether 
face shape was affected by BMI after excluding 153 potential confounders. Group 4 used less 
strict criteria but only recruited people with epilepsy. Group 4 was used to see if SVs in 
genotyped patients could be detected. SPG = Stereophotogrammetry 
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Figure 55 Recruitment of subjects for Group 5, a study of face shape change with age. All 
people with epilepsy, with serial images taken were included in this study. 
Height and weight were recorded as in Chapter 2. BMI was then calculated and when 
BMI is referred to later in this chapter, the units are in kgm-2 unless otherwise stated.  
Group 3 was used to explore the relationship between principal components (PCs) and 
BMI. Group 4 was used to test whether the effect of BMI could be minimised. Group 5 
was used in four DSMs to see if there are changes to FSD and face shape over time. 
6.3.2 STATISTICS 
In testing the first hypothesis, group 3 DSMs were used. Spearman’s rank correlation 
coefficient was calculated for associations. Since some data were not normally 
distributed, I used the Kruskal-Wallis non-parametric test to compare different BMI 
groups. Then standard multiple regression was applied to assess the strength of any 
relationships, with a minimum ratio of 5 cases per independent variable. DSMs use 
multiple PCs to describe facial shape and there were 81 PCs for Face3 (whole face), 172 
PCs for Eyes3, 70 PCs and 79 PCs for Mouth3, used to describe 99% of the total 
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variation in shape. To maintain 5:1 ratio, as per standard multiple regression 
assumptions, some PCs were not assessed. PCs were selected consecutively from the 
first PC in all cases until the 5:1 ratio was reached. This is because successive PCs 
explain less variation in a face shape than the ones preceding them. For those PCs 
associated with BMI, tests of ANOVA deviation from linearity were performed to check 
that PCs varied linearly with BMI (Figure 56). 
 
Figure 56 An example of the relationship between one principal component (PC 2) and body 
mass index (BMI) in adult subjects with height and weight measurements, who formed 
group 3. Testing for deviation from linearity showed that the relationship was significantly 
likely to be linear. 
For the second hypothesis, which was to assess if the effect of weight and BMI on FSD 
was predictable, standard multiple regression in a DSM of group 4 confirmed that PCs 1 
to 4 were significantly associated with BMI in this DSM too as expected. It was 
important to reassess this as PCs are not the same in different DSMs. Then group 4 was 
divided into two subgroups, for training and validation. Validation was to see if 
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adjustment for BMI affected the difference in FSD between people with SVs and people 
without SVs. The training set comprised people who had not been genotyped. The 
validation set was of genotyped people with known BMI, and either had SVs or no SVs. 
Therefore, using formulae developed from the training set, I aimed to adjust face 
shapes in the validation set to a standard BMI and see how this affects FSD. Specifically, 
the purpose was to see if FSD was still significantly different between people with SVs 
and people without SVs, once FSD was adjusted for BMI. All of the genotyped people in 
the validation set had been part of Group 2, the group of all genotyped people with or 
without height and weight measurements, which was studied in Chapters 4 and 5. 
Simple linear regression with BMI as an independent predictor was used to quantify 
the change in PCs 1 to 4 for each unit of BMI in all subjects not part of group 2, for each 
sex separately. The remaining PCs were not altered. These 4 PCs were then adjusted for 
weight in the calculation of an adjusted FSD value according to the following formula: 
FSD(𝑥𝑎𝑑𝑗)
2
= 𝛴(𝑥𝑃𝐶1 − 𝑚𝑃𝐶1 − ((𝑤𝑥 − 20) × 𝑏𝑃𝐶1))
2
+  (𝑥𝑃𝐶2 − 𝑚𝑃𝐶2 − ((𝑤𝑥 − 20) × 𝑏𝑃𝐶2))
2
+  (𝑥𝑃𝐶3 − 𝑚𝑃𝐶3 − ((𝑤𝑥 − 20) × 𝑏𝑃𝐶3))
2
+  (𝑥𝑃𝐶4 − 𝑚𝑃𝐶4 − ((𝑤𝑥 − 20) × 𝑏𝑃𝐶4))
2 + (𝑥𝑃𝐶5 − 𝑚𝑃𝐶5)
2
+  (𝑥𝑃𝐶6 − 𝑚𝑃𝐶6)
2 + ⋯ 
where x is an arbitrary subject’s face which is compared to m, its matched mean from 
the control set, xadj is the face adjusted for a BMI of 20.0kg/m2, wx is the BMI of subject x, 
and b is the gradient in the linear equation of the relationship of BMI with a particular 
PC (for PC1 to PC4). 
This formula is similar to the original formula used to calculate FSD except that the 
terms for the first four PCs include: ((w – 20) x b). This term is an adjustment made for 
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weight using the previously derived linear regression equations for the first four PCs. 
The term is still valid if the subject’s BMI (w) is less than 20 kgm-2. 
For example, for the first male subject, his BMI was 39.2kg/m2 and the coefficient for 
PC1 was 0.053 for males. Therefore, PC1 was reduced by 0.053 × (39.2 – 20.0) to adjust 
it for a BMI of 20.0. PC1 for this subject was then subtracted by his matched mean 
subject’s PC1. This was repeated for PC2, PC3 and PC4. FSD was then recalculated with 
the new BMI-adjusted values for PC1-PC4 for all subjects in the group. Therefore, all of 
the PCs associated with BMI changes are now adjusted for each subject’s BMI, and all 
other PCs are not changed. 
In the validation set of genotyped people of known BMI, the Mann-Whitney U test was 
used to test for a significant difference in BMI-adjusted FSD between those with 
pathogenic SVs and those without pathogenic SVs. 
For the longitudinal study of facial ageing, differences in FSD and BMI between the set 
of first and second images of subjects were compared using the related samples 
Wilcoxon signed rank test. Spearman’s rank correlation coefficient was also measured 
for the difference in FSD with other variables. Bonferroni correction was applied for 
multiple comparisons.  
Analysis was conducted using SPSS (versions 19-23, SPSS Inc; Chicago, IL, USA). 
6.4 RESULTS 
6.4.1 SUBJECT POPULATION 
For group 3, the group of people of known BMI, I recruited 432 subjects in total, of 
whom 373 were patients and the remainder were unaffected relatives. Table 32 
summarises their characteristics grouped by sex and BMI. The mean BMI was not 
significantly different between men (27.4; n=196; 45%) and women (27.3), but men 
had a greater mean age (44.4 vs 40.1 years; n=432; p=0.001). I divided people by BMI 
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into 4 groups: underweight (BMI<18.5), of normal weight (BMI 18.5 – 24.9), 
overweight (BMI 25 – 29.9) or obese (BMI >29.9). For each sex, height and age did not 
differ significantly between the BMI groups. 
Relatives were significantly older than patients (55.3 vs 39.9 years; p<0.001), and 41 of 
the 59 were parents of patients with epilepsy. Relatives did not have a significantly 
different height, weight or BMI to patients. 
BMI categories  
(kgm-2) 
<20 20 – 24.9 25 – 29.9 ≥30 All 
Male subjects 
Total  (n) 
Patients  (n) 
Relatives (n)  
10 
10 
00 
57 
52 
05 
77 
67 
10 
52 
43 
09 
196 
172 
024 
Age   (yrs) 
Height  (m) 
Weight  (kg) 
42.3 
1.77 
59.7 
41.4 
1.79 
74.5 
45.9 
1.76 
84.1 
045.8 
01.75 
104.4 
44.4 (14.1) 
1.77 (0.08) 
85.4 (16.1) 
PC 1 
PC 2 
PC 3 
-0.268 
-0.792 
-0.915 
-0.744 
-0.374 
-0.316 
-0.906 
-0.195 
-0.118 
-1.225 
-0.985 
-0.522 
-0.911 (0.457) 
-0.189 (1.144) 
-0.046 (1.017) 
Female subjects 
Total  (n) 
Patients (n) 
Relatives (n) 
20 
19 
01 
90 
75 
15 
62 
53 
09 
64 
54 
10 
236 
201 
035 
Age   (yrs) 
Height  (m) 
Weight  (kg) 
38.3 
1.62 
50.1 
38.1 
1.65 
61.7 
42.3 
1.63 
71.7 
41.3 
1.62 
96.4 
40.1 (13.6) 
1.63 (0.07) 
72.8 (18.6) 
PC 1 
PC 2 
PC 3 
-0.393 
-0.672 
-0.414 
-0.199 
-0.429 
-0.049 
-0.048 
-0.014 
-0.143 
0.255 
0.417 
0.504 
-0.053 (0.453) 
-0.111 (0.973) 
-0.158 (1.051) 
Table 32 Characteristics of all 432 participants, grouped by sex and BMI category. The 
majority of participants were patients (n=373), not relatives (n=59). All other values shown 
are the means (standard deviation in parentheses). Height and age were not significantly 
different in people of different BMI. Using multiple regression, PCs 1 to 3 in the whole face 
DSM were significantly associated with BMI and weight in each sex, and they are seen to 
increase significantly between BMI groups. 
6.4.2 FACIAL SHAPE AND ASSOCIATION WITH BMI AND BODY WEIGHT 
For the whole face DSM, 81 PCs were used, which accounted for 99% of the variation in 
facial shape. Men and women were assessed separately. In men (n=196), I used the first 
39 PCs, which explain 98.1% of facial shape, in a standard multiple regression analysis. 
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Using a maximum of 39 PCs maintains the minimum 5:1 ratio of cases to independent 
variables. The coefficient of determination (R2) was 0.709 for BMI and 0.713 for body 
weight (Table 33). In women (n=236; 5:1 ratio), regression analysis using the first 47 
PCs (98.3% of facial shape) resulted in a coefficient of determination of 0.701 for BMI 
and 0.713 for body weight. All coefficients were highly significant (P<0.0001). When 
looking at individual PCs in the regression model, only PCs 1 to 3 were significantly 
associated with BMI (P≤0.001) and weight (P<0.05) in both sexes. 
The three other DSMs looked at different face regions, and none of these were as 
strongly associated with BMI or weight as the whole face (Table 33). The periorbital 
DSM gave the highest coefficients of determination with weight (R2=0.695 in men; 
0.666 in women) and BMI (R2=0.643 in men; 0.636 in women). The relationship with 
BMI and weight was less strong for the perioral DSM (0.573≤R2≤0.664), and weak for 
the perinasal DSM (0.305≤R2≤0.389). 
DSM Sex % var BMI Weight Height 
Whole face 
Male 98.1 0.709 0.713 0.365 
Female 98.4 0.701 0.713 0.456 
Periorbital 
Male 96.8 0.643 0.695 0.396 
Female 97.2 0.636 0.666 0.389 
Perinasal 
Male 98.3 0.389 0.389 0.370 
Female 98.6 0.305 0.308 0.296 
Perioral 
Male 98.1 0.664 0.652 0.384 
Female 98.4 0.573 0.587 0.342 
Table 33 Coefficients of determination (R2) from standard multiple regression analysis are 
shown. For each of the 4 DSMs, analysis was of 196 men and 236 women. Regression 
analysis was conducted using a limited number of PCs as variables (39 for men; 47 for 
women), and the degree of overall shape variation expressed by these modes is shown as a 
percentage (% var). The strongest association with BMI and body weight is for the whole 
face DSM. The periorbital and perioral DSMs show a weaker association, and the perinasal 
DSM is the least associated with BMI and weight.  Height showed a weaker association with 
all DSMs. 
6.4.3 GRAPHICAL REPRESENTATION OF FACIAL CHANGE WITH BMI 
I used the whole face DSM to see which areas of the face change with BMI graphically. 
To avoid bias from individual face characteristics, minimum groups of 30 face images 
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were chosen at each extreme of BMI values. The mean underweight female face (BMI 
19.5; n=30) was compared with the mean obese female face (BMI 41.2; n=30), and was 
associated with change in facial width. The mean underweight male face (BMI 20.6; 
n=30) was next compared to the mean obese male face (BMI 36.0; n=30), and similar 
facial shape changes were seen, but more markedly so. The changes are easier to detect 
on a computer monitor in colour but images are shown below to aid understanding 
(Figure 57). 
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Figure 57 (A) The mean face of the most underweight women (mean BMI=19.5; n=30) is 
shown from the whole face DSM in profile and frontal views. (B) The mean face of the most 
overweight women (mean BMI=41.2; n=30) is shown under this. On screen, it is colour-
coded on a red-green-blue axis that represents inward-null-outward displacement, 
respectively, along the surface normal of the mean underweight female face. Above, it is 
shown in grayscale with red-green-blue replaced by white-grey-black, respectively. (C and 
D) The corresponding images are shown for the most underweight men (mean BMI=20.6; 
n=30) and the most overweight men (mean BMI=36.0; n=30). All images are to the same 
scale, and the mean male faces are larger than for females. In both sexes, no inward 
displacement is seen with an increase in BMI, as shown by the lack of white. The midline 
structures of the face, including the orbits, the nose and the lips show little change with BMI 
(light grey areas in B and D). In contrast, there is marked outward soft tissue displacement 
on both sides of the face of 5-10mm, which is more pronounced inferiorly (dark grey areas). 
There is also outward displacement around the lateral half of the orbits and over the 
maxilla. 
6.4.4 FACIAL SHAPE CHANGE WITH HEIGHT 
I explored whether facial shape could predict height. Standard multiple regression 
showed that facial shape was less useful for prediction of height than for BMI or weight, 
with coefficients of determination ranging from 0.296 to 0.456 (Table 33). In women, 
the whole face was the most useful predictor of height (R2=0.456), whereas in men, the 
periorbital region (R2=0.396) or perioral region (R2=0.384) were the most useful. 
6.4.5 SENSITIVITY ANALYSIS FOR AGE 
Facial shape may be affected by a number of factors other than BMI and I conducted a 
further regression analysis after attempting to control for them. Ageing affects the face, 
and atrophic changes are known to occur particularly from 50 years onwards (Albert et 
al., 2007). Facial muscle and fat atrophy would be expected to affect calculations of BMI. 
In earlier studies, this change from ageing was not a significant issue because all subject 
faces were compared to age-matched control faces. Therefore, here I excluded all 
participants above 50 years of age (n=59 for males; n=55 for females). These exclusions 
mean there were fewer male subjects (119) and fewer female subjects (163). To 
maintain the minimum 5:1 ratio of cases to variables, standard multiple regression was 
reassessed using only the first 23 PCs in 119 men, which resulted in a similar 
coefficient of determination to before (R2=0.709 for BMI; R2=0.722 for weight). In 163 
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women, I used the first 32 PCs and found a similar coefficient of determination 
(R2=0.666 for BMI; R2=0.623 for weight). The coefficients for height were similar to 
before (R2=0.349 in men; R2=0.443 in women). Therefore, there is no significant effect 
on the relationship of PCs to BMI, weight or height, when including people over 50 
years. 
6.4.6 ADJUSTMENT OF FSD FOR BMI 
To test the second hypothesis, a DSM of the whole face was created comprising non-
genotyped subjects in a training set and genotyped subjects in a validation set, 
collectively called group 4. The training set included 147 male and 184 female subjects 
with epilepsy, who had not been genotyped. The validation set contained 98 patients 
with epilepsy, who had been genotyped. Nine of the 98 patients had SVs. As already 
shown for group 3, in this new group and DSM, BMI was still significantly associated 
with each of PC1, PC2 and PC3 in both males and females and linear regression 
equations were then calculated (Table 34). 
  PC1 PC2 PC3 
Females B -0.029/kgm-2 0.048/kgm-2 -0.031/kgm-2 
R2 0.231 0.167 0.087 
Significance p=4.8 x e-12 p=8.7 x e-9 p=0.00005 
Males 
 
B -0.053/kgm-2 0.088/kgm-2 -0.092/kgm-2 
R2 0.254 0.231 0.249 
Significance p=7.8 x e-11 p=7.1 x e-10 p=1.3 x e-10 
Table 34 Simple linear regression equations for the first three PCs in male and female 
subjects in a training subgroup of group 4, with the coefficients here used to adjust the first 
three PCs for the effect of BMI using BMI=20kgm-2 
BMI-adjusted FSD was still significantly greater in people of known BMI with SVs than 
in people without (11.4 vs 9.42; p=0.013; n=98; Figure 58). A receiver operating 
characteristic (ROC) curve showed that a BMI-adjusted FSD cut-off of 10.69 has a 
sensitivity of 77.8% and specificity of 75.3% in detecting people with SVs (Figure 59). 
This is more accurate than using FSD values that were not adjusted for BMI (see 
Chapter 4, Figure 40), which is confirmed by an area under the curve of 0.75. This area 
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under the curve compares to areas under the curve of 0.61, 0.64 and 0.69 using the 
unadjusted perinasal region FSD, periorbital region FSD and whole face FSD in all 
genotyped patients. Therefore, BMI-adjusted FSD is better able to discriminate between 
people with SVs and people without SVs within my cohort, than unadjusted FSD values. 
 
Figure 58 FSD of the whole face, after adjustment for BMI differences, remains greater in 
people with SVs (n=9) than in people without SVs (n=91). The analysis was only performed 
in people who had been genotyped to look for pathogenic SVs and had had BMI measured. 
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Figure 59 A receiver operating characteristic (ROC) curve of BMI-adjusted FSD as a method 
of detecting people with SVs (n=9) in a total sample of 98 genotyped subjects with epilepsy. 
The area under the curve is 0.753 and an optimal BMI-adjusted FSD cut-off value of 10.69 
gives a sensitivity of 77.8% and specificity of 75.3%. 
6.4.7 LONGITUDINAL STUDY OF CHANGES IN FSD WITH AGE 
There were 105 people with epilepsy who underwent repeat stereophotogrammetry 
during a subsequent clinical encounter. Of these, 19 people were excluded because the 
subject was too old to have suitable age-matched controls (>52 years for men; >54 
years for women). Thus, 86 people were included with at least two images taken. The 
mean age was 37.8 years and 51 were female subjects. The time interval varied from 2 
weeks to 2.6 years (mean 1.3 years; median 1.2 years). The mean BMI was 28.1 in the 
set of first images of subjects and 28.6 in the set of second images of subjects, which 
was not significantly different (Paired samples t-test; p=0.16). Overall, there was no 
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difference in Face5 FSD (9.37 vs 9.38; p=0.35; n=86), Eyes5 FSD (13.2 vs 13.1; p=0.085; 
n=86) or Mouth5 FSD (7.06 vs 6.95; p=0.15; n=86). For the perinasal DSM, Nose5 FSD 
was significantly smaller from the first image to the second image (8.84 vs 8.66; 
p=0.008; n=86). This suggests that FSD of the whole face, the periorbital region or the 
perioral region, can be a robust measurement of face shape that does not significantly 
vary in a period of up to two years in an individual. 
Looking at individual images, one could expect that FSD values should be identical 
between the initial and repeat images, and a study of correlation can confirm this. 
Pearson’s correlation coefficient suggests that a strong positive correlation between 
initial and repeat FSD values exists in the whole face DSM (r=0.75; n=86; Figure 60), 
perinasal region (r=0.87; Figure 62) and perioral region (r=0.74; Figure 63). In the 
periorbital region, correlation is weaker (r=0.63; Figure 61). A scatter plot for each 
DSM shows that correlation appears to be weakest in those people with the highest FSD 
values. In other words, for some people with high FSD value at one time point, the FSD 
could be substantially lower at the other time point. This may mean that in some 
people, FSD is high due to technical error during image capture, such as poor 
positioning, given that my earlier reproducibility study has shown that such factors can 
raise FSD in the same subject. Alternatively, it may also mean FSD is more likely to 
change during a long time interval and I explored this next. 
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Figure 60 Correlation between initial FSD and repeat FSD of the whole face for people who 
underwent serial imaging. Overall, there is strong positive correlation (r=0.75; n=86). 
 
Figure 61 Correlation between initial FSD and repeat FSD of the periorbital region for 
people who underwent serial imaging. Overall, there is moderate positive correlation 
(r=0.63; n=86). 
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Figure 62 Correlation between initial FSD and repeat FSD of the perinasal region for people 
who underwent serial imaging. Overall, there is strong positive correlation (r=0.87; n=86). 
 
Figure 63 Correlation between initial FSD and repeat FSD of the perioral region for people 
who underwent serial imaging. Overall, there is strong positive correlation (r=0.74; n=86). 
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The change in Face5 FSD was assessed against the time interval between images and 
there was no correlation, suggesting that there is no systematic error in measurement, 
although a scatter plot does show there are a number of outliers with repeated FSD 
(Figure 64).  
 
Figure 64 Scatter plot of change in Face5 FSD with the time interval between the first image 
and second image in 86 subjects. Overall the median difference is not significantly different 
between the first and second image (9.37 vs 9.38; p=0.35; n=86). It can be seen though that 
there are some outliers with 8 of 86 subjects having a change in Face5 FSD of greater than 
2. Outliers were seen at any time interval between 0.5 – 2.7 years and this did not increase 
with time. 
Eight of 86 subjects have a change in Face5 FSD of greater than two. Visual inspection 
of the extreme outliers with the greatest difference in FSD between the two images 
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shows that there are visible discrepancies that explain the change in FSD. The FSD for 
regions of the face are very useful in determining the source of the discrepancy. 
For the three faces with the biggest change in Face5 FSD, the FSD values are shown for 
all DSMs (Table 35). 
 Change in FSD between both images 
 Face5 Eyes5 Nose5 Mouth5 
Subject 1 5.82 11.24 -0.37 0.00 
Subject 2 -5.76 -20.47 -2.25 -0.06 
Subject 3 -9.76 -0.22 -0.61 -0.82 
Table 35 The change in FSD in all DSMs between the first and second image for the three 
subjects with the greatest change in Face5 FSD. The table shows that FSD in the periorbital 
DSM (Eyes5), perinasal DSM (Nose5) or the perioral DSM (Mouth5) did not necessarily 
correlate with changes in Face5 FSD. In subjects 1 and 2, the change in Face5 FSD appears 
to be due to a difference in the upper face and periorbital region with minimal difference in 
the perioral region. In subject 3, the difference in Face5 FSD is due to a difference in the 
outer border of the face which is not captured by the DSMs of parts of the face. 
In subjects 1 and 2, the change in Face5 FSD appears to be due to a difference in the 
upper face and periorbital region with minimal difference in the perioral region and a 
slight difference in the perinasal region. In subject 3, the difference in Face5 FSD is due 
to a difference in the outer border of the face, which affects Face5 FSD. However, this 
difference occurs in a part of the face that is not included in the periorbital, perinasal or 
perioral regions; hence these DSMs of parts of the face are not affected. Inspection of 
the raw images confirms the expected differences in the face surface (Figure 65). 
Subjects 1 and 2 have hair obscuring part of the forehead in the first image, which also 
affected the underlying face surface. Subject 3 also has hair obscuring the side of the 
face in the first image, which is less apparent in the second image. 
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Figure 65 Cropped images of the foreheads of three subjects with the largest changes in 
Face5 FSD between the first and second image. Hair obscures the forehead and periorbital 
region in subject 1 (top row) and subject 2 (middle row) in the first image but not the 
second image. In subject 3, hair covers the side of the face in the first image but not the 
second image, although this is not easily seen in the cropped images. 
Note that in the earlier study with pathogenic SVs, coverage of the face was assessed on 
visual inspection after image capture by a physician blinded to clinical details and a 
sensitivity analysis was conducted excluding those with visible acquired deformities on 
the face. 
6.5 DISCUSSION 
I used 3D stereophotogrammetry and dense surface modelling to analyse facial shape 
in a UK population of people with epilepsy and their relatives. The first part of this 
study demonstrates that weight and BMI do significantly affect face shape, as expected. 
Face shape analysis using PCs can determine 60-70% of the variance in BMI and 
weight. More importantly, BMI and weight affect PCs used in face shape analysis in a 
predictable manner. With increasing BMI, the predominant change seen was an 
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increase in soft tissue width over the sides of the face. This area is only included in the 
whole face DSM and this DSM shows stronger correlation with BMI. The perinasal DSM 
has the weakest association with weight and BMI, suggesting that there is little soft 
tissue change around the nose with an increase in weight. This is confirmed on the 
colour-coded facial images. Perinasal DSM therefore may not be sensitive in detecting 
syndromes associated with change in weight or BMI. On the other hand, perinasal DSM 
should also be the least affected by obese or underweight subjects who may confound 
FSD in other DSMs. For example, Smith-Magenis syndrome is associated with facial 
dysmorphism, including the nose, and obesity. An obese person would be expected to 
have increased FSD in all DSMs, but least of all in the perinasal DSM. An obese person 
with Smith-Magenis syndrome would be expected to have increases in PCs for all DSMs 
due partly to increased BMI, but least affecting the perinasal DSM. Thus, the perinasal 
DSM may be best able to detect this syndrome in a group of people of different weight 
and BMI. The periorbital and perioral DSMs are more strongly associated with weight 
and BMI, with coefficients of determination over 0.57. This may be because these DSMs 
include more of the facial width and so are sensitive to the increases in width that occur 
with increasing weight. 
There is a weaker relationship between facial shape and height. Forensic studies in 
other ethnicities using skull measurements have found coefficients of determination of 
between 0.10 and 0.36 between height and craniofacial measurements (Chiba and 
Terazawa, 1998; Pelin et al., 2010). I found that my methods give coefficients from 0.30 
to 0.46 using any one of the DSMs. This suggests that using DSMs of facial regions 
instead of skull measurements does not detract from the accuracy of estimation of 
height. It is another application in which stereophotogrammetry and dense surface 
modelling are equivalent or superior to traditional anthropometry, although this is of 
limited clinical relevance. 
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Another study in a UK population used a photonic scanner to look at body shape and 
weight in over 9000 people (Wells et al., 2007). This involved subjects undressing and 
maintaining a posture for 6 seconds for image capture. The authors found that 
correlation coefficients ranged from 0.67 to 0.92 between weight and selected body 
measurements, such as hip circumference. This would suggest that R2 ranges between 
0.45 and 0.85. My study found R2 up to 0.71 using DSMs, in a smaller group of subjects, 
using a less ‘invasive’ and faster method. This suggests that more detailed techniques 
using measurements in the whole body provide no added benefit in estimating weight 
than using face shape alone. 
BMI and weight themselves do not account for the effect of distribution of fat, and 
measures such as waist circumference and waist-height ratio are thought to be more 
useful clinically to assess the health risks of obesity (Ashwell et al., 2012). Patterns of 
craniofacial fat deposition may predict particular obesity-related disorders or 
mortality, and could be detected using stereophotogrammetry and DSMs. For example, 
patients with OSA, which is strongly linked to obesity, have a distinct craniofacial 
profile (Banabilh et al., 2009; Lee et al., 2010). Currently, methods of describing these 
craniofacial changes use cephalometry, with radiation exposure, and/or cumbersome 
intra-oral measurements (Lam et al., 2005). 
Many genetic obesity syndromes are associated with facial dysmorphism and it has 
been suggested that others are still unrecognised (Farooqi and O’Rahilly, 2005). One 
example is the novel finding of 16p11 deletions in 0.7% of the morbidly obese 
population (Walters et al., 2010). DSMs have already been used to identify dysmorphic 
syndromes, and may also aid identification of atypical face shape in obese subjects from 
comparison of facial shape with that expected for an average weight, height and age. 
DSMs are well-suited for facial shape analysis in obesity: conventional anthropometry 
relies on easily identifiable landmarks on the face, which are mostly located around the 
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eyes, nose, mouth, ears or bony landmarks, but I show that obesity mainly affects the 
lateral aspect of the face, which has few such landmarks. 
I also show that conversely, in cases where obesity may hide atypical facial features, 
FSD may be adjusted to account for BMI. This correction study was performed in a 
different group, group 4, to that exploring the relationship of BMI to face shape initially. 
The reason for this was that the first hypothesis was to see how much of face shape 
variation was associated with weight and BMI. To be more accurate, the largest sample 
size possible was used, including relatives without epilepsy. Exclusion criteria were 
only strict in avoiding potential serious confounding factors, such as those with any 
genetic syndrome and those with any known facial injury. In the study of the second 
hypothesis, I was demonstrating how FSD could be corrected for weight and BMI. To do 
this, the study sample used people with epilepsy only, for whom I have used FSD 
already. This study then uses my method of BMI adjustment to see how it affects an 
earlier analysis I performed in people with and without SVs. In Section 4.4.12, I 
acknowledged that BMI may be a confounder in the analysis of people with and without 
SVs, but had no means of adjusting FSD for this other than to exclude people with BMI 
outside the accepted normal range. Here I was able to show that FSD, adjusted for BMI, 
is still able to discriminate between people with pathogenic SVs and people without. 
The effectiveness of this method is still to be assessed in larger samples. The first step 
is to repeat validation in a larger sample to see if BMI-adjusted FSD is superior to FSD 
in detecting SVs. Adjustment for BMI has to be performed with care, as it represents 
additional recalculation that may lose some of the information from PCs and the 
unadjusted FSD value. Indeed, for novel syndromes or novel SVs, it may not be known 
whether BMI or weight are affected and adjusting FSD for BMI would make it 
impossible to establish this. 
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A limitation of BMI analysis is that the BMI of reference subjects is not known. It has 
been assumed that using the mean face of 30 reference subjects is sufficient to avoid 
changes in BMI between the mean matched faces. It would be prudent to check this in 
future studies, perhaps by recruitment of different reference subjects with BMI 
measurements. This is further discussed in Chapter 9. Another clear study limitation 
was that most participants had epilepsy. People with epilepsy tend to have a greater 
BMI than those without, partly because of a more sedentary lifestyle (Ben-Menachem, 
2007). Epilepsy itself is not known to affect facial shape, but may occasionally be 
associated with underlying genetic or developmental syndromes that do cause 
dysmorphism. All known such cases were not included. I did not assess the effect of 
anti-epileptic drugs. These drugs may cause weight gain or weight loss (Ben-
Menachem, 2007). 
For the ageing study, the perinasal DSM showed a significant decrease in FSD over time 
but the other DSMs do not. The decrease is small (FSD 8.84 to 8.66). For the other parts 
of the face, there is no significant change. There may be two reasons for this. Firstly, 
some of those with epilepsy in this group may develop a more typical face shape 
(especially the nose) with age. This is known to occur in certain syndromes, such as 
22q11 deletion syndrome (Hammond et al., 2005). Secondly, an atypical nose shape in 
the initial image may be from poorly controlled seizures and trauma. In Chapter 4, it 
was seen that nearly 5% of patients with epilepsy had suffered from visible deformity 
of the nose due to a suspected fracture.  
Excluding the perinasal DSM though, it appears that FSD is a measure that is not 
affected by age within a time interval of 2 years. The time interval is too short for a 
detailed study of how FSD may change with age. Given that FSD is a measurement that 
is matched for age, one would not expect FSD to change significantly in control subjects, 
as their comparators should show the same ageing changes. Factors that could cause 
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change include weight change, facial injury, underlying genetic syndromes and 
technical errors during image capture. Some dysmorphic syndromes become less 
prominent with age and it would be interesting to see if FSD is less able to detect such 
syndromes with age too. Other characteristics in the repeated images of subjects such 
as individual PCs or inter-landmark distances were not assessed. Previous studies have 
shown that the face changes with age, but these changes are of the order of a few 
millimetres over decades. Stereophotogrammetry would probably be able to detect 
these, but one needs a much longer time interval. Indeed, to my knowledge, no 
longitudinal study on face shape during ageing has been conducted using 
stereophotogrammetry because of the relative infancy of this technique. Nonetheless, 
my findings in this ageing study are useful as it corroborates my earlier reproducibility 
studies. FSD is calculated by matching each subject’s face to the mean face of the 30 
closest reference images by age and sex. When FSD is calculated after the median time 
interval of 1.2 years in this study, some of the underlying matched reference images are 
different as the subject is older. With an increasing time interval, the proportion of 
matched reference images that are different becomes greater and hence the mean face 
generated is likely to differ more. However, I did not see any association between 
change in FSD and the time interval between images in this small sample over a 
relatively short time interval. This means that change in the underlying reference 
images used does not appear to make a measurable difference to FSD. It suggests that 
the method of using 30 matched reference images to calculate FSD is sound. 
An important finding in the ageing study is that FSD correlates more strongly in 
repeated measurements over time when FSD is smaller. A minority of people with a 
high FSD were not found to have a high FSD when measured at a different time interval 
(either in the first or the second image). Visual inspection of the face images and the 
other FSD values is useful in this situation to clarify FSD differences due to inadequate 
image capture. It confirms the importance of ensuring the face surface is fully covered 
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by stereophotogrammetry. If this is not possible, then only a DSM of part of the face 
should be used – for example, the perinasal and perioral DSMs were robust to the 
changes in examples shown earlier in this chapter. The first images in most subjects in 
the longitudinal ageing study were taken early during recruitment. By the time of 
second images, my image capture technique and protocol had been refined and this 
may explain part of the discrepancy. For example, a hairband was used to shift long hair 
off the face surface. 
A major limitation of the ageing study is that I only had one time interval between 
images and that interval was less than 3 years in all cases. A longer longitudinal ageing 
study would show if age confounds face shape analysis despite the use of age-matched 
controls. Also there was no clinical information on drug use or history of trauma 
between the images. 
6.6 CONCLUSION 
In conclusion, I have shown that changes in facial shape are clearly associated with BMI 
and weight and illustrated the location and extent of these changes. I also show that 3D 
stereophotogrammetry and dense surface modelling are useful methods for analysis of 
facial shape changes. The effect of BMI on facial shape can be reduced using 
recalculating FSD after adjusting for BMI. Reanalysing a study presented in Chapter 4, it 
is shown that adjustment for BMI does not appear to reduce the usefulness of FSD. 
I have also conducted the first analysis of longitudinal changes in DSMs of the face and 
parts of the face showing that FSD does not change significantly over a period of up to 
2.5 years. However, it is important to acquire face images using correct technique and 
then visually inspect the image to ensure quality.  
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CHAPTER 7: FACE SYMMETRY IN DEVELOPMENTAL BRAIN 
LESIONS 
7.1 INTRODUCTION 
Human face shape is known to be dependent on underlying brain development 
(Marcucio et al., 2015). This has long been recognised in conditions such as 
holoprosencephaly, microcephaly or lissencephaly, which are associated with facial 
malformations (Demyer et al., 1964; Winter, 1996). One explanation for this association 
is the physical proximity of the anterior neural tube and forebrain to the facial 
prominences. In mice, different rates of brain growth are known to affect the size and 
shape of the embryonic face (Marcucio et al., 2011). The brain also produces a number 
of molecular signals that are important for facial development, such as SHH or BMP 
proteins, and the interruption of these signalling pathways cause facial malformations 
(Marcucio et al., 2005). A further reason is that facial structures primarily derive from 
neural crest cells, which in turn form from the dorsal neural tube (Cordero et al., 2011). 
Abnormal brain development may also manifest as epilepsy. This can occur from both 
genetic causes, such as in tuberous sclerosis, or from acquired causes, such as in 
hippocampal sclerosis (Malmgren and Thom, 2012). However, there is often overlap. 
For example, people with febrile seizures, mesial temporal lobe epilepsy and 
hippocampal sclerosis were more likely to have a common variant in the SCN1A gene 
(Kasperavičiūtė et al., 2013). With the advent of higher resolution magnetic resonance 
imaging (MRI) of the brain, more subtle disorders of neuronal migration and 
development have also been discovered to be a cause of epilepsy (Aronica and Crino, 
2014; Raymond et al., 1995). These malformations of cortical development can be 
divided into a number of types, including band heterotopia, dysembryoplastic 
neuroepithelial tumours, focal cortical dysplasia and periventricular heterotopia 
(Sisodiya, 2004). For each of these, genetic causes are now also recognised. 
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Concurrent with advances in brain imaging, analysis of face shape is now possible in 
much greater detail with stereophotogrammetry and dense surface modelling. Facial 
asymmetry has not been studied in people with epilepsy to my knowledge. Most 
studies have been performed in orthodontics. A review article in 2015 states that 
visible facial asymmetry has a prevalence of 12-74% in the general population with no 
difference seen in different ethnicities (Thiesen et al., 2015). Most of the studies were 
those predominantly assessing deviation of the mandible and maxilla from the midline. 
The method of face shape analysis, such as anthropometry or cephalometry, and the 
strictness of the criteria used, determine the prevalence of asymmetry. For example, 
85% prevalence of facial asymmetry was found by a group which defined asymmetry as 
>2mm deviation from the midline for any midline facial bone landmark. Dense surface 
modelling has been successfully used before to show that there is increased facial 
asymmetry in boys with autism (Hammond et al., 2008), a neurodevelopmental 
disorder, which may be due to a range of genetic factors (de la Torre-Ubieta et al., 
2016). Developmental brain lesions, also called malformations of cortical development, 
could conceivably be the result of abnormal forebrain development and thus also affect 
ipsilateral (or contralateral) facial development if unilateral.  
7.2 HYPOTHESES 
I hypothesised that facial asymmetry can be quantified using dense surface models 
generated from stereophotogrammetry and that facial asymmetry was increased in 
people with epilepsy and underlying malformations of cortical development compared 
to that in people with epilepsy and no such malformations. 
7.3 METHODS 
7.3.1 RECRUITMENT, IMAGE CAPTURE AND FACE SHAPE ANALYSIS 
Participants were recruited as described for group 6 in Chapter 2 (Figure 66). Out of 
869 people recruited in total, 374 were excluded due to one of the following reasons: 
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subject not known to have epilepsy, no MRI images or reports available for the subject 
or the presence of an acquired lesion, an undefined lesion or multiple lesions on the 
MRI scan. Undefined lesions included any lesion that could not be diagnosed and also 
includes those MRI scans deemed to have significant movement artefact and 
insufficient quality to exclude a lesion by the reporting radiologist. Acquired lesions 
comprised stroke, traumatic injury, cavernomas, brain atrophy, facial surgery, 
intracerebral cysts and tumours. Any person with multiple lesions, such as 
hippocampal sclerosis with periventricular heterotopia, was also excluded. 
 
Figure 66 Recruitment of subjects into group 6. Overall, 495 people with epilepsy and MRI 
results available were included in the study, along with 386 reference subjects used for 
matching to help calculate FSD. SPG = stereophotogrammetry 
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Image capture, was performed as in Chapter 2. All face images were assessed by one of 
two operators (Vamsi Chinthapalli or Jan Novy), blinded to the MRI findings at the time. 
Any acquired image deformity was recorded for each image as well as the location of 
the deformity. Acquired deformity comprised facial hair, piercings, scars or raised skin 
lesions. Those images with the mouth open were noted. The location of any deformity 
was used to assess which dense surface models (DSMs) should be excluded in a 
sensitivity analysis. For example, a patient with a suspected previous nasal fracture 
would typically be excluded from the Face6 and Nose6 DSMs but not from Eyes6. 
7.3.2 DENSE SURFACE MODELLING 
Dense surface modelling was performed as for all previous DSMs with the additional 
step below of mirror image creation. 
Mirror images were created after landmarking using an automated procedure in the 
DSMExplorer software program. All paired landmarks on a particular subject’s image 
are reassigned to their opposite landmark (e.g. left exocanthion is labelled as ‘right’ 
exocanthion). Before the thin plate spline step, when a face surface is deformed and 
aligned with a base surface, the relabelling means that a face surface is reflected in the 
midline to allow the landmarks to match up with the landmarks on the base surface. A 
dense correspondence is created as usual for this mirror image with subsequent 
principal component analysis. Both unreflected and mirror images are all included in 
the resulting DSM. Note that manual landmarking is only performed once for a face 
image and the mirror image uses the same landmarks, which helps reduce error. 
DSMs of the whole face (Face6), periorbital region (Eyes6), perinasal region (Nose6) 
and perioral region (Mouth6) were created in which 99% of the shape variation was 
explained using 97, 239, 79 and 92 PCs, respectively. 
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7.3.3 REFLECTED FACE SHAPE DIFFERENCE 
After the DSM was created including these mirror images for all subjects, I calculated 
the distance between each face and its mirror image in terms of the square root of the 
sum of squared differences of every principal component. This is different to FSD, in 
which the distance between a face and its age-matched, sex-matched mean reference 
face was calculated. Algebraically, the formula is: 
FSD(𝑥,𝑟) = √∑ (𝑥𝑖−𝑟𝑖)2
𝑛
𝑖=1    for 𝑥 ∈ 𝑀 
where i indexes the n principal components (PC1, PC2, PC3, etc.) capturing 99% shape 
variation in dense surface model M and x is an arbitrary subject’s face which is 
compared to r, its reflected face surface image. 
This formula has been derived by me alone for this study and the distance was termed 
the ‘reflected face shape difference’. A similar measure has been used before to detect 
facial asymmetry in autism spectrum disorders (Hammond et al., 2008). Like FSD, 
reflected FSD only measures the size of any difference in the face images. 
One can see that for reflected FSD, control subjects are not necessary as a subject’s face 
is compared only with its reflection. 
7.3.4 CLASSIFICATION OF DEVELOPMENTAL BRAIN LESIONS 
Only those with available brain MRI reports by a neuroradiologist, clinical 
documentation of MRI findings, or imaging review by an experienced neurologist were 
included in the study. Based on these findings, subjects were categorised according to 
the presence or absence of a developmental brain lesion and the side of any lesion. For 
the purposes of this study, developmental brain lesions were defined as those visible 
on MRI and comprised: band heterotopia (BH), dysembryoplastic neuroepithelial 
tumour (DNT), focal cortical dysplasia (FCD), hippocampal sclerosis (HS), 
periventricular heterotopia (PVH), tuberous sclerosis (TS) or an undefined/other 
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malformation of cortical development (MCD). Tuberous sclerosis was defined either as 
the most likely radiological diagnosis based on the presence of cortical tubers or as 
otherwise clinically confirmed tuberous sclerosis, such as from histology or genetics, 
with an abnormal MRI scan. I appreciate that the cause of hippocampal sclerosis is 
likely to be complex, comprising genetic, developmental and acquired factors, including 
seizure severity (Walker, 2015), but for the purposes of this analysis, it has been 
included as a developmental brain lesion (labelled as ‘HS’). The malformations in the 
MCD group included people with a type of malformation present in less than four 
others in the group, people with multiple types of defined malformations, or people 
with an indeterminate malformation based on imaging. They are listed in Section 7.4.1. 
It is acknowledged that there are more detailed classifications available for such 
developmental brain lesions based on clinical features, high-resolution imaging, genetic 
testing and neuropathology (Barkovich et al., 2012). However, there are limitations of 
these classifications, which include misuse of terminology, such as polymicrogyria, and 
the limited use of many categories of malformations in clinical practice (Guerrini and 
Dobyns, 2014). Another limitation is the meaningfulness of more detailed classification, 
with recent discoveries that supposedly distinct malformations, such as lissencephaly 
and polymicrogyria-like malformations, may have the same affected gene. 
7.3.5 STATISTICAL ANALYSIS 
The Mann-Whitney U test was used to compare means between groups. The Kruskal-
Wallis test was used to compare people without HS, with left-sided HS, with right-sided 
HS and with bilateral HS. Analysis was conducted using SPSS (versions 19-23, SPSS Inc; 
Chicago, IL, USA). 
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7.4 RESULTS 
7.4.1 SUBJECT POPULATION 
I recruited 495 participants. Of these, 329 had no lesion and 166 had a developmental 
brain lesion. Ninety-three people had HS, 26 had FCD, 12 had PVH, 10 had DNTs, 7 had 
BH, 5 had TS and 13 had MCD. The median age of subjects with a developmental brain 
lesion was 7.2 years greater than subjects without a lesion and there was a similar sex 
ratio in both groups (Table 36). However, there were different sex ratios for different 
lesion types, with the majority of DNT, FCD, TS and MCD lesions occurring in men, in 
contrast to the other types.  
The thirteen people with MCD comprised:  Seven with extensive mixed malformations 
of cortical development involving cortical and white matter (in one case bilateral), two 
with polymicrogyria, two with a cortical abnormality similar to focal cortical dysplasia 
but more extensive, one with schizencephaly, and one with bilateral pachygyria and 
DCX gene mutation. 
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 Structural lesion 
 None Any BH DNT FCD HS PVH TS MCD 
Number 329 166 7 10 26 93 12 5 13 
Unilateral lesion 
only 
- 133 1 10 26 82 4 0 10 
Age (median, IQR) 35.0 
(17.0) 
42.2 
(14.6) 
38.1 
(18.9) 
43.0 (8.7) 35.6 
(17.3) 
44.5 
(13.7) 
38.5 (9.8) 29.6 
(10.0) 
33.9 
(15.2) 
Sex (% male) 43.8 44.6 28.6 60.0 69.2 34.4 41.7 60.0 61.5 
Median reflected 
FSD 
8.71 9.54 8.99 9.25 9.35 9.53 8.58 8.91 11.27 
Significance N/A p=0.001 p=0.466 p=0.885 p=0.138 p=0.002 p=0.642 p=0.961 p=0.002 
People with no acquired facial deformity 
No acquired 
deformity 
268 135 4 8 17 81 12 5 8 
Median reflected 
FSD of images with 
no acquired 
deformity 
8.51 9.48 8.82 9.25 9.48 9.52 8.58 8.91 12.53 
Significance N/A p=0.001 p=0.668 p=0.996 p=0.308 p=0.001 p=0.922 p=0.846 p=0.004 
 
Table 36 Details for all participants in the study with the number in each group and age and sex characteristics. The median reflected face shape difference 
(FSD) is shown for the total number in each group as is the significance of the result when compared with the reflected FSD in participants with no 
malformation of cortical development. The analysis is repeated after exclusion of people with acquired facial deformity as judged from face images only and 
blind to MRI or clinical information. Overall, developmental brain lesions are associated with significantly greater facial asymmetry as judged by reflected 
FSD and this is also true for the categories of HS and MCD. There is no change in these findings after exclusion of people with acquired facial deformity. BH = 
band heterotopia, DNT = dysembryoplastic neuroepithelial tumour, FCD = focal cortical dysplasia, FSD = face shape difference, HS = hippocampal sclerosis, 
IQR = interquartile range, MCD = other malformation of cortical development, PVH = periventricular heterotopia, TS = tuberous sclerosis
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7.4.2 REFLECTED FSD IN PEOPLE WITH DEVELOPMENTAL BRAIN LESIONS 
Reflected FSD was higher in participants with a developmental brain lesion than in 
those without (9.54 vs 8.71; p=0.001; n=495).  
To explore this further, I compared individual brain lesions to those without any 
lesions (Table 36). Both those with bilateral lesions and those with unilateral lesions 
were included. Subjects with HS had a significantly higher reflected FSD (Figure 67; 
9.53; p=0.002; n=93), as did those with MCD (11.27; p=0.002; n=13). However, there 
was no difference in reflected FSD, compared to subjects with no lesion, in subjects 
with BH (8.99; p=0.466; n=7), DNT (9.25; p=0.885; n=10), FCD (9.35; p=0.138; n=26), 
PVH (8.58; p=0.642; n=12) and TS (8.91; p=0.961; n=5).  
 
Figure 67 Box plots of the distribution of reflected FSD for each type of developmental brain 
lesion. MCD had a significantly greater reflected FSD compared to 329 people with no MRI 
lesions (11.27 vs 8.71; p=0.002; n=13). HS also had a greater reflected FSD (9.53 vs 8.71; 
p=0.002; n=93). People with DNT and FCD had similar reflected FSD values to HS, but they 
were smaller groups and reflected FSD was not significantly different to people with no MRI 
lesions. BH = band heterotopia, DNT = dysembryoplastic neuroepithelial tumour, FCD = 
focal cortical dysplasia, FSD = face shape difference, HS = hippocampal sclerosis, IQR = 
interquartile range, MCD = other malformation of cortical development, PVH = 
periventricular heterotopia, TS = tuberous sclerosis 
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7.4.3 REFLECTED FSD IN UNILATERAL AND BILATERAL LESIONS 
Thirty-three participants had bilateral developmental lesions seen on MRI. This 
included the majority of those with BH (6 of 7), PVH (8 of 12) and TS (5 of 5). By 
contrast, all those with a DNT or FCD had unilateral lesions only. I looked at unilateral 
and bilateral lesions separately with the hypothesis that unilateral lesions may be 
associated with greater facial asymmetry. Both those with unilateral lesions (9.48; 
p=0.003; n=133) and those with bilateral lesions (9.83; p=0.028; n=33) had 
significantly greater reflected FSD values than in people with no lesion (median 8.71; 
n=329) and bilateral lesions were in fact associated with the highest median reflected 
FSD. 
7.4.4 PERIORBITAL, PERINASAL AND LOWER FACE REGIONS 
Next I assessed if particular areas of the face were significantly more asymmetric in 
those with developmental lesions. The periorbital region alone also showed 
significantly greater asymmetry using reflected FSD in those with lesions than those 
without (14.72 vs 13.46; p=0.001). This was also true for the lower face alone (8.90 vs 
8.32; p=0.006) but not for the perinasal region (8.12 vs 7.66; p=0.092). 
Both the periorbital and lower face regions had a significantly greater reflected FSD in 
the presence of unilateral brain lesions compared to no lesion (14.72 vs 13.46; 
p=0.005; periorbital, 8.8 vs 8.32; p=0.011; lower face). In addition, the periorbital 
region reflected FSD was also significantly greater in the presence of bilateral brain 
lesions (13.85 vs 13.28; p=0.027). 
7.4.5 HIPPOCAMPAL SCLEROSIS AND REFLECTED FSD 
I categorised every participant with HS on MRI into left HS, right HS and bilateral HS, to 
see if any particular subgroups were responsible for the increased face asymmetry 
(Figure 68). Median reflected FSD was significantly greater (p=0.003; Kruskal-Wallis 
test) in people with bilateral HS (11.12; n=11) than in left HS (9.69; n=46), right HS 
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(9.36; n=36) or no lesion (8.71; n=329). However, when assessing individual face 
region models, there was no significant difference (p=0.072 for periorbital region; 
p=0.164 for perinasal region; p=0.068 for perioral region). 
 
Figure 68 Comparison of face asymmetry in people with no hippocampal sclerosis (HS), left 
HS, right HS or bilateral HS. Reflected FSD was greater in people with bilateral HS (11.12; 
n=11) than in left HS (9.69; n=46), right HS (9.36; n=36) and no HS (8.71; n=329) 
Seventeen out of 93 subjects were included in a previous study and were diagnosed as 
having febrile seizures and mesial temporal lobe epilepsy in addition to HS 
(Kasperavičiūtė et al., 2013). These subjects did not have a significantly different 
reflected FSD compared to others with HS (9.33 vs 9.60; p=0.518). 
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7.4.6 ANALYSIS AFTER EXCLUSION OF ACQUIRED FACIAL DEFORMITY 
Sixty-one participants with no developmental lesion had a visible acquired image 
deformity, as did 21 participants with any developmental brain lesion. They were 
excluded in a subsequent analysis of my findings due to possible confounding of the 
results. Using the whole face, median reflected FSD was still significantly greater in 
people with any developmental lesion, people with HS and people with MCD when 
compared to people with no lesions (Table 36).  
The median reflected FSD of all those with an acquired image deformity was 9.77. I also 
looked at how much a specific deformity may affect reflected FSD. There were 15 
people with broken noses in their clinical history, who had also been excluded for nose 
scars or nose deviation on blinded review. In these 15 people, median reflected FSD 
was 9.29 for the whole face (vs 8.51 without deformity), 10.1 for the perinasal region 
(vs 7.55 without deformity), 15.1 for the periorbital region (vs 13.3 without deformity) 
and 9.04 for the perioral region (vs 8.26 without deformity). Calculations were also 
made for the periorbital, perinasal and lower face models after excluding images with 
acquired deformity. These are shown in Table 37. 
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Periorbital DSM (Eyes6) 
Lesion type None BH DNT FCD MCD PVH TS 
Number 315 5 9 25 9 12 5 
Median reflected FSD 13.28 13.16 15.1 13.87 15.53 13.29 13.71 
p value N/A 0.936 0.351 0.093 0.02 0.849 0.587 
 
Perinasal DSM (Nose6) 
Lesion type None BH DNT FCD MCD PVH TS 
Number 301 7 9 24 9 12 5 
Median reflected FSD 7.55 7.33 8.39 8.35 8.1 6.64 7.92 
p value N/A 0.903 0.24 0.455 0.127 0.361 0.293 
 
Perioral DSM (Mouth6) 
Lesion type None BH DNT FCD MCD PVH TS 
Number 307 7 10 21 8 12 5 
Median reflected FSD 8.26 8.92 8.23 8.28 9.52 9.31 7.19 
p value N/A 0.697 0.779 0.241 0.115 0.153 0.962 
Table 37 Median reflected FSD is shown for participants with no acquired image deformity 
in each of the three localised face models – periorbital, perinasal and the lower face. Values 
for significance were on comparison with participants who had no brain lesions. The 
number in each group is after removing all images with visible acquired deformity. None of 
the models found a significantly different reflected FSD in any malformation group, except 
for the periorbital model in detecting people with MCD. BH = band heterotopia, DNT = 
dysembryoplastic neuroepithelial tumour, FCD = focal cortical dysplasia, FSD = face shape 
difference, HS = hippocampal sclerosis, MCD = other malformation of cortical development, 
PVH = periventricular heterotopia, TS = tuberous sclerosis 
 
7.4.7 REFLECTED FSD AND ASSOCIATION WITH AGE AND SEX OF PARTICIPANTS 
To investigate if the sex of a person affected asymmetry, I calculated the reflected FSD 
separately for women (n=185) and men (n=144) without any developmental brain 
lesion. Men had a significantly greater reflected FSD than women (9.25 vs 8.33; 
p<0.001). 
Therefore, reflected FSD was then calculated separately by sex for those with any 
developmental brain lesion, including hippocampal sclerosis. In women only, reflected 
FSD was still significantly greater in those with lesions than those without (9.29 vs 
8.32; p=0.004; n=277). In men only, reflected FSD was no longer significantly greater 
(9.75 vs 9.25; p=0.066; n=218). 
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Age and reflected FSD were compared in people without lesions. There was a weak 
positive correlation between the two factors (ρ=0.253; n=329). Using simple linear 
regression, the line of best fit suggested that each year of age led to an increase in 
reflected FSD of 0.046. As described earlier, participants with developmental brain 
lesions had a greater median age than those with no lesion (Table 36). Therefore, I 
standardised reflected FSDs to an arbitrary age of 30.0 years. This was done by using 
the linear regression formula above to adjust each individual’s reflected FSD for the age 
as number of years older or younger than 30.0. A revised analysis showed that the 
reflected FSD in those with developmental lesions was still greater than in those with 
no lesion (9.14 vs 8.56; p=0.007; n=495). 
7.4.8 REFLECTED FSD AND PRESENCE OF STRUCTURAL VARIANTS 
It was found earlier that people with structural variants have an atypical face shape 
using dense surface modelling in Chapter 4. Here it was assessed if such people also 
had increased face asymmetry. There were 224 people who had not been found to have 
structural variants and 21 people who had structural variants. I found no significant 
difference in reflected FSD between people with structural variants and those without 
(10.17 vs 9.38; p=0.127; n=245). 
7.4.9 REFLECTED FSD AND BODY MASS INDEX 
Body mass index may affect a participant’s facial shape, especially in epilepsy due to the 
effects of medications, altered lifestyle and underlying syndromes. I repeated the 
analysis in only those subjects with a body mass index in the normal range (greater 
than or equal to 18.5 kg/m2 and less than 25 kg/m2; Flegal et al., 2013). A total of 145 
people were included and those with developmental brain lesions (n=43) had a greater 
median reflected FSD than those without (9.19 vs 7.97; p=0.007). 
The difference was also significant for perioral lower face reflected FSD (8.80 vs 7.63; 
p=0.004), but not for periorbital or perinasal reflected FSD. 
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7.4.10 HANDEDNESS AND REFLECTED FSD 
Handedness was recorded for 428 out of 495 subjects. Six people stated they were 
ambidextrous and were excluded. In the remaining 422 subjects, there were 285 with 
no malformation of cortical development, of whom 234 were right-handed and had a 
significantly smaller reflected FSD than those who were left-handed (8.46 vs 9.18; 
Mann-Whitney U test; p=0.032; Table 38). 
In 137 people with a developmental brain lesion, 106 had a unilateral malformation 
and 31 had bilateral malformations. There were 22 left-handed people with the 
remainder being right-handed. Right-handed people with any unilateral malformation 
had a significantly smaller reflected FSD than left-handed people (9.47 vs 10.7; Mann-
Whitney U test; n=106; p=0.016; significant after Bonferroni correction). No significant 
difference was seen in reflected FSD between people who had a unilateral 
malformation ipsilateral to their dominant hand compared to those who had a 
unilateral malformation contralateral to their dominant hand (9.59 vs 9.69; Mann-
Whitney U test; n=106; p=0.714). Data are also shown for the largest single group of 
malformations, which was people with hippocampal sclerosis. It appears that FSD is 
also lower in this group in right-handed people. Data were not assessed for any other 
single group of malformations given the small numbers involved; for example, there 
were only 1-3 left-handed people for any other individual malformation. 
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 Handedness 
 Right Left 
Location of any brain lesion 
No lesion 8.46 (234) 9.18 (51) 
Right hemisphere 9.47 (45) 10.50 (8) 
Left hemisphere 9.35 (46) 11.11 (8) 
Bilateral 9.27 (24) 10.17 (6) 
Hippocampal sclerosis 
Right hemisphere 8.93 (23) 9.76 (5) 
Left hemisphere 9.43 (30) 12.16 (6) 
Bilateral 10.45 (6) 12.89 (3) 
Table 38 The relationship of handedness of subjects to reflected FSD in the presence of 
developmental brain lesions and more specifically for hippocampal sclerosis. In those with 
no lesions on MRI, right-handed subjects had a significantly smaller reflected FSD than in 
left-handed people (8.46 vs 9.18; p=0.032). 
7.5 DISCUSSION 
This study uses an established method of quantifying face shape variation, which has 
been used in people with epilepsy and other disorders. The method has been used to 
assess facial asymmetry specifically, as judged by the measurement of reflected FSD 
between a face image and its mirror image. The same measurement was also 
previously used in a study of children with autism spectrum disorders (Hammond et 
al., 2008). In the current cohort, I found that developmental brain lesions, as a 
collective group, may be associated with an increase in facial asymmetry. In particular, 
hippocampal sclerosis and unclassified malformations of cortical development were 
most easily detected. The presence of bilateral brain lesions appeared to be associated 
with greater facial asymmetry. By contrast, putatively pathogenic structural variants 
were not associated with facial asymmetry. There is also a significant effect of age and 
sex on facial asymmetry. Finally, developmental brain lesions were still associated with 
increased facial asymmetry after attempting to control for a number of factors, 
including age, sex, body mass index and acquired facial deformity. 
Using the whole face DSM was found to discriminate asymmetry best, followed by the 
periorbital DSM and then by the other two DSMs. This order is in keeping with the 
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results found in people with pathogenic structural variants earlier. The finding could 
suggest that the nose, maxilla and lower jaw show less variation in symmetry for 
anatomical reasons, such as the need for adequate dental occlusion to enable chewing. 
However, it could also suggest that these structures are less influenced by the forebrain 
during development, and hence there is less asymmetry of these in people with 
developmental brain lesions. In terms of the mechanism by which developmental 
abnormalities in the forebrain may increase facial asymmetry, there may be disturbed 
and asymmetrical molecular signalling. It is unlikely that a direct physical effect of the 
malformation affects the face, given that many lesions, such as hippocampal sclerosis, 
do not affect overall brain size and shape significantly. 
Facial asymmetry has been described as part of the wider phenomenon of fluctuating 
asymmetry, which refers to small deviations in symmetry in an organism and has been 
thought to be correlated to the degree of “developmental instability” (Dongen, 2006). 
Developmental instability is a concept describing the sensitivity of an organism to 
pathogens, toxins or genetic mutations. In humans, the known association of facial 
attractiveness and symmetry has been justified as an evolutionary means of assessing 
developmental instability in potential mates (Rhodes, 2006). Since the 1970s, facial 
asymmetry in particular has been associated with chromosomal disorders, such as 
Down syndrome and trisomy 14 (Thornhill and Møller, 1997). 
With stereophotogrammetry and the increased sophistication of facial asymmetry 
measurement, other studies have been conducted. One study of 60 Chinese adults used 
landmarks on 3D face images and the deviation of these from facial planes in three 
dimensions (Huang et al., 2013). In their study, nasion was defined as being in the 
vertical midline of the face and a triangle connecting nasion and both exocanthions was 
defined to be in the horizontal plane. These definitions mean that asymmetry affecting 
nasion or the exocanthions are not adequately detected and also that such asymmetry 
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could lead to errors in the planes used, leading to errors in calculations of their facial 
asymmetry index. Even without this error, this landmark-based method is incapable of 
detecting facial asymmetry that does not affect landmarks. 
The largest stereophotogrammetry study has used data from the Avon Longitudinal 
Study of Parents and Children (Pound et al., 2014). The authors of the study found that 
in children, increased facial asymmetry was not associated with increased periods of ill 
health, defined by the presence of symptoms such as earache or vomiting, but 
neurodevelopmental disorders were not specifically assessed. They used a landmark-
based geometric morphometric approach. One of their secondary findings was that IQ, 
which had been measured in some children, was significantly correlated with facial 
symmetry, although it appears to be very weak with a Pearson’s correlation coefficient 
of -0.056 (Pound et al., 2014). The measurement used by this group is a correlation 
coefficient and not an absolute value, and also it had to be controlled for face size. Both 
of these suggest that reflected FSD may be a better marker of face asymmetry, although 
their study was in children not adults. 
On the other hand, another study using stereophotogrammetry and dense surface 
modelling found that facial asymmetry was increased in boys with autism spectrum 
disorder as well as unaffected mothers of such boys (Hammond et al., 2008). The 
findings in the current study lend support to the theory that abnormal development of 
the brain, using the phenotype of autism or cortical malformations, leads to increased 
facial asymmetry. Bilateral malformations may be an indirect marker of the extent of 
abnormal brain development, which in turn could be associated with the extent of facial 
asymmetry. 
Facial asymmetry also existed in people with epilepsy without developmental brain 
lesions. It is likely that even in people without epilepsy or any other neuropsychiatric 
disorder, there will be some asymmetry. Farkas and colleagues found asymmetry of up 
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to 3mm for landmarks in one of the earliest studies in North American people (Farkas 
and Cheung, 1981). In one of the two previous stereophotogrammetry studies, such 
asymmetry existed in control boys (Hammond et al., 2008) and in the other study, the 
extent of asymmetry was not described; only correlations are stated (Pound et al., 
2014). A study using laser scanning found an “average” difference of 3mm between 
facial measurements on the left and right side in one study of healthy Finnish 
adolescents (Djordjevic et al., 2013). This normal asymmetry could theoretically be lost 
in certain developmental syndromes, although there was no trend or suggestion of 
decreased reflected FSD in those with any particular cortical malformation. 
Facial injury and trauma is potentially a significant confounding factor in this study.  
Unlike other factors such as age and BMI, facial injury/trauma is more likely to cause 
unilateral differences to the face shape and hence probably increase facial asymmetry. 
The two previous studies of face asymmetry using stereophotogrammetry do not 
mention or exclude subjects with acquired face deformity (Hammond et al., 2008; 
Pound et al., 2014). In this chapter, I first excluded people with visible acquired image 
deformity on blinded review. This led to two findings. Firstly, reflected FSD is still able 
to distinguish people with mixed or undefined malformations of cortical development 
and of hippocampal sclerosis alone. Secondly, those people with visible acquired facial 
deformity do have a corresponding increase in reflected FSD of approximately 1 unit 
from 8.71 to 9.77. Clinical history was also available but was not used to avoid 
subjective bias in excluding people with injuries that may not have affected face shape. 
However, the clinical history and the blinded review were both used in conjunction to 
identify 14 people with no malformation of cortical development and with a history of 
nose fracture that was visible on the face image. In these 14 people, median reflected 
FSD was also greater, especially in the perinasal and periorbital regions as expected. 
These results mean that face shape analysis for symmetry should take into account face 
injury and trauma in future. 
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Another finding was that right-handed people had a smaller reflected FSD in all groups 
analysed compared to left-handed people. There was no observed difference between 
lesions ipsilateral to or contralateral to the dominant hand of subjects. It is not clear 
why left-handedness is associated with increased facial asymmetry in my study. A 
higher prevalence of left-handedness has been documented in people in autism 
spectrum disorders, schizophrenia and Down syndrome (Lindell and Hudry, 2013). A 
small study of children with both focal cortical dysplasia and hippocampal sclerosis 
were more likely to be left-handed than in the general population (Maulisova et al., 
2016). It may be that left-handed people had undetected malformations of cortical 
development, which led to increased facial asymmetry. Another possibility is that left-
handedness and malformations of cortical development are both independent 
predictors of increased facial asymmetry. 
There are a number of limitations of this study. The most important limitation is that 
the study had very small numbers of cases for individual brain lesions other than HS. 
The strongest association of any type of lesion with facial asymmetry was for HS, which 
was also easily the largest group. It may be that with larger groups of people with DNT, 
FCD and other types of lesions, one could assess which of these lesions may increase 
facial asymmetry. 
I did not have full clinical phenotypes for all participants. For example, some of the 
subjects may have autism spectrum disorders, which are now known to be associated 
with facial asymmetry in boys (Hammond et al., 2008). The phenotypes may also have 
evolved since my data collection. Malformations of cortical development have an 
evolving classification increasing in complexity, such as with new genetic factors or the 
use of 7-Tesla MRI scans (Guerrini and Dobyns, 2014). This also means that lesions 
detected on MRI may be misclassified. Only 22 of the 166 people with developmental 
brain lesions had undergone surgery and therefore there was no pathological 
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confirmation of diagnosis in the majority of cases. Detection requires neuroradiological 
expertise as well as appropriate high resolution sequences. Indeed, in one of our 
centres, the use of a higher resolution MRI scanner enabled an increased diagnostic 
yield for DNT, FCD and HS (Winston et al., 2013). Another limitation is that despite the 
largely objective method used, the landmarking of face images and the assessment of 
acquired image deformity remain subjective steps in which the operator must judge the 
best placement. Blinding and high reproducibility may not be sufficient to eliminate 
bias or error at this step. 
Our findings with developmental brain lesions are in a group of people with epilepsy 
and it is not clear if the results could be generalised to people with other 
developmental brain lesions in the absence of epilepsy. This caution over 
generalisability is also true of my findings that face asymmetry may be increased in 
men and with age. 
7.6 CONCLUSION 
This study supports the hypothesis that abnormal development of the brain may result 
in abnormal development of the face. There is greater asymmetry of face shape in 
people with epilepsy with developmental brain lesions than in people with epilepsy 
without a developmental brain lesion. The presence of bilateral brain lesions is 
associated with greater asymmetry than unilateral lesions. Hippocampal sclerosis alone 
is associated with increased face asymmetry. Right-handed subjects appear to have less 
face asymmetry than left-handed subjects. Facial injury needs to be carefully assessed 
as this increases face asymmetry significantly. Further research is needed to elucidate 
the molecular mechanisms whereby this occurs in lesions such as HS. 
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CHAPTER 8: FACE SHAPE IN HNF1B HAPLOINSUFFICIENCY 
8.1 INTRODUCTION 
The hepatocyte nuclear factor 1-beta (HNF1B) gene is a transcription factor that is 
important for organogenesis. Mouse studies have shown that HNF1B deficiency is lethal 
and the gene is expressed during embryonic development of the visceral endoderm 
(Coffinier et al., 1999), including the gut (D’Angelo et al., 2010), kidneys (Hiesberger et 
al., 2004), pancreas (Haumaitre et al., 2005), biliary system and liver (Coffinier et al., 
2002). In humans, heterozygous mutations or deletions of the HNF1B gene can lead to 
renal cysts or malformations (Edghill et al., 2006), pancreatic atrophy with exocrine 
and endocrine insufficiency (Bellanné-Chantelot et al., 2004; Horikawa et al., 1997), 
hepatobiliary dysfunction (Roelandt et al., 2012), and genital tract malformations 
(Oram et al., 2010). 
More recently, deletions involving the HNF1B gene have also been associated with 
autism, schizophrenia, developmental delay and facial dysmorphism (Moreno-De-Luca 
et al., 2010; Nagamani et al., 2010). Seizures and structural brain abnormalities have 
been associated with both deletions and duplications of 17q12, which encompasses the 
HNF1B gene (Mefford et al., 2007; Nagamani et al., 2010). Such structural brain 
abnormalities include frontal gliosis, hippocampal hyperintensities, and hippocampal 
atrophy (Moreno-De-Luca et al., 2010; Nagamani et al., 2010). In one study, those with 
deletions were thought to have consistent facial features, which included arched 
eyebrows, slanting palpebral fissures, and a depressed nasal bridge (Moreno-De-Luca 
et al., 2010). However, in others with deletions, there was no facial dysmorphism or 
there were only inconsistent features in a minority, such as a triangular face, epicanthal 
folds, low-set ears, or micrognathia (Edghill et al., 2008; Moreno-De-Luca et al., 2010; 
Nagamani et al., 2010). No obvious facial dysmorphism or structural brain abnormality 
has been reported in people with HNF1B point mutations (Bellanné-Chantelot et al., 
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2004; Edghill et al., 2006). Our group has described one person with epilepsy and a 
microdeletion encompassing the HNF1B gene (Kasperavičiūtė et al., 2011), but a review 
suggests that epilepsy only occurs in isolated cases and may not be linked to this gene 
specifically (Bockenhauer and Jaureguiberry, 2016). 
It is possible that HNF1B, a gene that directs embryonic development and is expressed 
in the developing mammalian brain (Makki and Capecchi, 2011), may affect facial 
morphology. As explained in Chapter 1, facial development is known to be dependent 
on signals from the developing forebrain and aberrations in one may be associated with 
aberrations in the other (Marcucio et al., 2015). Subtle facial dysmorphism or 
asymmetry may not have been considered in earlier case series of HNF1B mutations. 
Three-dimensional stereophotogrammetry and dense surface modelling have been 
previously used to analyse facial morphology and symmetry in genetic and 
neuropsychiatric syndromes (Hammond et al., 2004, 2005; Cox-Brinkman et al., 2007; 
P. Hammond et al., 2008). One finding was of significantly increased facial asymmetry 
in autism spectrum disorders, which may be due to unidentified genetic factors (P. 
Hammond et al., 2008). I have also applied dense surface modelling to explore 
consequences of underlying SVs (including deletions), syndromes and brain lesions in 
people with epilepsy in chapters 5, 6 and 7, as well as in collaboration in other studies 
(Coppola et al., 2013; Novy et al., 2012). 
Here I used dense surface models (DSMs) to further investigate facial shape in a pilot 
study of children and adults with mutations or deletions of the HNF1B gene. 
8.2 HYPOTHESIS 
I hypothesise that as a gene implicated in neurodevelopmental disorders and expressed 
in the developing brain, HNF1B, is important in facial development and that FSD is able 
Page | 279  
 
to detect a significantly atypical or asymmetric face shape in people with mutations or 
deletions in this gene. 
8.3 METHODS 
8.3.1 RECRUITMENT, IMAGE CAPTURE AND FACE SHAPE ANALYSIS 
Subjects and their relatives were recruited during a support group event at the UCL 
Institute for Child Health as detailed below and in Chapter 2 (group 7).  Inclusion 
criteria were all subjects with a mutation or deletion of the HNF1B gene. Exclusion 
criteria were those people who could not be compared to reference subjects due to age 
(>52 years for men; >54 years for women) or ethnicity (only white Europeans 
included). 
This is the only study in the thesis that compared the group of interest to the group of 
reference subjects, instead of other people with epilepsy. It was not appropriate to 
compare this group to any of the subjects with epilepsy that were recruited during the 
course of this research because the presence of epilepsy may be a confounder for 
multiple reasons outlined in Chapter 1. Not all of the subjects here with HNF1B 
mutations or deletions had epilepsy. Face images of reference subjects were therefore 
used for comparison, and these subjects were recruited and landmarked by Peter 
Hammond and Mike Suttie as described in Chapter 2. I have shown that there is good 
inter-operator reproducibility in Chapter 3. The reference subjects had no known 
syndrome but did not undergo genotyping. DSMs were created as described in Chapter 
2. The DSMs included reflected face images used to calculate reflected FSD as well as 
FSD. 
8.3.2 GENETIC ANALYSIS 
One of three methods had been used to detect HNF1B gene abnormalities. Two of these 
methods were all applied by and analysed by a collaborating group at the University of 
Exeter comprising Dr Coralie Bingham, Dr Rhian Clissold and Prof Sian Ellard. Gene 
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sequencing was performed as previously described (Oram et al., 2010). In summary, 
nine exons and the minimal promoter were amplified using polymerase chain reaction, 
with tagging of sequence-specific primers, and then were sequenced in forward and 
reverse directions using the Big Dye Terminator Cycler Sequencing Kit (Applied 
Biosystems, Warrington, UK). Sequences were analysed using Mutation Surveyor 
Software (SoftGenetics, LLC, State College, PA) and checked against published 
polymorphisms and mutations.  
Multiplex ligation-dependent probe amplification (MLPA) dosage analysis was 
performed in subjects who had no mutations on gene sequencing, as described earlier 
(Edghill et al., 2008). In summary, nine exon-specific probes were used with the MEN1 
MLPA Kit (#P017; MRC Holland, The Netherlands) in a fluorescently labelled multiplex 
ligation/PCR reaction. The data were analysed using GeneScan and Genotyper version 
2 analysis software (Applied Biosystems, Warrington, UK).  
The laboratories were the North East Thames Regional Genetics Service and the 
Molecular Genetics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter. 
Oligonucleotide array comparative genomic hybridisation (aCGH) was performed in 
one case, using the Nimblegen 135K microarray (Roche Nimblegen) and analysed using 
CGH Fusion software (Infoquant, UK). This case was analysed at the clinical genetics 
laboratory in Great Ormond Street Hospital for Children NHS Trust. 
All testing was performed in accordance with manufacturers’ instructions. 
8.3.3 STATISTICAL ANALYSIS 
The Mann-Whitney U test was used to compare people with a defect of the HNF1B gene 
to the control population. Analysis was conducted using SPSS (versions 19-23, SPSS Inc; 
Chicago, IL, USA). 
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8.4 RESULTS 
8.4.1 SUBJECT POPULATION 
Eight probands with HNF1B gene abnormalities were recruited, along with two 
unaffected relatives (Table 39). One proband has already been investigated for facial 
changes and is part of earlier analyses (see Chapter 2) and is described in the literature 
(Kasperavičiūtė et al., 2011). Gene sequencing identified point mutations in four 
people, including one frameshift mutation due to loss of a single base, and MLPA or 
aCGH found deletions in the remaining four. Their images were compared in four DSMs 
each with 197 control images, comprising 98 male subjects and 99 female subjects 
(Table 40). 
 Subject Relation Age 
(yrs) 
Sex HNF1B 
genotype 
Method 
used 
Matched 
face shape 
difference 
Reflected 
face 
shape 
difference 
01 Proband Brother 
of 02 
11.3 Male HNF1B exon 9 
del 
MLPA 7.31 6.76 
02 Proband Brother 
of 01 
14.2 Male HNF1B exon 9 
del 
MLPA 10.09 10.28 
03 Proband - 21.4 Male c.511T>C, 
p.W171R 
(missense 
mutation) 
Sequencing 9.87 10.31 
04 Proband - 29.2 Male 17q12 del aCGH 12.11 9.44 
05 Proband - 35.5 Male c.826C>T, 
p.R276* 
(nonsense 
mutation) 
Sequencing 9.47 11.84 
06 Proband - 35.8 Female Met1_Trp557del MLPA 10.87 12.85 
07 Proband - 43.5 Male c.832delG, 
p.V278fsdelG 
(frameshift 
mutation) 
Sequencing 11.48 10.44 
08 Proband - 46.9 Female c.451T>C, 
p.S151P 
(missense 
mutation) 
Sequencing 14.23 21.81 
Table 39 Details for all subjects with HNF1B abnormalities, including age, sex, type of 
HNF1B gene defect and the results for face shape difference. 
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 Control subjects Subjects with HNF1B 
abnormalities 
Number 197 8 
Age in years (median, IQR) 28.6 (20.7) 32.4 (18.1) 
Sex   (male, %) 98 (50%) 6 (75%) 
Matched FSD  (median) 8.79 10.45 
Significance N/A p=0.007 
Reflected FSD  (median) 10.38 8.86 
Significance N/A p=0.007 
Table 40 Characteristics of the control group and the group of subjects with HNF1B gene 
abnormalities. Both FSD and reflected FSD were significantly increased in subjects with 
HNF1B abnormalities. 
8.4.2 FSD AND REFLECTED FSD IN PEOPLE WITH HNF1B GENE ABNORMALITIES 
The median FSD for the eight probands was significantly higher than in the 197 
controls (Figure 69 panel A; 10.45 vs 8.79; p=0.007). Three control subjects were 
outliers and excluding them did not affect the significance of the results. Reflected FSD 
was then calculated from the set of both original and reflected face surfaces. Median 
reflected FSD was also significantly higher in the eight probands than in controls 
(Figure 69 panel B; 10.38 vs 8.86; p=0.007). 
 
Figure 69 (A) Box plots of the median, interquartile range and range show FSD is 
significantly greater in people with HNF1B gene abnormalities compared to controls 
(median 10.45 vs 8.79; p=0.007). (B) Similar box plots for reflected FSD also show it is 
significantly greater in people with HNF1B gene abnormalities (median 10.38 vs 8.86; 
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p=0.007). Outliers over 1.5 or 3 times the interquartile range from the upper quartile are 
shown in circles or asterisks respectively. Excluding all outliers maintains significance. 
There was significant positive correlation between FSD and reflected FSD in reference 
subjects (n=197, ρ=0.65; p<0.001) but not in probands (n=8, ρ=0.43; p=0.29). In 
addition, there was no significant difference in FSD and reflected FSD between 
probands with gene deletions (n=4) and those with point mutations (n=4). 
8.4.3 VISUAL INSPECTION OF MEAN FACES 
The mean face surface of the eight probands was synthesised using the mean for every 
principal component, and compared with the mean face surface of the control subjects 
(Figure 71). This did not show any clear changes in the overall face surface shape of 
probands, but there was outward displacement of 1-2mm at the lower eyelid, the nasal 
tip, and the mandible. Note that this visual group comparison, unlike FSD and reflected 
FSD, does not standardise for age and sex differences between controls and probands. 
To investigate the nature of facial asymmetry, the mean face surface was compared to 
the mean reflected face surface, separately for controls and for probands. In the 
graphical comparisons, probands appear to show more asymmetry over the 
anterolateral surface of the mandible and the zygoma (Figure 71). 
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Figure 70 The mean face of all eight probands is shown using a white-grey-dark grey heat 
map, representing inward-null-outward displacement in millimetres along the surface 
normal, compared to the mean face of all control subjects. This was viewed on a computer 
monitor with red-green-blue replacing white-grey-dark grey to identify changes more 
easily. There is no marked difference seen in the mean face. However, there is a suggestion 
of increased displacement from the average at the palpebral fissures, the nasal tip and the 
mandible. Note this only looks at the mean faces in probands and may not represent 
individual face shape changes from control face images. 
 
Figure 71 The mean control face surface is shown on the left (A) and compared to its 
reflected face surface using grayscale heat maps. The equivalent comparison for the mean 
face surface of all eight probands and its reflection is shown on the right (B). The heat maps 
are shaded white-grey-black for inward-null-outward displacement along the surface 
normal respectively. In probands, there appears to be noticeable facial asymmetry over the 
anterolateral surfaces of the body of the mandible. No discernible asymmetry is seen in 
control faces. 
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8.5 DISCUSSION 
Dense surface modelling showed that in people with HNF1B deletions or mutations, 
there was a significantly more atypical face shape with increased asymmetry, when 
compared with matched controls. However there appeared to be no common facial 
features underlying this difference in shape and symmetry. 
Previous studies of HNF1B mutations found no common facial features or 
dysmorphism in those affected. Two previous studies provided detailed phenotypes in 
people with HNF1B deletions and found that fourteen people had no facial 
dysmorphism and one had prognathism (Edghill et al., 2008; Nagamani et al., 2010). 
One study of eighteen people with HNF1B deletions described facial phenotypes of nine 
people (Moreno-De-Luca et al., 2010). All nine had a 1.4Mb deletion of 17q12, which 
contained 15 genes, including HNF1B. Of these, seven were thought to have cranial 
shape abnormalities, which included a high forehead, scaphocephaly, and frontal 
bossing. Four had ear abnormalities, such as fleshy earlobes or prominent lobes. Eight 
had arched eyebrows, and six had upslanting or downslanting palpebral fissures – 
“mildly” or “slightly” in four of these cases. Nasal abnormalities included a depressed 
nasal bridge in seven cases and a tubular shape in four cases. The mouth was thought to 
be dysmorphic in four cases. The authors concluded that there were similar mild facial 
dysmorphic features in all nine cases. Such dysmorphism was not noted in the subjects 
here, and may reflect the involvement of other genes on facial shape, or the small 
sample size. 
Supporting the involvement of other genes, there was one subject, 04, in this study with 
a 17q12 deletion containing genes other than HNF1B. He had a 2.1Mb deletion with 16 
genes in the deletion interval, and his case, including dysmorphic features, has been 
reported previously (Kasperavičiūtė et al., 2011). It was hypothesised that 
haploinsufficiency of another 17q12 gene, ACACA, contributed to mild facial 
Page | 286  
 
dysmorphism. He was also noted to have overlapping facial features with the subjects 
in the above study by Moreno-De-Luca and colleagues, who also have a heterozygous 
deletion of the ACACA gene (Moreno-De-Luca et al., 2010). In the current study, FSD for 
subject 04 was higher than the median for the probands, although this was not true for 
reflected FSD. 
In Chapter 4, FSD detected a more atypical face shape in people with epilepsy and 
genomic changes, but did not find common features in those affected. In contrast, the 
method has identified common facial features in discrete syndromes or genetic 
disorders, including those with no obvious detectable dysmorphism (Cox-Brinkman et 
al., 2007; Hammond et al., 2005). Haploinsufficiency of HNF1B is one genetic disorder 
but in this small study, I found no similarity in facial shape amongst people with the 
condition. One hypothesis is that HNF1B may closely regulate the development of the 
face when expressed as a transcription factor in the embryo, such that in its absence 
there is greater variation in the resulting face shape, including increased asymmetry. 
There was no difference in facial shape and symmetry between the four probands with 
a deletion compared to the four with point mutations. This agrees with studies that 
have found similar clinical phenotypes in people with deletions and mutations (Edghill 
et al., 2008). 
Increased facial asymmetry in the probands may be relevant to the known association 
of HNF1B with autism spectrum disorders. Children with autism spectrum disorders 
were earlier found to have increased facial asymmetry using dense surface modelling 
and this was partly due to right periorbital prominence (Hammond et al., 2008). These 
children were not genotyped and some may have had HNF1B mutations or deletions; in 
this study, subjects were not formally evaluated for features of autism spectrum 
disorder.  
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A limitation of the findings is that this was a small study because of difficulty in 
recruitment of affected subjects. Two patients were also brothers and thus shared facial 
features in them could have influenced the mean face surface of all subjects with 
HNF1B gene abnormalities. Dense surface modelling in a larger group of affected 
individuals may help to show common features and also any differences between those 
with mutations and those with deletions. The reference control population used was 
not genotyped and was also recruited separately by different operators and sometimes 
a different camera. These may all have introduced errors in calculating FSD as explored 
in my earlier reproducibility studies. 
8.6 CONCLUSION 
In conclusion, the findings here support a role of HNF1B in regulation of facial 
morphogenesis. Whilst it would seem that there are no shared facial features amongst 
people with deleterious changes in HNF1B, the sample size is small, and further cases 
will need to be evaluated for definitive conclusions. 
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CHAPTER 9: DISCUSSION 
To my knowledge, this is the first time that stereophotogrammetry and dense surface 
modelling have been used to study people with epilepsy. In addition, it is the first study 
to use a single metric, Face Shape Difference (FSD), to characterise if a face shape is 
atypical. 
9.1 STEREOPHOTOGRAMMETRY 
I have shown here that stereophotogrammetry can be successfully applied to a 
population of people with epilepsy. In total, 869 people were recruited for my study 
over two years. Subjects included adults and children. People with severe intellectual 
disability were recruited as were subjects who were wheelchair-bound. The portability 
of the camera allowed recruitment at different sites, including hospitals in Europe and 
a support group event in London. Resources required are minimal. The camera has 
been used in a space of approximately six square metres and required a tripod, chair, 
table and a power source. 
The Canfield Vectra CR10 camera system used here is a commercial 
stereophotogrammetry system devised for clinical use, which is comparable to other 
such camera systems (Tzou et al., 2014). This camera has been previously used in 
studies of face and breast shape (Cox-Brinkman et al., 2007; de Menezes et al., 2010; 
Ghoddousi et al., 2007; P. Hammond et al., 2008; Metzler et al., 2014; Othman et al., 
2013; Quan et al., 2011; Roostaeian and Adams, 2014; Rosati et al., 2014, 2012, 2010; 
Rossetti et al., 2013). Two reproducibility studies looked at error in distances and 
angles between facial landmarks (de Menezes et al., 2010; Ghoddousi et al., 2007). 
In this thesis, my camera was used in a different environment, such as different lighting 
conditions. It was used in a different population of subjects, including those with 
intellectual disability and children. There are differences in image capture due to 
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seating position, instructions given to subjects and how images were judged to be 
acceptable. There are then also differences in landmarks used. In addition, the actual 
camera is a complex machine that may have had technical faults. For all of these 
reasons, I initially conducted reproducibility studies. 
9.2 REPRODUCIBILITY STUDIES 
Inter-operator and intra-operator reproducibility error was assessed for landmark 
positioning by using calculated distances between landmarks, with the results being 
comparable to previous studies. Individual landmarks varied in terms of 
reproducibility error and the least reproducible landmarks were similar to those found 
previously too. As far as I am aware, for the first time in stereophotogrammetry studies 
of the human face, I then also assessed the reproducibility error due to head 
positioning relative to the camera and camera calibration, a step that is needed in every 
imaging session to assemble a 3D image. Calibration did not affect reproducibility. 
However, I showed that head position, especially lateral rotation of the neck (i.e. 
turning to look left or look right) beyond 5 degrees from the midline may adversely 
affect image capture. This was controlled for by asking subjects to fixate on an object 
vertically above the centre of the camera and checking images for fixation. Such visual 
inspection alone appeared to be adequate in terms of reproducibility of landmarks and 
FSD. However, it is a finding for other stereophotogrammetry studies to note. 
Face expression was also assessed for four expressions: mouth open, lip puckering, 
smiling and neutral expression. Other studies have only looked at reproducibility of 
landmarks in subjects with these expressions. I sought to see how much these 
expressions affected landmark positions and FSD. It was shown that FSD is sensitive to 
facial expressions, even those which may not appear to affect FSD. For example, the 
periorbital region FSD is significantly increased by subjects smiling, even though 
landmarks around the eyes do not seem to change significantly. 
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Therefore, there are three aspects to consider in future studies: landmarking, head 
positioning and face expression. Landmarking is the predominant subjective step in the 
whole process of stereophotogrammetry and dense surface modelling. When the same 
images are landmarked a second time and included in a different DSM, correlation of 
FSD between the original and repeat images is imperfect: ρ=0.90-0.94. For face surfaces 
to be used in databases for comparison, landmarking and subsequent FSD need to show 
as little variation as possible. Within the same DSM, repeat landmarking did not alter 
FSD greatly: the median difference in one DSM was 0.1 units, which was 0.4% of the 
range of FSD values seen in the DSM. Nevertheless, landmark reproducibility is likely to 
suffer with different operators and more than one operator is necessary for practical 
use of this technique in clinical settings.  
Recently, algorithms have been developed to automate landmark placement based on 
changes in contour between surface points and the authors were able to use the 
algorithms for placement of 20 of the 22 landmarks used in my study (Katina et al., 
2016). These 20 landmarks only omitted palpebrale superius and palpebrale inferius, 
and included the least reproducible landmarks: alari nasi, cheilion, gnathion, nasion 
and otobasion inferius. They found that automated placement showed the greatest 
benefit for the landmarks that were least reproducible for observers to place. They also 
note that their definitions for landmarks may differ from traditional definitions, as do 
some of my definitions (listed in Chapter 2). This does not matter for dense surface 
modelling providing there is consistency in landmarking. Landmarks themselves are 
not compared, unlike in traditional direct or indirect anthropometry.  
Another option may be to avoid landmarking altogether and this is discussed in 
Chapter 3. The purpose of landmarking in dense surface modelling is to allow face 
surfaces to be registered to a base mesh, which then allows a dense correspondence of 
points to be created. In brain imaging, registration of brain shape may be carried out 
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using automated volume-based image registration, in which Procrustes analysis is 
employed to units of brain volume (termed ‘voxels’). In orthodontics, voxels have been 
used with CT scan data of the facial skeleton. Indeed, voxel-based registration was at 
least equivalent to surface landmark-based registration in one study (Almukhtar et al., 
2014). A caveat here is that only three surface landmarks were used to align surfaces. 
Aside from this study using CT imaging and voxels, no study to my knowledge has 
attempted to register face surfaces without the use of any landmarks. Theoretically, 
polygon-based surface registration may be possible in future though.   
For head position, I attempted to see if image analysis was able to determine if a 
subject’s head position was optimal (in Chapter 4). This was done by calculating axes 
across a person’s face. Unfortunately, my technique to determine the angle of rotation 
of the head in each axis only worked for one subject after analysis of multiple previous 
images of the same subject at different angles, in which the subject used a chin rest for 
accuracy. It is difficult to use more elaborate mounts used to keep the head in one 
position, such as those used for slit lamp examination, visual perimetry or optical 
coherence tomography, because they interfere with the image capture of the face 
surface. Using a chin rest may be the best method to help maintain head position but 
needs to be used carefully to ensure the rest is outside of the area of coverage of the 
whole face DSM. 
Facial expressions are also difficult to correct for in stereophotogrammetry studies. 
Few studies mention facial expression and how it was assessed. This includes 
stereophotogrammetry studies in children or subjects with autism (Aldridge et al., 
2005; Hammond et al., 2008; Hammond et al., 2005; Heike et al., 2009), although one 
study recommends that, in future studies, children should have their mouth closed for 
image capture (Heike et al., 2009). In my own study, I asked participants to keep their 
lips closed, not to smile and to look ahead at the fixation target. The field of forensic 
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science has explored the effect of face expressions on face recognition using 2D photos 
and a review paper in 2010 mentioned possible strategies to counter different facial 
expressions for 3D face images but also noted that objective methods are “urgently 
required” (Smeets et al., 2010). The group advocates the creation of a database or 
gallery of different facial expressions or suggests that only parts of the face that do not 
vary with face expression are used. The latter approach is possible with dense surface 
modelling by using regional DSMs of the periorbital, perinasal or perioral regions, as 
shown in my study. 
9.3 DENSE SURFACE MODELLING AND FSD 
Dense surface modelling has been used in the analysis of face images since 2004 
(Hammond et al., 2004). It has been applied in the study of 11 genetic disorders, using 
adults and children in predominantly white European populations (Bhuiyan et al., 
2006; Cox-Brinkman et al., 2007; de Souza et al., 2013; Hammond et al., 2012a, 2012b, 
2005, 2004; Heulens et al., 2013; Tobin et al., 2008). The technique has also been used 
in autism spectrum disorders and fetal alcohol syndrome (Hammond et al., 2008; Suttie 
et al., 2013). 
The technique involves registration of landmarked face images, which is divided into 
three steps within one software program, DSMExplorer. The steps are of Procrustes 
analysis, thin-plate spline deformation and dense correspondence creation. After this, 
the final step in previous analyses was principal component analysis. Principal 
component analysis describes a particular set of images using principal component 
vectors that successively explain as much of the remaining variation in face shape as 
possible. The principal components are specific to that set of images, or DSM. 
The step of principal component analysis itself is needed to reduce the dataset to a 
manageable size and in the calculation of FSD. However, this step captures only 99% of 
the total face shape variation explained by the principal components. By definition, 
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there is loss of 1% of information on face shape and this is by design. The creator of the 
DSMExplorer program shows that for a typical DSM, increasing the accuracy of 
principal component analysis to 99.9% requires approximately trebling the number of 
PCs and reduces the average error of a point co-ordinate by 10%. In one example, using 
a DSM containing 193 face images, 146 PCs were required to obtain 99.9% of the 
variation between face shapes with a root mean square error of 0.90mm for point co-
ordinates, but only 56 PCs to obtain 99% of the variation with a root mean square error 
of 1.03mm (Hutton, 2004). Thus, Hutton concluded that using sufficient PCs to explain 
98-99% of the variation was satisfactory. The current error is less than in studies by 
other groups using principal component analysis to describe face shape, in which 13-
25% of information is lost in the principal component analysis step (Hennessy et al., 
2010, 2007, 2002; Prasad et al., 2015). 
Another drawback of principal component analysis is that it is specific to a dataset. 
Although in all DSMs here, the first PC describes face size, for example, the exact 
dimension of the vector is likely to be slightly different. This means that FSD, which is 
calculated from the underlying PCs, cannot be directly compared between different 
DSMs. A consequence of this is that all face images to be compared must be processed 
together using the DSMExplorer software to create a DSM that contains the images. 
This is partly why different DSMs of the whole face had to be created for the different 
chapters of this thesis. Creation of a DSM therefore limits the ease of analysis. For 
example, to analyse a new face image of a person with a HNF1B mutation, a new DSM 
must be created using the new subject and all of the existing people with HNF1B 
mutations or deletions, as well as all controls. Future software versions could consider 
allowing a new face image to be added to an existing DSM. The problem of comparing 
different DSMs still exists however. Other alternatives to principal component analysis, 
such as linear discriminant analysis and independent component analysis, are also 
specific to a dataset. Furthermore, linear discriminant analysis, which has been used in 
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DSMs before (Hammond et al., 2005), requires a priori classification into two categories 
of images in a dataset. 
FSD is a novel metric used here for the first time. Unlike previous studies using DSMs 
and PCs, I was not looking at people with one syndrome or one condition. In the case of 
a single clinical syndrome, a number of methods have been used to assess face shape 
from visual inspection to identifying particular PCs that are different in controls and 
affected subjects, to linear discriminant analysis or other shape classification methods 
(Cox-Brinkman et al., 2007; Hammond et al., 2012a, 2012b, 2005). I was analysing the 
extent to which SVs could alter face shape from the expected average face shape, but I 
acknowledged that different SVs may exert different effects on face shape. FSD 
quantified the extent of the difference from the average matched face. To do this, it 
compared the difference in every PC between a chosen face surface and the matched 
average face surface. 
9.4 REFERENCE SUBJECTS 
The average face shape was chosen as the mean of thirty faces from a reference set of 
faces of the same sex, of the closest age to the face being analysed. On visual inspection, 
the average face of thirty reference faces appeared to be smooth and no individual 
subject’s face appeared to unduly influence the average face shape. Using fewer faces, 
such as ten, could mean that one distinctive reference face could distort the average 
face. On the other hand, using more faces would require a larger sample of reference 
faces. I acknowledge that the variable of the number of faces could be further explored 
to see if more faces can increase the accuracy of FSD. 
As it was, my study was limited by age and ethnicity of the reference subjects. 
Reference subjects were all white Europeans. The age ranges for the mean faces were 
2-52 years for male subjects and 2.5-54 years for female subjects. These restrictions 
meant the exclusion of approximately 20-25% of all recruited subjects for whom FSD 
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was calculated, which was for the studies in chapters 4, 5 and 6. Increasing the 
reference sample in terms of age and ethnicity is important for larger studies using 
FSD. Ethnicity itself was restricted to white Europeans for this work. The historical 
term ‘Caucasian’ was not used as it is too broad, for example including people in the 
Middle East, and it is too vague. Ethnic variations in face shape has been studied using 
stereophotogrammetry by one group who thought there were detectable differences 
between “native” dental students in Wales, Slovakia and Hungary (Kau et al., 2010). 
Another group found differences between a British and a Dutch population (Hopman et 
al., 2014). Therefore, it may be that ethnicity should be further refined into, for 
example, white British people to limit differences due to ethnic origin. Another 
limitation of the reference subjects is that very little information was known about 
them. Their age, sex and ethnicity was known but there was no information about 
previous facial injury or surgery or BMI. None had been genotyped either and it was 
assumed that the reference subjects had no SVs. As mentioned before, using 30 
reference subjects limits the effect that one person has on the mean face shape, but a 
better method in future would also be to gather more data on reference subjects. 
9.5 DENSE SURFACE MODELLING AND THE RELATIONSHIP TO BMI AND AGEING 
Face shape is strongly related to BMI and weight with over 60% of variance in BMI or 
weight predicted by the first three PCs of one DSM (see Chapter 6). The PCs appear to 
have a linear relationship with BMI and this allows one to attempt to correct for BMI. I 
have shown that such correction is possible in DSMs. 
Similar to facial expression, BMI is not mentioned in many stereophotogrammetry 
studies, especially those in genetic or developmental disorders. When it is considered, 
approaches have included scaling all face images to the same vertical size to assess 
shape only (Suttie et al., 2013). However, increasing BMI leads to increased lateral 
facial size, which is not accounted for using vertical scaling.  Other studies mention 
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weight but suggest it is not relevant to the shape changes seen (Hennessy et al., 2010; 
Prasad et al., 2015). Other studies do not mention weight at all (Claes et al., 2014; 
Hammond et al., 2005; Kau et al., 2010; Paternoster et al., 2012). However, studies 
using DSMs should recognise that BMI can affect face shape significantly in terms of 
PCs, and data on height and weight should be collected for all participants. Another 
possible application of stereophotogrammetry and dense surface modelling is in the 
detection of certain craniofacial fat deposition patterns, as these patterns are thought 
to be a risk factor for obstructive sleep apnoea (Banabilh et al., 2009). 
I have only performed one longitudinal study of subjects, in which the change in FSD 
over time was noted. The purpose was to study the effect of ageing, but given that the 
maximum time interval between images was less than three years, the study could only 
provide limited information to answer this question. However, the benefit of this 
longitudinal study was that it helps to confirm that FSD is a robust measure even as 
subjects grow older and their face images are compared to different age-matched 
reference face images to calculate FSD. An additional factor that was found to affect FSD 
in eight subjects was change in hair length or hairstyle between images, especially with 
inadvertent coverage of the forehead. Hair bands were used to avoid this. 
9.6 FSD AND GENETIC DISORDERS INCLUDING SVS AND HNF1B MUTATIONS OR 
DELETIONS 
In Chapter 8, I have shown that my protocol for image capture with this specific camera 
is suitable for analysing a specific genetic disorder, in this case disease due to HNF1B 
haploinsufficiency. I found that in a small group of eight affected subjects, there was an 
increase in FSD and also facial asymmetry. This study shows that FSD is useful in 
analysis of face shape in one disorder. If a disorder alters face shape from the average 
face, then it would be expected to increase FSD for affected patients. No common facial 
features were found though. It could be that FSD is sensitive to changes in face shape of 
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any kind, but that the identification of particular facial characteristics in a condition 
requires larger numbers of patients. Similar studies of FSD would be helpful in 
recurrent pathogenic SVs seen in epilepsy. For example, 15q13.3 microdeletions have 
been described to be associated with changes in the nasal tip or head size in a minority 
of patients (Lowther et al., 2015; van Bon et al., 2009). I was able to recruit five people 
with one recurrent SV (16p13.11 microdeletion) and no change in face shape was 
found, but this was a very small sample. 
In Chapter 4, I showed that FSD is able to differentiate between faces of people with 
epilepsy and a pathogenic SV and those of people with epilepsy without a pathogenic 
SV. This was a two-step study in which a training set was used to calculate an optimum 
FSD threshold value in one DSM. In a second DSM, the training set was used to adjust 
the previous FSD value to an FSD threshold value for the second DSM. This FSD 
threshold was then tested on a new validation set. I obtained 66-80% sensitivity and 
65-78% specificity using FSD of the whole face in detection of people with pathogenic 
SVs within a group with epilepsy. 
FSD is therefore promising as a measurement of atypical face shape that may reflect 
underlying pathogenic copy number variation. However, there are a number of hurdles 
to overcome. My findings were in 181 subjects of whom 43 had pathogenic SVs. The 
study needs to be replicated in a larger sample. As mentioned above, recent research 
has suggested that ethnic differences within Europe can affect face shape, and some of 
my subjects were recruited at European sites or were recruited in the UK but had 
European ancestry. I explored the effect on FSD of potential face shape difference 
between people from the UK and people from other European centres in a sensitivity 
analysis, excluding people recruited from mainland Europe. I found that the changes in 
FSD remained significant. Also, the reference subjects were recruited both in the UK 
and mainland Europe, helping to minimise any differences due to different ethnic 
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origins within Europe. Not all subjects underwent BMI measurements and this may 
have affected results too. For 98 subjects who had BMI measurements, adjusting whole 
face FSD for BMI made it more sensitive and specific (78% and 75%, respectively). Of 
course, some SVs may affect BMI directly so correction for BMI may not be appropriate 
in SVs of unknown function. It was also seen that intellectual disability was more 
prevalent in people with pathogenic SVs, and intellectual disability was also associated 
with an altered face expression. Both intellectual disability and altered face expression 
were also excluded in a sensitivity analysis, and these are both likely to be potential 
confounders for future stereophotogrammetry studies of novel SVs too. All of these 
limitations need to be addressed by having a larger, more representative reference 
subject group and by more careful image acquisition and phenotyping. For example, it 
is possible with care to obtain adequate images in people with intellectual disability 
and children through distraction and repeated imaging, as has been used in my method 
and in others’ guidelines (Heike et al., 2010). 
After replication in a larger group of subjects with epilepsy, if FSD is successful, the 
next step would be to test it in subjects without epilepsy. It may be particularly useful 
in people with unexplained intellectual disability or other neurodevelopmental 
disorders for example. FSD would not replace genetic testing though. A finding of 
increased FSD could be an additional clinical reason to perform genetic testing in some 
individuals. Traditional clinical assessment of face shape is performed mainly by 
dysmorphologists (subspecialists within the field of clinical genetics), and I have shown 
that, even now, these specialists use only ‘subjective’ definitions for 62% of all terms 
describing the face and body (Section 1.1.4). There are only approximately 3 clinical 
geneticists per million population in the UK and 7% of clinical geneticists specialise in 
adults (Cooksey et al., 2006). Outside of clinical genetics, there is a lack of knowledge 
and a lack of confidence among other physicians, including neurologists (Burke et al., 
2006; Mainous et al., 2013; Salm et al., 2014). Therefore, FSD may be able to assist 
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many clinicians in detection of atypical face shape. FSD itself does not appear to detect 
‘dysmorphic’ features alone. In this group of subjects with pathogenic SVs, some had 
high FSD values but were not thought to be dysmorphic by their treating clinician. An 
exploratory study in which four neurology research fellows, who all conduct general 
neurology consultations in the UK, were asked to assess for dysmorphism also found 
that FSD of the whole face was more sensitive than three of the four neurologists in 
detecting pathogenic SVs. It would be useful to compare this with a trained 
dysmorphologist as well. 
Another use of FSD is to further characterise the phenotype of known genetic 
disorders. An increase in FSD in a person could prompt more detailed face analysis, for 
example using heat maps to look objectively at different regions in the face (as shown 
in Chapter 8). Dense surface modelling and heat maps have already shown previously 
unrecognised facial features in mild Wolf-Hirschhorn syndrome and Bardet-Biedl 
syndrome (Hammond et al., 2012a; Tobin et al., 2008). This allows for better 
understanding of the genes affected in SVs or mutations. A genome-wide association 
study has shown that one gene, PAX3, expressed in the neural crest affects the shape of 
the nose (Paternoster et al., 2012). This was based on a landmark-based study of face 
shape. FSD lends itself well to similar genome-wide association studies to look for novel 
candidate genes involved in facial development. It has a clear advantage in being able to 
describe shape change in the whole face not just those parts that are able to be 
landmarked (Hammond and Suttie, 2012). This type of study would probably require 
recruitment of many thousands of subjects though, given that 4700 subjects were 
included in the earlier genome-wide association study. 
In Chapter 5, I looked for any relationship of FSD to neurodevelopmental genes, and it 
appeared that FSD of the whole face was positively correlated with the number of 
genes highly expressed in the human embryonic forebrain. This was a crude approach 
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using a human transcriptome atlas. The finding can be explained from current 
knowledge of face and brain development, but would first need to be confirmed in 
another group as well. It rests on a number of assumptions, such as the level of gene 
expression in the forebrain being high for genes affecting facial development or that 
these genes all exert an equal effect on face shape at the embryonic stage. Therefore, 
further studies are needed, perhaps taking into account the growing knowledge of gene 
function, gene interactions and gene pathways. 
An important practical limitation for clinical use of stereophotogrammetry in genetic 
disorders is the cost of the stereophotogrammetry system. The successor to the 
Canfield Vectra CR10 camera system, the three-camera pod Canfield M3 system, retails 
for $13000 to $27000 (in US dollars) depending on used or new systems. The clinical 
utility of the camera depends on its absolute cost, and also the cost relative to 
alternative diagnostic methods. Detection of SVs may be performed using whole 
genome sequencing or aCGH instead, for which the costs have been rapidly falling. The 
benefit of a stereophotogrammetry system may be to suggest those patients who would 
benefit from genetic testing. In addition, it has other clinical applications not studied 
here, such as for recording facial injuries or changes to the face due to anti-epileptic 
drug use. 
9.7 REFLECTED FSD AND CORTICAL MALFORMATIONS INCLUDING HIPPOCAMPAL 
SCLEROSIS 
Reflected FSD is a metric quantifying facial asymmetry that has been used in one 
previous study of face symmetry in autism spectrum disorders and found to be higher 
in boys with autism spectrum disorder and their mothers (Hammond et al., 2008). I 
found that, in people with epilepsy, reflected FSD was higher for people with 
hippocampal sclerosis and certain types of mixed malformations of cortical 
development. Therefore, reflected FSD appears to be able to detect abnormal 
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development of the central nervous system, as judged by the presence of 
malformations of cortical development or the presence of autism. This is in contrast to 
people with epilepsy and pathogenic SVs, for which there was no increase in reflected 
FSD. Hence, reflected FSD offers an adjunct to the measurement of FSD alone in 
detecting neurodevelopmental abnormalities. Reflected FSD has the added advantage 
of needing no reference group of people: each face surface image is compared to its 
own reflection in the vertical midline. This makes the measurement more robust with 
none of the limitations for FSD in terms of age or ethnicity of subjects. A set of reference 
subjects would still be helpful to understand more about facial asymmetry. For 
example, it is not clear if asymmetry is increased in people with more severe epilepsy 
due to trauma, and this could be a confounder if people with malformations of cortical 
development were more likely to have epilepsy of greater duration or greater severity 
than other people with epilepsy. 
It does not appear that facial asymmetry is directly caused by mechanical effects of 
underlying brain lesions, given that lesions as small as hippocampal sclerosis, were also 
associated with significant facial asymmetry. Reflected FSD was highest in those with 
bilateral lesions, suggesting that face asymmetry may be a marker of the severity of 
underlying brain pathology in some people with epilepsy, rather than a marker of 
corresponding asymmetric brain pathology. This would fit with current theories of face 
symmetry as a phenotype for underlying ‘developmental instability’ in a person, in 
which greater sensitivity and exposure to genetic mutations, toxins, trauma or 
infections, may lead to greater facial asymmetry (Dongen, 2006). Related to this, it was 
found that left-handed people had greater facial asymmetry than right-handed people, 
and left-handedness has previously been associated with neurodevelopmental 
disorders (Lindell and Hudry, 2013). 
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Facial symmetry has been little studied in comparison to face shape, but with 
stereophotogrammetry and dense surface modelling, it is possible to investigate facial 
asymmetry at the same time as face image capture for atypical facial shape. Unlike for 
FSD and the presence of SVs, I was unable to replicate the results in a second validation 
set and this would be important to determine a threshold for reflected FSD which may 
predict the presence of a malformation of cortical development. A larger study set 
would also help explore the relationship of facial asymmetry with rarer malformations 
of cortical development, such as dysembryoplastic neuroepithelial tumours, which 
were not assessed individually here due to the small numbers of subjects. 
9.8 LIMITATIONS OF THE PRESENT STUDY 
9.8.1 RECRUITMENT OF REFERENCE SUBJECTS 
As noted above (Section 9.4), my reference group limited analysis of FSD to white 
European people only up to an age of 52-54 years. For FSD to be used more widely, 
many more subjects need to be recruited into the reference group. This allows two 
benefits. Firstly, it means a greater number of faces may be ‘averaged’ limiting the 
contribution of any one face. Secondly, it allows finer comparisons. For example, it may 
be best to compare a 34-year-old man’s face with an average of 30 faces of other 34-
year-old men rather than 30 faces of those between 32 and 36 years. Also as noted, 
there are fine ethnic variations in face shape even in a category such as white 
Europeans (Kau et al., 2010). A larger reference group could match people to those of 
similar ethnic origins more accurately. No analysis at all was possible for people of 
Asian or African origin. 
9.8.2 RECRUITMENT OF PEOPLE WITH EPILEPSY 
A limitation in some of the individual studies here was the small sample size. The 
recruitment of a larger number of people is needed to explore all of my preliminary 
findings more fully. There are a number of factors to consider here. To recruit more 
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participants, more cameras are needed or the same camera will need to be used more 
times. Although the camera is portable, transporting it requires a specialised container 
over 1.5m long as well as transport of the calibration plate, personal computer and 
tripod separately. The camera also requires the use of an area of six square metres with 
privacy for subjects and needs re-calibration after set-up in the new location. 
Portability was thus limited and the majority of participants were recruited at one 
location only (the Chalfont Centre for Epilepsy). This may have led to a bias in 
recruitment of those people who were attending clinic there or were admitted there. 
People in other parts of the country, people with well-controlled epilepsy not needing 
tertiary referral, or people with severe epilepsy who could not attend clinic, may all be 
under-represented. 
I sought to recruit people who had been genotyped and especially those with SVs in one 
of the studies. Some genotyped subjects were found to have SVs as part of a previous 
study using SNP arrays (Heinzen et al., 2010). However, others were selected to have 
clinical array CGH, presumably due to clinical suspicion of the presence of an SV, which 
may have been due to facial dysmorphism. Therefore, I cannot generalise my findings 
of a more atypical face shape to all those people with epilepsy and SVs from the current 
study. 
I have noted that full data did not exist for all participants, which was partly the reason 
for the number of subgroups in the studies above. Having data on neuropsychometry 
findings, imaging findings, genotyping, BMI and epilepsy or trauma history for every 
subject would be helpful. For example, body mass index was shown to affect face shape 
in a predictable manner and thus needs to be considered in any future study of face 
stereophotogrammetry. It also allows more powerful analysis: For example, it may be 
that only those subjects with intellectual disability show increased face asymmetry 
with a developmental brain lesion. However, I could not assess if this was the case as 
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not everyone who had undergone stereophotogrammetry and MRI scanning had had 
neuropsychological results. 
9.8.3 STEREOPHOTOGRAMMETRY 
Currently there are no formal guidelines on stereophotogrammetry for face shape 
analysis. However, I have shown that facial expression, face orientation and previous 
facial trauma may all affect findings. These may all have introduced errors in face shape 
analysis, especially angle of face orientation which could not be measured 
retrospectively. For subjects with altered face expression or those with facial trauma – 
both of which may be associated with severe epilepsy or intellectual disability – the 
only option was to exclude them in sensitivity analyses or include them as they were. It 
would be better if there was a method to ignore only the affected area of trauma. 
Hair needs to be excluded specifically from studies too. Use of a hairband can help 
avoid this. Facial hair may also obscure or alter the face shape outline and the effect of 
this needs to be considered. Again, it would be helpful to be able to remove the affected 
area alone from analysis. 
One other aspect is the part of the face included. In my study, the ears and the 
underside of the chin were not included. However, these are likely to provide useful 
information on face shape. Ear size and shape is useful in clinical dysmorphology and 
indeed there are more dysmorphological terms to describe the ear than any other part 
of the face (Table 1). Using a camera system that reliably captures the ears as well may 
increase the accuracy of the findings. 
9.8.4 LANDMARKING 
Landmarking is the major operator-dependent step between image capture and dense 
surface modelling. I have shown that there is a measurable intra-operator and inter-
operator reproducibility error in landmark placement. This also appears to correlate 
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with experience of landmark placement and is complicated by the imprecise definition 
of many landmarks, which were inherited from direct anthropometry studies. I 
specifically assessed the effect of landmarking a second image of a control subject on 
FSD and found that landmarking could introduce an intra-operator error of 1-1.5% of 
FSD (Table 13). This error may be greater between operators and needs to be 
considered in future studies. 
9.8.5 DENSE SURFACE MODELLING AND FSD 
I have noted that as part of the reduction in the volume of data, principal component 
analysis leads to loss of 1% of information about face shape. Given that principal 
component analysis seeks to explain as much variance as possible with limited PCs, it 
may be that the discarded 1% of information includes the most unique aspect of a 
subject’s face. Again, this would blunt the accuracy of my technique and should be 
assessed using different thresholds, such as 98% or 99.9% of variance, to see if the 
findings are still valid. 
9.9 CONCLUSIONS 
The aims of my study were to show that stereophotogrammetry and dense surface 
modelling are reproducible and accurate techniques for face shape analysis as well as 
to show that structural variants and developmental brain lesions that are associated 
with epilepsy may affect face shape. Specifically, I expected to see changes in two new 
metrics of face shape, FSD (for atypical face shape) and reflected FSD (for face shape 
asymmetry). The findings may be summarised as: 
1. Stereophotogrammetry and landmark placement using the Canfield Vectra 
CR10 camera is highly reproducible. Landmark placements and FSD are not 
affected by camera calibration but are affected by head position and face 
expression (Chapter 3). 
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2. In people with epilepsy, face shape, as measured by FSD, may be used to 
differentiate between those with pathogenic structural variants and those 
without such variants. Face shape may comprise the whole face or only a 
certain part of the face. Facial injury, facial expression, body mass index and 
anti-epileptic drug history do not appear to explain this difference (Chapter 4). 
3. There may be a positive correlation between the number of genes, within a 
structural variant, which are highly expressed in the embryonic forebrain, and 
atypical face shape, as measured by FSD. FSD may also be able to detect people 
with epilepsy who have a deletion greater than 500 kilobases of DNA (Chapter 
5). 
4. Face shape varies in a predictable manner with changes in weight and body 
mass index. The effect of body mass index can be minimised in analyses using 
face shape. The method of face shape analysis used here is robust to changes in 
age in adults of up to 2.5 years (Chapter 6). 
5. Facial asymmetry appears to be greater in people with epilepsy and a 
developmental brain lesion than those without a lesion; this includes just those 
people with hippocampal sclerosis. Bilateral lesions and facial injuries may 
increase facial asymmetry further (Chapter 7). 
6. The method of analysis used here is also successful in investigating the effect on 
face shape and symmetry of a single genetic disorder (Chapter 8). 
This thesis demonstrates a novel use for the techniques of stereophotogrammetry and 
dense surface modelling, in detecting atypical face shape by means of the metric ‘FSD’. 
Factors affecting the reproducibility of FSD are assessed, including individual steps in 
the process of deriving FSD (such as camera calibration, image acquisition and image 
landmarking) as well as external factors, such as head positioning, facial expression and 
body mass index. I demonstrate methods to try and limit the effect of these potentially 
confounding variables. I then show that FSD appears to be able to detect face shape 
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change in a group of people with epilepsy and pathogenic structural variants, including 
an assessment of its accuracy as a diagnostic test. I also further study a metric of facial 
asymmetry, reflected FSD, that has been used before and show that it may be able to 
detect increased facial asymmetry in people with epilepsy and malformations of 
cortical development. Finally, I apply my techniques, including FSD and reflected FSD, 
to a group of people with a single genetic disorder and show that they appear to detect 
face shape changes that have not been previously described. 
Stereophotogrammetry, dense surface modelling, FSD and reflected FSD appear to be 
promising tools in investigating children and adults with epilepsy and may also be 
useful in other populations which are associated with genetic disorders, including 
structural variants, or neurodevelopmental disorders. The techniques are more 
objective than previous methods of face shape measurement and show high 
reproducibility. 
9.10 FUTURE DIRECTIONS 
9.10.1 STEREOPHOTOGRAMMETRY 
Stereophotogrammetry cameras continue to evolve incrementally, but the basic 
premise remains the same. An example is a new 3dMD camera system that allows for a 
series of 3D face images to be acquired at a rate of 60 images per second. This is to 
allow the operator to choose the most appropriate image for further analysis. From my 
study, it is important to choose an image with a neutral expression and natural head 
position with the eyes open and mouth closed. As noted, children and people with 
intellectual disability may be less able to do this for a single image and thus being able 
to acquire images rapidly is helpful. Another manufacturer, Canfield, has developed a 
handheld 3D camera system which has now been validated for face imaging (Camison 
et al., 2017). Greater portability allows for easier recruitment of subjects. Cost remains 
a major barrier for most of these professional imaging systems. One team has 
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experimented with using much cheaper smartphones for 3D image capture, though 
there was decreased accuracy and the need for marking of the subject’s face (Barbero-
Garcia et al., 2017). 
Landmarking is the only operator-dependent step after image acquisition and requires 
clinicians or researchers to be trained in identification of face landmarks and even with 
training, inter-operator reproducibility is worse than intra-operator reproducibility in 
my study and others (Gwilliam et al., 2006; Plooij et al., 2009; Schaaf et al., 2010). 
Therefore, avoiding this step or making it objective would be helpful in reducing error 
in any face shape analysis. There are now techniques being developed for such 
automated landmark placement, which may even work on incomplete face surfaces 
(Katina et al., 2016; Sukno et al., 2015). 
9.10.2 DENSE SURFACE MODELLING AND FSD 
Dense surface modelling remains the most sophisticated method of analysing face 
shape but improvements are possible for future studies. One current limitation is the 
need to create a separate DSM for each analysis. Separate models were used to analyse 
each region of the face: the whole face, the periorbital region, the perinasal region and 
the perioral region. Another separate model was used to analyse asymmetry, which had 
involved the creation of 3D mirror images of each subject’s face image. The creation of 
dynamic models in which a new face image may be added to a DSM database of existing 
face images, without recalculating the principal components for every face image again, 
would significantly speed up analysis and would be necessary for routine clinical use. 
This would entail new software programming as principal component analysis may 
need to be replaced by an alternative method, such as factor analysis, with adjustment 
of the metric then used for face shape.  
After principal component calculation, I used a metric which calculates the difference 
between an ‘average’ matched face and the subject’s face across all principal 
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components. Each principal component is equally weighted in this calculation. 
However we know that later principal components will explain a smaller amount of 
variation. It could be argued that the differences in principal components should also 
be weighted. On the other hand, later principal components may be the ones that are 
best at identifying dysmorphism and simply occur later because they are the ones that 
are deviated from average more rarely in the population. Therefore, in a larger 
genotyped dataset, it would be useful to assess the accuracy of different metrics based 
on principal components, of which FSD is just one. An algorithm could also be used 
either within the DSM software or in an external application to automate the 
calculation of FSD and reflected FSD. 
9.10.3 GENETIC STUDIES 
The studies here suggest that face shape is affected in a number of pathogenic SVs 
thought to cause epilepsy. It would be useful to assess if this is true for all known 
pathogenic SVs in people with epilepsy or if there are only certain SVs that affect face 
shape. There are now more sophisticated classifications of SVs and pathogenicity may 
be based on larger databases of known SVs as well as SVs containing epilepsy genes or 
in known epilepsy hotspots (Lal et al., 2015; Fry et al., 2016). 
Related to this, further studies of individual SVs are needed. I found no common face 
shape features in five people with 16p13.11 deletions, the largest group in my study for 
an individual SV. Larger numbers for this and other SVs are needed to detect more 
subtle effects on face shape. Even if changes are identified, studies in different 
ethnicities would be useful to see if similar effects are noted on face shape. 
Apart from pathogenic SVs, other types of SVs and other genetic mutations may also 
affect face shape. Careful face shape phenotyping, using stereophotogrammetry, in 
these cases may help understand the effect of these genetic changes.  
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For some adults with particular genetic syndromes, stereophotogrammetry and DSM 
can quantify the change in facial shape from the ‘average’ face as well as showing the 
effect on face shape graphically. This graphical representation may help clinicians, 
especially those in adult medicine without dysmorphology training, to recognise these 
features in future. Serial stereophotogrammetry could further identify the age at which 
a condition exerts the most prominent effect on face shape. 
There has been one genome-wide association study using facial landmarks 
(Paternoster et al., 2012) which found an association between nasion-menton distance 
and the PAX3 gene. Given that principal components and FSD incorporate information 
about face shape outside of the landmarks themselves, genome-wide association 
studies using either of these parameters may find genes associated with face shape 
more successfully. 
Further studies of genetic disorders could look at children primarily. Older children 
would be able to co-operate with stereophotogrammetry but they would be hopefully 
less exposed to environmental factors that may affect face shape such as drugs or 
trauma. Also, some genetic disorders are known to be less easily detected after 
adulthood (Hammond et al., 2005). 
9.10.4 IMAGING STUDIES 
The most logical follow-up study after my findings in Chapter 7 would be to confirm if 
all types of developmental brain lesion are associated with increased facial asymmetry. 
I had only shown this for people with hippocampal sclerosis. Also, it would be useful to 
know if the presence of bilateral lesions increases asymmetry for lesions other than 
hippocampal sclerosis. Handedness appears to exert a significant effect on asymmetry 
with increased facial asymmetry seen in left-handed people. It is unclear what the 
mechanism for this is and it may be from confounding variables such as the known 
higher prevalence of left-handedness in some neurodevelopmental disorders. Detailed 
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phenotyping, including neuropsychological assessment and full clinical history, can 
help detect such confounders. 
I was only able to perform an assessment of face shape in relation to the categorical 
variables of presence or absence of unilateral and bilateral developmental brain 
lesions, as diagnosed by a neurologist or neuroradiologist. Co-registration of MRI scans 
with 3D face images would be very helpful to quantitatively assess face shape with 
intracranial lesions, although this has not been performed with stereophotogrammetry 
yet. One difficulty in combining the two sets of data is that MRI provides volumetric 
data whereas stereophotogrammetry provides a ‘point cloud’ of sets of 3D co-ordinates 
only.  MRI scanners are able to capture face shape information themselves and it may 
be simpler to use just this modality. One group used MRI scans with software 
processing afterwards to produce a face surface image with a ‘point cloud’ and showed 
that 86% of data points were within 2mm of the gold standard of 
stereophotogrammetry (Knoops et al., 2017). This may be sufficient accuracy to have 
accurate co-localisation with brain imaging findings. 
For malformations of cortical development, the classifications have changed since the 
diagnosis was made in some subjects (Barkovich et al., 2012). Therefore, it may be that 
future studies with the new classification are better able to detect an association 
between face asymmetry and imaging findings. As well as the classification, MRI 
scanners and imaging protocols are more advanced. Scanners with magnetic field 
strengths of 7 Tesla have entered clinical practice and been shown to detect lesions, 
particularly subtle FCD, not seen in lower field strength scanners (de Ciantis et al., 
2016).  
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APPENDIX 1: IMAGE CAPTURE PROTOCOL 
An image capture protocol for other researchers in the group was created by the author 
to enable image capture by them as well. This protocol contains practical information 
on the use of the Canfield Vectra CR10 camera, the Mirror Vectra software and basic 
image quality control procedures at the time of image capture. It is reproduced 
overleaf. 
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